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Summary
The metabolic network of an organism refers to the set of biochemical transformations
(reactions) that occur within the organism which allows it to maintain life. The network
deﬁnes what nutrients the organism can use, for example to harvest energy through cel-
lular respiration, what it cannot use, and what it needs for growth. This thesis deals
with the metabolic reconstruction of two haloarchaeal species, and on the development of
computational models from them.
Extremely halophilic archaea inhabit hypersaline environments, such as salt lakes, salt
ponds and marine salterns, which relatively few organisms have been able to adapt to.
For the primary subject of this work, Halobacterium salinarum, we present a genome-scale
metabolic reconstruction that consists of 695 reactions, 485 genes and 548 metabolites. Al-
though semi-automated bioinformatic methods were used during reconstruction, our eﬀort
involved a great deal of manual curation so the resulting network is of high quality. We
demonstrate that even prior to any formal modeling eﬀort, the network is already valuable
because it represents a literature-linked summary of the existing metabolic knowledge.
Indeed, the reconstruction led to improvements to the existing genome annotation, and
facilitated the formulation of biological predictions that led to further experimental work;
for example with respect to the production of pentoses and the biosynthesis of aromatic
amino acids.
Using the reconstructed network for Halobacterium salinarum as basis, we created a
constraints-based model to perform an integrated analysis of energy generation, nutrient
utilization and biomass production, during both aerobic and phototrophic growth. We
made several unexpected, biologically relevant ﬁndings, including: (1) that the organism
degrades essential amino acids during respiration, and even under phototrophic conditions,
when the cells should already have abundant energy. This is unexpected, particularly in
the latter situation, because such behavior can lead to cells terminating their growth ear-
lier than necessary; (2) that carbon incorporation rates were surprisingly low also under
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both aerobic and phototrophic conditions. Note that during phototophy, one would typ-
ically expect nutrient consumption to be just in quantities that are suﬃcient for biomass
production since energy can already be derived from light rather than from the supplied
nutrients. Because of the low incorporation rates, considerable amounts of metabolites
were produced and accumulated in the medium, some of which likely resulted from forms
of overﬂow metabolism; and (3) that arginine fermentation actually occurs simultaneously
with respiration and photosynthesis, even though cells should already have abundant en-
ergy. This is in contrast to the common assumption that the fermentation process only
plays a secondary, alternative role. Moreover, our results also show that arginine fermenta-
tion can actually produce usable energy in levels that are comparable to the two ”primary”
modes.
The initially suprising ﬁndings mentioned above are consistent with an emerging picture
that Halobacterium salinarum takes an approach toward growth that favors the here and
now, even at the cost of longer-term concerns. We believe that the seemingly greedy
behavior actually consists of adaptations by the organism to its natural environments,
where nutrients are not only irregularly available but may altogether be absent for extended
periods that may span several years. Such a setting probably predisposed the cells to grow
as much as possible when the conditions become favorable, so that the probability of
survival until the next growth-conducive period is maximized. Consistent with this, the
capacity of the halobacteria to survive in adverse conditions for extended periods is well
established.
From a more methodological point-of-view, we developed a hybrid, genome-scale ﬂux
balance model with both dynamic and constraints-based aspects. The dynamic parts of
the model are used to incoporate growth data, such as nutrient consumption and growth
rates, to the constraints-based model core in the form of additional constraints. The
constraints are derived through linearization of the dynamic parts of the model at speciﬁc
points during growth, and the linearized values at each time point are considered to be
valid for the interval that contains the point. Although a number of similar hybrid models
have already been constructed in the past, the systems used for the dynamic components
of these models are too simple; in particular they cannot account for transport patterns
that change qualitatively during growth. This is a particularly restrictive limitation for this
study because, in the experimental growth data that we generated, some amino acids clearly
show qualitative changes in their transport patterns during growth. For example, alanine
at the start of growth accumulates in the medium, but later on switches to consumption.
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To overcome this limitation, we propose and use a new system for dealing with the dynamic
aspects of such hybrid models. Brieﬂy, the system that we employ uses two equation forms;
one basic deﬁnition and another more descriptive one. For each metabolite (nutrient), each
of these forms is individually applied using a process that involves solving inverse problems
(parameter optimization). From the results of these individual applications, a ﬁnal choice
is made between the two forms based on clear measures of improvement of the second form
over the basic deﬁnition, or the lack thereof. The process can be easily automated, and
as such not only can our proposed system account for qualitatively changing transport
patterns, but it can actually detect their presence. Moreover, since qualitative changes in
nutrient transport are often the result of, or at least related to, another event, our method
can actually uncover relationships between metabolites in the form of coordinated pattern
changes. For example, we were able to automatically detect known relationships, such
as between arginine and ornithine, and we were also able to uncover possible interaction
dynamics, such as competitive inhibition, between other metabolites.
This work is structured into ﬁve parts. Chapter 2 is an introduction to the halophilic
archaea and their environments. Chapter 3 deals with the reconstruction of the metabolic
network of Halobacterium salinarum and its uses. Speciﬁc aspects of the archaeon’s
metabolism are also discussed. In Chapter 4, we describe how we derived a constraints-
based model from the reconstructed network. In addition, this chapter also contains the
results of our analysis of the aerobic growth of Halobacterium salinarum. Chapter 5 is
similar to the previous chapter, except that the analysis is done for cells grown under
phototrophic conditions. Finally, Chapter 6 describes the results of both the metabolic
reconstruction and modeling of Natronomonas pharaonis.
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Zusammenfassung
Das metabolische Netzwerk eines Organismus besteht aus einem Satz biochemischer Trans-
formationen (Reaktionen), welche in dem Organismus vorkommen and ihn am Leben
erhalten. Das Netzwerk legt fest, welche Na¨hrstoﬀe der Organismus nutzen kann, um
beispielsweise Energie durch zellula¨re Atmung zu gewinnen, was der Organismus nicht
nutzen kann und was er zum Wachstum beno¨tigt. Diese Untersuchung befasst sich mit der
metabolischen Rekonstuktion zweier haloarchaealer Organismen, und mit der Entwicklung
rechnergestu¨tzter Modelle fu¨r diese.
Extrem halophile Archaeen leben in ho¨chst salzhaltiger Umgebung wie Salzseen, Salztu¨mpeln
und marinen Salinen, an die sich relativ wenige andere Organismen anpassen konnten. Fu¨r
das Hauptthema dieser Arbeit, Halobacterium salinarum, beschreiben wir eine genomweite
metabolische Rekonstruktion welche aus 696 Reaktionen, 478 Genen und 550 Metaboliten
besteht. Obwohl halbautomatische bioinformatische Methoden wa¨hrend der Rekonstruk-
tion genutzt wurden, beno¨tigte unser Vorgehen eine erhebliche Menge manueller Nachar-
beit, um ein Netzwerk hoher Qualita¨t zu erstellen. Wir zeigen, dass das Netzwerk bere-
its vor jeglichem formalen Modellierungsversuch wertvoll ist, weil es eine mit der Liter-
atur verzahnte Zusammenfassung des vorhandenen metabolischen Wissens darstellt. So
fu¨hrte die Rekonstruktion zu Verbesserungen der existierenden Genom-Annotation und
erleichterte die Formulierung biologischer Vorhersagen, welche weitere experimentelle Ar-
beiten nach sich zogen; als Beispiele seien die Herstellung von Pentosen und die Biosynthese
aromatischer Aminosa¨uren genannt.
Unter Benutzung des rekonstruiertenen metabolischen Netzwerks fu¨r Halobacterium
salinarum als Basis, haben wir ein “constraint-basiertes” Modell (Randbedingungs-basiertes
Modell) erstellt, um eine integrierte Analyse des Energiemetabolismus, des Na¨hrstoﬀverbrauchs
und der Produktion von Biomasse, sowohl unter aeroben als auch unter phototrophen
Wachstumsbegingungen zu erarbeiten. Dabei machten wir mehrere unerwartete biologisch
relevante Beobachtungen: (1) der Organismus baut essentielle Aminosa¨uren ab und zwar
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sowohl zu Zeiten, wo er atmet, also auch unter phototrophen Bedingungen, wenn die Zellen
eigentlich bereits genug Energie zur Verfu¨gung haben sollten. Das is vor allen bei letzteren
unerwartet, denn dieses Verhalten kann dazu fu¨hren, dass die Zellen ihr Wachtum fru¨her
als notwendig beenden mu¨ssen; (2) die Einbauraten fu¨r Kohlenstoﬀ waren erstaunlich
niegdrig, ebenfalls sowohl unter aeroben als auch unter phototrophen Bedingungen. Es
sollte bedacht werden, dass man erwarten wu¨rde, dass der Na¨hrstoﬀverbrauch wa¨hrend
der Phototrophie gerade fu¨r die Produktion von Biomasse ausreicht, da Energie ja bere-
its aus Licht gewonnen werden kann und somit zur Verfu¨gung gestellten Na¨hrstoﬀe dafu¨r
nicht eingesetzt werden mu¨ssten. Auf Grund der geringen Einbauraten mu¨ssen erhebliche
Mengen von Metaboliten erzeugt und im Medium angereichert werden, wobei einige davon
wahrscheinlich aus Formen des U¨berlauf-Metabolismus stammen; (3) die Fermentation von
Arginin ﬁndet gleichzeitig mit Atmung und Photosynthese statt, obwohl die Zellen bereits
ausreichend mit Energie versogt sein sollten. Das widerspricht der allgemein anerkannten
Meinung, dass Fermentationsprozesse nur eine untergeordnete, alternative Rolle spielen.
Zudem zeigen unsere Ergebnisse, dass die Mengen der durch Fermentation von Arginin
erhaltenen nutzbaren Energie vergleichbar zu denen sind, die aus den anderen “prima¨ren”
Modi gewonnenen werden.
Die hier beschriebenen und anfangs unerwartenten Beobachtungen passen zu einem sich
abzeichnenden Gesamtbild, na¨mlich dass Halobacterium salinarum bezu¨glich des Wachs-
tums auf das “hier und jetzt” setzt, selbst auf Kosten la¨ngerfristiger Belange. Wir glauben,
dass das scheinbar gefra¨ssige Verhalten in Wirklichkeit eine Anpassung des Organismus
an seine natu¨rliche Umgebung darstellt, wo Na¨hrstoﬀe nicht nur unregelma¨ssig verfu¨gbar
sind, sondern sogar teilweise fu¨r erhebliche Zeitra¨ume, die mehrere Jahre umfassen ko¨nnen,
vollsta¨ndig fehlen. Eine solche Szenerie pra¨disponiert die Zellen so stark wie mo¨glich zu
wachsen, wenn die Bedingungen vorteilhaft sind, so dass die Wahrscheinlichkeit maximiert
wird, bis zur na¨chsten wachstumsfo¨rdernden Phase zu u¨berleben. Im Einklang damit hat
sich gezeigt, dass Halobacterien fa¨hig sind unter widrigen Umsta¨nden u¨ber lange Zeitra¨ume
zu u¨berleben.
Von einem mehr methodischen Standpunkt haben wir ein hybrides genomweites ﬂux-
balance Modell (Fluss-Balance Modell) sowohl mit dynamischen als auch mit constraint-
basierten Aspekten entwickelt. Die dynamischen Teile des Modells wurden benutzt, um
Ergebnisse von Wachstumsversuchen wie Na¨hrstoﬀverbrauch und Wachstumsraten in den
Kern des constraint-basierten Modells einzufu¨gen und zwar in Form zusa¨tzlicher Randbe-
dingungen. Die Randbedingungen wurden durch Linearisierung der dynamischen Teile
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des Modells zu bestimmten Zeitpunkten wa¨hrend des Wachstums gewonnen und die lin-
earisierten Werte an jedem Zeitpunkt fu¨r das diesen Punkt enthaltende Intervall als gu¨ltig
angenommen. Obwohl eine Reihe a¨hnlicher hybrider Modelle in der Vergangenheit kon-
struiert worden sind, sind die Systeme, welche fu¨r die dynamischen Komponenten der
Modelle benutzt wurden, zu sehr vereinfacht, insbesondere ko¨nnen sie keine Transport-
muster beru¨cksichtigen, die sich wa¨hrend des Wachstums qualitativ a¨ndern. Das ist eine
besonders starke Einschra¨nkung fu¨r diese Untersuchung, weil einige Aminosa¨uren eindeutig
qualitative A¨nderungen des Transportmusters wa¨hrend des Wachstums in unseren exper-
imentellen Messungen gezeigt haben. Beispielsweise reichert sich Alanin am Beginn des
Wachstums im Medium an, wa¨hrend spa¨ter eine Umstellung auf Alanin-Verbrauch stat-
tﬁndet.
Um diese Beschra¨nkung zu beseitigen benutzen wir ein von uns vorgeschlagenes neues
System, um mit den dynamischen Aspekten solcher hybrider Modelle umzugehen. Kurz
gesagt nutzt das von uns vorgeschlagene System zwei Formen einer Gleichung; eine ele-
mentare Deﬁnition und eine weitere, welche anschaulicher ist. Fu¨r jeden einzelnen Metabo-
liten (Na¨hrstoﬀ) ist jede dieses Former individuell angewendet worden unter Nutzung eines
Prozesses zur Lo¨sung des mathematischen “inverse problem” (Optimierung der Param-
eter). Auf Grund der Ergebnisse wird fu¨r den jeweiligen Metaboliten eine endgu¨ltige
Entscheidung zwischen den beiden Formen getroﬀen, welche darauf beruht, dass die zweite
gegenu¨ber der elementaren Form zu einer eindeutigen Verbesserungen fu¨hrt oder eine
solche Verbesserung ausbleibt. Dieser Prozess la¨sst sich leicht automatisieren und so
kann unser vorgeschlagenes System nicht nur sich qualitativ a¨ndernde Transportmuster
beru¨cksichtigen, sondern deren Vorhandensein sogar aufspu¨ren. Zudem kann unsere Meth-
ode sogar Beziehungen zwischen Metaboliten auf Grund koordinierter A¨nderungen des
Transportmusters aufdecken, denn qualitative A¨nderungen im Na¨hrstoﬀtransport sind oft
das Ergebnis von - oder zumindest bekoppelt an - andere Ereignisse. Beispielsweise haben
wir automatisch bereits bekannte Verknu¨pfungen erhalten, wie die zwischen Arginin und
Ornithin und wir konnten bei anderen Metaboliten eine mo¨gliche Interkations-Dynamik
erkennen, wie beispielsweise kompetitive Hemmung.
Diese Arbeit ist in fu¨nf Teile geliedert. Kapitel 2 ist eine Einfu¨hrung zu halophilen Ar-
chaeen und ihrer Umwelt. Kapitel 3 befasst sich mit der Rekonstruktion des metabolischen
Netzwerks von Halobacterium salinarum, sowie dessen Anwendungen. Speziﬁsche Aspekte
aus dem Metabolismus dieses Archaeons werden diskutiert. In Kapiel 4 beschreiben wir
wie wir das contraint-basierte Modell aus dem rekonstruierten metabolischen Netzwerk
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entwickelt haben. Weiterhin entha¨lt dieses Kapiel die Ergebnisse unserer Analyse des
aeroben Wachstums von Halobacterium salinarum. Kapitel 5 ist a¨hnlich dem vorangehen-
den Kapitel, allerdings wurden die Analysen fu¨r Zellen gemacht, welche unter phototro-
phen Bedingungen gewachsen sind. Zuletzt beschreibt Kapitel 6 die Ergebnisse sowohl der
metabolischen Rekonstruktion als auch der Modellierung fu¨r Natronomonas pharaonis.
Chapter 1
Introduction
Metabolism refers to the set of biochemical processes (reactions) that occur within living
organisms that allow them to grow and reproduce, to maintain their structures, and to
respond to their environments. For example, the catabolic pathways of metabolism are
involved with the breakdown of large molecules, and as such deﬁne what materials a cell
can use for growth and energy. On the other hand, anabolic pathways are concerned with
the construction of cellular building blocks from the nutrients provided, and accordingly
deﬁne what can be synthesized and what needs to be provided externally in order for
growth to be possible. The collection of all metabolic pathways within a cell is referred
to as its metabolic network. This thesis deals with the reconstruction of the metabolic
networks of two extremely halophilic archaeal species, and on the development and use
of computational models derived from them. Our aim was for an integrative analysis of
bioenergetics, nutrient consumption and growth, under the particularly harsh (hypersaline)
environments where the haloarchaea thrive but very few other organisms on Earth have
been able to adapt to. To this end, both computational (e.g., modeling) and experimental
(e.g., generation of time-series growth data) work were performed. An introduction to
the biological subject matter is provided in Chapter 2. An overview of the overall thesis
structure is shown in Figure 1.1.
Although most of the tasks (transitions) shown in Figure 1.1 were performed for each
of the two haloarchaeal species analyzed in this study, in this introduction the case for
Halobacterium salinarum is used for illustration. This thesis summarizes interdisciplinary
work by the author as it describes both computational modeling and experimental work.
Most of the experimental results used for the modeling and simulations were produced by
the author in Prof. Oesterhelt’s group at the Max Planck Institute of Biochemistry (MPI).
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Figure 1.1: Petri net representation of the overall structure of this thesis. Yellow places
(ellipses) in the graph represent external entities that were used, while green places represent
entities that were produced in this work. The transitions (blue rectangles) correspond to research
tasks, which were performed in the thesis work. Adjacent to each transition is an orange box
specifying in which chapter(s) the action is described. Single letter codes are associated to each
transition so that they can be easily referred to from the main text.
Metabolic reconstruction
Metabolic reconstruction (Figure 1.1, transition A), roughly speaking, refers to the task
of assembling the reactions that are known (or believed) to occur within an organism
into a network. Clearly, one way of accomplishing this task is through a search of the
literature for reactions that have already been experimentally described for Halobacterium
salinarum. However, a network constructed exclusively from experimental evidence will
be incomplete. The problem is that while metabolic pathways are typically conserved, at
least in part, across groups of species, direct experimental evidence is often only available
for a small subset of model organisms. The diﬃculty is particularly severe when working
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small fraction of metabolic reactions would have been experimentally characterized. This
leads to the second main resource for metabolic reconstruction, bioinformatics.
Most biochemical reactions require enzymes under physiological conditions; enzymes are
crucial because they allow organisms to drive desirable but otherwise thermodynamically
unfavorable reactions by coupling them to favorable ones. This fact is very important for
metabolic reconstruction because enzymes are proteins, and proteins are coded for by genes.
Therefore, the question of whether a particular reaction occurs within an organism can be
indirectly answered by asking whether the required enzyme-coding gene is present. In turn,
this latter question can be addressed by matching genes from other organisms that are
known to code for the necessary enzyme to the gene complement of the subject organism;
this is a bioinformatic problem. For obvious reasons, such a problem transformation is
very helpful for organisms with completely sequenced genomes, such as Halobacterium
salinarum. Full details on the reconstruction procedure used in this study can be found in
Chapter 3.
The genome-scale metabolic network for Halobacterium salinarum is one of the most
signiﬁcant outputs of this study. Using an existing reconstruction as basis (Falb, 2005),
in this thesis, the network was doubled in size to cover nearly 700 reactions. Reconstruc-
tion of the network was very laborious because extensive manual curation is necessary in
order to ensure high reliability. For example, over 80 unique literature references are as-
sociated with the network as experimental evidence, covering about 30% of the reactions
(a detailed breakdown of the reactions by evidence is given in Chapter 3). Each of these
references had to be reviewed individually. Moreover, given that most of these references
are experimental in nature, a nontrivial level of competence with respect to the relevant
biochemical subjects had to be acquired ﬁrst. The necessity for extensive manual curation
is further discussed in Chapter 3. The reconstruction for the second haloarchaeal species,
Natronomnas pharaonis, is described in Chapter 6.
One of the most important uses of reconstructed metabolic networks is to serve as
foundation for the development of computational models. However, even prior to any
modeling eﬀort, the network is already valuable in that it represents a summary of the
current knowledge regarding the metabolism of the organism. For example, by analyzing
the network (Figure 1.1, transition B), one could identify interesting regions – such as those
associated with missing functions in the network that, based on physiological data, should
be present – and subsequently form biological predictions. For Halobacterium salinarum,
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among the “gaps” that we found are missing initial steps in the sythesis of aromatic amino
acids, and the lack of a synthetic pathway for riboses. The ﬁrst is noteworthy because while
aromatic amino acids are necessary components of the biomass, they are known not to be
essential for the organism, and as such must be produced de novo. Likewise, riboses are
precursors of nucleotides (DNA and RNA), and accordingly also essential components of the
biomass. Separate research eﬀorts on these two subjects were initiated, the work done by
colleagues at the MPI, in part due to the observations made in this study. In addition, the
reconstruction eﬀort also lead to improvements/updates to the existing primary annotation
of the halophile’s genome.
Constraints-based models
The development of dynamic (kinetic) models requires knowledge of the intricate regulatory
features of the system in question. Unfortunately, such information is normally diﬃcult to
obtain. Indeed, it is often the case that enzyme kinetic parameters are available only for a
limited number of model organisms. This, not even considering the fact that KM values are
typically derived from in vitro assays, a condition that casts suspicion on their validity in
vivo (Teusink et al., 2000; Theobald et al., 1997; Rizzi et al., 1997). Accordingly, kinetic
models of metabolism have mostly been limited to relatively small networks. In part due
to the diﬃculties mentioned, constraints-based models have emerged as successful alter-
natives. Rather than requiring detailed, diﬃcult to obtain information, constraints-based
models need only available physicochemical information such as stoichiometry, reversibility
and energy balance (Edwards et al., 2000; Edwards and Palsson, 1999; Ramakrishna et al.,
2001). This distinction is particularly relevant because genome-scale metabolic reconstruc-
tions, which are performed here, already include a lot of this information. Indeed, each of
the two metabolic networks reconstructed in this study is used for the development of the
respective constraints-based core model (Figure 1.1, transition E).
In addition to the reconstructed network, the other main component for the develop-
ment of a constraints-based core model (Figure 1.1, transition E) is a characterization of
the biomass of the respective organism. The characterization is used to deﬁne a “growth
reaction” (Figure 1.1, transition D), which is essentially a pseudoreaction that consumes
biomass components (reactants) in the proper ratio and produces a unit of population (such
as cells). Note that adding this to the metabolic network and specifying a particular ﬂux
to it, for example one derived from observed growth rates, imposes additional constraints
on the network; e.g., it deﬁnes pathways that need to be activated for the production of the
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in this study (Figure 1.1, transition C). This involved measurements of individual amino
acids at diﬀerent optical densities (population levels). Values for the rest of the biomass
components were derived, and in some instances directly obtained, from existing data.
Details on the creation of the growth function are provided in Chapter 4.
Growth simulations using hybrid models
Constraints-based models can be used to perform growth simulations (Figure 1.1, transition
G) by integrating appropriate data, such as those that describe nutrient consumption and
growth rates. These data are typically enforced as additional constraints. For example,
an observed glucose consumption rate of r can be integrated into the model by setting
the glucose transport ﬂux to r. With respect to Halobacterium salinarum, growth media
used for the halophile typically include several amino acids. Accordingly, in this study,
we used a growth medium that contains 15 amino acids. Time-series data showing the
consumption and production of these amino acids during growth were produced in this
thesis (Figure 1.1, transition F). Data sets were generated for both aerobic (Chapter 4)
and phototrophic (Chapter 5) conditions, in order to allow for a comparison between the
two main bioenergetic modes of Halobacterium salinarum. Oxygen consumption was also
monitored under aerobic conditions. Growth simulations were performed on the basis of
these data.
One limitation of basic constraints-based models is that they are essentially static, i.e.,
the contraints do not change. While this is ﬁne for continuous cultures where nutrient
consumption and growth rates are maintained, it is not applicable to batch cultures where
the rates are not constant. One way in which this issue has been addressed is through the
use of hybrid models. The idea is to use dynamic models for the system inputs (e.g., nutri-
ents) and outputs (e.g., by-products), and then linearize the system at various points during
growth. At each of these speciﬁc points, the transport equations are evaluated, and the val-
ues are assumed to be valid for an interval containing the point. This approach has been
applied to a number of biological systems (Mahadevan et al., 2002; Varma and Palsson,
1994). However, the dynamic models that have been used thus far are very simple in
that they assume that transport rates are only proportional to the current population size.
This makes them applicable only to certain intervals during growth in batch cultures. The
problem is that in batch cultures, nutrient consumption rates are not just a function of the
population size; the current growth phase also aﬀects the relevant processes. Moreover,
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the dynamic models that have been used thus far cannot account for transport patterns
that qualitatively change during growth. For example, in our cultures we observed alanine
to initially accumulate in the medium, and then switch to consumption after some time.
Previously used models cannot account for such events.
Due to the methodological limitations mentioned above, we propose (and use) a new
system for dealing with the dynamic aspect of the hybrid models. Essentially, the new sys-
tem uses two equation forms; one basic formulation that can adequately describe transport
patterns that do not qualitatively change during growth, and another that is better suited
for transport patterns that do qualitatively change. Both forms are individually applied
to each nutrient, by solving inverse problems (parameter optimization), and the decision
to use the more complex form instead of the other for the ﬁnal model is made based on
clear indications of improvement, or the lack thereof. The process can be easily automated.
Accordingly, not only can our proposed system account for qualitatively changing trans-
port patterns, but it can actually detect their presence, through the automatic selection
between the two equation forms. Moreover, since qualitative changes in the system are
often the result of, or at least related to, another event, our method can actually uncover
relationships between metabolites in the form of coordinated pattern changes. We demon-
strate the value of the system by applying it to the Halobacterium salinarum growth data.
The method was able to detect an interaction between arginine and ornithine transport,
which is an interaction rooted in the well-known arginine fermentation pathway. The re-
sults also uncovered possible interaction dynamics between other metabolites, for which we
could form biological hypotheses regarding the nature of the interactions (e.g., competitive
inhibition). The modeling system is explained in detail in Chapter 4.
Integrative analysis of growth
The growth simulations performed in this study (Figure 1.1, transition G) allowed for an
integrated analysis of bioenergetics, nutrient utilization and biomass production. Genome-
scale metabolic networks conveniently link these three aspects of cellular growth. For
the case of Halobacterium salinarum, we made several unexpected, biologically relevant
ﬁndings, including: (1) that the organism degrades essential amino acids even under pho-
totrophic conditions, when the cells should already have abundant energy. Such behavior
can lead to cells terminating their growth earlier than necessary; (2) that carbon incorpo-
ration rates were surprisingly low under both aerobic and phototrophic conditions. During
phototrophy, one would typically expect nutrient consumption to be just in quantities that
7are suﬃcient for biomass production since energy can already be derived from light rather
than from the supplied nutrients. Due to the low incorporation rates, the model pre-
dicts that considerable amounts of metabolites are likely produced and accumulated in the
medium; and (3) that arginine fermentation occurs simultaneously with, and is in fact com-
parable in terms of energy output to, respiration and photosynthesis. This is in contrast to
the common assumption that the fermentation process only plays a secondary, alternative
role to the two main bioenergetic modes. Experimental veriﬁcation was performed on some
of the predictions (Figure 1.1, transition H), including the rapid accumulation of ornithine
due to arginine fermentation (Chapter 4).
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Chapter 2
The Halophilic Archaea
2.1 Natural Environments
The extremely halophilic archaea are a diverse group of euryarchaeota that inhabit hyper-
saline environments such as salt lakes, salt ponds and marine salterns. These environments
can vary widely in their ionic composition depending on the surrounding geology and gen-
eral climatic conditions. For example, hypersaline marine lagoons, which originate by the
evaporation of sea water, accordingly reﬂect the ionic composition of sea water. Environ-
ments of this type, referred to as thalassohalines, have Na+ as the dominant cation, Cl−
as the main anion, and have pH which is neutral to slightly alkaline. In contrast, other en-
vironments have ionic composition that diﬀer greatly from sea water. For example, in the
Dead Sea, divalent cations (Mg2+, Ca2+) are far more abundant than monovalent cations
(Na+) (Ma’or et al., 2006). Such environments are termed athalassohaline. Two examples
of hypersaline environments, namely Lake Zug from Wadi Natrun in Egypt and a salt pond
in the Arabian desert, are depicted in Figure 2.1.
The Great Salt Lake in Utah, classiﬁed as thalassohalinic, has an ionic composition
that is essentially a ten-fold concentration of sea water. Given the considerable chal-
lenges that extremely high concentrations of ions pose, it is remarkable that life not
only survives, but thrives under such conditions. Microorganisms which have been iso-
lated from the Great Salt Lake include photosynthetic algae (two strains of Dunaliella)
(Van Auken and McNulty, 1973), aerobic archaea (strains of Halobacterium sp. and Halo-
coccus) (Post, 1977a,b), anaerobic archaea (Methanohalophilus mahii) (Paterek and Smith,
1985, 1988), aerobic heterotrophic bacteria (Halomonas variabilis, Pseudomonas halophila
and Gracilibacillus halotolerans) (Dobson and Franzmann, 1996; Fendrich, 1988; Waino et al.,
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1999), and anaerobic bacteria (Halanaerobium praevalens, Halanaerobium alcaliphilum,
Desulfobacter halotolerans and Desulfocella halophila) (Zeikus, 1983; Zeikus et al., 1983;
Tsai et al., 1995; Brandt and Ingvorsen, 1997; Brandt et al., 1999). Similarly, in the atha-
lassohalinic Dead Sea, which, given its exceedingly high concentrations of divalent cations
(1.9 M Mg2+, 0.4 M Ca2+), can be hostile even to organisms that are already adapted to
the highest salt concentrations, numerous organisms have also been isolated. These in-
clude the halophilic archaea Haloarcula marismortui (Ginzburg et al., 1970), Haloferax
volcanii (Mullakhanbhai and Larsen, 1975), Halorubrum sodomense (Oren, 1983a) and
Halobaculum gomorrense (Oren et al., 1995), the aerobic halophilic bacteria Halomonas
halmophila (Dobson et al., 1990), Chromohalobacter marismortui (Ventosa et al., 1989),
Chromohalobacter israelensis (Rafaeli-Eshkol, 1968) and Salibacillus marismortui, the anaer-
obic halophilic bacteria Halobacteroides halobius (Oren et al., 1984), Sporohalobacter lortetii
(Oren et al., 1987) and Orenia marismortui, and even halophilic funji (Buchalo et al., 1998,
1999).
Figure 2.1: Examples of hypersaline environments. Left: Lake Zug from Wadi Natrun,
Sahara Desert, Egypt (photograph from Antiquity 77, No 296, June 2003). The amount of wa-
ter in the lakes of Wadi Natrun varies greatly during the year, and lakes can fuse or disappear.
Egyptian craftsmen have used the evaporitic deposits from these lakes for over 6,000 years. Na-
tronomonas pharaonis was isolated from lake Gabara of the Wadi Natrun (Soliman and Truper,
1982). Right: A salt pond in the Arabian desert. The red color is due to the presence of
Halobacterium salinarum.
Hypersaline lakes, both natural as well as man-made such as saltern crystallizer ponds,
are generally colored red due to the presence of dense communities of halophilic microor-
ganisms (Oren and Rodriguez-Valera, 2001). The red color is due to the C-50 carotenoids,
mainly α-bacterioruberin and derivatives (Kushawa et al., 1975; Kelly et al., 1970), of the
Halobacteriaceae (archea), the massive amounts of β-carotene which are produced by
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Dunaliella (algae) under suitable conditions, and, recently, a carotenoid or carotenoid-
like compound from the bacteria Salinibacter that diﬀers from archaeal bacterioruberins
and algal L-carotene. Although numerous factors contribute to the red colorization, there
is consensus that the optical properties of saltern brines are primarily determined by the
archaeal community because of the low in vivo optical cross-section of the algal L-carotene
(Oren et al., 1992, 1994) and the relatively smaller Salinibacter population. Given the
massive blooms of extremely halophilic organisms that can be observed through the red
colorization of their habitats, salt produced from solar salterns, when not processed fur-
ther, can easily spoil. A gram of solar salt may contain millions of viable cells that can
survive for several years under practical storage conditions (Tansil, 1984).
We mentioned earlier that the characteristics of hypersaline environments are greatly
inﬂuenced by the surrounding geology and general climatic conditions. Indeed, the ionic
composition of these places can vary dramatically from year to year based on these. For
example, the Dead Sea, which with a shoreline located at 415 m below sea level is the
lowest place on Earth, receives fresh water inﬂow from ﬂood runoﬀ and from the Jordan
river during the rainy season. The year-to-year variability in the amount of these inﬂows
is high; in a very rainy year the amount can be twice as much as the average, and in a
particularly dry year the inﬂow can be negligible. Accordingly, ion concentrations drop as
a result of large inﬂows due to dilution, and increase during periods where there is little
or no signiﬁcant freshwater run (Oren, 2002).
In addition to the relatively immediate consequences that the changing inﬂows have
made on the lake, they have also had a cumulative, long-term eﬀect. The water balance
of the Dead Sea has been negative since the beginning of the 20th century (Gavrieli et al.,
1999). This, in part, is because of changing climatic conditions, but is also the result
of intensiﬁed human intervention in the lake’s water regime. Signiﬁcant diversion of the
freshwater supply from the Sea of Galilee and the Jordan river started in the early 1950’s.
As a result, the ionic strength of the lake, particularly in the upper layers, has also steadily
increased (Figure 2.2).
2.2 Taxonomy
Members of the taxonomical group referred to now as archaea have long been considered as
bacteria (archaebacteria) because of their prokaryotic morphology, circular genomes, and
gene organization in operons. However, with the advent of sequencing and other molecular
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Figure 2.2: Long term changes in the Dead Sea. Left: Water level of the Dead Sea.
The water balance of the lake has been negative since the beginning of the 20th century (data
starting from 1992 reﬂected in the ﬁgure). This decrease in water level was caused by climatic
changes and human intervention in the lake’s water regime. Right: Salinity of the Dead Sea.
The decreasing water level of the lake has been accompanied by increasing ionic concentrations.
Salnity is expressed as sigma units, indicating the density excess to the standard reference of
1000 kg m−3. The charts were taken from the Israel Oceanographic and Limnological Research
(ISRAMAR) website (http://isramar.ocean.org.il/DeadSea/, accessed June 2008).
technologies, the inadequacies of the then existing taxonomic classiﬁcation scheme were
realized. In 1977, Woese and Fox showed that the archaea could clearly be distinguished
from the bacteria and the eucaryotes as a third domain of life by applying rRNA phy-
logeny (Woese and Fox, 1977). The elevation of the archaea to a separate domain was
further supported by their distinctive features such as cell membranes containing prenyl
side chains that were ether-linked, rather than ester-linked, to a glycerol molecule (sn-
glycerol-1-phosphate) that has a steriochemistry diﬀerent from that found in bacteria.
Further work on archaeal genomes revealed that the archaea also share features with the
eucarya, and in fact may be closer to them than to the bacteria with which they were
orginally grouped together. In this respect we should also mention that the archaea have
been proposed as a possible bridge between the other two domains (Eisen, 1999).
Although this study focuses on the haloarchaea, halophilic microorganisms can be found
in all three domains of life: Archaea, Bacteria and Eucarya (Oren, 1999). In each of these
domains are representative organisms that can grow at the highest salt concentrations. For
example, the family Halobacteriaceae of the archaea and the unicellular algae of the genus
Dunaniella in the domain Eucarya can be found in the Dead Sea, which is a NaCl-saturated
environment. Likewise, the recently discovered Salinibacter ruber and members of the genus
Halorhodospira, all from the bacterial domain, can be found in saltern crystallizer ponds
and soda lakes, respectively. With that said, it is remarkable that halophilic microorganims
are often interspersed between non-halophilic relatives in the phylognetic tree (Oren, 2002,
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p.23-24). This suggests that adaptation to life in hypersaline environments may have arisen
many times during evolution (Falb, 2005, p.5). However, it must be noted that there
are some notable cases of phylogenetically coherent groups consisting entirely or almost
entirely of halophiles. These are the order Halanaerobiales and the family Halomonadaceae
of the bacteria, and the family Halobacteriaceae of the order Halobacteriales in the domain
Archaea.
Figure 2.3: Distribution of halophilic microorganisms. Halophilic microorganisms can
be found in all three domains of life. In the ﬁgure, groups which have at least one halophilic
representative are marked with blue boxes. The ﬁgure was taken from Oren, 2008.
Currently known halophilic microorganisms occur within the domain Archaea in three
families; the Halobacteriaceae, the Methanospirillaceae and the Methanosarcinaceae. This
work focuses on the ﬁrst, which is unlike the other two families as they include members
that are not halophilic. Indeed, the Halobacteriaceae includes some of the the most salt-
requiring and salt-tolerant microorganisms that have been found to date. In part due to
the interest generated by its members’ strict dependence on high salt concentrations for
growth and structural stability, the Halobacteriaceae have been the subject of most studies
that involve halophilic microorganisms.
The Halobacteriaceae, currently the only family within the order Halobacteriales, forms
a branch within the Euryarchaeota near the Methanonomicrobiales. Some two decades ago,
the diversity within this family was limited to rod-shaped, Halobacterium-type cells and
to cocci of the genus Halococcus, and was therefore considered low. Since that time how-
ever, many new isolates exhibiting remarkable diversity have been found. With respect
to morphology, the Halobacteriaceae now includes ﬂat and extremely pleomorphic cells
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(Mullakhanbhai and Larsen, 1975), the species Haloarcula japonica which exhibits trian-
gular and trapezoidal conformations (Takashina et al., 1990), and the truly remarkable
Haloquadratum walsbyi (Figure 2.2) which is ﬂat and perfectly square in shape (Walsbyi,
1980; Bolhuis et al., 2004, 2006; Burns et al., 2007). The family Halobacteriaceae (and ac-
cordingly also the order Halobacteriales) currently has 36 validly described species (Table
2.1).
Figure 2.4: Darkfield micrograph of Halo-
quadratum walsbyi. This halophilic archaeon
was ﬁrst described by Walsbyi in 1980, charac-
terizing it as having the form of a thin rectangu-
lar sheet (Walsbyi, 1980). H. Walsbyi dominates
aquatic environments with high concentrations
of NaCl and MgCl2, the latter posing additional
dessication stress by lowering water activity to
extremely low levels. The image was extracted
from Bolhuis et al., 2004.
2.3 Physiology and Metabolism
2.3.1 Osmoadaptation
Biological membranes are permeable to water. For this reason, it is impossible for mi-
croorganisms living in hypersaline environments to maintain a hypoosmotic intracellular
condition with respect to the osmotic pressure of the medium in which it lives. This
is true even for halophilic organisms. Given that at least some level of Turgor pressure
has to be maintained to allow expansion and growth of cells, various strategies that en-
able cells to cope with the osmotic stress have evolved. Of the various mechanisms that
have been observed, the most common in nature is the accumulation of organic compat-
ible solutes. The term originally coined by Brown and Simpson (Brown and Simpson,
1972), compatible solutes increase the osmotic pressure of the cytoplasm to provide os-
motic balance. They are termed compatible because they do not signiﬁcantly disrupt
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Table 2.1: Genera and species under the order Halobacteriales.
Genus Species Genus Species
Halobacterium Halobacterium salinarum Halococcus Halococcus morrhuae
Halobaculum Halobaculum gomorrense Halococcus saccharolyticus
Halorubrum Halorubrum saccharovorum Halococcus salifodinae
Halorubrum sodomense Natrialba Natrialba asiatica
Halorubrum lacusprofundi Natrialba magadii
Halorubrum coriense Natronobacterium Natronobacterium gregoryi
Halorubrum distributum Halogeometricum Halogeometricum borinquense
Halorubrum vacuolatum Natronococcus Natronococcus occultus
Halorubrum trapanicum Natronococcus amylolyticus
Haloarcula Haloarcula vallismortis Haloferax Haloferax volcanii
Haloarcula marismortui Haloferax gibbonsii
Haloarcula hispanica Haloferax denitrificans
Haloarcula japonica Haloferax mediterranei
Haloarcula argentinensis Natrinema Natrinema pellirubrum
Haloarcula mukohataei Natrinema pallidum
Haloarcula quadrata Haloterrigena Haloterrigena turkmenica
Haloquadratum Haloquadratum walsbyi Natronorubrum Natronorubrum bangense
Natronomonas Natronomonas pharaonis Natronorubrum tibetense
The list was adapted from Oren, 2006.
processes that normally occur within cells. For example, they are very poor enzyme in-
hibitors. Currently known molecules which are used as compatible solutes include betaine
(Imhoﬀ and Rodriguez-Valera, 1984), ectoine (Galinski et al., 1985; Galinski, 1995), amino
acids with diﬀerent steriochemistry such as N-acetyl-β-lysine (Sowers et al., 1990) and β-
glutamine (Lai et al., 1991), and even carbohydrates derivatized to reduce reactivity like
glucosylglycerol and α-mannosylglyceramide (Silva et al., 1999; A et al., 2005).
The Halobacteriaceae produce no organic solutes. Rather, they use the inorganic ions
that are already in their surroundings to achieve osmotic balance. For example, Halobac-
terium pumps large amounts of potassium into the cytoplasm so that the intracellular K+
concentration is considerably greater than the extracellular Na+ concentration. This en-
sures that cells maintain a positive water balance and counteract the tendency to become
dehydrated at high osmotic pressure and ionic strength. The use of such inorganic ions is
radically diﬀerent from using organic compatible solutes because the ions themselves reach
very high concentrations inside the cells. A total Na+ and K+ concentration reaching as
high as 6.12 M has been reported (Matheson et al., 1976). In contrast, salt concentra-
tions in microorganisms that predominantly use organic compatible solutes remain very
low. This is a very important distinction because the intracellular machinery of halophilic
microorganisms that use nonorganic ions as their solute will further have to be adapted
to a hypersaline cytoplasm. The presence of salts in molar concentrations is in general
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devastating to proteins and other macromolecules. Under such conditions, hydrophobic
interactions are enhanced, potentially essential electrostatic interactions are interfered with
due to charge shielding, and water availability is lowered (Oren, 2002; Madern et al., 2000;
Zaccai and Eisenberg, 1991). Indeed, unadapted proteins tend to aggregate or collapse,
and often lose function. One way through which the Halobacteriaceae have coped is by
using large amounts of the acidic amino acids glutamate and aspartate in most of their
proteins, and by having only very little of the basic amino acids lysine and arginine. Such a
strategy leads to an excess of negative charges on protein surfaces, which can then help to
prevent aggregation. Proteins of the Halobacteriaceae, with some exceptions, have become
so specialized that they denature and lose activity when not in high salt concentrations.
For these reasons, members of the family are considered as the hardcore of the halophilic
community.
2.3.2 Nutrition and Transport
The members of the Halobacteriaceae are varied in their nutritional requirements. In
the past, the general consensus was that their demands are complex, to the extent that
some could only be met in culture through the inclusion of large concentrations of yeast
extract or other rich sources of nutrients. In the case of Halobacterium salinarum, then
and up to now the most well-studied archeal halophilic species, deﬁned media designed
for its isolates typically contained between 10 and 21 amino acids, and in some cases had
to be further supplemented with vitamins, nucleosides, and glycerol (Dundas et al., 1963;
Grey and Fitt, 1976; Onishi et al., 1965; Shand and Perez, 1999). However, the prevailing
view changed when Haloferax mediterranei was later isolated because it was found to
be able to grow on simple compounds, such as succinate and acetate, as single carbon
and energy source (Rodriguez-Valera et al., 1980; Juez and Kushner, 1983). Indeed, such
simple growth requirements are now typically found in the genera Haloferax and Haloarcula
(Oren, 2002, p.126), although vitamins and some other supplements can have stimulatory
eﬀects.
The Halobacteriaceae are basically aerobic heterotrophs. The nutrients which they use
come from the other microorganisms present in their hypersaline environments. For exam-
ple, glycerol and tricarboxylic acid cycle intermediates are excreted by the alga Dunaliella
and the cyanobacterium Microcoleus chtonoplastes (Zvyagintseva et al., 1995), respectively.
Since the halophilic archaea are often the most halophilic in their communities, the materi-
als left after the eventual death of other microorganisms as a result of increasing salinity also
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become available to them (see Section 2.5). Accordingly, their environments can become
quite rich in nutrients. Most halophilic archaea preferentially use amino acids as carbon
and energy source (Oren, 2002, p.127). In fact, some organisms such as Halobacterium
salinarum require at least a number of them in order to grow due to deﬁciencies in biosyn-
thetic capabilities (Gonzalez et al., 2008). With respect to carbohydrates, simple sugars
such as glucose and sucrose are not readily used by all members. In fact, active transport
of glucose has been experimentally excluded for Halobacterium salinarum (Severina et al.,
1991). In contrast, species of Haloferax and Haloarcula can grow with the hexose as the
only carbon source. Halococcus saccharolyticus, Haloferax valcanii and Halorubrum sac-
charovorum excrete acetate when grown on glucose, although they are able to use acetate
as well (Oren, 2002, p.129).
Various amino acid transport systems in the cytoplasmic membrane of Halobacterium
salinarum have been characterized. Cell envelope vesicles have been shown to accumulate
19 commonly occurring L-amino acids, in response to either a light-induced membrane
potential or the establishment of a sodium gradient, or both (MacDonald et al., 1977).
The carrier systems were found to be as variable in their properties as those found in
other organisms. For example, while some are highly speciﬁc to a particular amino acid,
others transport several amino acids competitively. Some, like glutamate, are activated
by a chemical gradient of sodium only. In contrast, others can function in the complete
absence of such a gradient. Many of the amino acid transport systems speciﬁcally de-
pend on Na+ ions. These include leucine (MacDonald and Lanyi, 1975) and glutamate
(Birkeland and Ratkje, 1985; Lanyi et al., 1976). The transport of glutamate is unique in
that its uptake is driven by the sodium gradient only.
Two transport systems for acetate and propionate have been detected in the alkaliphilic
Natronococcus occultus. One is a high aﬃnity system that is driven by the Na+ gradient
over the membrane (Kevbrina et al., 1989). Glucose and fructose are also transported
by sodium-driven systems in Haloferax volcanii (Takano et al., 1995; Tawara and Kamo,
1991). In contrast, neither a Na+ nor a H+ gradient alone drives active phosphate trans-
port in Halobacterium salinarum. Rather, the process depends on cellular ATP level
(Zoratti and Lanyi, 1987). Multi-drug eﬄux transporters have been described in Haloferax
volcanii (Miyauchi et al., 1992, 1997).
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2.3.3 Motility and Taxis
The Halobacteriaceae currently have two mechanisms described for motility: the use of ﬂag-
ella and the production of gas vesicles. In the case of Halobacterium salinarum, ﬂagella are
right-handed and helical, and can generate forward and backwards directed movement by
rotating clockwise and counterclockwise, respectively (Alam and Oesterhelt, 1984). This
is quite diﬀerent from the ﬂagella of bacteria which are left-handed. Cells are predom-
inantly monopolar in the logarithmic phase, and bipolarly ﬂagellated in the stationary
phase. Flagellar bundles do not ﬂy apart during the switch from clockwise to counter
clockwise rotation or vice versa (Marwan et al., 1991). While ﬂagella-related genes have
been identiﬁed in many species of the order Halobacteriales, including Haloarcula maris-
mortui and Natronomonas pharaonis, and very likely these use a similar system, the use
of ﬂagella is not universal. For some members like Haloquadratum walsbyi, there is no
indication, whether physiological or genetic, of the existence of an analogous system. An
electron microscope image of a Halobacterium salinarum cell where the ﬂagellum is readily
visible is provided in Figure 2.5-left.
Figure 2.5: Motility structures. (Left:) Electron microscope image of a single Halobacterium
salinarum cell. The ﬂagellum is readily visible. Unlike their bacterial counterparts, haloarchaeal
ﬂagella are right-handed. (Right:) Electron tomographic image of a single Haloquadratum walsbyi
cell. Gas vesicles (GV), recognizable by their spindle shapes, are found at the borders of the cell.
The image was taken from Bolhuis et al., 2004.
Gas vesicles form the second class of motility structures that have been described
for the Halobacteriaceae (Figure 2.5-right). These are gas-ﬁlled subcellullar organelles
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that enable cells to ﬂoat on or near the surface of their aquatic environments by con-
ferring buoyancy. Such a capability can be especially advantageous for halophilic mi-
croorganisms because oxygen, which can quickly become limiting in hypersaline envi-
ronments, is generally more abundant in the upper water levels (Beard et al., 1997).
Gas vesicles have cylindrical or spindle-shaped morphology that is determined geneti-
cally (Simon, 1981). They have proteinaceous membranes that are extremely stable,
rigid, gas permeable, and lipid-free. Gas vesicles have been reported for Halobacterium
salinarum (Shukla and DasSarma, 2004; Halladay et al., 1993), Haloferax mediterranei,
Halogeomtricum borinquense (Montalvo-Rodriguez et al., 1998), Halorubrum vacuolatum
(Mwatha and Grant, 1993), and Haloquadratum walsbyi (Walsbyi, 1980; Bolhuis et al.,
2004).
Halobacterium salinarum was screened for substances that could induce chemotactic
behavior (Storch et al., 1999). These include amino acids and derivatives, dipeptides, car-
bohydrates, central metabolites, inorganic ions, and a few esoteric compounds. Of the
over 80 tested, six amino acids, namely leucine, isoleucine, valine, methionine, cysteine
and arginine, and several peptides were identiﬁed as chemoattractants. Three compounds
known to be typical bacterial repellents also elicited phobic responses. In addition to
chemotaxis, Halobacterium salinarum has also been described to exhibit aerotactic be-
havior that is mediated by two oxygen-sensing transducers (Hou et al., 2000) as well as
phototaxis through sensory rhodopsins (Krah et al., 1994; Bogomolni and Spudich, 1982;
Hildebrand and Dencher, 1980).
2.4 Completely Sequenced Genomes
At the time of writing (October 2008), the genomes of six haloarchaeal strains have been
completely sequenced. Halobacterium salinarum strain NRC-1 was published in 2000 as
Halobacterium sp. NRC-1 (Ng et al., 2000). The genome of another strain, Halobacterium
salinarum R-1, also became available at about the same time, but was only published
recently (Pfeiﬀer et al., 2008a). This species is particularly noteworthy as it has emerged
as one of the model organisms of the archaea, in part due to the ease with which it
is cultured in the laboratory (DasSarma et al., 1995), and also because it is the model
organism for producing bacteriorhodopsin. The genome of the Dead Sea isolate, Haloarcula
marismortui, was published in 2004, and was extensively compared with Halobacterium
sp. NRC-1. In addition to Halobacterium salinarum strain R1, our lab has also completed
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sequencing the genomes of Natronomonas pharaonis (Falb et al., 2005) and Haloquadratum
walsbyi strain HBSQ001 (Bolhuis et al., 2006). The genome sequence of Haloferax volcanii
is available on the University of Maryland Biotechnology Institute (UMBI) website and
on the Halolex database (Pfeiﬀer et al., 2008b), but still awaits publication. Sequencing
projects are currently underway for more members of the family Halobacteriaceae; these
are Halobaculum gomorrense (Allers and Mevarech, 2005), the psychrotolerant halophile
Halorubrum lacusprofundi (Allers and Mevarech, 2005), a second Haloquadratum walsbyi
strain, C23T (Dyall-Smith and Oesterhelt, unpublished), a third Halobacterium salinarum
strain, GRB (Oesterhelt, unpublished), Natrialba magadi, and Natronomonas moolapensis
(Dyall-Smith and Oesterhelt, unpublished), which was previously called isolate 8811.
2.5 Dynamics of Blooms
Because the properties of hypersaline environments are tightly linked to their surround-
ing geology and general climatic conditions, halophilic microorganisms are also aﬀected
by these abiotic factors. Perhaps the best characterized example is that of the Dead Sea.
Systematic monitoring of the spatial and temporal distribution of the microbial commu-
nities in the Dead Sea has been ongoing since 1980, and this has enabled a reasonable
understanding of the biological processes in the lake, the main components of its biota,
and the dynamics of their appearance and decline (Oren, 2002; Oren and Gurevich, 1995a,
p424). As will be discussed in Section 4, the dynamics brought about by abiotic factors
can be very important considerations for interpreting the observed behavior of cells and
the results of metabolic reconstructions.
The unicellular green alga Dunaliella parva is responsible for all of the primary pro-
ductivity in the Dead Sea. However, no growth of the alga is possible when the salt
concentration of the water column is invariably high. Blooms of Dunaliella in the Dead
Sea occur only after signiﬁcant dilution of the upper levels by the inﬂux of freshwater.
For example, a very rainy winter (1979-1980) preceeded the summer of 1980. The large
amounts of rain water that entered the lake at that time initiated a meriomitic episode
(Oren and Shilo, 1982), i.e., the stratiﬁcation of the water column where salinities are sig-
niﬁcantly lower at the upper levels. This enabled the Dunaliella population to grow near
the surface. In turn, this allowed the archaeal community to bloom at the expense of the
organic material produced by the alga. Although the halophilic archaea do not require the
reduction in salinity to grow, their dependence on primary producers nevertheless makes
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them subject to the abiotic factors. Given that these blooms of the primary producer
can be years in between, growth of the dependent microorganisms can likely become very
competitive.
2.6 Motivation
The existence of microorganisms that thrive in physically or geochemically extreme con-
ditions that are detrimental to the majority of life on Earth is a subject that has received
much interest. Among these extremophiles are the halophilic archaea, which have be-
come so adapted to their environments that they require hypersaline conditions in order
to live. To date, ﬁve haloarchaeal species have been completely sequenced, six if the two
Halobacterium strains are counted separately, and more are currently underway.
Genome sequences are rich sources of information for understanding microorganisms be-
cause they deﬁne the molecular inventories of the cells. Genome sequences can be mined, for
example, using computational methods for gene identiﬁcation, functional assignment, and
metabolic pathway reconstruction. In this study, we perform metabolic reconstruction for
two haloarchaeal species, namely Halobacterium salinarum and Natronomonas pharaonis,
and develop and use computational models derived from these. Reconstructed networks
by themselves are already valuable because they, by revealing signiﬁcant portions of the
molecular inventories of the microorganisms and organizing them into coherent groups,
can already lead to biologically interesting predictions and insights. However, the use
of appropriate computational methods can even further expand their utility, for example
by allowing growth simulations under speciﬁc conditions. Given the ongoing sequencing
projects for the Halobacteriaceae, not to mention those for halophilic members of other tax-
onomic groups, comparative genomics will become even more important in the near future
for providing insight into life in hypersaline environments. We believe that a considerable
fraction of the discoveries that will be made from these sequencing eﬀorts will come from
the analysis of metabolic networks, using network reconstruction in concert with methods
from systems biology.
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Chapter 3
The Metabolism of Halobacterium
salinarum
This chapter deals with the reconstruction of the metabolic network of Halobacterium sali-
narum. We begin with an introduction to the halophile by describing its physiology, with
a particular emphasis on aspects of reasearch interest (Section 3.1). Next, we give a short
introduction to metabolism and to the typical steps taken in reconstructing a metabolic
network (Section 3.2). Full details on the reconstruction methods used for Halobacterium
salinarum are provided in Section 3.3, where the importance of extensive manual curation
for producing a network with high reliability is also dicussed.
In Section 3.4, we start to discuss the actual results of the metabolic reconstruction. One
of the most signiﬁcant uses of such reconstructed metabolic networks is to serve as foun-
dations for the development of computational models (discussed in succeeding chapters).
However, even prior to any modeling eﬀort, each of of these networks is already valuable
in that it represents a summary of the current knowledge regarding the metabolism of
the respective organism (Halobacterium salinarum in this case). Uses of such a network
include: (1) by simple inspection of the pathways one could already say a lot about the
physiology of the microorganism; e.g., looking at the catabolic pathways that are present
reveals what nutrients the organism could use to derive energy. The pathways also deﬁne
what possible fates supplied nutrients could have, and as such are critical for labeling stud-
ies. Detailed discussions are provided for several pathways, including central metabolism
(Section 3.5), synthesis and degradation of amino acids (multiple sections), fatty acid
metabolism (Section 3.6.6), and nucleotide metabolism (Section 3.7.1). A second use of
reconstructed networks is that (2) through a more detailed analysis, one could identify
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interesting regions – such as those associated with missing functions in the network that,
based on physiological data, should be present –, and subsequently form biological predic-
tions. Two examples of these “knowledge gaps” that we found include missing initial steps
in the sythesis of aromatic amino acids (Section 3.7.3), and the lack of a synthetic path-
way for riboses (Section 3.7.2). Separate research eﬀorts aimed at elucidating these two
subjects were initiated, the work done by colleagues, in part due to the observations made
in this study. Other such gaps, which point out regions in the metabolic network where
possible novel mechanisms may lie, are also discussed. Finally, (3) the reconstruction eﬀort
itself lead to improvements/updates to the existing primary anotation of the halophile’s
genome.
3.1 The Model Archaeon
Halobacterium salinarum is a model organism for the halophilic branch of the archaea.
Although its doubling time is considerably longer than E. coli, it is as easy to culture in the
lab, which makes it an excellent system for investigating archaeal genetics and functional
genomics. Halobacterium salinarum is rod-shaped (Figure 3.1, right), motile, and is one
of the few species known that can live in saturated salt solutions. It, as well as other
Halobacteria, can be found in the Great Salt Lake, the Dead Sea, and other hypersaline
environments, such as solar salterns (Figure 3.1, left). They can be easily identiﬁed in
bodies of water through the reddish hue that they impart due to their bacterioruberins.
3.1.1 Bacteriorhodopsin and Other Retinal Proteins
Halobacterium salinarum has four related retinal proteins in cell membranes; these are
bacteriorhodopsin (BR), halorhodopsin (HR), and the two sensory rhodopsins SRI and
SRII. These proteins have been the subject of much study, and to a large extent have
fueled the sustained interest in the organism. Halorhodopsin is involved in maintaining iso-
osmolarity of the cytoplasm during cell growth by transporting chloride ions, nitrate, and
other halides into the cell using light energy (Bamberg et al., 1993; Schobert and Lanyi,
1982). Its structure has been resolved at 1.8 A˚ resolution (Kolbe et al., 2000), which
allowed for very detailed descriptions of its mechanisms. The two sensory rhodopsins (SRI
and SRII) mediate phototactic behavior which permits cells to avoid harmful blue and UV
light, and to accumulate in regions favorable for photosynthesis (Hoﬀ et al., 1997; Spudich,
1998). Finally, bacteriorhodopsin is a light-driven proton pump, which is perhaps the single
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Figure 3.1: Massive Growth of halophilic archaea in a saltern. Left: Massive growth
of halophilic archaea can be seen in this aerial view of the “Salterns of Torrevieja” in Costa
Blanca, Spain. Seawater is evaporated in these salterns to produce solar salt. The red-purple
colour is mainly due to bacterioruberins of the halophilic archaea, including Halobacterium sali-
narum. Right: An EM image of a Halobacterium salinarum cell. The ﬂagella, which gives the
microorganism motility, is clearly visible.
subject matter that Halobacterium salinarum is most well-known for.
BR is currently the only known nonchlorophyll structure that allows photosynthesis
(Oesterhelt, 1988). It converts the energy of green/orange light (500 - 650 nm) into an
electrochemical proton gradient, which in turn can be used by ATP-synthase to produce
energy. For this reason, it is a critical player in cellular metabolism during phototrophy,
and is therefore an integral component of this study.
Bacteriorhodopsin is the best understood ion transport protein, and has become a
paradigm for membrane proteins in general and transporters in particular (Haupts et al.,
1999). The numerous investigations into its atomic structure using X-ray crystallography
or electron diﬀraction at various resolutions (Luecke et al., 1999; Grigorieﬀ et al., 1996,
and many others) have resulted in detailed characterizations of the subprocesses involved
in proton translocation and to the identiﬁcation of the relevant structural parts. These
include the proton release pathway on the extracellular side, the reprotonation pathway in
the cytoplasmic half channel, and the cytoplasmic membrane surface for proton capture
and guidance (Oesterhelt, 1988). In addition, a tremendous amount of eﬀort has been
made, using a host of biophysical methods, to determine the exact nature of the changes
in BR at each step, from the absorption of photons to the vectorial transport of protons
out of the cells, and these have lead to the elucidation of the complete catalytic cycle of
BR at the molecular level (Haupts et al., 1999).
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Figure 3.2: The 3-D structure of bacteri-
orhodopsin. Bacteriorhodopsin (BR) functions as a
light-driven proton pump that can build up a proton mo-
tif force, which in turn can be used by ATP-synthases to
produce ATP. BR is currently the only known nonchloro-
phyll structure that allows photosynthesis. It contains
a retinal molecule that is responsible for absorption of
green/orange light (500 - 650 nm). The image was taken
from Essen et al., 1998.
3.1.2 Flexible Bioenergetics
Despite the focus on bacteriorhodopsin, photosynthesis is not the only means by which
Halobacterium salinarum can generate energy. Indeed, the bioenergetic capabilities of
Halobacterium salinarum are quite extensive. Alternative mechanisms for producing energy
that it employs include respiration and the fermentation of arginine (Hartmann et al., 1980;
Dundas and Halvorson, 1966). Halobacterium salinarum is also one of the few reported
organisms that can use potassium gradients for long term energy storage, in a battery-like
manner (Wagner et al., 1978).
Oxygen solubility is adversely aﬀected by high salt concentrations and elevated tem-
peratures. Consequently, halophilic microorganisms frequently encounter microaerobic or
even anoxic conditions in their hypersaline environments. Despite this, haloarchaea gen-
erally still grow heterotrophically using respiration (Mu¨ller and DasSarma, 2005). In the
case of Halobacterium salinarum, cells under laboratory conditions have been described to
consume oxygen at about 3-4 times their volume per hour (Oesterhelt and Krippahl, 1973).
If their environment becomes microaerobic or anoxic, for example as a result of a high cell
density promoted by aerobic growth, then cells can still employ respiration by using alter-
native terminal electron acceptors, such as dimethyl sulfoxide (DMSO) and trimethylamine
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N-oxide (TMAO) (Mu¨ller and DasSarma, 2005; Oren and Tru¨pper, 1990). The respiratory
chain of Halobacterium salinarum as well as its capacity to ferment arginine are discussed
in more detail in Chapter 4.
3.1.3 Industrial Applications
Bacteriorhodopsin exhibits outstanding levels of physical and chemical stability compared
to other proteins. This and the fact that its full catalytic cycle has been completely
elucidated make BR a viable model for the integration of biological functional systems into
technical applications. Bacteriorhodopsin is currently being developed for applications in
optical security (Hampp and Neebe, 2006), optical data storage (Yao et al., 2005), and
holography (Barnhardt et al., 2004).
The excellent optical properties of BR form the basis of its promising applications. An
eﬃcient photoreaction, with a quantum eﬃciency of 64%, and a high degree of reversibility
make it superior to current synthetic organic materials. A characterized photochromism -
the reversible transformation between two forms (states) through the absorption of elec-
tromagnetic radiation - allows for controlled manipulation of the structure. The pho-
tochromism of BR is characterized by two dominant states; the initial B-state and the
M-state with maximum absorptions at 570 nm 410 nm, respectively. Exposing the struc-
ture to light with a wavelength in the green to red regime causes it to switch its color from
purple to yellow. The yellow intermediate returns thermally to the purple-colored state
with an adjustable time constant. Where desired, the reverse process can also be photo-
chemically induced by exposing BR to blue light (Hampp and Neebe, 2006). Finally, as BR
is a protein, its amino acid sequence can be modiﬁed using standard molecular, biological
methods. In particular, some amino acid regions can be modiﬁed without inﬂuencing its
function. These are excellent locations for inserting molecular tags that can be used for
identiﬁcation.
3.2 Introduction to Metabolic Reconstructions
3.2.1 Metabolism and Metabolic Pathways
Metabolism refers to the set of chemical processes that occur within a living organism that
are necessary for the maintenance of life. These processes allow organisms to grow and
reproduce, to maintain their structures, and to respond to their environments. Metabolism
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is usually divided into two categories; catabolism and anabolism. The former has to do with
the breakdown of large molecules, for example to harvest energy using cellular respiration.
In contrast, anabolism is concerned with the construction of cellular components, such
as amino acids and nucleotides, from simpler substrates, often with the use of energy.
Accordingly, the metabolism of an organism determines which substances it will ﬁnd useful
and which it will ﬁnd worthless or even detrimental.
The chemical reactions of metabolism are usually organized into metabolic pathways.
These are sequences of biochemical reactions in which a chemical is transformed into an-
other via several intermediates. Under physiological conditions, most biochemical reac-
tions require enzymes, and often need additional cofactors in order to function properly.
Enzymes are crucial to metabolism because they allow organisms to drive desirable but
thermodynamically unfavorable reactions by coupling them to favorable ones. Given that
metabolic pathways can be quite elaborate due to the many chemicals that may be in-
volved, participating compounds are commonly categorized into main or side reactants.
This is especially helpful when visualizing pathways as metabolic maps (Figure 3.3), since
side reactants can be shown using less visible proﬁles or even completely omitted. The
collection of all metabolic pathways within a cell is referred to as its metabolic network.
3.2.2 Metabolic Reconstruction
The rate at which biological data is accumulated has tremendously increased in recent
years. For example, over the past decade the number of sequences stored in the GenBank
database has followed an exponential curve with a doubling time of between 12 and 15
months. This is in no small part due to the rapid advances in sequencing technologies
(reviewed in Chan, 2005). As of June 1, 2008, 812 genomes have been published, and work
is underway for 90 archaea, 1766 bacteria and 936 eukarya.
With the explosion of biological data came the realization of the need for methods that
can organize and analyze the accumulating information. In this context, computational
methods have come into prominence in biology. Although the words are sometimes used
interchangeably, the contributions of the computational sciences to biology can be roughly
classiﬁed into two broad categories: bioinformatics and systems biology. Bioinformatics,
as deﬁned by the National Institute of Health (NIH) of the USA, is the “research, devel-
opment, or application of computational tools and approaches for expanding the use of
biological, medical, behavioral or health data, including those to acquire, store, organize,
archive, analyze, or visualize such data”. Put more simply, bioinformatics is concerned with
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Figure 3.3: A section of the Roche Applied Science “Biochemical Pathways” wall
chart showing a segment of the tricarboxylic acid (TCA) and some nearby reactions.
Main reactants are indicated using more visible prints, and are shown with their chemical struc-
tures provided. Interconversions between these main components are indicated with directed
arrows, while side reactants are linked using more acuate arrows. The enzymes that catalyze the
reactions are shown in blue. Compounds known to inﬂuence enzyme activities are indicated by
minus/plus signs, depending on their regulatory eﬀect. Arrow color is used to deﬁne the type
of organism in which a reaction occurs; black for general pathways, red for prokaryotes, blue for
animals and green for plants/yeast.
the development and maintenance of databases and comparative tools for the analysis of
biological data. On the other hand, systems biology is concerned with the hypothesis-
driven investigation of speciﬁc biological problems using computational methods, with the
primary goal of discovery and the advancement of biological knowledge.
One important aspect of the study of biological systems is the (partial) reconstruction
of cellular networks. This procedure refers to the collection and organization of all cellular
constituents and processes which are potentially relevant to a physiology of interest. The
reconstruction serves to sort individual components into context, and provides a convenient
platform for the visualization and analysis of relevant data. In the case of metabolism, the
network components are enzymes, reactions and metabolites. A reconstructed metabolic
network can be used to visualize high-throughput data, such as the regulatory factors
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of enzyme-genes when the system is subjected to diﬀerent conditions. Moreover, graph
theoretic algorithms, including those for topological analysis, can be applied to the net-
work in order to obtain insights on its overall properties (Albert et al., 2000; Albert, 2005;
Jeong et al., 2000; Tanaka, 2005; Stelling et al., 2002). And last but not least, the recon-
struction can serve as a solid basis for the development of more sophisticated computational
models.
3.3 Methods
3.3.1 Creating the Enzyme Inventory
Obtaining a draft metabolic network for an organism is primarily a bioinformatic problem.
The typical steps taken to create such a draft network is provided in Figure 3.4. Given
that most metabolic reactions are driven by enzymes, the obvious ﬁrst step is to obtain an
enzyme inventory. For most microorganisms, the primary resource in obtaining this list
would most probably be its one-dimensional genome annotation.
Gene Finding
A one-dimensional annotation of a genome, put very simply, refers to the identiﬁcation of
“interesting” regions within the genome, such as those connected to genes, rRNAs, and
tRNAs, and the assignment of (putative) functions to their products whenever possible.
In small prokaryotes, the identiﬁcation of genes (Figure 3.4, transition A), or “gene ﬁnd-
ing”, is largely a matter of identifying long open reading frames (ORFs). However, some
tricky situations do arise, such as when long ORFs overlap on opposite strands and cause
ambiguities as to which are true coding regions (Stein, 2001). Gene ﬁnding becomes increas-
ingly tricky as genomes get larger. Currently available gene ﬁnding tools include GLIM-
MER (Salzberg et al., 1998), GENSCAN (Burge and Karlin, 1997), Genie (Reese et al.,
2000), GeneMark.hmm (Besemer and Borodovsky, 1999), Grail (Uberacher and Mural,
1991), HEXON (Solovyev et al., 1994), and REGANOR (Linke et al., 2006).
GC-rich genomes are characterized by a low frequency of stop codons (TAA, TGA,
TAG), which leads to a severe overprediction of potential genes. In Halobacterium sali-
narum, the GC content is 68%, and this led to an average of 1.7 additional spurious open
reading frames of at least 100 codons for every gene coding for a real protein (Tebbe et al.,
2005; Aivaliotis et al., 2007). In addition, problems related to incorrect gene start codon as-
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Figure 3.4: Summary of steps leading to a draft network. The yellow curved boxes
(places) correspond to intermediate results in obtaining a draft metabolic network for an organ-
ism. Processes that link these intermediate results are represented by blue rectangles (transitions).
Some popular tools and resources relevant to the transitions are provided to the right. Typically,
the ﬁrst two steps are performed by the people who publish the genome. This is true for Halobac-
terium salinarum, so we only had to use (gene) protein function prediction methods in speciﬁc
cases. One-letter codes are attached to each transition for easy reference from the main text.
signment are also aggravated in the archaea because ribosome binding sites (Shine-Dalgarno
boxes) are poorly conserved and mainly precede genes within transcription units but are
not found in the case of leaderless mRNAs (Falb, 2005; Sartorius-Neef and Pfeifer, 2004;
Torarinsson et al., 2005). Because of these diﬃculties, standard gene prediction tools had
to be supplemented with methods that exploit features of halophilic proteins, for example
their acidic isoelectric point proﬁles, and with experimental data such as the proteomic
identiﬁcation of coding regions (Falb, 2005). Fortunately, such processed data are typically
already available when a microbial genome is published. In this study, we used the expert-
validated gene sets for Halobacterium salinarum strain R1 (Figure 3.5) and Natronomonas
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pharaonis available in the Halolex database (Pfeiﬀer et al., 2008b).
Figure 3.5: A representation of the
genome of Halobacterium salinarum.
Proteins are marked in the outer circle in
a strand-speciﬁc manner. The central circle
shows stable RNAs. Insertion elements are in-
dicated in the innermost circle. The image was
taken from the Halolex website (Pfeiﬀer et al.,
2008b).
Gene Function Assignment - Homology
When the hot-spots in the genome have been adequately identiﬁed, the next step in the
annotation is to obtain a deﬁnitive catalogue of the proteins of the organism, where a
putative function is assigned to each element whenever possible (Figure 3.4, transition
B). To be sure, a rigorous experimental characterization remains the authoritative basis
for assigning gene function. However, the extremely rapid pace at which sequences are
generated precludes the possibility of performing experiments in each case. In this context,
computational methods that require only the sequence for predicting function have been
developed, and these, to a degree, have been widely successful.
Two genes are said to be homologous if they share a common ancestry, i.e., they come
from the same gene of a common ancestor species. Furthermore, both are orthologous to
each other if they are from distinct species, and paralogous otherwise. This concept of
homology carries powerful implications in that it, with certain assumptions, often allows
function to be “transferred” from one gene (protein) to another (Bork et al., 1998). For
example, a protein that is homologous to a permease very likely also serves a transport-
related function. In bioinformatics, homology among proteins and DNA is often concluded
on the basis of sequence similarity (Altschul et al., 1990, 1997); if two or more genes have
a score that is above a certain threshold using some sequence similarity system, then they
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are likely homologous. While not perfect, for instance because sequence similarity can
arise from other reasons, such as by chance in short sequences or in diﬀerent proteins
being selected for on the basis of having to bind to a particular structure, the system for
determining homology by sequence similarity has been extensively used. Indeed, up to now
it still serves as the primary source for annotating genes of newly sequenced organisms with
function.
Perhaps the most popular set of tools for comparing sequences at the nucleotide or
protein level is the BLAST family of tools (Altschul et al., 1990, 1997; Zhang et al., 2000;
Zhang and Madden, 1997; Madden et al., 1996). Typically, new query proteins, such as
those obtained from newly sequenced genomes, are each “blasted” against several diﬀerent
databases. At this step, it is important to bear in mind that the accuracy of the results
is, to a large extent, determined by the quality of the reference proteins used. For one
thing, the nature of transfering functions based on sequence similarity itself dictates that
incorrect annotations can also be easily transferred. In this respect, SWISS-PROT and
SWISS-PROT TrEMBL (Boeckmann et al., 2003; O’Donovan et al., 2002) have emerged
as among the most valuable sequence repositories (Stein, 2001). SWISS-PROT is a cu-
rated collection of conﬁrmed protein sequences that have been extensively annotated and
cross-referenced with other bioinformatic databases. Annotations include bibliographic
references, functional descriptions, biological roles, protein family assignments and, when
available, links to structural data.
Supplementing Homology Searches - Gene Context Analysis
Even with the level of success achieved by homology-based methods, it was recognized that
further systems that could supplement them had to be developed. Problems associated
with relying exclusively on homology include the fact that the stringent requirement of
ﬁnding for a given query protein a match with known function cannot always be satisﬁed,
and the well-known reality that two proteins with the same function need not necessarily
have similar sequences. It was against this backdrop that methods which exploit gene
context have emerged as successful complements.
True to their namesake, context-based approaches use contextual information such as
gene fusion, the conservation of local gene neighborhoods, and the co-occurrence of genes
across genomes. In the ﬁrst case, proteins encoded by genes with homologs which are
fused in another organism tend to be functionaly related (Enright et al., 1999; Snel et al.,
2000; Marcotte et al., 1999). Likewise, in the second case, genes which are signiﬁcantly
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encountered as neighbors across genomes, detected by the conservation of either gene
order (Dandekar et al., 1998) or genes in a run (Overbeek et al., 1999), also tend to be
functionaly related. Finally, in the third case, functionally linked proteins are assumed to
be inclined to evolve in a correlated fashion, and as such can be found by comparing their
phylogenetic proﬁles (Pelligrini et al., 1999). While these methods typically do not predict
speciﬁc functions by themselves, they are used to predict higher level functions, such as
the participation of a protein in a particular structural complex or metabolic pathway.
In the case of Halobacterium salinarum, protein function assignments based on various
homology methods and other approaches are already available in the Halolex database
(Pfeiﬀer et al., 2008b). Accordingly, in this study we only had to use protein function
assignment methods in speciﬁc cases, such as in instances where new relevant sequences
are created or characterized.
3.3.2 Reconstructing the Reaction Network
Protein (gene) function is a central concept that can cause much confusion. For exam-
ple, an annotation that reads “growth related” tells you about one biological process in
which a protein is involved in, but not much else. Because of this, it is often convenient
to diﬀerentiate between context-independent molecular functions and context-dependent
roles. For example, a protein may be a “transporter” that is “involved in drug resistance”
because it is used to remove toxic materials inside cells. In addition, several nomencla-
ture and classiﬁcation schemes that can help organize and standardize annotations have
already been developed. These include EC (Enzyme Commission) numbers for enzymes
(Fleischmann et al., 2004), TC numbers for transporters (Saier, 2000) and gene ontologies
(Harris et al., 2004). Given that proteins with enzymatic function are the most relevant
ones in metabolic reconstructions (Figure 3.4, transition C), we devote some time to de-
scribe the EC numbering system.
The Nomenclature Committee of the International Union of Biochemistry and Molecu-
lar Biology (NC-IUBMB) introduced a classiﬁcation and nomenclature system of assigning
what are called EC numbers. This system is function centric, i.e., identiﬁers are assigned
on the basis of the reaction catalyzed, rather than on structure (sequence). For example,
two enzymes receive the same EC number even if they are from diﬀerent organisms as long
as they catalize the same reaction. An EC “number”, similar to an IP address, is actu-
ally formed by four numbers separated by dots. Each successive number corresponds to a
classiﬁcation that is more speciﬁc than the one before it. The ﬁrst number represents the
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Table 3.1: Top-level EC Numbers.
Group Description Typical Reaction
EC 1.-.-.- Oxidoreductases; transfer of electrons from one molecule to
another.
AH2 + B ↔ A + BH2
EC 2.-.-.- Transferases; transfer of a functional group (methyl, acyl,
amino or phosphate) from one substance to another.
AX + B ↔ A + BX
EC 3.-.-.- Hydrolases; hydrolysis of a chemical bond. AB + H2O ↔ AH + BOH
EC 4.-.-.- Lyases; nonhydrolytic breakdown of various chemical
bonds, often forming a new double bond or a new ring struc-
ture.
A=B + X-Y ↔
X
|
A-
Y
|
B
EC 5.-.-.- Isomerases; intramolecule rearrangement. A ↔ B
EC 6.-.-.- Ligases; linking together of two molecules, such as the sugar
phosphate backbones of DNA.
A + B + NTP ↔ A-B +
NDP + P
Adapted from Fleischmann et al., 2004.
type of reaction that is catalyzed. For example, oxidoreductases, enzymes that catalyze
the transfer of electrons from one molecule to another, are assigned EC numbers that begin
with “1”. The six current top-level classiﬁcations are listed in Table 3.1. Further details on
the classiﬁcation system can be found in Boyce and Tipton, 2000 and in Tipton and Boyce,
2000. While not a perfect system, for example because it cannot always capture the small
diﬀerences between the enzymes of diﬀerent organisms that catalyze similar but not iden-
tical reactions, particularly with respect to diﬀering substrate and coenzyme speciﬁcities,
EC numbers can signiﬁcantly aid the process of moving from a genome annotation to a
metabolic network by providing a convenient means of linking relevant databases.
Other useful resources for functional information on enzymes include the BRENDA
(Schomburg et al., 2004) and ENZYME (Bairoch, 2000) databases. BRENDA is a com-
prehensive collection of enzyme and metabolic information based on primary literature.
It is classiﬁed according to the EC system, which makes it a convenient reference for re-
constructions that also use the system. In contrast to other databases, the content of
BRENDA is not limited to a speciﬁc aspect of enzymes nor is it speciﬁc to an organism,
although it covers organism-speciﬁc information. The database covers data on functional
and molecular properties, enzyme names, catalysed reaction, occurrence, sequence, kinet-
ics, substrates/products, inhibitors, cofactors, activators, structure and stability. Finally,
perhaps one of the most important features of BRENDA is that its content is continu-
ously updated by manual extraction from publications searched in the literature. Expert
curation should help ensure that the database is of high quality. Both the BRENDA and
ENZYME databases contain lists of synonyms for enzymes, which can aid the process of
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connecting genes annotated with enyzamtic functions to reaction databases.
With the list of the relevant genes and their functional annotations in hand (Section
3.3.1), the next step in the metabolic reconstruction process is to compile the set of pu-
tative reactions that occur within the organism (Figure 3.4, transition D). This is usually
done by searching the list of annotated genes and proteins against pathway and reaction
databases using protein names, EC numbers or any other identiﬁers. It is at this step
where the earlier mentioned enzyme synonym lists can be extremely helpful, particularly if
one begins the process of metabolic reconstruction with a pre-existing genome annotation
that does not use the EC system. There are several excellent resources that contain com-
prehensive reaction information that can be conveniently coupled to genome data, such
as the Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa et al., 2002) and
MetaCyc (Caspi et al., 2006). In the case of Halobacterium salinarum, a partial metabolic
reconstruction that is based on the KEGG structure already exists (Falb, 2005). Because
we used this previous work as the starting point of our reconstruction eﬀort, the resulting
network of this study also primarily relies on the conventions of the KEGG framework.
The Kyoto Encyclopedia of Genes and Genomes is actually a collection of databases
that are designed to be resources for understanding higher order functional meanings and
utilities of organisms from their genomes. These are the GENE database, which contains
gene catalogs of completely sequenced genomes as well as some partial ones, the SSDB
database, which deﬁnes homology relations of protein coding genes in complete genomes,
the PATHWAY database, which contains generalized protein interaction networks involving
various cellular processes, the LIGAND database, which contains information on chemical
compounds and reactions, and several others. In this study, we used the LIGAND database
as the basis of reaction deﬁnitions, and the PATHWAY database for visualization.
While the primary annotation eﬀort for a genome is focused on the identiﬁcation and
characterization of important regions, such as those associated with protein-coding genes,
rRNAs, and tRNAs, the process of network reconstruction, on the other hand, is concerned
with the description of the interactions between these components, their products and with
other biological elements. In the case of metabolism, the relevant genes are primarily those
that code for enzymes, as these determine the interaction links between metabolites (wiring
diagram) by deﬁning what reactions are (putatively) possible. Accordingly, a network
reconstruction provides an additional layer of information over the primary annotation. In
this respect, a reconstructed network can be thought of as a two-dimensional annotation
of a genome (Figure 3.6) (Palsson, 2004).
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Figure 3.6: 2D Genome Anno-
tation. Genome annotations typi-
cally serve as the primary resource for
the reconstruction of cellular, includ-
ing metabolic, networks. In the ﬁgure,
each state of a biological component is
a row in the matrix, and each column
represents a chemical transformation
among the components. The entries
in the matrix are the stoichiometric
coeﬃcients of that transformation, or
a link in a reaction network. This
work focuses on the metabolic compo-
nents of the network. The image was
taken from Palsson, 2004.
3.3.3 The Role of Manual Curation and Literature Search
The procedure described in Figure 3.4 results in a draft metabolic network. Unfortunately,
the series of mostly (semi-)automatic steps produces a reconstruction that is neither com-
plete nor accurate (Iliopoulos et al., 2001; Devos and Valencia, 2001, 2000). Manual cura-
tion, including a comparison of the network with knowledge from literature, is necessary
to correct the errors and to ﬁll in gaps. Some typical sources of errors are described below:
• Incorrect or insuﬃcient entries in the primary annotation - Genome annotations are
subject to the limitations of the protein function prediction methods that were used
in their creation. For example, OE2647F (VNG1148G in the NRC-1 strain) was
originally annotated as an “amino acid kinase” (“ornithine carbamoyltransferase”).
However, the fact that it is a conserved neighbor of mevalonate kinase (EC 2.7.1.36)
suggested that it is somehow involved in the production of isoprenoids. Indeed, the
ortholog in Methanocaldococcus jannaschii was found to phosphorylate isopentenyl
phosphate.
• Newly characterized reactions (pathways) - It generally takes some time for databases
such as KEGG to include newly characterized reactions (pathways). This is especially
true if the reactions are limited to only a few organisms. For example, the classi-
cal biosynthetic pathway for isopentenyl pyrophosphate (IPP) through mevalonate
proceeds as follows: hydroxymethyl-glutaryl-CoA (HMG-CoA) is produced from
acetoacetyl-CoA and acetyl-CoA (EC 2.3.3.10). HMG-CoA is reduced to mevalonate
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(EC 1.1.1.34), which is phosphorylated to mevalonate phosphate (EC 2.7.1.36), which
is converted to mevalonate diphosphate after a second phosphorylation step (EC
2.7.4.2), which is then ﬁnally decarboxylated to IPP (EC 4.1.1.33) (Figure 3.7). How-
ever, in Methanocaldococcus jannaschii, it was demonstrated that the second phos-
phorylation step is actually preceded by the decarboxylation step (Grochowski et al.,
2006), rather than the other way around. Genetic evidence suggests that Halobac-
terium salinarum likely uses this modiﬁed pathway (Falb et al., 2008), which at the
time of writing is still not in KEGG. Accordingly, the “noncanonical” reactions had
to be manually deﬁned. Another example is the alternative pathway for aromatic
amino acid synthesis described in Section 3.7.3.
• Inconsistencies and ambiguities between protein and function identiﬁers in diﬀerent
databases - Even if two databases already share at least one naming convention, prob-
lems relating to the nature of the shared convention will still have to be dealt with.
In the case of the EC system, several pathway repositories assign partially qualiﬁed
EC numbers (partial EC numbers) to some reactions. For example, KEGG assigns
the partial id of EC 3.1.3.- to the reaction (KEGG id R07280) in which 5-amino-
6-(5’-phosphoribitylamino)uracil is hydrolyzed and a phosphate group is removed.
Accordingly, one may erroneously assign to this reaction any gene that satisﬁes the
ﬁrst three components of the EC number, as has been observed in several databases
including KEGG (Green and Karp, 2005). The problem is that EC 3.1.3.-, by deﬁ-
nition, does not denote a speciﬁc reaction. Rather, it only speciﬁes that the relevant
enzyme is from a particular group, which in this case is the set of phosphoric mo-
noester hydrolases. Situations like this need to be handled on a case by case basis.
With respect to R07280, the two reactions before and after it in the linear segment
of the pathway (riboﬂavin biosynthesis) in which it is involved have adequate genetic
evidence in Halobacterium salinarum. Accordingly, it is likely that the reaction is
also present in the organism. Certainly, the situation only gets worse if enzyme-gene
synonym lists have to be used because the pertinent databases do not share naming
conventions.
• Organism-speciﬁc cofactor requirements - Cofactor requirements are often organism-
speciﬁc and have to be found elsewhere. The BRENDA database is a very convenient
resource for this task.
• Unspeciﬁed reaction reversibilities - Reversibility information is not explicitly in-
cluded in the KEGG databases. At best, KEGG uses single or bidirectional arrows in
3.3 Methods 39
its reference pathway images to indicate that a reaction is reversible or “irreversible”,
respectively. These visual indicators can sometimes be inconsistent between path-
ways (images). For these reasons, in this work we had to obtain reversibility in-
formation from other sources. In particular, we used organism-speciﬁc data from
literature as the primary basis. If this was not available, literature data from closely
related organisms was used. In the absence of both, we used the assignments made
in other reconstructions as well as the annotation by Ma and Zeng (Ma and Zeng,
2003), where the reversibility of each KEGG-deﬁned reaction was assigned based on
biochemical principles.
Figure 3.7: 2D Modified mevalonate path-
way. One reason why manual curation is crucial
to the reconstruction process is that it generally
takes some time for databases to include newly
characterized reactions (pathways). This is espe-
cially true if the reactions are limited to only a few
organisms. For example, isopentenyl pyrophos-
phate (IPP) is the precursor of numerous impor-
tant cellular constituents, including lipids and reti-
nal. The classical biosynthetic pathway for IPP
through mevalonate begins with the production
of hydroxymethyl-glutaryl-CoA (HMG-CoA) from
acetoacetyl-CoA and acetyl-CoA (EC 2.3.3.10).
HMG-CoA is reduced to mevalonate (EC 1.1.1.34),
which is phosphorylated to mevalonate phosphate
(EC 2.7.1.36), which is converted to mevalonate
diphosphate after a second phosphorylation step
(EC 2.7.4.2), which is then ﬁnally decarboxylated
to IPP (EC 4.1.1.33). However, in Methanocal-
dococcus jannaschii it has been demonstrated that
the second phosphorylation step is preceded by the
decarboxylation step (Grochowski et al., 2006).
Genetic evidence suggests that Halobacterium sali-
narum likely uses this modiﬁed pathway, which
is currently not in KEGG. The red arrows cor-
respond to the reactions of the classical pathway
which are not in the modiﬁed pathway. The modi-
ﬁed steps are indicated in green. Putative enzyme-
genes from Halobacterium salinarum R1 for each
step of the pathway are provided in blue.
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3.3.4 Filling the Gaps
Given that genome annotation is never really “completed” but rather evolves as new in-
formation is added, the same can also be said of metabolic reconstruction. Nevertheless,
some general properties that have to be fulﬁlled before releasing the ﬁrst “deﬁnite” ver-
sion of the reconstruction can be deﬁned. First, the metabolic capabilities represented by
the reconstructed network should be consistent with the physiology of the organism. For
example, if it is known that a particular amino acid, say phenylalanine, is not essential
for the microorganism, then a biosynthetic pathway for phenylalanine must be present.
Furthermore, if the reconstruction is to be used as the basis of a genome-scale metabolic
model with the purpose of yield and ﬂux predictions, such as in this study, the essential
pathways should be complete, and the rest of the network be left with as little unresolved
gaps as possible.
In this study, we deﬁne a pathway gap to mean a speciﬁc reaction for which no direct
support, genetic or bibliomic, could be found but nevertheless can be present in the or-
ganism because the activity of the pathway to which it belongs to has been adequately
established. The likelihood of such a reaction being present in the organism is particularly
high if the existence of other nearby reactions, such as those before and after it in the case
of linear pathways, can be justiﬁed. One example of a pathway with gaps in Halobacterium
salinarum is the biosynthesis of cobalamin.
Cobalamin (coenzyme B12) is a cofactor that is produced by some bacteria as well
as some archaea from uroporphyrinogen III (uroIII). Two distinct pathways for the con-
version of uroIII to the cobalamin intermediate adenosylcobinamide have been identiﬁed
from diﬀerent microorganisms; an anaerobic pathway in Salmonella typhimurium (cbi/cob
genes) and an aerobic pathway in Paracoccus denitriﬁcans (cob genes) (Roth et al., 1996).
The major diﬀerence between the two pathways, other than the diﬀering conditions under
which they are induced, is in the time of cobalt insertion. In the anaerobic pathway, cobalt
is inserted early in the reaction sequence using sirohydrochlorin cobaltochelatase (CbiX,
EC 4.99.1.3), while in the aerobic pathway, cobalt is inserted relatively later using a diﬀer-
ent cobaltochelatase (CobN, EC 6.6.1.2). In the case of Halobacterium salinarum, uroIII
is also likely the precursor of cobalamin (Falb, 2005, p.122-123). Moreover, the gene set
of the organism resembles both sets from the two model organisms, and has homologs of
the two types of cobalt chelatases, EC 4.99.1.3 (CbiX, OE3221F) and EC 6.6.1.2 (CobN,
OE3230F). This is consistent with the fact that Halobacterium salinarum can grow both
aerobically and anaerobically.
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Figure 3.8: Filling the gaps - Coenzyme B12 biosynthesis. The original image was
created using KEGG by coloring the “Porphyrin and Chlorophyll Metabolism” reference pathway
according to Halobacterium salinarum R1 genes. Each box in the ﬁgure corresponds to a reaction,
where the label is either an EC number or the name of the protein(s) associated with it. Boxes
that correspond to an enzyme for which the genome of Halobacterium salinarum putatively codes
for are ﬁlled in green. For obvious reasons, automatically reconstructing the biosynthetic pathway
for cobamide coenzyme (Vitamin B12) will leave some “gaps” (indicated in red for the anaerobic
pathway). These as well as those from other pathways had to be closed manually before we used
the network as the basis for further computational analyses.
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Figure 3.8 shows the “Porphyrin and Chlorophyll Metabolism” reference pathway from
KEGG, which includes both pathways for cobalamin biosynthesis, colored according to the
Halobacterium salinarum R1 gene set. Each box in the ﬁgure corresponds to a reaction,
where the label is either an EC number or the name of the protein(s) associated with
it. Boxes that correspond to an enzyme for which the genome of Halobacterium salinarum
putatively codes for are ﬁlled in green. Clearly, an automated reconstruction of the biosyn-
thetic pathway for cobalamin will leave some “gaps” (indicated in red for the anaerobic
pathway). These gaps are due to reactions for which the associated enzyme-gene could
not be assigned in the organism. Nevertheless, this does not mean that the gaps are really
reactions that do not occur in Halobacterium salinarum. The fact that most of the other
reactions in the pathway have ample genetic support is a strong indication that the path-
way is active in the organism. Moreover, that genes for the reactions adjacent to these gaps
could be assigned suggest that the gap reactions are likely also present. It is well known
that two genes with the same function need not have similar sequences, such as in the case
of convergent evolution, which may be the reason the pertinent genes remain unassigned.
Figure 3.9: The cobalamin cluster of Halobacterium salinarum. The ﬁgure shows the
genome region of Halobacterium salinarum where the genes associated with cobalamin synthesis
are encoded (blue segments). The green segments denote genes for which no function has been
assigned. Given the colocation of these unassigned genes with cobalamin biosynthesis elements
and the preservation of this colocation in other microorganisms, it is very likely that these genes
are also involved in cobalamin metabolism, and are good candidates for ﬁlling up the gaps in the
pathway.
The systematic identiﬁcation of pathway gaps, and network reconstruction in general,
can also lead to the recognition of possible gene functional assignments, or details con-
nected to them, that may have been missed by the primary annotation. In connection
with the cobalamin biosynthesis example, four genes that are located within the cobal-
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amin cluster of Halobacterium salinarum currently have unassigned function (Figure 3.9);
OE3218F, OE3219F, OE3224F and OE3249F. However, their colocation with cobalamin
biosynthesis genes is a good indication that they are also involved in the metabolism of
the coenzyme. This possibility is further bolstered by the observation that the gene neigh-
borhood is preserved in other species. For these reasons, the unassigned genes are good
candidates for the (speciﬁc) gap reactions mentioned previously (Figure 3.8). Another
example is nucleotide salvage; purine-nucleoside phosphorylase activity has been reported
in the literature for Halobacterium salinarum (Stuer-Lauridsen and Nygaard, 1998). How-
ever, there is currently no gene that is assigned this function. It is possible that one of the
two genes that are currently annotated in the primary annotation as “uridine phosphory-
lase” (EC 2.4.2.3; OE2311R and OE3603R) is actually a purine-nucleoside phosphorylase
(Section 3.7.1).
3.4 Network Overview
The reconstructed metabolic network for Halobacterium salinarum includes 485 genes, 695
reactions and 548 distinct metabolites (Table 3.2). The network includes both putative
reactions, i.e., those with bioinformatic evidence only, as well as experimentally demon-
strated ones. The pathways in the network include central metabolism, biosynthetic and
degradative pathways for amino acids, fatty acid degradation, an alternative pathway for
shikimate biosynthesis, purine and pyrimidine metabolism, oxidative phosphorylation, and
biosynthetic pathways for several vitamins and cofactors. 86% of the ORFs have reli-
able proteomic identiﬁcation (Aivaliotis et al., 2007; Klein et al., 2005; Tebbe et al., 2005).
More than 99% of the R-1 (Pfeiﬀer et al., 2008a) genes in the network are directly mapped
to the Halobacterium sp. NRC-1 genome (Ng et al., 2000).
A total of 571 reactions were taken directly from KEGG, although a signiﬁcant number
of them were modifed to correct errors or achieve balance. The rest of the reactions, 27
internal and 97 transport, were manually deﬁned. The reactions in the network were sub-
divided into eight highlevel functional categories based on the major metabolic roles of the
cell (Figure 3.10). Of these, “Amino acid metabolism” is currently the largest, which may
be due to the fact that the organism relies primarily on amino acids for its nutrition. How-
ever, there are still a signiﬁcant number of pathways associated with vitamins and cofactors
that are still not completely understood so the majority composition of the amino-acid-
metabolism-related reactions may change in the future. Long-chain fatty acid metabolism
44 3. The Metabolism of Halobacterium salinarum
Table 3.2: Comparison of genome and reconstruction with other organisms.
Archaea Bacteria
H. salinarum M. barkeria E. colib H. influenzaec H. pylorid
Genome statistics
Length (bp) 2.7Mb 4.8Mb 4.6Mb 1.8Mb 1.7Mb
G-C content 68% 39% 51% 38% 39%
ORF 2867 5072 4288 1743 1590
With assigned function 1179 2656 1011 1091
No assigned function 1688 1632 732 499
Reconstructed metabolic network
Reactions 695 619 931 461 381
Biochemical conversions 598 531 767 317 292
Transport 97 88 164 144 89
Reactions with assigned ORF (%) 558(80%) 509(82%) 873(94%) 412(89%) 272(71%)
Metabolites 550 558 625 367 332
ORFs (% of ORFs w/ assigned function) 485(41%) 904(34%) 400(40%) 290(27%)
aTaken from (Feist et al., 2006).
bTaken from (Reed et al., 2003).
cTaken from (Schilling and Palsson, 2000).
dTaken from (Schilling et al., 2002).
Figure 3.10: The distribution of reactions by category. The reconstructed metabolic net-
work for Halobacterium salinarum includes 485 genes, 695 reactions and 548 distinct metabolites.
The reactions in the network were subdivided into eight high-level functional categories, of which
“Amino acid metabolism” is currently the largest. The “Lipid and s-layer” and “Vitamins and
cofactors” categories are likely signiﬁcantly underrepresented because several pathways belonging
to these are yet to be characterized.
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was separated from the category involving lipids and other outer coverings, with which
they are typically associated, because archaeal lipids are derived from isoprenoids. Some
speciﬁc pathways are discussed in later sections.
Most reactions in the network have either bioinformatic, speciﬁcally genetic (58%),
or bibliomic support (8%), or both (22%) (Figure 3.11). However, given that the recon-
struction also served as the basis for a genome-scale computational model, the network
also includes a signiﬁcant number of reactions with neither type of evidence. Transporters
and metabolic gaps (Section 3.3.4), mostly in pathways for vitamins and cofactors, ﬁgure
prominently in this respect (Figure 3.12). In the former, the diﬃculty is that transport
proteins generally have sequences that are similar to each other even if they facilitate for
diﬀerent substrates. This means that it is often diﬃcult to say anything more than that
a protein is involved in transport. In the latter, a considerable number of gaps exist in
vitamin and cofactor biosynthesis pathways because the archaea, including Halobacterium
salinarum, commonly employ modiﬁed versions of the current model systems for these
pathways, which are mostly from bacterial species. For example, genes could not be as-
signed for several steps in the biosynthetic pathway of coenzyme A, including pantothenate
synthetase (EC 6.3.2.1) and its suceeding step, pantothenate kinase (EC 2.7.1.33). Nev-
ertheless, these reactions were included as metabolic “orphans” because coenzyme A is a
component of several biomass constituents.
Genetic and literature
Genetic only
Literature only
None
22.3%
11.2%
8.3%
58.2%
Figure 3.11: Network evidence. Most reactions in the network have bioinformatic or bib-
liomic support. However, a signiﬁcant number of reactions with neither type of evidence are also
included because they are necessary to complete the network in preparation for computational
modeling. A total of 82 unique literature references are associated with the reactions.
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Table 3.3: Reactions and enzymes in the network by KEGG defined pathways. A
total of 571 reactions were taken directly from KEGG with at most minor modiﬁcations. The
table lists the KEGG-deﬁned reference pathways that include at least one reaction or enzyme
that is in the reconstructed network. The number of enyzmes (reactions) that are shared as well
as the total in each pathway are indicated. Reactions can belong to several reference pathways.
The rest of the reactions in the network, 27 internal and 97 transport, were manually added.
Pathway Enz.a Rxn.b Pathway Enz. Rxn.
Glycolysis / Gluconeogenesis 19/40 13/47 N-Glycan biosynthesis 1/27 1/37
Citrate cycle (TCA cycle) 15/23 15/29 Nucleotide sugars metabolism 8/31 9/35
Pentose phosphate pathway 15/35 12/43 Streptomycin biosynthesis 5/14 2/19
Inositol metabolism 4/6 2/8 Polyketide sugar unit biosynth... 2/5 1/28
Pentose and glucuronate interc... 4/54 3/61 Aminosugars metabolism 5/39 4/45
Fructose and mannose metabolis... 8/62 5/68 Lipopolysaccharide biosynthesi... 2/20 0/21
Galactose metabolism 8/37 4/50 Peptidoglycan biosynthesis 1/17 0/27
Ascorbate and aldarate metabol... 2/32 0/36 Glycerolipid metabolism 6/38 6/42
Fatty acid biosynthesis (path ... 1/14 0/40 Glycerophospholipid metabolism 2/51 1/69
Fatty acid biosynthesis (path ... 3/7 18/25 Glycosphingolipid metabolism 1/28 0/39
Fatty acid metabolism 12/29 30/47 Ganglioside biosynthesis 1/11 0/25
Synthesis and degradation of k... 4/6 4/6 Pyruvate metabolism 23/66 26/70
Biosynthesis of steroids 12/36 18/88 1- and 2-Methylnaphthalene deg... 5/17 0/42
Bile acid biosynthesis 4/26 0/46 Tetrachloroethene degradation 1/5 0/11
Ubiquinone biosynthesis 8/15 5/34 Nitrobenzene degradation 2/18 0/31
Androgen and estrogen metaboli... 2/26 0/58 Glyoxylate and dicarboxylate m... 9/58 9/62
Oxidative phosphorylation 9/16 3/9 1,2-Dichloroethane degradation 1/4 0/4
Urea cycle and metabolism of a... 5/34 6/35 Benzoate degradation via CoA l... 8/38 2/45
Purine metabolism 37/100 64/145 Propanoate metabolism 17/48 13/51
Pyrimidine metabolism 29/62 61/109 Ethylbenzene degradation 1/8 0/14
Glutamate metabolism 22/36 22/36 Styrene degradation 3/18 3/20
Alanine and aspartate metaboli... 19/42 18/37 Butanoate metabolism 19/52 16/53
Tetracycline biosynthesis 1/3 1/5 C5-Branched dibasic acid metab... 3/21 2/22
Glycine, serine and threonine ... 28/59 27/65 One carbon pool by folate 10/24 12/30
Methionine metabolism 11/37 12/39 Methane metabolism 2/27 1/27
Cysteine metabolism 9/23 7/26 Carbon fixation 13/23 14/29
Valine, leucine and isoleucine... 22/33 32/43 Reductive carboxylate cycle (C... 11/13 12/14
Valine, leucine and isoleucine... 5/15 6/24 Thiamine metabolism 5/14 5/16
Lysine biosynthesis 9/29 7/37 Riboflavin metabolism 11/13 13/15
Lysine degradation 13/53 9/56 Vitamin B6 metabolism 2/24 0/38
Arginine and proline metabolis... 16/73 17/86 Nicotinate and nicotinamide me... 13/32 10/35
Histidine metabolism 17/40 15/38 Pantothenate and CoA biosynthe... 12/27 12/28
Tyrosine metabolism 13/70 7/106 Biotin metabolism 1/12 2/10
1,1,1-Trichloro-2,2-bis(4-chlo... 1/10 0/13 Folate biosynthesis 11/25 18/36
Phenylalanine metabolism 6/45 1/53 Retinol metabolism 1/10 1/11
gamma-Hexachlorocyclohexane de... 2/23 0/43 Porphyrin and chlorophyll meta... 26/64 29/89
Benzoate degradation via hydro... 3/48 0/60 Terpenoid biosynthesis 7/15 7/16
Tryptophan metabolism 11/60 5/80 Limonene and pinene degradatio... 5/22 2/59
Phenylalanine, tyrosine and tr... 22/31 22/35 Nitrogen metabolism 16/56 14/70
Novobiocin biosynthesis 6/6 2/35 Sulfur metabolism 12/30 9/30
beta-Alanine metabolism 9/32 6/34 Caprolactam degradation 3/21 0/22
Taurine and hypotaurine metabo... 2/17 1/18 Alkaloid biosynthesis I 3/38 1/46
Aminophosphonate metabolism 1/15 0/15 Alkaloid biosynthesis II 1/13 0/38
Selenoamino acid metabolism 13/22 0/24 Aminoacyl-tRNA biosynthesis 17/21 17/21
Cyanoamino acid metabolism 2/19 1/22 Biosynthesis of siderophore gr... 3/8 1/5
D-Glutamine and D-glutamate me... 1/12 2/11 Biosynthesis of vancomycin gro... 1/1 0/13
Glutathione metabolism 3/27 2/30 Biosynthesis of type II polyke... 2/3 0/14
aThe number of enzymes in the reference pathway that are also in the reconstructed network over the
total number of enzymes in the reference pathway.
bThe number of reactions in the reference pathway that are also in the reconstructed network over the
total number of reactions in the reference pathway.
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Figure 3.12: Network evidence by category. Most reactions with neither bioinformatic nor
bibliomic support is either a transporter or belongs to a vitamin or cofactor biosynthesis pathway.
In the former, the diﬃculty is that transport proteins generally have sequences that are similar
to each other even if they facilitate for diﬀerent substrates. Accordingly, it is often diﬃcult to say
anything more than that a protein is involved in transport. In the latter, numerous gaps exist in
these biosynthetic pathways because the archaea, including Halobacterium salinarum, commonly
employ modiﬁed versions of the existing reference systems (mostly from bacterial species).
3.5 Central Metabolism
In addition to the improvements that metabolic reconstruction can contribute to the pri-
mary annotation, the resulting network is also valuable in that it represents a literature-
linked summary of the current knowledge regarding the organism’s metabolism. Biological
predictions can already be made from it, even prior to any explicit modeling eﬀort. In
this section, we discuss metabolic pathways of Halobacterium salinarum that are related
to central metabolism. Other pathways are covered in later sections.
3.5.1 Glycolysis/Gluconeogenesis
Glycolysis is the sequence of reactions that converts glucose into pyruvate with the con-
comitant production of ATP. Although the term is often used synonymously with the
Embden-Meyerhof (EM) pathway, alternative pathways, such as the Entner-Doudoroﬀ
(ED) pathway exist. Glycolysis is a major mode of energy production in many prokary-
otes as well as some eukaryotes (e.g., mature erythrocytes, heavily-exercising muscle and
fermenting yeast). It is one of the most well-known metabolic pathways.
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Carbohydrate-utilizing haloarchaeal species, such asHaloferax mediterranei and Haloar-
cula vallismortis, have been reported to grow on fructose, glucose, sucrose and mannitol
via a modiﬁed EM pathway (Altekar and Rangaswamy, 1992). It was observed that the
enzymes of the pathway, i.e., ketohexokinase (EC 2.7.1.3), 1-phosphofructokinase (EC
2.7.1.56) and fructose 1,6-bisphosphate aldolase, were present under all growth condi-
tions. Furthermore, these halophiles are also capable of glucose degradation via the semi-
phosphorylated Entner-Douderoﬀ (ED) pathway (Falb, 2005, pp.112). However, not all
halophilic archaea are carbohydrate-utilizers. In Halobacterium salinarum, reconstruction
of all three glycolytic routes, i.e., the EM, ED and pentose phosphate (PP) pathways,
showed that it is unlikely that the organism catabolizes glucose (Falb, 2005, pp.112). With
respect to the EM pathway, a gene for the key enzyme 6-phosphofructokinase (EC 2.7.1.11)
could not be assigned, and neither for the new archaeal types of the enzyme that use ADP
as co-substrate instead of ATP. With respect to the semiphosphorylated ED pathway, only
a subset of its enzymes, glucose dehydrogenase and 2-keto-3-deoxygluconate kinase, ap-
pear to be present. The degradation of other sugars is also unlikely despite the presence
two sugar kinase homologs (OE4535F, OE3606R). These ﬁndings are consistent with the
fact that active transport of glucose has been experimentally excluded for Halobacterium
salinarum (Severina et al., 1991). The reconstruction of some central metabolic pathways
are graphically illustrated in Figure 3.13.
While it is unlikely that glucose and other similar sugars are catabolized by Halobac-
terium salinarum, it has been reported that the exogenous addition of glucose and galac-
tose can stimulate growth of the microorganism to some extent (Gochnauer and Kushner,
1969). One possible explanation for this is that supplying the carbohydrates exogenously
removes the burden from the cells of having to produce the necessary amount of sugars for
biomass formation; several cellular constituents contain sugar moities. When the BR over-
producing strain Halobacterium salinarum S9 was fed with 2H7-glucose, deuterium label
was found in the sugar moieties of the major glycolipid S-TGA-1. Furthermore, saccharide
units were also found attached to halobacterial surface proteins, such as the S-layer protein
and ﬂagellins (Sumper, 1987). If the carbohydrates are not supplied, they are likely syn-
thesized via reversal of the EM pathway (gluconeogenesis). Labeling (Ghosh and Sonawat,
1998) and enzyme activity studies (Rawal et al., 1988; D’Souza and Altekar, 1998) have
shown a complete and functional reverse EM pathway in Halobacterium salinarum. The
genes required for the triose part of the pathway could be assigned in the microorganism
(Falb, 2005, pp.112).
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Figure 3.13: EM pathway, TCA cycle and some associated reactions. Green arrows
represent biochemical transformations that are present in Halobacterium salinarum. Although
some reactions likely do not occur in the halophile, they are nevertheless shown (red arrows) to
complete the pathways in which they belong. A pair of adjacent boxes nearby each green arrow is
used to signify the level of bioinformatic (left) and experimental (right) support associated with
the corresponding reaction. Green denotes that the evidence is strong, red that there is none, and
yellow indicates an intermediate level. Glycolysis via the EM pathway is not possible in Halobac-
terium salinarum as it lacks the key enzyme 6-phosphofructokinase (EC 2.7.1.11). However,
activity of the reverse EM pathway (gluconeogenesis) has been experimentally demonstrated. A
complete TCA cycle has been shown for the halophile using labeling studies.
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3.5.2 Tricarboxylic Acid Cycle
The tricarboxylic acid cycle (TCA cycle), also known as Krebs’ cycle, is a pathway (cycle)
involved in the chemical conversion of carbohydrates, fats and proteins into carbon dioxide
and water to generate a form of usable energy through respiration. The net eﬀect of the
cycle is the oxidation of two carbons to CO2, with the concomitant production of energy
(ATP or GTP) and reducing power (e.g., NADH). The TCA cycle was studied in Halobac-
terium salinarum using 13C nuclear magnetic resonance spectroscopy (Ghosh and Sonawat,
1998), speciﬁcally in cells grown in the presence of glucose and alanine. Results were indica-
tive of a complete cycle in the archaeon (Figure 3.13). Isotopomer analysis of glutamate
labeling suggested that the ﬂux through pyruvate:ferredoxin oxidoreductase (EC 1.2.7.1)
accounted for 90% of the total pyruvate entering the TCA cycle, while pyruvate caboxylase
(EC 6.4.1.1) accounted for 10%.
The results of the labeling studies on the TCA cycle (Ghosh and Sonawat, 1998) also
showed that: (1) The malic enzyme played a considerable role, accounting for 7% of the to-
tal label that entered the cycle. Approximately 42% of the label went through the ﬂux from
α-ketoglutarate to glutamate, and about 41% was recycled. (2) The inclusion of malonate,
a competitive inhibitor of succinate dehydrogenase, reduced the cycling of the label in the
cycle. However, buildup of the intermediates before the succinate dehydrogenase reaction
(EC 1.3.99.1) was not observed. This suggested that either the oxaloacetate pool, which is
necessary for condensation with acetyl-CoA in the citrate synthase reaction (EC 2.3.3.1),
was depleted or the TCA cycle enzymes existed as a cluster or a metabolon, such that
an inhibition of any one enzyme would inhibit the entire cycle. And (3) pyruvate mainly
enters the TCA cycle under aerobiosis, while its transamination to alanine is enhanced
under anaerobic conditions.
3.5.3 Bypass Pathways
Acetate enters the citric acid cycle as acetyl-CoA, where it is fully oxidized to CO2. Thus,
the cycle, in conjunction with respiration, allows the molecule to be used as an energy
source. Indeed, fatty acids are degraded to acetyl-CoA molecules by beta oxidation, and
are major sources of energy in some organisms. However, neither the TCA cycle nor its
reversal are enough for the (reverse) process of carbohydrate biosynthesis from acetate.
This capability is essential for organisms that can grow with acetate as the only carbon
source. Rather, the capacity is aﬀorded for by the glyoxylate cycle, which bypasses the
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reactions of the TCA cycle where carbon is lost in the form of CO2. Speciﬁcally, isocitrate
undergoes cleavage into succinate and glyoxylate via the action of isocitrate lyase (EC
4.1.3.1). Glyoxylate then condenses with acetyl-CoA (EC 2.3.3.9) to yield malate, which
can then be converted to phosphoenolpyruvate. The net eﬀect of the cycle is the conversion
of two two-carbon molecules (acetate) to a four-carbon compound.
In Halobacterium salinarum, activity of the two key glyoxylate cycle enzymes were
detected after citrate in the growth medium was replaced by acetate (Aitken and Brown,
1969). However, the observed induction of isocitrate lyase by acetate could not be repeated
in a later study (Oren and Gurevich, 1995b). Moreover, of the two strains that were
investigated, namely Halobacterium halobium R1 and Halobacterium salinarum strain 5,
isocitrate lyase activity could only be detected in the former. During reconstruction, we
were unable to assign genes for both key enzymes in Halobacterium salinarum R1, and
neither could we for Halobacterium sp. NRC-1. We should note that the cycle is not
really as critical in Halobacterium salinarum as it is in other microorganisms because the
archaeon already requires amino acids that enter central metabolism as three- or four-
carbon molecules, and as such will not grow with acetate as the sole carbon source anyway.
Nevertheless, the glyoxylate cycle enzymes were included in the network (Figure 3.13).
Another route through which D-lactate may be formed is through the methylglyoxal by-
pass. This sequence of reactions has been thought of as a bypass for glycolysis, particularly
of the EM pathway. In it, methylglyoxal is produced from dihydroxyacetone phosphate
(glyerone phosphate) by methylglyoxal synthase (EC 4.2.3.3). Next, methylglyoxal joins
with reduced glutathione to form S-lactoylglutathione, through the operation of glyoxalase
I (EC 4.4.1.5). Finally, S-lactoylglutathione is hydrolyzed, via the action of glyoxalase II
(EC 3.1.2.6), to glutathione and D-lactate. Note that some other -SH molecule could be the
coreactant, and not glutathione. Although the role of the methylglyoxal bypass in cellular
metabolism is not completely understood, one possibility is that it aﬀords the the forma-
tion of acetyl-CoA from dihydroxyacetone phosphate under conditions where the phosphate
concentration is low; the normal glycolytic route through glyceraldehde 3-phosphate dehy-
drogenase (EC 1.2.1.12, EC 1.2.1.13, EC 1.2.1.59) requires an additional orthophosphate
molecule. With respect to the halophilic archaea, the presence of methylglyoxal synthase
and glyoxalase I have been investigated in several species (Oren and Gurevich, 1995c). Re-
markably, only the activity of the latter enzyme was detected in Halobacterium salinarum.
Consistent with this, we were not able to assign a gene for methylglyoxal synthase during
reconstruction (Figure 3.13). Accordingly, the archaeon may have an alternative pathway
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that leads to methylglyoxal.
3.6 Catabolic Pathways
Catabolism refers to the set of metabolic pathways that break down molecules into smaller
units in order to provide energy (e.g. ATP) and/or to generate metabolic intermediates
for use in subsequent anabolic reactions. For example, polysaccharides, nucleic acids and
proteins are broken down into monosaccharides, nucleotides and amino acids, respectively.
The oxidative degradation of acetate to two CO2 molecules by the TCA cycle, discussed
earlier, is another example of catabolism. In this section, we outline the (putative) catabolic
capabilities of Halobacterium salinarum with respect to several large molecules. In addition,
an oxidative phosphorylation pathway is also proposed.
3.6.1 The Respiratory Chain
During the breakdown of metabolites, such as in the degradation of acetate via the TCA
cycle, reducing power in the form of NADH or some other carrier can be produced. This
reducing power can be used to produce further ATP through respiration, in addition to the
ATP that is already generated by substrate level phosphorylation during the breakdown
process itself. During aerobic respiration, electrons are transferred from the carriers (e.g.,
NADH) to molecular oxygen through a series of redox reactions mediated by an electron
transport chain. At speciﬁc stages of this process, protons (H+) are pumped out by
respiratory complexes, which results in the establishment of a proton motive force (pmf)
across the membrane. In turn, the pmf is used by ATP synthase (EC 3.6.3.14) to produce
ATP from ADP.
The capacity of Halobacterium salinarum to produce energy through respiration has
been demonstrated (Sreeramulu et al., 1998; Oesterhelt and Krippahl, 1973). Consistent
with this, the halophile has analogs of all ﬁve oxidative phosporylation complexes that
are found in mitochondria and E. coli (complexes I through V, Figure 3.14). However,
signiﬁcant diﬀerences from its better-studied counterparts can be discerned. For example,
the subunits of complex I that comprise the NADH acceptor module (nuoEFG) could not
be assigned. Indeed, it has been experimentally excluded that NADH is oxidized by a type
I dehydrogenase in H. salinarum. Rather, NADH is oxidized by a non-homologous type II
NADH dehydrogenase that also reduces quinones but is incapable of proton translocation
(Sreeramulu et al., 1998). Nevertheless, the conservation of eleven complex I subunits
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Figure 3.14: Proposed Oxidative Phosphorylation Pathway. H. salinarum has analogs
of all ﬁve respiratory complexes found in mitochondria and E. coli (complexes I to V). The boxes
beneath each complex represent genes coding for speciﬁc subunits, which are often encoded
adjacently in the genome (indicated by solid connections or by shared borders). Black broken
lines are used to indicate that the connected genes, while not adjacent, are in the same genetic
vicinity. The red broken line indicates that the cbaD and hcpB genes are fused in the archaeon.
The proposed pathway has some notable diﬀerences from its more well-studied counterparts in
E. coli or mitochondria. For example, genes coding for cytochrome c, which normally carries
electrons to the terminal oxidase, could not be found in H. salinarum. Experimental evidence
indicates that the function is likely performed by the copper protein halocyanin.
with high levels of sequence similarity make it likely that the complex is functional and
translocates protons. Moreover, the lack of the NADH-speciﬁc acceptor module and the
experimental evidences that NADH is not oxidized by complex I make it likely that the
complex I analog actually accepts electrons from another donor molecule, which we left
unspeciﬁed in Figure 3.14. In addition, the H. salinarum pathway is also diﬀerent in that
menaquinone, rather than ubiquinone, is the likely mobile carrier used to shuttle electrons
from the complex I analog to the complex III analog. A similar proposal has been made
for the closely related organism Natronomonas pharaonis (Scharf et al., 1997; Falb et al.,
2005).
Two other important diﬀerences of the proposed pathway from the systems in mito-
54 3. The Metabolism of Halobacterium salinarum
chondria and E. coli are the composition of the complex III analog and the mobile carrier
which carries electrons to the terminal oxidase (complex IV analog). The cytochrome c1
subunit (petC) of E. coli complex III, responsible for transfering electrons to the mobile
carrier of the organism, cytochrome c, does not seem to have a homolog in H. salinarum.
In fact, genes which code for cytochrome c could also not be assigned. Accordingly, we
believe that H. salinarum likely uses a diﬀerent carrier. We propose this to be halocyanin,
which is a blue copper protein originally isolated from N. pharaonis (Scharf and Engelhard,
1993). A similar function has been proposed for the molecule in N. pharaonis, based on
its localization as a membrane protein and its midpoint potential that is consistent with a
mobile carrier’s (Scharf et al., 1997). This proposed function is further supported by the
fact that the halocyanin gene, hcpB, is fused with the cbaD subunit of complex IV in H.
salinarum (Pfeiﬀer et al., 2008a).
Very little is known regarding the stoichiometry of the proton translocating processes
in the respiratory chain of H. salinarum. Fortunately, while information on the individual
components are unavailable, data on the aggregate process of respiration exists. This is
very important for modeling because it determines the overall energy production capability
of the organism. O2 pulse experiments indicated an ATP to O2 ratio of 1:1. Measurements
of initial proton uptake during phosphorylation demonstrated a ratio of 10:1 between H+
and ATP (Hartmann et al., 1977). These values are consistent with the experimentally
determined photosynthetic stoichiometries of 22 photons per ATP and 2 photons per H+,
given that light inhibits respiration with an observed stoichiometry of 24 photons per O2
molecule (Hartmann et al., 1977; Oesterhelt and Krippahl, 1973). We ﬁxed the stoichiom-
etry of the oxidative phosphorylation pathway in the model according to these values.
3.6.2 Glutamate (C5) Family of Amino Acids
Halobacterium salinarum preferentially utilizes amino acids. In line with this, a wide range
of catabolic capabilities for amino acids can be deduced from its genome. With respect to
glutamate, uptake of the amino acid has been described to require respiration or a min-
imum gradient in NaCl (Birkeland and Ratkje, 1985). The uptake process was reported
not to be inhibited by a number of acids with similar chemical groups but was inhibited
by the D entantiomer. Glutamate can enter central metabolism in one step, speciﬁcally
through the TCA cycle as α-ketoglutarate, via the action of any one of a number of possible
transamination reactions (e.g., EC 2.6.1.1, EC 2.6.1.19, etc...). Numerous such reactions
exist because glutamate and α-ketoglutarate are linked to the transfer of amine groups in
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several pathways. In addition, it can also be predicted from the gene equipment of Halobac-
terium salinarum that the halophile degrades glutamate to mesaconate via enzymes of the
β-methylaspartate pathway (glutamate fermentation), which are encoded within the mam
gene cluster (OE4204F-OE4207F) (Falb, 2005, pp.119-120). Mesaconate might further
be converted to citramalate and subsequently to pyruvate and acetate as in thermophilic
anaerobic bacteria (Plugge et al., 2001). For the reason that glutamine can be converted
to glutamate through simple transamination reactions, the possibilities that exist for the
latter also apply to it.
Figure 3.15: Catabolism of the glutamate (C5) family
of amino acids. Glutamate can enter central metabolism
in one step, speciﬁcally through the TCA cycle as 2-
oxoglutarate, via the action of any one of a number of pos-
sible transamination reactions. In addition, the gene com-
plement of Halobacterium salinarum also indicates that the
archaeaon can catabolize glutamine, proline, arginine and his-
tidine through conversion to glutamate. The arrows repre-
sent reactions and the orange circles intermediate metabo-
lites. Near each reaction is a box that indicates the level
of genetic evidence for the biochemical transformation; green
denotes strong evidence and yellow that there are several can-
didate genes for the reaction but the substrate speciﬁcity of
each is diﬀucult to determine.
The gene equipment of Halobacterium salinarum also indicates the capacity for the
catabolism of proline, arginine and histidine, via conversion to glutamate. The ﬁrst, pro-
line, can be dehydrogenated to 1-pyrroline-5-carboxylate (EC 1.5.99.8; OE3955F), which
can then be converted to glutamate after a second dehydrogenation step (EC 1.5.1.12;
several possible ORFs). A speciﬁc ORF for the second enzyme could not be assigned
because the substrate speciﬁcities of several dehydrogenases could not be determined
using sequence similarity alone. The second, arginine, can be deiminated to citrulline
(EC 3.5.3.6; OE5208R), which can be split into ornithine and carbamoyl phosphate (EC
2.1.3.3; OE5205R). The resulting ornithine can then be converted to proline after the re-
moval of an amine group (EC 4.3.1.12; OE4121R, OE2945F). A fermentative pathway
for arginine is discussed in the following chapter. Finally, the third, histidine, can be
converted to urocanate (EC 4.3.1.3; OE2739F), which can be turned into 4-imidoazolone-
5-propanoate (EC 4.2.1.49; OE2734F), which can be hydrolyzed to N-formimino-glutamate
(EC 3.5.2.7; OE2738F), which can then be hydrolyzed to glutamate and formamide (EC
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3.5.3.8; OE2736F). A summary of the catabolic capabilities for the glutamate family of
amino acids is provided in Figure 3.15. In addition to glutamate, active transport has
also been demonstrated for glutamaine, proline, arginine and histidine (MacDonald et al.,
1977).
3.6.3 Branched-chain Amino Acids
Reconstruction of the catabolic pathways for the branched-chain amino acids was particu-
larly problematic because several of the steps involve enzymes for which genetic evidences
are ambiguous. That is, several candidate genes are present for the general functions (e.g.,
“dehydrogenase”), but it is impossible to assign substrate speciﬁcities to them using the
available methods. Nevertheless, it is very likely that complete and functional degradative
pathways exist for leucine, isoleucine and valine, given the presence of the key enzymes.
Indeed, as will be discussed later, numerous indications that leucine and isoleucine are
preferred respiratory substrates of Halobacterium salinarum were found in the course of
this study.
The Na+-gradient-driven transport of L-leucine and D-leucine has been described in
Halobacterium salinarum. It was suggested that D-leucine transport is coupled with two
moles of Na+, whereas L-leucine transport is coupled with one mole of Na+ (Tanaka et al.,
2000). Leucine is a chemoattractant of the archaeon (Storch et al., 1999). Degradation
of the amino acid proceeds via its conversion to hydroxymethylglutaryl-CoA (hmg-CoA),
which can then be split to acetyl-CoA and acetoacetate (EC 4.1.3.4). The former can
readily enter the TCA cycle, and the latter can be converted to acetoacetyl-CoA via
the action of acetoacetate succinyl-CoA transferase (EC 2.8.3.5; OE5189F or OE4211F).
Acetoacetyl-CoA can then be converted to two molecules of acetyl-CoA through the oper-
ation of acetoacetyl-CoA thiolase (EC 2.3.1.9; OE3884F).
Similar to leucine, valine and isoleucine are actively transported by Halobacterium
salinarum (MacDonald et al., 1977), and both are also chemoattractants of the halophile
(Storch et al., 1999). The catabolism of isoleucine proceeds by its transformation to 2-
methylacetoacetyl-CoA (several steps). With the participation of another CoA molecule,
2-methylacetoacetyl-CoA can be split into propanoyl-CoA and acetyl-CoA through the
action of a thiolase (EC 2.3.1.16; OE3884F). Propanoyl-CoA can be carboxylated to
(S)-methylmalonyl-CoA (EC 6.4.1.3; OE1939F, OE3175F), and then epimerized to (S)-
methylmalonyl-CoA (EC 5.1.99.1; OE1718R). Entry into central metabolism (TCA cy-
cle) can then be completed after transformation to succinyl-CoA (EC 5.4.99.2; OE1721F,
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OE2005F, OE1972F). Valine also enters central metabolism through propanoyl-CoA as
succinyl-CoA.
3.6.4 Glycine, Serine, Threonine and Alanine
Alanine enters central metabolism through pyruvate. One way through which this can be
accomplished is through the action of alanine dehydrogenase (EC 1.4.1.1). The enzyme
from Halobacterium cutirubrum has been partially puriﬁed, and was investigated with
respect to enzymatic properties and thermal stability (Kim and Fitt, 1977). However, an
ORF for the enzyme in the R1 genome remains to be assigned. Alternatively, alanine
can also be converted to pyruvate through transamination reactions with diﬀerent amine
acceptors, such as oxaloacetate and aspartate (EC 2.6.1.1; OE1755F, OE1944R, OE2619F)
(Bhaumik and Sonawat, 1994). The reverse reaction, pyruvate to alanine, was reported to
occur primarily under anaerobic conditions.
Figure 3.16: Catabolism of glycine, serine, threonine
and alanine. Green arrows represent biochemical transfor-
mations that are present in Halobacterium salinarum. Nearby
each reaction is a pair of adjacent boxes; these signify the level
of bioinformatic (left) and experimental (right) support asso-
ciated with the biochemical transformation. Green denotes
that the evidence is strong, red that there is none, and yellow
indicates an intermediate level.
Similar to alanine, serine enters central metabolism as pyruvate, through the opera-
tion of serine deaminase (also called threonine ammonia-lyase) (EC 4.3.1.19; OE3931R).
Likewise, glycine also enters as pyruvate, via conversion to serine using the enzyme hy-
droxymethyltransferase (EC 2.1.2.1; OE3036F). Alternatively, glycine can also be cleaved
(several reactions) to donate its methyl group, via tetrahydrofolate, to several biosynthetic
pathways. Since the transformation of glycine to serine is reversible, then serine can also
be catabolized through the conversion to and cleavage of glycine. Finally, threonine can be
converted, through an intial deamination to 2-oxobutanoate (EC 4.3.1.19; OE3931R) and
a succeeding reduction step, to propanoyl-CoA, and thus subsequently enter the TCA cycle
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as succinyl-CoA. Although genes for the enzyme of the succeeding step, alpha-ketobutyrate-
ferredoxin oxidoreductase (EC 1.2.7.2), still await assignment, its activity has already been
characterized using enzymatic assays (Kerscher and Oesterhelt, 1977). Since threonine can
be reversibly converted to glycine with the release of an acetaldehyde molecule (EC 4.1.2.5;
OE4436R), then the possibilities for glycine and serine also exist for threonine, and vice
versa, although the reverse direction will require the input of the acetaldehyde molecule.
The catabolic possibilities for alanine, serine, glycine and threonine are summarized in
Figure 3.16.
3.6.5 Aromatic Amino Acids
As with some eubacteria like Escherichia coli, Halobacterium salinarium has two types of
transport systems for aromatic amino acids: one common system and one speciﬁc trans-
porter for each of the three substrates (Lobyreva and Plakunov, 1987). However, the ar-
chaeon in addition has a second tyrosine-speciﬁc high aﬃnity system, for a total of ﬁve
transport systems associated with aromatic amino acids. When phenylalanine exceeds
[14C]tyrosine by four to sixfold, it inhibits competitively tyrosine transport of the common
system. When phenylalanine is provided in 50- to 100-fold molar excess, it inhibits in a
non-competitive way the speciﬁc high aﬃnity system for tyrosine. In contrast, the speciﬁc
low aﬃnity system for tyrosine is practically insensitive to phenylalanine (Lobyreva et al.,
1994). One possible reason for having multiple transport systens is because an excess in
the medium of one aromatic amino acid will result in the uptake inhibition of the other
two in the common system. In addition, due to the existence of common regulatory sites
in the biosynthetic pathways, an excess of one amino acid in the cells will result in the
inhibition of biosynthesis of the other two. In turn, these possibilities can depress growth.
The presence of two tyrosine-speciﬁc systems was thought to be involved in widening the
range of optimal concentrations for the amino acid in the medium.
Tyrosine enters central metabolism as fumarate and acetoacetate (acetoacetyl-CoA)
via homogentisate in some mammals, bacteria and fungi. Phenylalanine can share this
catabolic route after a multistep conversion to 4-hydroxyphenylpyruvate. Alternatively,
gram positive bacteria have been described to degrade tyrosine to pyruvate and succi-
nate, via 2,5-dihydroxyphenylacetate (homoprotocatechuate) rather than homogentisate
(Sparnins and Chapman, 1976). In Halobacterium salinarum, there is no clear genetic in-
dication that either of these pathways are present. Nevertheless, several observations were
made in this study that suggested that the archaeon has the relevant catabolic capabilities
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(Chapter 4), possibly through some other means.
3.6.6 Fatty Acids
Although the membrane lipids of Halobacterium salinarum consist exclusively of deriva-
tives of the dialkylglycerol diether, 2,3-diphytanyl-sn-glycerol (archaeol), small amounts of
fatty acids have been detected in the halophile. Even-numbered chains, such as palmi-
tate and stearate, are bound components of some of the archaeon’s membrane proteins
(Pugh and Kates, 1994). For example, halorhodopsin assembles into trimers around a cen-
tral patch consisting of palmitic acid (Kolbe et al., 2000). These ﬁndings suggested that a
fatty acid synthase (FAS) system might be operative in Halobacterium salinarum. The hy-
pothesis is further supported by the ﬁnding that whole cells of Halobacterium cutirubrum
incorporates [14C]acetate into fatty acids (Kates et al., 1968), and by the isolation of a
cell-free enzyme system that catalyses the biosynthesis of fatty acids from acetyl-CoA and
malonyl-CoA (Pugh et al., 1971). However, fatty acid metabolism is an enigmatic aspect
because there is currently no genetic indication for any type of FAS system in the ar-
chaeon, and it was reported that only a fraction of the activity remains at the high salt
concentrations ( > 4 M) which are typically encountered in the cytoplasm of the organism
(Pugh et al., 1971).
In contrast to the biosynthetic pathway, all genes for the catabolism of fatty acids
through the β-oxidation pathway are present in halobacterial genomes. This pathway con-
sists of a recurring sequence of four steps that continues until the entire chain is cleaved into
acetyl-CoA units: (1) oxidation by FAD or some other acceptor via the action of acyl-CoA
dehydrogenase (EC 1.3.99.3; several candidate ORFs); (2) hydration of the bond between
C-2 and C-3 (from the chain end) using enoyl-CoA hydratase (EC 4.2.1.17; OE3846R,
OE1641R); (3) oxidation by NAD+, thus converting the hydroxyl group into a keto group
(EC 1.1.1.35; OE2015R, OE2871F, OE3846R); and (4) cleavage of 3-ketoacyl CoA by the
thiol group of another CoA molecule (EC 2.3.1.16; OE3884F), which results to acetyl-CoA
and a residual chain that is shortened by two carbon atoms. Considering the presence of
the requisite genes and the signiﬁcance of fatty acids given their availability in halobacterial
environments, it is somewhat surprising that there has been no report on their oxidation
up until recently. Nevertheless, Natronomonas pharaonis was found to be able to grow
with fatty acids of various lengths as the sole carbon source (especially C14) (Ko¨nigsmaier,
2006). With respect to Halobacterium salinarum, only short-chain fatty acids are possible
because medium- and long-chain molecules in high concentrations diminish its growth.
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3.7 Biosynthetic Pathways
Most of the biosynthetic pathways for amino acids and cofactors in Halobacterium sali-
narum were covered by a previous reconstruction (Falb, 2005). Accordingly, in this study
details are only provided for those that were signiﬁcantly modiﬁed or updated.
3.7.1 Nucleotides, Amino Acids and Lipids
The gene complement of Halobacterium salinarum shows the complete set of requisite en-
zymes for the de novo synthesis of inosine monophosphate (IMP) from ribose 5-phosphate
(rib5P) and uridine monophosphate (UMP) from carbamoylphosphate and rib5P. Further-
more, all genes for the subsequent synthesis of purines and pyrimidines required for DNA
and RNA synthesis are also present in the genome. However, as is typical of the archaea,
there are some signiﬁcant diﬀerences compared to the existing model systems. For example,
halophiles have a domain fusion pattern of purine synthesis enzymes that diﬀers from all
other organisms (Falb, 2005); genes required for steps 3 (EC 2.1.2.2) and 9 (EC 2.1.2.3) are
fused (OE2292F) instead of genes for steps 9 and 10 (EC 3.5.4.10). Moreover, the IMP cy-
clohydrolase domain (EC 3.5.4.10) that can be found in most organisms is completely miss-
ing in halophiles and some other archaea (e.g. Methanococcus jannaschii and Archaeoglobus
fulgidus). This domain is responsible for the conversion of 5-aminoimidazole-4-carboxamide
ribonucleotide (ZMP or AICAR) to IMP. Instead, halophiles, including Halobacterium sali-
narum, and some methanogens possess a gene (OE4329F) that encodes an archaeal type
of IMP cyclohydrolase which has no sequence similarity to the bacterial and eukaryotic
enzymes (the preceeding information are reviewed in Falb, 2005, pp.116). The product
of the non-orthologous gene was puriﬁed from Methanococcus jannaschii (Graupner et al.,
2002). Finally, purine-nucleoside phosphorylase activity has been reported in the litera-
ture for Halobacterium salinarum (Stuer-Lauridsen and Nygaard, 1998), although there is
currently no gene that is assigned this function. Accordingly, it is possible that one of the
two genes that are currently annotated as “uridine phosphorylase” (EC 2.4.2.3), namely
OE2311R and OE3603R, is actually a purine-nucleoside phosphorylase.
As mentioned earlier, membrane lipids of archaea consist of glycerol diether lipids with
prenyl side chains. The glycerophosphate (GP) backbone of these molecules is sn-glycerol-
1-phosphate (G-1-P), which is the enantiomer of the bacterial and eukaryal counterpart
(Nishihara et al., 1999). So far, there has been no exception to this distribution of the
GP backbone stereoconﬁguration. Stereochemical inversion of exogenously supplied glyc-
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Table 3.4: Summary of amino acid metabolism.
AA Synthesis Degradation AA Synthesis Degradation
Alanine yes yes Leucine no yes
Arginine noa yes Lysine no yesb
Aspartate yes yes Methionine no yes
Asparagine yes yes Phenylalanine yes probablec
Cysteine yes Proline yes yes
Glutamate yes yes Serine yes yes
Glutamine yes yes Threonine yes yes
Glycine yes yes Tryptophan yes no
Histidine yes yes Tyrosine yes probable
Isoleucine no yes Valine no yes
aAlthough long considered as essential, some preliminary results reported in this study suggest that
arginine synthesis is possible.
bKey enzymes of the pathway could not be found but label from the amino acid turning up in isoprenoid
molecules indicates degradation.
cKey enzymes could not be assigned but uptake rates greatly exceeded biomass incorporation rates.
erol phosphate has been shown to take place during lipid biosynthesis in Halobacterium
salinarum (Kakinuma et al., 1988; Nishihara et al., 1999). Sn-glycerol-3-phosphate spe-
ciﬁc dehydrogenase (EC 1.1.99.5; OE3763F, OE3764F, OE3765F) and glycerol kinase (EC
2.7.1.30; OE3762R) for the “common” sterioisomer have been detected in cell-free ho-
mogenates of the archaeon (Wassef et al., 1970).
In contrast to the versatility of Halobacterium salinarum with respect to amino acid
catabolism, as indicated by its gene equipment, the halophile is somewhat limited when
it comes to their biosynthesis. While other haloarchaea can grow using single carbon
sources, such as Natronomonas pharaonis which can grow on acetate, several amino acids
(10 or 15) are typically added to synthetic growth media used for Halobacterium sali-
narum (Oesterhelt and Krippahl, 1973; Grey and Fitt, 1976). It is somewhat surprising
that up until recently, there has been no eﬀort to systematically determine which of the
supplemented amino acids are truly indispensable, and which ones only support growth.
Nevertheless, the previous metabolic reconstruction for Halobacterium salinarum indicated
that six are essential, namely arginine, lysine, methionine, leucine, isoleucine and valine
(Falb, 2005, pp.120). This proposed set, except for lysine, ﬁts well with the amino acids
that are chemoattractants of the archaeon (Storch et al., 1999).
Arginine has long been held as an essential amino acid for Halobacterium salinarum.
However, due to modeling results that will be discussed in the succeeding chapter, we
proceeded to verify whether ornithine can substitute for arginine in the medium. The
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results of the experiments were positive. However, after doing the veriﬁcation, we also went
on to conﬁrm that arginine is indeed essential by trying to grow Halobacterium salinarum
with neither the amino acid nor ornithine supplied. The results this time were much
more surprising because we were able to observe growth (Figure 3.17, left). Although the
doubling time was much longer and the maximum cell density reached was just about a
fourth of that when either arginine or ornithine is supplied, the density change was enough
to preclude the possibility that the observed growth was only due to small amounts of
either nutrient introduced during inoculation. Unfortunately, replicates failed to achieve
similar results. Nevertheless, it is clear that arginine is critical for good growth in terms
of speed and the maximum population size reached.
The possibility that arginine may not be an essential amino acid for Halobacterium
salinarum prompted us to reevaluate the parts of the primary annotation and the recon-
struction that are related to arginine synthesis. From the gene equipment of the halophile,
it is clear that all the enzymes (genes) necessary for converting ornithine into arginine are
present. Therefore, the only problem is getting to ornithine itself. We were able to ﬁnd
two possibilities in which this may be achieved (Figure 3.17, right): (1) Halobacterium sali-
narum has an ornithine cyclodeaminase (EC 4.3.1.12; OE4121R) that allows ornithine to
be broken down into proline and NH3. Although the reaction was reported in Clostridium
sporogenes to either be irreversible or to have an equilibrium that is far in the direction of
proline (Costilow and Laycock, 1971), a near zero availability of ornithine may be enough
to drive the equilibrium in the other direction, considering that all reactions are essen-
tially reversible. On the other hand, proline can already be derived from glutamate. (2)
An alternative possibility is to derive ornithine directly from glutamate 5-semialdehyde,
rather than through proline, using ornithine aminotransferase (EC 4.3.1.12). Candidate
genes for this function exist in the genome, including OE3168R which is currently anno-
tated as a “pyridoxal phosphate-dependent aminotransferase (homolog to acetylornithine
aminotransferase)”.
3.7.2 The Pentose Phosphate Pathway and Ribose Production
The Pentose Phosphate Pathway (PPP) commonly occurs in bacteria and eukaryotes.
Some of its main functions are the production of pentoses, the synthesis of erythrose 4-
phosphate, and the generation of NADPH. In the archaea however, the role of the PPP has
been an open question. In fact, current information suggest that archaeal members fulﬁll
the PPP functions in diverse ways. For example, pentoses are typically formed through
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the oxidative branch of the PPP. However, some archaeal species are believed to utilize the
non-oxidative branch (NOPPP) rather than the oxidative branch (Choquet et al., 1994;
Yu et al., 1994; Dandekar et al., 1999), and others that lack the NOPPP are believed to
utilize a reverse ribulose monophophate pathway (RuMP) (Orita et al., 2006; Kato et al.,
2006; Grochowski et al., 2005). Both alternative routes are not present in Halobacterium
salinarum.
The oxidative branch of the PPP (OPPP) is responsible for the conversion of glucose
6-phosphate to ribulose 5-phosphate. This reaction sequence proceeds via an initial de-
hydrogenation of the substrate to glucono-1,5-lactone 6-phosphate (EC 1.1.1.49), which is
then followed by hydrolysis to gluconate 6-phosphate (EC 3.1.1.31). The pathway is com-
pleted with the oxidative decarboxylation of gluconate 6-phosphate to ribulose 5-phosphate
(EC 1.1.1.44). No functional oxidative PPP has been described in the archaea yet (Falb,
2005, p.113). In Halobacterium salinarum, genes for the ﬁrst two steps could not be as-
signed. However, activity of the initial step (EC 1.1.1.49) has been experimentally proven
(Aitken and Brown, 1969). The enzyme for the ﬁnal step seems to be present (EC 1.1.1.44;
OE4581F), but it only shows N-terminal domain homology with known sequences. Accord-
ingly, the OPPP remains a possibilty for pentose production in the archaeon (Figure 3.18).
Even if pentoses are not produced through the OPPP, the presence of the ﬁnal enzyme
in the sequence (EC 1.1.1.44) as well as that of ribose-5-phosphate isomerase (EC 5.3.1.6;
OE4185F) suggest that the biosynthetic route at least goes through gluconate 6-phosphate.
The latter enzyme isomerizes ribulose 5-phosphate to ribose 5-phosphate, which can already
be converted to the ribonucleotide precursor phosphoribosyl diphosphate (PRPP) (EC
2.7.6.1; OE4085R). As an alternative to the OPPP, gluconate 6-phosphate can be produced
through the direct phosphorylation of gluconate (EC 2.7.1.12) (Figure 3.18). In support
of this possibility, labeled glucose has been shown to be metabolized to gluconate by
Halobacterium salinarum cells (Sonawat et al., 1990). If this is indeed the route for pentose
synthesis, then it would explain the seeming presence of an incomplete semi-phosphorylated
EntnerDoudoroﬀ pathway in Halobacterium salinarum, particularly if the gene currently
assigned as 2-keto-3-deoxygluconate kinase (EC 2.7.1.45) actually facilitates the missing
step.
A structurally novel phosphopentomutase was recently characterized in the hyper-
thermophilic archaeon Thermococcus kodakaraensis. Searching for a homologous gene in
Halobacterium salinarum returned OE2318R, which was orginally annotated as “phos-
phohexomutase (phosphoglucomutase (EC 5.4.2.2), phosphomannomutase (EC 5.4.2.8))”.
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The phosphopentomutase activity (EC 5.4.2.7) together with 2-deoxyribose 5-phosphate
aldolase (EC 4.1.2.4; OE3616F) allows the interconversion of deoxyriboses with acetalde-
hyde and glyceraldehyde 3-phosphate (Figure 3.18), and accordingly provides a link be-
tween central metabolism and deoxypentoses. This pathway presents another possibility
for producing the ribonucleotide precursor PRPP, speciﬁcally if Halobacterium salinarum
has the capability of bringing back deoxyriboses to the level of riboses. However, we should
note that even if this pathway were in the archaeon, the presence of the ﬁnal steps from 6-
phospho-gluconate to PRPP make it likely that the latter can still be derived from 6-carbon
sugars.
3.7.3 Biosynthesis of Aromatic Amino Acids
The biosynthetic pathways for aromatic amino acids are well established in bacteria and
eukaryotes. In the archaea however, analysis of several genomes, including Halobacterium
salinarum, has revealed examples where essential enzymes could not be assigned based on
sequence searches (Higuchi et al., 1999). Particularly, genes could not be found for the ﬁrst
two steps of the shikimate pathway, which itself comprises the early steps in the biosynthesis
of aromatic amino acids. The ﬁrst step in this established pathway is an aldol-like conden-
sation of erythrose 4-phosphate with phosphoenolpyruvate to form 3-deoxy-D-arabino-2-
heptulosonate 7-phosphate (DAHP), via the action of 2-dehydro-3-deoxyphosphoheptonate
aldolase (EC 2.5.1.54). DAHP is then converted into 3-dehydroquinate (DHQ) by 3-
dehydroquinate synthase (EC 4.2.3.4). Consistent with the apparent absence of the genes,
biochemical and labeling experiments (Fischer et al., 1993; Tumbula et al., 1997) suggested
that a noncanonical series of reactions is responsible for either the biosynthesis of DHQ
or its precursor, erythrose-4-phosphate. It was recently shown that the former is true in
Methanocaldococcus jannaschii, and that erythrose-4-phosphate is not at all involved in
the pathway (White, 2004).
The ﬁrst step in the recently elucidated pathway is a transaldolase reaction between L-
aspartate semialdehyde and 6-deoxy-5-ketofructose 1-phosphate to form compound I. This
step is catalyzed by the product of gene MJ0400. Next, compound I is oxidatively deam-
inated to 3,7-dideoxy-D-threohepto-2,6-diulosonic acid through the action of the MJ1249
gene-product. Finally, the result of the previous step is cyclized to DHQ, also via the
action of the MJ1249 enzyme. A search for orthologs of MJ0400 and MJ1249 in the
Halobacterium salinarum genome returned OE1472F and OE1475F, respectively. Both
genes are in the tryptophan operon, which is a good indication that at least a similar path-
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way is in operation in the halophile. Experimental eﬀort aimed at validating the presence
of the pathway, including the conﬁrmation of the reported substrates, was initiated in part
due to the reconstruction. We should note that evidence for the existence of the alter-
native pathway in Halobacterium salinarum was produced more than a decade ago, but
obiously was not recognized as such, in a study that involved labeling of bacteriorhodopsin
residues (Engelhard et al., 1990). They described a then unexplained speciﬁc labeling of
tryptophan by 13C-aspartate. The labeling pattern they observed is consistent with the al-
ternative precursor pathway proposed in Methanocaldococcus jannaschii. Finally, we should
note that the menaquinone precursor chorismate is also derived from shikimate. Given that
quinones are responsible for shuttling electrons between some respiratory complexes, then
the proposed pathway is also relevant for oxidative phosphorylation.
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Figure 3.17: Essentiality of arginine. It has been a long-held assumption that arginine
is an essential amino acid for Halobacterium salinarum. However, in one of our experiments,
we were able to observe growth in a culture that had neither arginine nor ornithine included
in the medium (left image, blue diamonds). This prompted us to reevaluate the parts of the
primary annotation and the reconstruction that are related to arginine synthesis. From the
gene equipment of the halophile, it is clear that all the genes necessary for converting ornithine
to arginine are present (right image), and therefore the only problem is getting to ornithine
itself. One possibility for achieving this is through a reversal of ornithine cyclodeaminase (EC
4.3.1.12; OE4121R) that normally allows ornithine to be broken down into proline and NH3.
An alternative possibility is to derive ornithine directly from glutamate 5-semialdehyde using
ornithine aminotransferase (EC 4.3.1.12), for which candidate genes exist, including OE3168R
that is currently annotated as a “pyridoxal phosphate-dependent aminotransferase (homolog to
acetylornithine aminotransferase)”.
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Figure 3.18: The Pentose Phosphate Pathway and ribose production. Green arrows
represent biochemical transformations that are present in Halobacterium salinarum. Although
some reactions do not occur in the halophile, they are nevertheless shown (red arrows) to complete
the sequences to which they belong. A pair of adjacent boxes nearby each green arrow is used
to signify the level of bioinformatic (left) and experimental (right) support associated with the
corresponding reaction. Green denotes that the evidence is strong, red that there is none, and
yellow indicates an intermediate level. As with all archaea, the pentose phosphate pathway is
“broken” in Halobacterium salinarum. Possible reactions that can complete the production of the
ribonucleic acid (RNA, DNA) precursor phosphoribosyl pyrophosphate (PRPP) are indicated in
orange.
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Figure 3.19: Biosynthesis of aromatic amino acids. It was recently shown that 6-deoxy-
5-ketofructose 1-phosphate and L-aspartate semialdehyde are the precursors of aromatic amino
acids in Methanocaldococcus jannaschii, rather than erythrose 4-phosphate and phosphoenolpyru-
vate. A search for orthologs of the two genes involved, MJ0400 and MJ1249, in the Halobacterium
salinarum genome returned OE1472F and OE1475F (shown in blue in the ﬁgure), respectively.
That orthologous genes exist in the halophile, and that both genes are in the tryptophan operon,
is a strong indication for a similar pathway in Halobacterium salinarum. In part due to the recon-
struction, experimental eﬀort aimed at conﬁrming the pathway, including the reported substrates,
is currently underway. The ﬁgure was adapted from White, 2004.
Chapter 4
Systems Analysis of H. salinarum
Aerobic Growth and Bioenergetics
This chapter deals with the development of a computational model from the metabolic
reconstruction described in the previous chapter and on the use of the model for the
analysis of growth under aerobic conditions. We begin with an introduction to dynamic
models of metabolism, by describing some of the more popular formalisms currently used
(Section 4.1). In Section 4.1.5, we describe the practical diﬃculties that are typically
encountered in developing such dynamic models, which have limited their application to
mostly small networks. We then move on to the constraints-based modeling framework,
which circumvents these diﬃculties, in exchange for detail. The models used in this study
are hybrids that have both kinetic (dynamic) and constraints-based components.
Although hybrid models with both kinetic (dynamic) and constraints-based aspects
have been constructed in the past, the dynamic components of these models are too simple
to be applicable to our problem at hand. In particular, previous approaches cannot ac-
count for transport patterns that change qualitatively during growth. This is a particularly
restrictive limitation for this study. To overcome this, we propose a new system for deﬁn-
ing the dynamic aspects of the hybrid models that not only can account for qualitatively
changing transport patterns, but can actually detect their presence (Section 4.2.1). More-
over, our method can uncover relationships between metabolites, which is demonstrated
by automatically detecting the relationship between arginine and ornithine that is deﬁned
by the arginine fermentation pathway.
This chapter also contains: (1) a description of how we characterized the Halobacterium
salinarum biomass, including an experimental determination of the protein fraction (Sec-
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tion 4.3); (2) the growth data we generated for the aerobic condition (Sections 4.2.3 and
4.2.4); and (3) results of our aerobic simulations (Sections 4.4 to 4.8.2).
4.1 Introduction to Metabolic Models
Considerable eﬀort has been devoted to the mathematical description of metabolic function.
In this section, several formalisms that have been developed for this purpose are reviewed.
We begin by introducing kinetic modeling using Michaelis-Menten-type rate laws and two
canonical modeling systems. Then, we describe the fundamentally diﬀerent constraints-
based framework, which, unlike the others, does not require kinetic information to be
available. This distinction is signiﬁcant because kinetic data are typically diﬃcult to obtain.
Accordingly, although constraints-based models are less detailed, much larger networks can
be handled.
4.1.1 Chemical Kinetics
Chemical kinetics is the study of rates of chemical processes. In contrast to thermodynam-
ics, chemical kinetics does not focus on energy levels, but rather on the temporal aspects
of a reaction. For example, how fast does a reaction proceed? What factors aﬀect the
speed of the reaction? Certainly, the answers to these questions involve thermodynamic
considerations at a deeper level. However, kinetic studies center directly on metabolite
concentrations and ﬂuxes.
In the overwhelming majority of studies, spatial features are ignored by chemical kinetic
models, and it is implicity assumed that all participating metabolites are available in a
homogenous mix. A typical biochemical rate function relates the velocity of a reaction to
the concentrations of the chemical species involved. For example, in the simple case of the
ﬁrst-order degradation of a metabolite X that does not involve an enzyme, the chemical
reaction rate can be written as
dX
dt
= X˙ = −kX (4.1)
where k is a positive rate constant that represents the turnover per time unit. Equation
4.1 has the solution
X = X0e
−k·t (4.2)
where X0 is the initial concentration of the substrate (that is, X(t0)). Equation 4.2, which
allows the direct evaluation of the concentration of X as a function of time, could be
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derived analytically in this example, but this is not always the case. In kinetic studies,
diﬀerentiation is almost always with respect to time (as in Equation 4.1). Factors that
can aﬀect a reaction’s speed include the nature, physical state and concentration of the
reactants, as well as temperature and the presence of catalysts.
4.1.2 Michaelis-Menten-type Rate Laws
In the early 1900’s, Leonor Michaelis and Maud Menten proposed a reaction scheme for
enzyme-catalyzed reactions. They postulated that the substrate S and the catalyzing
enzyme E are in fast equilibrium with their complex (ES), which would then dissociate to
yield either the product P and the free enzyme or the substrate and the free enzyme. The
system can be mathematically written as
S˙ = k−1(ES)− k1S ·E (4.3)
˙(ES) = k1S · E − (k−1 + k2)(ES) (4.4)
P˙ = k2(ES) (4.5)
where k1, k−1 and k2 are rate constants. The assumption is that the laws of chemical kinet-
ics apply; i.e., that all species are in a homogenous mixture, and that the concentrations
are high enough to justify averaging what are essentially stochastic processes.
To obtain the familiar algebraic form of the Michaelis-Menten rate law, further as-
sumptions are necessary (Torres and Voit, 2002, p.14). These are: (1) the total enzyme
concentration ET is constant (i.e., ET = E + (ES) = c, where c is a constant); (2)
the total substrate concentration ST is much larger than the total enzyme concentration
(i.e., ST >> ET ); and (3) the concentration of the intermediate complex is constant (i.e.,
˙(ES) = 0), which implies the earlier postulation that the processes forming and destroying
(ES) are much faster than the overall conversion of S into P . With these assumptions,
using equations 4.4 and 4.5 allows us to write the rate of product formation as
P˙ =
VmaxS
KM + S
(4.6)
where KM = (k−1 + k2)/k1 and Vmax = k2ET . This rate law form, along with many
generalizations, has been immensely successful in the characterizaion of enzymes and the
analysis of simple pathways in vitro. However, because of the numerous assumptions made
in their derivations, care must be exercised in their use. For example, the supposition of a
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constant total enzyme level makes these rate laws inapplicable to systems where regulation
of the enzyme is of interest.
4.1.3 Biochemical Systems Theory
Biochemical systems theory (BST) is a canonical modelling framework that is based on
ordinary diﬀerential equations (ODE). In it, biochemical processes are represented using
power-law expansions in the variables of the system (Savageau, 1969a,b, 1970; Voit, 2000).
It is based mathematically on Taylor’s theorem; speciﬁcally by executing Taylor lineariza-
tion in log space. A typical BST model will have the form
X˙i =
p∑
k=1
γik
n+m∏
j=1
X
fijk
j (4.7)
where n is the number of dependent variables, m is the number of independent variables, p
is the number of processes aﬀecting Xi, and γik and fijk are parameters which are estimated
at a speciﬁc operating point. As a testament to the generality of the formalism, diﬀerential
equations from diﬀerent contexts, including those that are recognized as among the most
general, can be recast into equivalent BST forms (Irvine and Savageau, 1990). Accordingly,
the system can handle complex behaviors such as oscillations, saturation and chaos, which
are abundant in biology.
One very attarctive feature of BST models is that all parameters have well-deﬁned
biological interpretations. For example, the parameter fijk describes how a metabolite Xj
aﬀects the process k, which in turn aﬀects metabolite Xi. Speciﬁcally, a value greater
than zero for the parameter indicates a positive inﬂuence on the process, while a value
below zero a negative inﬂuence, such as in the case of inhibition. Note that if fijk were
zero, then X
fijk
j = 1, which means that metabolite Xj essentially drops out from the
term for k. This property makes the formalism particularly useful for network inference
(Kimura et al., 2005; Gonzalez et al., 2007; Liu and Wang, 2008). Past applications of
BST to metabolic networks include glycolysis in Lactococcus lactis (Voit, 2006), sphin-
golipid metabolism in S. cerevisiae (Alvarez-Vasquez et al., 2004), and human red blood
cell metabolism (Ni and Savageau, 1995).
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4.1.4 Linlog Kinetics
Metabolic control analysis (MCA) is a framework that was developed for the rational re-
design of metabolic pathways (Kacser and Burns, 1973; Heinrich and Rapoport, 1974). In
it, control aspects are quantiﬁed using coeﬃcients that describe how changes in enzyme
or extracellular eﬀector concentrations aﬀect ﬂuxes and intracellular metabolite concen-
trations. These coeﬃcients are deﬁned relative to a reference state, which is typically
the steady state. Accordingly, the practical applications of MCA are necessarily limited,
because the theory is only valid for inﬁnitesimal changes where linearization is a good
approximation. One way of getting around this problem is to develop kinetic models from
which control coeﬃcients can be calculated or the optimal distribution of enzyme lev-
els determined using numerical optimization. The linlog formalism is one such approach;
speciﬁcally, it is an attempt to integrate kinetic modeling and MCA into one framework
(Visser and Heijnen, 2002).
Similar to BST, the linlog framework uses approximative non-mechanistic rate equa-
tions. The main advantage of these approaches is that although they are not as detailed,
the number of parameters that have to be estimated is decreased. Accordingly, the ex-
perimental eﬀort needed for their identiﬁcation is reduced as well. The argument is that
metabolic re-design does not require detailed mechanistic models because of homeostasis
constraints. In linlog, a reaction rate will typically have the form
v = e
⎛
⎝a0 +
n∑
j=1
aj ln xj
⎞
⎠ (4.8)
where e is the enzyme level, n is the number of metabolites (species) that aﬀect the reaction,
the x’s are metabolite concentrations, and the a’s are parameters. Clearly, the reaction
rate is proportional to the enzyme level, and the eﬀect of the metabolites is a linear sum
of the (nonlinear) logarithms of their concentrations. Although developed in the context
of metabolic redesign, linlog can evidently be also used for metabolic modeling in general.
4.1.5 Constraints-based Models
All of the formalisms that have been discussed so far are for the development of kinetic
models. In order for any one of them to be applicable, knowledge of the intricate regulatory
features of the system in question is required. Unfortunately, such information is normally
diﬃcult to obtain. Indeed, it is often the case that enzyme kinetic parameters are available
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for only a limited number of model organisms. This, not even considering the fact that
KM values are typically derived from in vitro assays, a condition that casts suspicion
on their validity in vivo (Teusink et al., 2000; Theobald et al., 1997; Rizzi et al., 1997).
Accordingly, kinetic models of metabolism have mostly been limited to relatively small
networks.
Figure 4.1: Principles of constraint-based modeling. As the name suggests, the idea
of constraints-based modeling is to begin with a large, unconstrained solution space, and then
proceed by narrowing it down through the addition of constraints. A three-dimensional ﬂux space
for a given metabolic network is depicted here. Without any constraints the ﬂuxes can take on
any real value (left). After application of stoichiometric, thermodynamic and enzyme capacity
constraints, the possible solutions are conﬁned to a region in the total ﬂux space (center), termed
the allowable solution space. Any point outside of this space violates one or more of the applied
constraints. Given that it is typically the case that even with all constraints in place the solution
space is still large, particular solutions can be identiﬁed using linear programming by introducing
cellular objective assumptions, such as optimal ATP or biomass production. The ﬁgure was taken
from Reed et al., 2003.
In part due to the diﬃculties mentioned above, the constraints-based framework has
emerged as a successful alternative to kinetic models. Rather than requiring detailed
information that can be diﬃcult to obtain, constraints-based models need only generally
available physicochemical information such as stoichiometry, reversibility, energy balance,
and, when available, reaction velocities (Edwards et al., 2000; Edwards and Palsson, 1999;
Ramakrishna et al., 2001). As the name suggests, the principle of the framework is to
begin with a large solution space, and then proceed by narrowing it down through the
addition of constraints (Figure 4.1). To illustrate, consider a metabolic network with three
reactions. Without any further information, the ﬂux through each reaction can be any real
number. However, if it is known that all three reactions are irreversible, then we can add
the constraint that the ﬂux through each must be greater than or equal to zero. Similarly,
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if the exact ﬂux through one of the reactions is known, for example through experimental
measurement, then an equality constraint can be enforced for that reaction. Finally, given
that it is typically the case with real networks that even with all the constraints in place the
solution space is still large, particular solutions can be identiﬁed using linear programming
by introducing cellular objective assumptions, such as optimality with respect to ATP or
biomass production. This procedure is referred to as ﬂux balance analysis.
Figure 4.2: A small illustrative network. It
is composed of the four metabolites: A, B, C and
D; and the six reactions r1, r2, r3, r4, r5 and r6.
The box is used to diﬀerentiate between inter-
and intracellular space.
Since the metabolic network for Halobacterium salinarum has 695 reactions (Section
(3.4), it is not very convenient for illustrating the development of a stoichiometric matrix,
which is central to constraints-based models. For this purpose, we use the small network
depicted in Figure 4.2. The network is essentially a branching pathway consisting of four
metabolites (A, B, C and D) and six reactions (r1 through r6). It can be conveniently
represented as the stoichiometric matrix
S =
r1 r2 r3 r4 r5 r6
A
B
C
D
⎡
⎢⎢⎢⎢⎢⎢⎣
1
0
0
0
−1
1
0
0
−1
0
1
0
0
−1
0
1
0
0
−1
0
0
0
0
−1
⎤
⎥⎥⎥⎥⎥⎥⎦
(4.9)
where each row corresponds to a metabolite and each column to a reaction. The entries
of S are the stoichiometric coeﬃcients that deﬁne the relationships between the reactions
and compounds. A positive value for sij indicates that compound i is produced in the left
to right direction of reaction j, while a negative value indicates that it is consumed. For
example, column two of S is deﬁned as [−1 1 0 0]T indicating that A is consumed and B is
produced by reaction r2.
As discussed in the the previous chapter, metabolism is responsible for converting the
available nutrients into usable energy and biomass (growth). In the case of Halobacterium
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salinarum, deﬁned media used for the archaeon typically consist of amino acids. Therefore,
in order for growth to be possible, its metabolism should be able to convert the amino acids
into the unsupplied components of its biomass, such as nucleotides, vitamins, and other
cofactors. The processes involved in these conversions can easily be translated into con-
straints by writing material balance around the metabolic network, using its stoichiometric
matrix S as in
S · v = b (4.10)
where v is a vector of reaction rates, and b is a vector containing the net metabolite
concentration changes. Note that unlike in kinetic models where reaction velocities are
directly computed from rate equations, metabolic ﬂuxes are the unknown quantities that
need to be determined in ﬂux balance models.
In order to simulate growth, a pseudoreaction that is often called the “growth function”
is added to the network. Formally, it is deﬁned as a reaction where the reactants are cellular
constituents, and the product is a unit of biomass. The stoichiometric coeﬃcients used for
the reactants are determined with respect to the unit of biomass used. For example, if the
product is deﬁned to be one gram of biomass, and it is known that this quantity on average
contains a moles of alanine, then a is used as the stoichiometric coeﬃcient of alanine. The
growth function is added to the stoichiometric matrix S, just like any other reaction in
the network. Although terms relating to energy maintenance are often integrated into the
growth reaction, this was not done in this study because we investigate systems where
growth rates vary with time.
As mentioned earlier, it is often the case with real networks that the available con-
straints are not enough to determine a unique solution; i.e, the systems are frequently
underdetermined. Nevertheless, particular solutions can be obtained using linear program-
ming, using the assumption that cells optimize their metabolism with respect to certain
objectives, such as growth and energy production. For example, the linear programming
problem can be posed as
Maximize f = vobj (4.11)
Subject To
S · v = b (4.12)
−∞ ≤ vj ≤ +∞ where rj ∈ Rrev (4.13)
0 ≤ vj ≤ +∞ where rj ∈ Rirrev (4.14)
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vj = cj where rj ∈ Rknown (4.15)
where obj is the index of the objective reaction (e.g., the growth reaction), Rrev is the
set of reversible reactions, Rirrev is the set of irreversible reactions, Rknown is the set of
reactions for which ﬂuxes are already known, and cj is the known ﬂux through each reaction
in Rknown. Note that metabolic ﬂux models are based on the separation of time scales
between cellular growth rates and metabolic transients. That is, metabolism typically has
transients that are shorter than a few minutes, while growth is typically measured in hours.
Accordingly, metabolic ﬂuxes are assumed to be in a quasi-steady state relative to growth.
The mechanisms by which metabolic ﬂux distributions are chosen is a complex interplay
of regulatory events at diﬀerent levels. More often than not, only a limited subset of these
are known in detail. Therefore, one may be surprised at the attempt of determining
a unique solution for considerably underdetermined systems by just using an objective
function. Nevertheless, the argument is that although the regulatory mechanisms for the
most part are unknown, metabolic networks, because of evolutionary pressures, are adapted
to work in concert to achieve “optimal metabolism”, so that the survivability of cells are
enhanced. It is expected that wild-type microorganism strains have metabolic phenotypes
that are deﬁned by a tendency to optimize their growth rates, at least in the environments
where they are found.
To investigate the extent to which optimality principles can describe the operation of
metabolic networks, Schuetz and coworkers systematically evaluated ﬂux balance predic-
tions using 11 objective functions against actual in vivo ﬂuxes. This was done in Es-
cherichia coli using data derived from 13C-based ﬂux analysis (Schuetz et al., 2007; Sauer,
2006). They reported that although no single objective adequately described the ﬂux states
under all conditions tested, they were able to identify two sets that allowed for biologi-
cally meaningful predictions without the need for further, potentially artiﬁcial constraints.
Speciﬁcally, they found that growth on glucose in oxygen or nitrate respiring batch cultures
is best described by nonlinear maximization of the ATP yield per ﬂux unit, and that linear
maximization of the overall ATP or biomass yield achieves the highest predictive accuracy
in continuous cultures under nutrient scarcity. It was concluded that the identiﬁed opti-
mality principles reﬂect, to some extent, the evolutionary selection of metabolic network
regulation that realizes the various ﬂux states.
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4.2 Methods
This study includes both computational and experimental work; a considerable fraction of
the data that were used for computational analysis were generated here. The computational
and experimental methods that were employed are described in this section.
4.2.1 Metabolite Consumption and Production Equations
The model for the consumption and production of metabolites had to satisfy the following:
(1) allow for multiple metabolites in the medium; (2) account for the possible (dynamic)
interactions between the supplied metabolites; and (3) account for changes in transport
rates/modes that may be brought about by time-varying growth rates. The ﬁrst require-
ment is because Halobacterium salinarum requires relatively rich media consisting of amino
acids, unlike other microorganisms such as Escherichia coli that can live on a single carbon
substrate. The second is because preliminary inspection of the nutrient time-course data
revealed that the utilization patterns of some metabolites change during growth; i.e., they
exhibit distinct modes. And the third is because our simulation of batch-grown cultures
goes past the logarithmic phase of growth.
For each nutrient Xi with a transport pattern that does not change signiﬁcantly, we
used a simple model consisting of three terms:
X˙i = kX,iXi,t + kγ,iγt + kγ˙,iγ˙t (4.16)
where X˙i is the uptake rate of nutrient i, γt is the population size at time t, γ˙t is the
current growth rate deﬁned as dγ
dt
(t), and kX,i, kγ,i and kγ˙,i are optimizable parameters.
The rationale of the construction is that the production or consumption of the metabolite
depends on the availability of the metabolite, the population size and the current growth
rate.
As mentioned earlier, inspection of the nutrient time-course data indicated that the
transport patterns of some metabolites qualitatively changes during growth. For example,
ornithine, at some point, switches from being produced and accumulated in the medium
to being steadily consumed by cells. Such changes may be brough about by interactions
with other metabolites, or by general changes in metabolism. For these nutrients we used
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a simple extension of Equation (4.16) that allows for two modes:
X˙i =
⎧⎨
⎩
k1,X,iXi,t + k1,γ,iγt + k1,γ˙,iγ˙t, if t < ti,b
k2,X,iXi,t + k2,γ,iγt + k2,γ˙,iγ˙t, if t ≥ ti,b
(4.17)
where k1,X,i, k1,γ,i, k1,γ˙,i, k2,X,i, k2,γ,i, k2,γ˙,i and ti,b are optimizable parameters. Similar
to the basic form, the consumption or production of each metabolite still depends on the
availability of the metabolite, the population size and the current growth rate. However, the
new parameter ti,b now separates time into two intervals, and the distinct set of parameters
for each of these allows the utilization pattern to qualitatively change in moving from the
ﬁrst to the second.
The use of either Equation 4.16 or Equation 4.17 was not chosen a priori. Rather, the
choice was made based on clear indications of improvement or the lack thereof. Speciﬁcally,
for each nutrient Xi, parameters were estimated for both equation forms by solving inverse
problems (parameter optimization) using experimental data. Systematically deﬁned sets
of initial guesses were used in solving the inverse problems (parameter estimation). Based
on the results, the more sophisticated form of Equation 4.17 was used in the ﬁnal model,
in favor over the simpler equation form, only if it resulted in a signiﬁcantly better ﬁt; i.e,
Equation 4.17 was used only if it led to a substantially reduced residual error, which is a
measure of the (dis-)agreement between model and data, when compared to that obtained
using Equation 4.16. Making the choice between the two forms in this way minimizes the
possibility of overﬁtting. In this respect, it is reassuring that although Equation 4.17 is
clearly better for some metabolites such as alanine and ornithine, it hardly makes any
improvement for others such as leucine and isoleucine that seem to be staples of the cells
(see results). In cases where Equation 4.17 is used, the optimized parameter ti,b, intuitively,
corresponds to a point near where the transport pattern changes qualitatively. Because
the choice between the two equation forms can be done automatically, the computational
system we employ not only accounts for changes in metabolite modes, but can actually
lead to their identiﬁcation, and, subsequently, to the recognition of the biological processes
behind them. The borders (ti,b) need not be equal for all Xi’s.
4.2.2 Hybrid Genome-scale Flux Balance Model
At particular intervals during growth, we obtained ﬂuxes that are consistent with the
observed nutrient depletion/accumulation and biomass formation by solving the linear
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program
Maximize f = vobj (4.18)
Subject To
S · v = 0 (4.19)
−∞ ≤ vj ≤ +∞ where j ∈ (Rr ∪Ef ) (4.20)
0 ≤ vj ≤ +∞ where j ∈ Ri (4.21)
−∞ ≤ vj ≤ 0 where j ∈ Eu (4.22)
vj = βj where j ∈ Em (4.23)
where v is a vector of ﬂuxes deﬁning the ﬂux vj through each reaction j, vobj is the objective
function, Rr is the set of reversible internal reactions, Ri is the set of irreversible internal
reactions, Ef is the set of exchange ﬂuxes associated with ubiquitous metabolites, and Em
is the set of exchange ﬂuxes that correspond to experimentally measured nutrients. The
set of ubiquitous compounds include CO2, H2O, Na
+, Cl− and H+. For each reaction
j ∈ Em, the value βj is the appropriate evaluation of the corresponding uptake equation
(4.16 or 4.17) for the interval. In this work, all of the supplied carbon and energy sources,
except for citrate, were included in Em. In addition, the set also includes ornithine, which
is initially accumulated in the medium, and oxygen. Biomass production is treated in a
similar manner by ﬁxing the ﬂux of the growth (pseudo-)reaction to observed rates. To
account for the possibility that cells produce and accumulate certain metabolites in the
medium, such as in the case of overﬂow metabolism, the set of one-way exchange reactions
Eu was introduced. It includes central metabolites such as acetate, pyruvate, malate and
GAP, nucleotides, and some sugars such as glucose. Unless otherwise speciﬁed, energy
production was used as the objective function.
4.2.3 Culture Conditions and Sample Preparation
Strain Halobacterium salinarum R1 (DSM 671) cells were grown in chemically-deﬁned
media, with composition deﬁned in Table 4.1. Preparatory cultures were grown in 100 ml
ﬂasks containing 35 ml of the medium to a cell density of ≈100 Klett (1 OD), from which
1 ml inoculants were taken to start the next culture. This was done repeatedly to adapt
cells to the growth conditions. All cultures were prepared in ﬂasks which had side arms to
measure turbidity (cell density) via a Klett photometer, and were carried out in duplicates.
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Cell suspensions were shaken at 105 rpm at 40◦C in the dark. At speciﬁc points, samples
were taken from the cultures so that 14-18 samples were collected over the growth period,
and these were stored at 4◦C. To separate the cells from the medium, the samples were
centrifuged for ﬁve minutes at 15,000 rpm, using a SS34 rotor. Pellets were resuspended
in 500 µl basal salt (medium without the amino acids) and spun down as before. Amino
acid analysis was performed on both the pellets and the original supernatants, using an
Amino Acid Analyzer (Biotronik LC3000).
Table 4.1: Composition of chemically-defined mediuma
Description Value Description Value
NaCl 4 M L-Glycine 1.0 mM
KNO3 1 mM L-Alanine 2.5 mM
KCl 27 mM L-Arginine 3.5 mM
MgSO4 * 7H2O 81 mM L-Isoleucine 3.4 mM
Sodium Citrate * H2O 1.7 mM L-Methionine 1.3 mM
K2HPO4 0.42 mM L-Proline 0.9 mM
KH2PO4 0.58 mM L-Phenylalanine 0.8 mM
FeSO4 * 7H2O 11.6 µM L-Serine 5.8 mM
CuSO4 * 5H2O 0.2 µM L-Threonine 4.2 mM
MnCl2 * 4H2O 1.8 µM L-Tyrosine 1.1 mM
ZnSO4 * 7H2O 1.5 µM L-Valine 2.5 mM
Na2MoO4 * 2H2O 0.1 µM L-Lysine 2.1 mM
L-Aspartate 3.0 mM Thiamin 16.5 µM
L-Glutamate 13.5 mM Folate 11.5 µM
L-Leucine 6.1 mM Biotin 2.1 µM
apH was adjusted to 7.2
4.2.4 Oxygen Consumption
The amount of dissolved oxygen in the medium (solution) was continuously monitored
using the “Fibox 3-trace v3, ﬁber-optic oxygen meter” from Precision Sensing GmbH (Re-
gensburg, Germany). Under conditions identical to those of the aerobic cultures, argon
was blown into a ﬂask that contains only the medium. When the amount of dissolved
oxygen in the solution dropped to zero, the argon source was removed, and the ﬂask was
equilibrated with air. We used the subsequent nonlinear rise of oxygen from 0% to 100%
saturation to characterize oxygen dissolution kinetics. Speciﬁcally, the oxygen transfer rate
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(OTR) was deﬁned as
OTR =
dx
dt
= k (xmax − x) (4.24)
where x is the amount of dissolved oxygen, and xmax is the maximum value of x, which
indicates saturation. The data and the model ﬁt are shown in Figure 4.3. With the
appropriate parameters for Equation (4.24), we then calculated the oxygen consumption
rate of a culture at time t using
consumption(t) = k (xmax − x) + m (4.25)
where m is the current rate at which x is changing in the culture. For the sake of com-
pleteness, we note that Equation (4.24) has the analytical solution
x = xmax − (xmax − x0) e−kt (4.26)
where x(0) = x0 is the initial condition.
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Figure 4.3: Dissolution kinetics of oxygen. Under conditions identical to those of the aerobic
cultures, argon was blown into a ﬂask that contained only the medium. When the amount of
dissolved oxygen in the solution dropped to zero, the argon source was removed, and the ﬂask
was equilibrated with air. The graph shows the velocity at which oxygen subsequently dissolved
into the cell-free solution. This was used to calibrate oxygen consumption measurements.
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4.3 Determination of Biomass Composition
The growth function described in Section 4.1.5 stoichiometrically correlates a unit of
biomass with the average composition of cells. Say that this pseudoreaction corresponds
to the production of one cell and that it is associated with column j of the stoichiometric
matrix S, then the value sij for each compound i that is a biomass consituent should reﬂect
how much of i is present in a cell on average. For example, there are about 186.3 attomoles
of alanine in a cell. If iala is the index for the amino acid in S, then siala,j = −186.38.
Other units of biomass are also possible, such as dry weight or optical density. Although
the growth reaction is typically used as the objective function in determining particular
ﬂux distributions during ﬂux balance analysis, in this study it is often also treated as a
constraint that is equated to observed growth rates. The approximate biomass composition
of Halobacterium salinarum is summarized in Table 4.2. We describe how we determined
the individual components in the following subsections.
4.3.1 Amino Acids
Amino acids are generally present in cells in two forms; as protein residues or as free
metabolites. Given that proteins are ubiquitous components of cells, amino acids generally
constitute a considerable fraction of the biomass. For Halobacterium salinarum, the cellular
concentration of each was experimentally determined by performing amino acid analysis on
samples taken at diﬀerent optical densities. The measurements for four distinct cultures
that were grown and processed separately are illustrated in Figure 4.4. The values are
inclusive of protein residues and free metabolites. Due to experimental limitations, the data
for aspartate and glutamate are already inclusive of asparagine and glutamine, respectively,
and the cysteine and tryptophan content could not be measured.
The cellular concentration of each amino acid shows a reasonably good linear corre-
lation with the optical density (red curves in Figure 4.4). This supports the idea of an
average cell, which is an assumption that is made by most genome-scale ﬂux balance mod-
els that simulate growth. The total value of 381.4 µg/OD·ml that we determined, which
corresponds to 49% of the cellular dry weight or 73% of the total organic mass, is consistent
with measurements of total protein content that indicated a value of approximately 400
µg/OD·ml (Koch, 2005). However, we should note that the cultures represented in Figure
4.4 are not the ones that were used for computational analysis; these were only used for
the initial determination of amino acid content. Although the conditions used are gener-
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Table 4.2: Average cellular biomass composition.
Compound Amount Compound Amount
(µg/ODml) (µg/ODml)
Amino Acidsa Nucleotidesb
Alanine 22.5 ± 5.2 dAMP 0.6
Arginine 26.9 ± 5.6 dTMP 0.6
Aspartate 42.0 ± 9.2 dGMP 1.3
Asparagine 9.6 dCMP 1.1
Cysteine 2.9 AMP 15.7
Glutamate 77.8 ± 23.2 UMP 14.7
Glutamine 13.4 GMP 34.9
Glycine 15.9 ± 2.9 CMP 31.1
Histidine 15.1 ± 3.0
Isoleucine 13.1 ± 3.0 S-Layer non AA
Leucine 24.1 ± 5.0 Glucosamine 0.6
Lysine 12.3 ± 2.5 Galactosamine 0.6
Methionine 5.4 Glucose 2.2
Phenylalanine 13.4 ± 2.6 Galactose 2.2
Proline 18.5 ± 4.5
Serine 13.9 ± 2.8 Membrane
Threonine 19.3 ± 4.2 Archaeol 20.0
Tryptophan 7.7
Tyrosine 6.3 ± 3.0 Othersc
Val 21.4 ± 4.9 ATP 2.0
aAmino acid content was measured from samples taken at diﬀerent optical
densities.
bThe exact ratio between DNA and RNA is not known. Nevertheless, the
total is consistent with a 610 fg cellular dry weight, after subtracting the other
major components of the biomass.
cCells also contain other compounds that may be essential to survival but
presumably contribute only little to the biomass. These metabolites were added
to the growth function by assuming that each was 0.01% of the total organic mass.
These are siroheme, FAD, NAD+, NADP+, tetrahydrofolate (THF), thiamin,
coenzyme-A, menaquinone, molybdenum cofactor, and cobamide coenzyme.
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Figure 4.4: Amino acid composition of the Halobacterium salinarum biomass. The
amino acid content of cells was measured at diﬀerent optical densities. The values shown for each
amino acid represent the total amount, including protein residues and free metabolites. Diﬀerent
ﬁlled shapes are used to represent 4 distinct cultures that were grown and processed separately.
Red broken lines are used to show the best linear ﬁts. Due to experimental limitations, the data
for aspartate and glutamate are already inclusive of asparagine and glutamine, respectively, and
the cysteine and tryptophan content could not be measured.
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ally similar, there are some diﬀerences, including the fact that these preparations were not
inoculated from cells that were as well-entrained. Amino acid analysis was repeated for
the cultures that were actually used for the growth simulations.
4.3.2 Nucleic Acids
Nucleic acids are macromolecules composed of chains of monomeric nucleotides, which
are universal in living things. These molecules carry genetic information or are parts of
structures within cells. The most common nucleic acids are deoxyribonucleic acid (DNA)
and ribonucleic acid (RNA). The former contains the genetic instructions used in the
development and functioning of all known living organisms and some viruses. The main
role of DNA molecules is the long-term storage of information. In Halobacterium salinarum,
DNA is organized into a main chromosome and four megaplasmids. We determined the
dAMP, dTMP, dGMP and dCMP stoichiometric coeﬃcients of the growth function by
counting directly from the DNA structures, assuming one copy of each.
Although very similar to DNA, RNA is diﬀerent in important structural details. For
one, while DNA is usually double stranded in cells, RNA can typically be found as single
strands. In addition, as the names suggest, RNA nucleotides contain ribose, while DNA
contains deoxyribose. RNA is produced from DNA through a process called transcription.
One of its main functions is the production of proteins. Speciﬁcally, a type of RNA called
messenger RNA (mRNA) carries information from DNA to structures called ribosomes.
These ribosomes can read mRNAs and translate the information they carry into proteins.
RNAs are also used for regulatory purposes, and are utilized by some viruses to replicate
their genomes by reverse transcription. Ribonucleic acids were approximated to comprise
20% of a cell’s organic mass, and the individual copy numbers of AMP, UMP, GMP, and
CMP were computed by weighting the total RNA content based on the chromosome’s 68%
GC composition.
The exact ratio between DNA and RNA in Halobacterium salinarum is not known.
Nevertheless, the current total nucleic acid content in the growth function is consistent
with a 610 fg cellular dry weight, after subtracting the other major components of the
biomass (proteins, lipids, salt, etc...). With respect to the computational model (Section
4.2.2), the ratio inﬂuences the ﬂuxes through only a very small part of the network because
DNA and RNA share most of the steps of their biosynthetic pathways.
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4.3.3 Surface Layer Glycoproteins
Rather than employing a true cell wall, Halobacterium salinarum uses what is called a
surface-layer as its outermost covering (Mescher and Strominger, 1976). This monolayer
covers the surface of the archaeon in a hexagonal macromolecular pattern. It consists of
subunits of a glycoprotein that is essential for maintaining the rod shape of the microorgan-
ism. The cell surface glycoprotein (CSG) contains three types of protein-linked saccharides
(Lechner and Sumper, 1987): (1) a single high molecular weight saccharide, which is com-
posed of repeats of sulfated pentasaccharides, that is connected to the polypeptide chain via
an Asn-GalNac linkage (Paul et al., 1986); (2) about 10 sulfated oligosaccharides that are
connected to the polypeptide via Asn-Glc linkages (Wieland et al., 1983); and (3) about
20 disaccharides (Glc-Gal) which are O-glycosidically attached to threonine residues of
the polypeptide chain (Mescher and Strominger, 1976). Although the contribution of the
polypeptide backbone of the CSG molecule to the biomass is already accounted for in the
growth function (Section 4.3.1), the carbohydrate units had to be included separately. A
schematic of the CSG is shown in Figure 4.5.
Figure 4.5: Schematic representation of
the cell surface glycoprotein. Numbering in-
dicates amino acid positions in the polypeptide
chain (black solid curve). The unﬁlled boxes
represent the repeated saccharide units. The
ﬁlled circles indicate the N-linked oligosaccha-
rides. The arrows represent the 0-linked Glc-
Gal disaccharides. The image was taken from
Lechner and Sumper, 1987. The carbohdrate
and sulphur units are the relevant molecules for
the deﬁnition of the growth function since the
polypeptide chain should already be accounted
for by the amino acid determination of the
biomass (Section 4.3.1).
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The CSG accounts for approximately 50% of the protein and all of the nonlipid carbo-
hydrates in the surface layer. We estimated its cellular copy number using structural data
from the closely related archaeon Haloferax volcanii (Kessel et al., 1988); seciﬁcally by ﬁt-
ting as much of the p6 lattice arrangement over the average surface area of Halobacterium
salinarum cells (9.99 x 10−8cm2). We then calculated the individual copy numbers of
the non-protein components using charaterization data of the CSG (Lechner and Sumper,
1987; Mescher and Strominger, 1976). Since there is still no assembly pathway for the
complete structure, its components were included separately in the growth function.
4.3.4 Membrane Lipids
Members of the family Halobacteriaceae have archaeal-type lipids that are based on iso-
prenyl chains attached to glycerol (Kamekura, 1993, 1998; Kamekura and Kates, 1988).
The diether core lipid is mostly 2,3-di-O-phythanyl-sn-glycerol (C20, C20), although some
species in addition contain the asymmetiric 2-O-sesterterpanyl-3-O-phytanyl-sn-glycerol
(C25, C20) (De Rosa et al., 1982; Dyall-Smith, 1995; Matsubara et al., 1994) and/or 2,3-
di-O-sesterterphanyl-sn-glycerol in diﬀerent amounts (De Rosa et al., 1983). Asymmetiric
core lipids (C25, C20) were also detected in Halobacterium halobium IAM13167, which may
be a Halobacterium salinarum strain (Morita et al., 1998).
For the sake of simplicity, and considering that complete biosynthetic pathways for
archaeal lipids have not yet been completely elucidated, only archaeol (2,3-di-O-phythanyl-
sn-glycerol) was used in the growth function. We assumed that lipids and proteins each
occupy 50% of the total cellular surface area. Accordingly, we approximated the lipid’s
copy number by dividing the surface area of a cell by the area occupied by the molecule
(65A2), since the membrane is a bilayer.
4.4 Consumption and Production of Nutrients
Consumption and production rates were modeled using diﬀerential equations of the form
of either Equation 4.16 or Equation 4.17 (see Section 4.2.1), with the rational that the
production or consumption of a metabolite depends on the availability of the metabolite,
the population size, and the current growth rate; note that growth-rate is time-varying in
batch cultures. The piecewise extension of Equation 4.16, Equation 4.17, was necessary
because several metabolites exhibited distinct modes over the growth period. For exam-
ple, alanine switches from production to consumption. After obtaining parameters for a
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Table 4.3: Comparison of transport equation forms.
Nutrient Basic Piecewise Error reduction
Alanine 0.3946 0.0300 92.4%
Aspartate 0.0135 0.0133 0.8%
Glutamate 0.4211 0.3947 6.3%
Phenylalanine 0.0009 0.0009 1.0%
Glycine 0.0075 0.0043 43.2%
Isoleucine 0.0171 0.0171 0.2%
Lysine 0.0245 0.0227 7.3%
Leucine 0.0599 0.0593 1.0%
Methionine 0.0144 0.0112 22.4%
Proline 0.0367 0.0167 54.5%
Serine 0.1810 0.1299 28.2%
Threonine 0.0803 0.0575 28.4%
Valine 0.0196 0.0128 35.0%
Tyrosine 0.0087 0.0082 6.6%
Ornithine 2.3873 0.0325 98.6%
The transport rate of each compound was modeled using a diﬀerential equation
of the form of either Equation (4.16) or Equation (4.17). The latter equation
form, which is a piecewise version of the former, was necessary because the up-
take patterns of several nutrients qualitatively change during growth. Columns
2 and 3 above list the best (lowest) residual error values for Equation (4.16)
and Equation (4.17), respectively. The rightmost column indicates how much
the error is reduced by using the piecewise version over the simpler form.
particular nutrient using both equations, we used the piecewise form only if it resulted in
at least a 10% residual error reduction in order to minimize the possibility of overﬁtting.
The best (lowest) residual error values we were able to obtain for each nutrient using
the two equation forms are listed in Table 4.3. Inspection of the results clearly shows that
the improvement gained in using the piecewise form is nearly negligible for a number of
metabolites, including aspartate, isoleucine, and leucine. In fact, it is very likely that the
slight decreases in the relevant residual errors are just due to overﬁtting to the noise in the
data. For the three amino acids mentioned, residual error values decreased by only 0.8%,
0.2%, and 1%, respectively. Considering that these same three amino acids, after arginine,
are also the ones with the highest uptake rates, it would seem that they are the preferred or
primary metabolites of H. salinarum during aerobic growth, at least among the nutrients
supplied. Unlike most of the other provided metabolites, their uptake patterns remained
constant, and their consumption rates high, up until their depletion. The experimental
nutrient utilization data and the corresponding model simulations are shown in Figure 4.6.
In contrast to the situation with aspartate, leucine and isoleucine, results showed (Table
4.3) that the piecewise transport equation form is clearly superior over the basic deﬁnition
(Equation 4.16) for ornithine, alanine and proline. For the latter amino acids, residual
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Figure 4.6: Nutrient consumption and production data from aerobically grown cells.
Experimental data are shown using diamonds (average) with error bars provided. Model sim-
ulations are illustrated using red broken curves. The transport patterns of several metabolites
qualitatively change during growth. For example, alanine and ornithine switch from production to
consumption. For such metabolites, the piecewise Equation (4.17) was used to model utilization,
and the corresponding ti,b parameter value, which represents a point near where the qualitative
change occurs, is indicated with an inverted green triangle.
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errors dropped by 98.6%, 92.4% and 54.5%, respectively. This was an indication that the
corresponding transport processes exhibit distinct modes. Indeed, transport of ornithine,
alanine and proline each exhibited a switch from production to consumption. Again, we
stress that we did not decide a priori to use the piecewise over the basic form of the
transport equation for any metabolite. Rather, the choices were made based on clear
indications of improvement. Therefore, not only can our methods account for changing
transport modes, but can actually lead to their identiﬁcation or veriﬁcation.
For the transport of a metabolite where the form of Equation 4.17 is clearly superior, the
boundary parameter ti,b indicates an approximate time for when the qualitative change in
the process occured. Similar to the use of the piecewise equation, the value of the parameter
was not set a priori but was optimized using data. In this respect, our methods actually
allow for the computational approximation of the critical points. The question therefore is
whether the values we obtained make biological sense. To a large extent, we believe that the
answer is yes. With respect to ornithine and proline, it is remarkable that their ti,b values,
which represent the points at which they switch from production to consumption, are close
to each other, and that both are near the time when arginine is depleted. This makes
sense because arginine is consumed rapidly by the cells, and both ornithine and proline are
downstream of its catabolic route. Indeed, the rapid depletion of arginine simultaneously
occurring with the rapid accumulation of ornithine in the medium is a clear indication of a
very active arginine fermentation pathway (see Section 4.8.2). Clearly, the ti,b parameters
we obtained, at least in this case, are not merely mathematically convenient, but in point
of fact correspond to, or reproduce, actual biological processes. Thus, as evidenced by this
example, not only do our methods identify the presence of distinct modes in the transport
processes but can actually lead to the elucidation of the reasons behind.
Valine uptake accelerates at approximately t = 77 h, near the time when isoleucine
is depleted. Similarly, the uptake rate of methionine accelerates at about t = 80 h, near
the time when leucine is depleted. While it is hard to conclude with certainty, given the
resolution and quality of the current data, that the acceleration of valine uptake actually
precedes that of methionine, it is very likely that the increased consumption rates for both
are the result of cells compensating for the depletion of leucine and isoleucine. Note that
the two branched-chain amino acids that were depleted seem to be preferred metabolites of
Halobacterium salinarum under aerobic conditions. Accordingly, cells would have had to
switch their metabolism to utilize more of the substitute sources in order to sustain their
growth. Alternative explanations are provided in Section 4.5.
92 4. Systems Analysis of H. salinarum Aerobic Growth and Bioenergetics
The other supplied metabolites with utilization patterns that we found to exhibit dis-
tinct modes are alanine, serine, threonine and glycine. The ﬁrst switches from gradual
production to rapid consumption, and the latter three demonstrate uptake rates that sig-
niﬁcantly accelerate. In each of these cases, the critical point seems to be near t = 92 h,
which is also near the time when proline, methionine and valine are depleted. Although
we believe that the increased consumption rates are also compensatory measures for the
depleted metabolites, it is again diﬃcult to conclude this with certainty given the current
data. Moreover, if true, it is also diﬃcult to determine whether which nutrients serve to
compensate for what.
4.5 Validation of the Critical Points
The consumption and/or production of a metabolite with a transport pattern that quali-
tatively changes during growth, i.e., exhibits distinct modes, was modeled using Equation
4.17. The ti,b parameter of this equation carries signiﬁcant qualitative interpretation be-
cause it indicates a point near where the qualitative change occurs. Its value is therefore
crucial for identifying possible biological reasons for the presence of the distinct modes.
For this reason, we performed further steps to investigate how well-deﬁned the values we
obtained are given the available data. Speciﬁcally, for each appropriate metabolite Xi, we
ﬁxed ti,b to speciﬁc values, and optimized for the best residual error that can be achieved
leaving all the other parameters free. As with before, we used systematically deﬁned initial
guesses (for the other parameters). The results are summarized in Figure 4.7. In the ﬁgure,
we plot for each metabolite the best residual error value as a function of ti,b (red broken
curves). The values inidicated are normalized to the overall minimum, and therefore good
values for ti,b are points at which the curve is near 1.0 (low).
Through manual inspection we found that most of the ti,b parameter values fall at
points that are near the time of depletion of at least one other supplied metabolite. For
example, the ti,b values initially obtained for ornithine and proline, where both metabolites
switch from production to consumption, are near the point at which arginine is depleted.
Similarly, the ti,b value of valine is near the depletion point of isoleucine. This can readily
be seen by comparing Figures 2 and 4.7. In such cases, we manually synchronized the
events by adjusting the ti,b’s. The ﬁnal values we used in our model are indicated by green,
inverted triangles in Figure 4.7.
It is clear that a global ti,b parameter value is not possible because of metabolites
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Figure 4.7: Parameter (ti,b) exploration for aerobically grown cells. The uptake patterns
of some supplied metabolites qualitatively change during growth. For such nutrients, the points
at which the changes occur are represented by the ti,b parameter of Equation 2. The above
graphs show for each metabolite the best residual error we were able to obtain for speciﬁc values
of ti,b normalized to the overall minimum (red broken curve). Accordingly, ideal values for ti,b
should be points where the curve is near 1.0 (lowest point). The actual parameter values used
in the ﬁnal model are indicated by green, inverted triangles. For comparison, we also indicate
the best residual error value we were able to obtain using the non-piecewise equation form (green
horizontal line).
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like ornithine that plainly switch mode before the rest. Nevertheless, arguments relating
to model simplicity may be made, given the current data, for using a common ti,b value
for all metabolites that change modes later in the growth period, particularly alanine,
glycine, methionine, serine, threonine and valine. Such synchronization could, for example,
be the result of a global (metabolic) shift that occurred at that time, which induced
the observed mode changes in the metabolites. While such an interpretation remains a
possibility, it is inferior to the current interpretation that most of the mode changes are
simply compensatory measures for the depletion of other nutrients in a number of ways.
The reasons include: (1) From Figure 4.7, it can be seen that there is no single value for
which the consumption/production models of the relevant nutrients are all at their best,
i.e., each is at a point where the residual error is lowest. (2) Also from Figure 4.7, it is
diﬃcult to reconcile the idea that the qualitative changes occur nearly simultaneously with
the observation that the curves of the relevant metabolites are quite diverse in their shapes;
for example, some curves reach their lowest point (1.0) a lot earlier than others, and also
begin rising earlier than others. If the events were indeed synchronized, then one would
expect the curves to be more similar than they are. And (3) non-synchronized ti,b values
allow for a more proportional total material uptake throughout growth. In contrast, forcing
a single common value, which should be taken from a very narrow window around t = 87.5
h (Figure 4.7), would mean that the total material uptake of cells from the time when
major metabolites (eg., leucine and isoleucine) are depleted up until the critical point
will be relatively very low compared to the rest of the growth period. Moreover, given
that all of the relevant mode changes are described by either an acceleration in uptake
rate or a switch from production to consumption, then the total material uptake starting
from the critical point on will be exceedingly high. Indeed, for methionine and valine, an
acceleration that takes place as late as t ≈ 87.5 would imply an incredibly high uptake rate
because both should already be depleted by about t = 92. We should note that an abrupt
increase in total material uptake is not something that is to be expected of a culture that
is slowing down with respect to growth (late log phase). Finally, nutrient substitution
has been described in bacteria and archaea. For example, E. coli has been shown to start
consumption of acetate once the glucose supply is depleted (Varma and Palsson, 1994;
Mahadevan et al., 2002).
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4.6 Carbon Fates
Nutrients consumed by cells can have various fates; they can be: (1) incorporated into the
biomass with at most very minimal changes, such as in the case of amino acids incorpo-
rated as protein residues or free metabolites; (2) converted to other biomass components,
typically after partial degradation; (3) oxidatively degraded to CO2 for the production of
energy through respiration; and (4) completely or partially degraded, for example down to
the level of small metabolites, and then secreted. Given that the rates at which most of the
supplied amino acids were consumed far exceeded the requirements for biomass incorpora-
tion as described in the fate (1) mentioned above, then at least one of the other possible
fates must also happen to the relevant amino acids. The results for individual metabolites
are summarized in Figure 4.8, and the comparison between total (global) carbon uptake
and total carbon incorporation (fates 1 and 2) is provided in Figure 4.9.
4.6.1 Degradation of Essential Amino Acids
Surprisingly, leucine, isoleucine, valine and methionine are among the nutrients that are
mostly degraded (see Figure 4.8) by Halobacterium salinarum, whether for energy or as
carbon skeleton donors. This was unexpected because the four are, along with lysine,
essential amino acids for the archaeon. That is, the microorganism cannot synthesize these
metabolites, and as such cannot grow if they are not exogenously supplied. For this reason,
one would typically expect that it is better for cells to use essential nutrients sparingly, for
example in accordance only with the requirements for biomass production, especially when
there are other non-essential sources of energy and carbon available. However, as discussed
earlier, leucine and isoleucine are even among the preferred metabolites of Halobacterium
salinarum (Section 4.4). The heavy rates at which the halophile catabolizes the essential
amino acids can cause it to prematurely terminate its own growth.
By t = 140 h, which is the boundary of our simulations, only about 7%, 8% and
4% of the amounts of leucine, isoleucine, and methionine, respectively, that have been
consumed have been directly incorporated into the biomass (fate 1). This means that
in each case, over 90% of the material that was taken up was used for other purposes,
which very likely involved at least partial degradation. While the exhibited behavior is
initially counterintuitive, we believe that it is actually an adaptation of the microorganism
to its environments, which are characterized not only by extreme salinity but also by eratic
nutritional availability. This is also supported by additional ﬁndings (see the rest of the
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Figure 4.8: Summary of nutrient uptake and incorporation rates under aerobic con-
ditions. The blue curves indicate the net amount of each amino acid that has been consumed
(positive) or produced (negative) as a function of time. The red curves, on the other hand, show
the total amount of each that has been incoporated into the biomass, whether integrated into
proteins or as free metabolites. Clearly, most of the supplied amino acids are taken up from the
medium at rates that far exceed the speeds at which they are directly incorporated. This implies
that the pertinent amino acids are, in addition, signiﬁcantly catabolized for energy, and/or are
used to synthesize the other biomass constituents that are not supplied.
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Figure 4.9: Total carbon consumption and biomass incorporation of aerobically
grown cells. The red curve shows the total amount of carbon that has been incorporated
into the biomass (computed using the biomass reaction deﬁnition and the time-dependent pop-
ulation size). On the other hand, the blue curve indicates the total amount of carbon that has
disappeared from the medium, calculated using the supplied nutrients and ornithine (ﬁlled tri-
angles are experimental data). At t = 140, only about 19% of the total carbon that has been
consumed can be accounted for by the biomass.
chapter and the next), and will be discussed in more detail in Section 5.3.
4.6.2 Investigating By-product Secretion
The four possible nutrient fates mentioned above can be grouped into two general cate-
gories; biomass incoporation (fates 1 and 2) and metabolic by-product secretion (fates 3
and 4). Only fate 1 is directly measurable using the experimental methods used in this
study. Nevertheless, with the approximation of the biomass composition in hand (Section
4.3), which was obtained using measurements, calculations and assumptions, analysis of
the other fates becomes possible. In particular, we correlated the nutrient utilization data
(Figure 4.6) with the growth function and the observed growth rates using ﬂux balance
analysis.
We repeated the determination of the amino acid content of the biomass for the spe-
ciﬁc cultures represented in Figure 4.6. The results are summarized in Figure 4.10. While
the relationships between the amino acid concentrations and the optical density are not
strictly linear, average errors from linear ﬁts are below 12.5% in all cases. Most of the
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Figure 4.10: Amino acid composition of biomass during aerobic growth. We repeated
biomass amino acid content determination for the speciﬁc cultures represented in Figure 4.6. The
amount of each was quantiﬁed at diﬀerent optical densities. The measurements include those that
are integrated into proteins (residues) and those that are free inside the cells. The red line in each
graph indicates the best linear ﬁt for the particular molecule. Average deviation from the line
in all cases is below 12.5%. Due to experimental limitations, we were not able to obtain values
for cysteine and tryptophan, and the values for aspartate and glutamate are already inclusive of
asparagine and glutamine, respectively.
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deviations are situated in the lower optical density range. With respect to the previous
set of measurements (Section 4.3.1), the most signiﬁcant diﬀerence is that the current re-
sults revealed a total amino acid content that is about 30% higher at approximately 503
µg/OD·ml. Possible factors that could have contributed to this discrepancy include dif-
ferences in the conditions used, including media composition, and the that fact we more
rigorously adapted the current cultures. The discrepancy is well within the range of inac-
curacy that may be introduced by morphological changes in the cells to the relationship
between biomass and optical density. Accordingly, we also adjusted the biomass require-
ment (composition) of the other constituents for the rest of the analysis described in this
chapter.
CO2 is an expected metabolic end-product of cells under aerobic conditions. Indeed, if
it is assumed that all carbon atoms that are taken up and do not appear in the biomass
are completely degraded through respiration, then CO2 should account for the bulk of the
by-product pool. We calculated the (theoretical) amount of oxygen that would have been
needed in our cultures under such a scenario at various points during growth, using ﬂux
balance analysis. However, measurements of actual oxygen consumption showed that cells
used only about 20% of the oxygen that they would have otherwise needed to completely
oxidize all the material. Therefore, respiratory-linked degradation was not the fate of most
of the carbon atoms that were consumed but did not get incorporated into the biomass.
Moreover, signiﬁcant quantities of (partially oxidized) by-products must have been formed
and accumulated in the medium, including very likely those that result from forms of
overﬂow metabolism. The results also show that the described situation already seems
to be the case even before the oxygen supply became limiting (about t = 30 h). The
computations are summarized in Figure 4.11. Note that the optimality assumptions of
ﬂux balance analysis have little to do with the predicted high by-product secretion rates.
Rather, the optimality principles only aﬀect the ratios between the by-products themselves;
for example, what percent is secreted as CO2 and what percent is secreted as partially
degraded metabolites. The latter type is likely because the repiratory rates exhibited by
the cells are clearly not suﬃcient to handle all the materials they consumed. Further ﬂux
analyses show that the most eﬃcient by-products with respect to energy production are
common intermediates such as acetate and succinate.
We observed a maximal respiratory rate of approximately 10 nmol O2/klett·ml·hr dur-
ing growth. At about t = 30 h, the amount of dissolved oxygen in the medium was reduced
to 0%. Given that prior to this point we could already observe large amounts of nutrients
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Figure 4.11: Theoretical (energy-optimal) and actual oxygen consumption rates. The
red broken curve indicates the amount of oxygen that would have been needed if all nutrients that
were taken up but did not get incorporated into the biomass were used for respiration. The blue
broken curve shows the actual oxygen utilization rate. The large discrepancy between the two
curves suggest that overﬂow metabolism is prevalent. The oxygen supply starts to become limiting
at about t = 30. The smaller peaks and troughs of the red curve are due to the discontinuities of
the piecewise models used for the uptake of several metabolites.
that were consumed but neither incorporated into the biomass nor subjected to oxidative
phosphorylation, then the respiratory process itself was likely the bottleneck prior to it.
After about t = 30 h however, cells could only respire in at most the rate at which oxygen
dissolved into the medium. Note that a 0% oxygen saturation level does not mean that
oxygen is no longer available to the cells because ﬂasks were kept open. Since growth
continued well past the point when the oxygen supply started to become limiting, the rate
of respiration dropped steadily from then on.
4.7 Bioenergetics
The bioenergetic fexibility of Halobacterium salinarum (Section 3.1.2) makes it an ideal
model organism for the integrated analysis of diﬀerent energy producing mechanisms which
are typically investigated separately. In particular, under the aerobic conditions that we
used, cells could derive energy (ATP) through respiration and substrate level phosphory-
lation (including arginine fermentation). We calculated the maximum (theoretical) energy
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that the system can produce at various points during growth, using ﬂux balance analysis
subject to the nutrient utilization (Figure 4.6) and oxgen consumption data, and evalu-
ated the result with respect to the contribution of respiration. The values are indicated in
Figure 4.12 by the red and blue curves, respectively. Speciﬁcally, we calculated the energy
produced by respiration (blue curve) using the observed oxygen consumption rates and an
ATP to O2 ratio of approximately 1:1 (Hartmann et al., 1977). On the other hand, the
system maximum energy (red curve) was calculated as
Emax(t) = vATP (t) + µγ˙(t) (4.27)
where γ˙(t) is the current growth rate, and µ is the growth-related energy that is implicitly
taken into account by the metabolic network in synthesizing the compounds included in
the biomass (Teusink et al., 2006). In order to ﬁnd ﬂux distributions that maximize energy
production, we introduced an ATP hydrolysis reaction (ATP + H2O = ADP + P) into the
network, and performed ﬂux balance analysis with it deﬁned as the objective function.
vATP (t) in Equation (4.27) refers to the ﬂux through this reaction.
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Figure 4.12: System energy in ATP equivalent. The red curve shows the maximum amount
of energy, computed using FBA, that the system can produce at various points during growth.
The blue curve indicates the amount of energy that is produced through respiration. Interestingly,
prior to the depletion of arginine (t ≈ 15), fermentation of the amino acid generates most of the
energy in the system, even more than respiration.
From Figure 4.12, it can be observed that the theoretical maximum amount of energy
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that the system can produce (red curve in Figure 9) is signiﬁcantly higher than what is
generated by respiration (blue curve). Although it may be the case that the actual energy
production of the system is lower than what the theoretical values indicate, it is clear that
at the early stages of growth (before approximately t = 15), very large amounts of energy
are generated that cannot be attributed to respiration. Inspection of the model revealed
that this is due to activity of the arginine fermentation pathway during that period. This
ﬁnding is quite signiﬁcant because arginine fermentation is normally assumed to play a
secondary bioenergetic role, i.e., an alternative to the primary modes of respiration and
photosynthesis. However, in contrast to the typical supposition, the fermentation process
occurs simultaneously with respiration, and is moreover highly active. We should note
that this conclusion, because of the constraints imposed by the observed rapid depletion
and accumulation of arginine and ornithine, respectively, is not subject to the optimality
assumptions used during FBA.
Our ﬁndings also indicate that arginine fermentation occurs at such high velocities that
its energy output becomes comparable to that of the respiration, even though it is much
less eﬃcient in terms of ATP production per unit substrate. Indeed, even if we increased
the eﬃciency of the ATP to O2 ratio that we used, which was obtained from oxygen
pulse experiments (Hartmann et al., 1977) that were not corrected for possible competing
processes, by a factor of 4 from 1:1 to 4:1, calculations would still indicate that arginine
fermentation out-produces respiration in our cultures. This is consistent with the fact that
Halobacterium salinarum can be grown with neither oxygen nor light just as readily, by
supplying large amounts of the amino acid.
After arginine was depleted at about t = 15 h (Figure 4.12), respiration accounted for
most of the energy produced in the system. The additional energy that can be produced
through the further non-respiratory-related degradation of other (non-arginine) nutrients
is signiﬁcantly smaller. This being the case, and in connection with the observations
made in Section 4.6, it is remarkable that non-respiratory-related processes account for
approximately 80% of the nutrients that were consumed but not incorporated into the
biomass. Again, the pertinent metabolites include essential ones. Unfortunately, the nature
and purpose of the catabolic processes remain unlcear.
4.8 Fluxome Prediction 103
4.8 Fluxome Prediction
The determination of internal metabolic ﬂuxes is very important because they describe
at the molecular level how an organism lives and grows. Unfortunately, in sharp contrast
to other ’omics’ technologies, ﬂuxome analysis has remained a laborious endeavor (Sauer,
2004). This is especially true for organisms such as Halobacterium salinarum, where car-
bon labeling, the experimental basis for ﬂux analysis, is complicated by the necessary
presence of multiple substrates in the medium. Accordingly, genome-scale measurements
of ﬂuxes for the archaeon are still very diﬃcult and impractical. In this study, we used our
constraints-based model to predict values for the ﬂuxes, or at least analyze their allowable
ranges. Speciﬁcally, we used ﬂux balance analysis to determine particular distributions,
and performed ﬂux variability analysis to calculate for each reaction its maxmimum and
minimum ﬂux values independent of any optimality assumption.
4.8.1 Variability Analysis
The ﬂuxome illustrated in Figure 4.13 was calculated using the observed consumption
and production rates during the log phase. In it, compounds that are taken up from the
medium are represented by yellow ellipses, and compounds which are accumulated in the
medium by red ellipses. Fluxes through reactions are represented by arrows, and thickness
is used to indicate strength. Considering that it is uncertain to what extent energy produc-
tion, or any of the optimality principles used in FBA, is actually the objective of cells in
vivo, we used ﬂux variability analysis (Mahadevan and Schilling, 2003) to complement the
results by computing the minimum and maximum possible ﬂuxes through each reaction
after removing all optimality assumptions. Fluxes through reactions for which the values
are either both positive or both negative are drawn in black. Intuitively, these are reactions
that are constrained enough by the network stucture, pseudo-stability and the observed
exchange ﬂuxes, to have non-zero activity regardless of any optimality assumption. That
is, the network structure and the measured data are already enough to guarantee the exis-
tence of the ﬂuxes and their indicated directions. We refer to these ﬂuxes as qualitatively
constrained.
During the log phase (t = 30 h), we found 378 (67%) of the 567 internal reactions of
the metabolic network to have qualitatively invariable ﬂuxes. Of these, 246 carry non-zero
ﬂuxes, and 132 are blocked under the conditions. The fact that measurements of a relatively
few input and output ﬂuxes already qualitatively determine the ﬂuxes through most of the
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Figure 4.13: Predicted fluxome during log phase (t=30 ) that maximizes energy
production. Yellow ellipses represent compounds that are taken up from the medium, while
light-red ellipses represent those that are accumulated in the medium. Larger ﬂuxes are drawn
with thicker arrows. Black and red arrows correspond to qualitatively invariable and qualitatively
variable (see main text) ﬂuxes, respectively. Side reactants, for the most part, are not depicted
in the ﬁgure. Yellow rounded boxes represent biochemical pathways.
Metabolite abbreviations: 3dhq - 3-dehydroquinate, 5,10mtthf - 5,10-methylenetetrahydrofolate, 6pglcn - 6-phosphogluconate,
ac-CoA - acetyl-CoA, Ala - alanine, Asn - asparagine, Asp - aspartate, asp4sa - aspartate 4-semialdehyde, Arg - arginine, Cys -
cysteine, dkfrcp - 6-deoxy-5-ketofructose 1-phosphate, gal - galactose, gap - glyceraldehyde 3-phosphate, cho - chorismate, glc -
glucose, Gly - glycine, glyc - glycerol, Glu - glutamate, Gln - glutamine, His - histidine, hmg-CoA - 3-hydroxy-3-methyl-glutaryl-CoA,
ipdp - isopenteny diphosphate, Ile - isolecuine, Leu - leucine, Lys - lysine, Met - methionine, mev - mevalonate, Orn - ornithine,
Phe - phenylalanine, Pro - proline, prop-CoA - propanoyl-CoA, prpp - 5-phosphoribosyl diphosphate, pyr - pyruvate, Ser - serine,
shk - shikimate, thf - tetrahydrofolate, Thr - threonine, Trp - tryptophan, Tyr - tyrosine, uppg-III - uroporphyrinogen III, Val -
valine.
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reactions is related to the bow tie structure of the metabolic network (Gonzalez et al.,
2008; Csete and Doyle, 2004). Catabolic pathways, which together form one fan of the
bow tie, fan-in into the knot of central metabolism to supply the common intermediates.
These pathways are highly linear and convergent in structure. Accordingly, nutrients which
are taken up and not directly incorporated into the biomass will have to go through the
associated catabolic pathway with no variability until the level of the common intermediates
is reached. Similarly, biosynthetic pathways, which form the other fan of the bow tie, fan-
out and branch from the knot of central metabolism, and are also highly linear in structure.
Thus, most biosynthetic routes of cellular constituents will also be invariable once past the
level of the metabolic core.
4.8.2 Nutrient Utilization
When an organism is grown on deﬁned substrates, it is often of interest to know which
pathways are active, and for what processes and to what extents the supplied substrates
are utilized. This information can be used to guide labeling studies as well as to interpret
results from experiments using similar conditions, such as transcript and protein expres-
sion data. As a simple example, given that the precise mechanisms for lipid formation in
Halobacterium salinarum is still unclear, it will be of interest to maximize the ﬂow of cen-
tral metabolites into lipid formation to facilitate labeling experiments. From the ﬂuxome
(Figure 4.13), it is clear that the high catabolic ﬂuxes from leucine and and lysine will have
to be reduced, such as by using mutants deﬁcient in genes associated with the pertinent
pathways. In this section, we describe how the supplied nutrients are utilized under the
aerobic conditions, and relate them with the current knowledge in the literature.
About 90% of the leucine taken up by cells is converted to hydroxymethylglutaryl-
CoA (hmg-CoA) during the log phase. In turn, most of the hmg-CoA enter the TCA
cycle through acetoacetate as acetyl-CoA, and some are converted to mevalonate (EC
1.1.1.34) on the way to the synthesis of archaeal isoprenoid lipids. Note that unlike higher
organisms that synthesize their isoprenoid chains from acetate, halobacterial species at
least in part synthesize their lipids from amino acids (Ekiel et al., 1986). While no gene
could be assigned for the enzyme hmg-CoA lyase (EC 4.1.3.4) in Halobacterium salinarum,
simulations indicated that the biochemical function must be present as it is needed to
channel the substantial quantities of leucine molecules that are not directly integrated into
the biomass. One candidate is the gene annotated as hmg-CoA synthase (EC 2.3.3.10),
which classically catalyzes a reaction that proceeds in the other direction. Alternatively,
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it is also possible that the organism uses a mechanism that is currently uncharacterized,
or that it is using a non-homologous gene.
Approximately 93% of isoleucine is degraded and enters the TCA cycle at two entry
points; C2 units enter as acetyl-CoA, and the ﬁnal C3 unit, propionate, is converted to
succinyl-CoA. Since the consumption rates of leucine and isoleucine exhibited among the
greatest reductions during phototrophic growth (Chapter 5) compared to aerobic growth,
it is likely that the two are the main respiratory substrates of Halobacterium salinarum
under the conditions used.
In contrast to the other two branched-chain amino acids, valine exhibited relatively very
little uptake activity during the log phase. However, consumption of the amino acid greatly
accelerated when isoleucine was depleted. Considering this and the fact that isoleucine and
valine share the catabolic route through propionate, it would seem that the latter is used
by the archaeon as an alternative to the former. Valine is in addition used to synthesize
coenzyme-A (minor ﬂux).
While it is diﬃcult to interpret the individual ﬂuxes into central metabolism from
glycine, serine and threonine due to interconversions among them, simulations showed
that the combined ﬂux is about 53% of their total uptake. The scheme depicted in Fig-
ure 4.13 represents an optimal conﬁguration where threonine and serine, at least in part,
are converted to glycine, which is then cleaved to NH3 and CO2. Prior to the depletion
of threonine and serine, the uptake rate of glycine was below the requirement for direct
biomass incorporation of the amino acid. This does not even consider the fact that glycine
also serves as the methyl donor, via tetrahydrofolate, in a number of biosynthetic reac-
tions. However, after serine or threonine was depleted, or both since the resolution of the
data does not allow us to diﬀerentiate between the two events, glycine uptake accelerated
considerably. This is consistent with the idea that threonine and serine were partially
converted to the amino acid in order to shoulder some of the requirements for it.
Aspartate exhibited the highest consumption rate next to arginine. Most of it likely
enters the TCA cycle as oxaloacetate, although, in addition, it is also: (1) used to synthesize
asparagine (EC 6.3.5.4); (2) oxidated to iminoaspartate (EC 1.4.3.16) on the way to the
synthesis of NAD+ (minor ﬂux); (3) used to synthesize the probable aromatic amino acid
precursor aspartate-4-semialdehyde (Section 3.7.3); and (4) is used in the metabolism of
nucleotides.
None of the key degradative enzymes for phenylalanine and tyrosine could be identiﬁed
in Halobacterium salinarum during the initial stages of reconstruction. However, similar
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to the case for hmg-CoA lyase (EC 4.1.3.4), simulations indicated that the archaeon likely
has the capability to degrade both amino acids. The uptake rate of each exceeded the
corresponding incorporation rate (Section 4.4), more notably for phenylalanine. Accord-
ingly, it is likely that the archaeon either uses non-homolgous enzymes or employs as of
yet uncharacterized pathways.
Analogous to the situations with phenylalanine and tyrosine, degradative enzymes could
also not be identiﬁed for lysine even though uptake of the amino acid signiﬁcantly exceeded
the requirement for biomass incorporation. Therefore, a catabolic pathway for the amino
acid is also likely. Indeed, it was observed in a previous study that labeled carbon atoms
from lysine turn up in isoprenoid molecules (Ekiel et al., 1986). Based on the observed
labeling pattern, it is likely that the pathway goes through acetoacetate (or acetoacetyl-
CoA).
We mentioned earlier that the ti,b parameters for ornithine and proline are remarkably
close to each other, and that both occur near the time when arginine is depleted (Section
4.4). We also pointed out that the situation revealed by our methods made sense since
both ornithine and proline are downstream of arginine’s catabolic route. Here, we discuss
the relationships between the three metabolites in more detail. Growth simulation at a
point before arginine depletion shows the situation depicted in Figure 4.14. From the
ﬁgure, it can be seen that arginine, which exhibited the highest uptake rate prior to its
depletion, is mostly deaminated to citrulline via the action of arginine deiminase (EC
3.5.3.6). In turn, citrulline is converted to ornithine and carbamoyl-phosphate by ornithine
carbamoyltransferase (EC 2.1.3.3). On one hand, ornithine is mainly transported outside
cells through an arginine-ornithine antiporter (≈ 95%). This means that most of the
arginine is transported into the cells for “free”. Small amounts of ornithine continue
through the catabolic route that, via proline, eventually leads to α-ketoglutarate. On the
other hand, carbamoyl-phosphate is mostly degraded to NH3 and CO2 in a reaction that
produces ATP from ADP (EC 2.7.2.2). To summarize the situation, arginine is rapidly
converted to ornithine through a process that results in the net production of ATP. The
carbon skeleton of ornithine is not further degraded, but is is rather secreted. As was
discussed earlier, arginine fermentation accounts for most of the energy in the cells at the
early stages of growth (Section 4.7).
Ornithine was not one of the metabolites in the medium that were originally measured
at the early iterations of our analysis of aerobic cultures. However, since we believed that
arginine is essential for Halobacterium salinarum and we observed that cells continued to
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Figure 4.14: Arginine, proline and or-
nithine metabolism. Prior to its deple-
tion, arginine exhibits the highest uptake
rate among the supplied nutrients. Most
of it is deaminated to citrulline, which is
then converted to ornithine and carbamoyl-
phosphate (cbp). Most of the ornithine
(≈ 95%) is transported outside through an
arginine-ornithine antiporter. On the other
hand, carbamoyl phosphate is primarily de-
graded to NH3 and CO2 in a reaction that
produces ATP from ADP. Simulations show
that at the beginning of growth this pro-
cess produces most of the energy in the cells.
The red broken arrows indicate connections
to other parts of the network.
grow well past the point when the amino acid was depleted, we concluded that the archaeon
was simply storing the carbon skeleton of arginine in a reusable form. Despite the fact that
arginine fermentation is often assumed to be repressed by the primary bioenergetic modes
of respiration and photosynthesis, our ﬁrst intuition then was still that the reusable form
is ornithine. This is the reason why we subsequently included it in the set of measured
metabolites. As has been described above, our initial intuition proved to be correct as
the succeeding results showed that ornithine is rapidly accumulated, and then gradually
consumed once the arginine supply is exhausted. In addition, our proposed scheme also
implied that ornithine should be able to substitute for arginine in the medium. Accordingly,
we also conﬁrmed this by growing Halobacterium salinarum in a medium were arginine is
replaced by ornithine. However, unexpected results where obtained when, in the interest of
completeness, we also tried to grow the archeaon with neither of the metabolites supplied,
and got positive results. Details on this aspect are discussed in Section 3.7.1.
Members of Halobacterium (salinarum, NRC-1, cutirubrum, halobium) have long been
reported not to grow on sugars. Indeed, active transport of glucose has been experi-
mentally excluded (Severina et al., 1991). Despite these ﬁndings however, the exogenous
addition of glucose and galactose have been described to stimulate growth to some extent
(Gochnauer and Kushner, 1969; Sonawat et al., 1990). We believe that this is in part due
to the signiﬁcant biosynthetic burden that is alleviated from the cells. Note that the surface
layer of the Halobacteria contain saccharide elements (Section 4.3). Under the speciﬁc set
of conditions being analyzed, simulations show that the archaeon must be using a reversal
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of the glycolytic pathway (gluconeogenesis) to fulﬁl its sugar needs. Pyruvate that enters
gluconeogenesis during the log phase is produced either through the decarboxylation of
malate or oxaloacetate (EC 1.1.1.40), or from serine (EC 4.3.1.19).
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Chapter 5
Phototrophic Growth of H.
salinarum
This chapter is a continuation of the analysis of Halobacterium salinarum’s growth. The
main diﬀerence from the previous chapter is that the focus is on phototrophic conditions.
This allows for a comparison between the two bioenergetic modes of respiration and pho-
tosynthesis. A discussion of the main ﬁndings for both conditions is provided in Section
5.3.
5.1 General Comparison with Aerobic Case
Phototrophic cultures were grown under generally similar conditions to the aerobic prepa-
rations, with the obvious exceptions of the absence of oxygen and the presence of illumi-
nation (white light). The ﬂasks were ﬁrst ﬂushed with nitrogen in order to remove oxygen,
and were then closed using air-tight septa. So as to maintain the anaerobic conditions of
the cultures while taking samples, syringes with long needles inserted through the septa
were used. We were able to observe ﬁnal optical densities well above 150 klett (1.5 OD),
comparable to the population levels achieved by their counterparts (see Figure 5.1). The
most apparent diﬀerence is with respect to having slower growth rates. While aerobic
preparations exhibited log phase doubling times of only roughly 11 hours, phototrophic
cultures demonstrated times close to 50 hours. The reason for this disparity is unclear.
Representative aerobic and phototrophic growth curves are depicted in Figure 5.1.
We repeated the procedure for the determination of biomass amino acid content (Sec-
tion 4.3.1) on the phototrophic cultures (Figure 5.2). Measurements revealed that they in
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Figure 5.1: Representative growth curves. (Left:) Cells grown aerobically in the dark. A
doubling time of approximately 11 hours was observed. (Right:) Cells grown anaerobically in
light. The culture exhibited a much slower growth rate with a doubling time of about 50 hours.
Please take note of the very diﬀerent time scales between the two graphs.
general have approximately 35% less of each amino acid per klett·ml compared to their
aerobic counterparts (Figure 5.3, top graph). However, this does not necessarily mean that
the content per cell is really lower. The discrepancies can very well be due to morpho-
logical diﬀerences between cells under the two conditions, which could have aﬀected the
relationship between optical density and cell count. In contrast, the relative contribution
of each amino acid to the total is remarkably constant between the two conditions (Figure
5.3, bottom graph).
5.2 Metabolite Consumption and Production
We modeled the consumption and production of metabolites during phototrophy using
the same procedure employed in the aerobic case (Section 4.2.1). Again, the ti,b parame-
ters, when applicable, reﬂect the points at which the qualitative changes in the transport
processes occur. The experimental data and the corresponding model simulations are il-
lustrated in Figure 5.4.
Analogous to the aerobic case, arginine was already depleted near the start of growth
with most of it converted to ornithine and secreted by cells into the medium. This is
interesting because arginine fermentation genes (arcABC) have been found to be repressed
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Figure 5.2: Amino acid composition of biomass during phototrophic growth. The
amount of each amino acid was measured at diﬀerent optical densities. The values indicated are
inclusive of those that are integrated into proteins (residues) and those that are free inside cells.
The red lines indicate the best linear ﬁts. Due to experimental limitations, we were not able to
obtain values for cysteine and tryptophan, and the values for aspartate and glutamate are already
inclusive of asparagine and glutamine, respectively.
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Figure 5.3: Comparison of the biomass amino acid composition between aerobic
and phototrophic cultures. The top and bottom graphs show absolute and relative values,
respectively. Phototrophic cultures in general have approximately 35% less of each amino acid
per klett·ml. However, this does not necessarily mean that the content per cell is really lower.
The discrepancies can very well be due to morphological diﬀerences between the cells under the
two conditions, which could have aﬀected the relationship between optical density and cell count.
The relative contribution of each amino acid to the total is remarkably constant between the two
conditions (bottom graph). However, it is worth noting that hydrophobic amino acids seem to
be slightly overrepresented under phototrophic conditions, and hydrophilic amino acids slightly
underrpresented. This is indicative of a higher expression ratio between membrane and cytosolic
proteins.
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during phototrophy, presumably to repress the secondary energy source (Pan et al., 2002).
However, the rapid depletion of the amino acid and the equally rapid accumulation of or-
nithine is a clear indication that the fermentation process was in fact active even under the
phototrophic condition. Considering that we used inoculants taken from cultures already
growing under phototrophy, it is unlikely that the observations are only due to the time
(lag) that is required for regulation to take eﬀect.
Next to arginine, aspartate exhibited the highest uptake rate, and is the second supplied
amino acid that is depleted at about t = 200 h. Up to that point, very little consumption of
glutamate could be observed, if at all. However, after the exogenous supply of aspartate was
exhausted, consumption of glutamate either started or accelerated appreciably. Therefore,
it would seem that glutamate is used as a substitute for aspartate under the conditions.
Note that both amino acids are just one step away from the TCA cycle. Methionine
consumption also accelerates at about the same point.
Some 200 hours later (t ≈ 400 h), phenylalanine is depleted, and threonine and serine
are nearly exhausted. In addition, alanine switches from production to consumption, and
the uptake of glycine accelerates. As pointed out earlier (Section 4.8.2), the three amino
acids glycine, serine and threonine are connected to each other through their degradative
pathways. Presumably, when glycine is no longer produced through the degradation of
excess amounts of either serine or threonine, then cells will have to transport more of it.
This is consistent with the observation under both aerobic and anaerobic conditions that
prior to the depletion of serine or threonine or both, glycine consumption is signiﬁcantly
lower than the rate at which it is incorporated into the biomass, not even considering its
role as the methyl donor in various biosynthetic pathways.
The depletion of phenylalanine coincided with a number of discernable qualitative
changes in the transport pattern of other metabolites, unlike in the aerobic case. In addi-
tion to the ones stated above, consumption of the amino acid serine seems to have stopped
at about the same time, even though growth, albeit already in the late log phase, could still
be observed. The reason for this is unclear. Serine was already nearly exhausted at about
0.2 mM by then. Nevertheless, we should point out that it is also at this point that alanine
switches from production to consumption, and that serine and alanine are metabolically
related to each other by virtue of degradation to pyruvate. Phenylalanine also, at least in
part, enters central metabolism through pyruvate, so the seeming synchronization of the
qualitative change in the transport pattern of this amino acid with those of serine and
alanine is possibly related to this fact. Moreover, we should also note that in the aerobic
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Figure 5.4: Nutrient consumption and production data from cells grown anaero-
bically in light. Experimental data are indicated using diamonds (average) with error bars
provided. Model simulations are illustrated using red broken curves. The transport patterns
of several metabolites qualitatively change during growth. For such metabolites, the piecewise
Equation (3) was used to model utilization, and the corresponding ti,b parameter value, which
represents a point near where the qualitative change occurs, is indicated with an inverted green
triangle. Note that serine uptake stops at around t = 400 h, and does not go down to zero. This
ﬁgure corresponds to Figure 4.6 for the aerobic case.
5.2 Metabolite Consumption and Production 117
case, not only were we unable to observe an arrest in serine uptake, but the switch of ala-
nine from production to consumption actually conincided with the acceleration of serine
consumption. Therefore, an anaerobic condition is likely also a factor for the observations,
ie., it is possible that phenylalanine played a more important role in the phototrophic case.
In this respect, we should note that the early steps in the biosynthesis of the aromatic
amino acids (Section 3.7.3) are shared with the pathway for the production of quinones,
which play critical roles in respiration.
Somewhat unexpectedly, the rates at which most of the supplied amino acids were
taken up from the medium far exceeded the rates at which they were directly incorporated
into the biomass (fate 1), analogous to the aerobic case. The results are summarized in
Figure 5.5. Again, the implication is that the consumed quantities of the pertinent amino
acids are considerably catabolized by the cells. Certainly, signiﬁcant portions of these
are used as building blocks (carbon skeleton donors) for the production of other biomass
constituents (fate 2), such as nucleotides and lipid molecules. However, even the substrate
requirements for the synthesis of these unsupplied biomass components are not enough to
explain the diﬀerences. This can readily be seen in Figure 5.6, which shows the total carbon
uptake against the total carbon incorporation. Accordingly, considerable quantities of other
metabolites (by-products) must also be produced and accumulated in the medium. This
is somewhat more unexpected under anaerobic conditions because the necessary oxidative
breakdown of nutrients by respiration does not occur. Under phototrophic conditions, one
would typically expect material consumption to be only near the quantity suﬃcient for
biomass production because energy can already be derived from light rather than from
the supplied metabolites. The energy yield of the non-respiratory degradation of these
materials should be very small compared to the energy produced through photosynthesis,
especially considering that arginine is the only fermentative substrate of H. salinarum.
Nevertheless, in retrospect, this behavior is consistent with the emerging picture that the
organism takes an approach toward growth that is focused on the here and now, even at the
cost of longer-term concerns. Indeed, the essential amino acids leucine, lysine, isoleucine,
methionine and valine are again among the amino acids that are taken up in amounts far
more than required for biomass formation.
When phototrophic cultures reached 150 klett (1.5 OD), approximately 30% of the
supplied carbon that has been consumed can be attributed to the biomass. In comparison,
19% was incorporated when aerobic cultures reached comparable levels of population (also
in the late log phase). This means that 70% and 81% are not incorporated under the
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Figure 5.5: Summary of nutrient uptake and incorporation rates under phototrophic
(anaerobic) conditions. The blue curves indicate the total amount of each amino acid that has
been consumed/produced. The red curves show the total amount of that particular amino acid
that has been incoporated into the biomass, wether integrated into proteins or as free metabolites,
as calculated from the population size and the growth (biomass) function. Similar to the aerobic
case, and somewhat unexpectedly, most of the supplied amino acids exhibited uptake rates that
far exceeded the rates at which they were incorporated. This implies that the amino acids, in
addition to biomass incorporation, are also catabolized signiﬁcantly.
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Figure 5.6: Total carbon consumption and biomass incorporation of phototrophically
grown cells. The red curve shows the total amount of carbon that has been incorporated into
the biomass (computed using the biomass reaction deﬁnition and the time-dependent population
size). On the other hand, the blue curve indicates the total amount of carbon which has disap-
peared from the medium, calculated using the supplied nutrients and ornithine (ﬁlled triangles
are experimental data). At t = 650, only ≈ 30% of the total carbon that has been consumed can
be found in the biomass.
phototrophic and aerobic conditions, respectively. Further adjusting the aerobic value of
81% to account for the respiratory-related oxidative degradation of nutrients (assuming a
1:1 CO2 to O2 ratio) reduces it to approximately 66%. Considering that the the growth
rates observed under phototrophy were nearly ﬁve-fold slower, it is remarkable that the
ratios are as close to each other as they are. Indeed, aerobic cultures already reached
150 klett after only slightly more than 80 hours, while, in stark contrast, phototrophic
cultures took about 450 hours to reach similar levels. It would therefore seem that a large
part of the nutrients that were taken up but neither incorporated into the biomass nor
used as respiratory substrates has more to do with growth (biomass production) than with
any form of maintenance. Accordingly, it is likely that some as of yet uncharacterized,
non-maintenance growth processes are at least partially responsible for the low carbon
incorporation rates.
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5.3 Environmental Adaptations
Several unexpected ﬁndings regarding the growth of Halobacterium salinarum were made
during the course of this study. First, essential amino acids are degraded under both aerobic
and phototrophic (anaerobic) conditions, even though energy should already be abundant.
That this is the case during respiration is already unexpected because this can lead to cells
stunting their own growth. However, that this is also true under phototrophic conditions
is surprising since energy can already be derived from light. Second, arginine fermentation
occurs simultaneously with respiration and photosynthesis. This is in contrast to the
typical assumption that the fermentation process plays a secondary, alternative role to
respiration and photosynthesis. Third, considerable amounts of metabolites are produced
and accumulate in the medium under both conditions, as a result of nutrients that are
consumed but not incorporated into the biomass nor used as respiratory substrates. And
fourth, in connection with the previous point, the total carbon incorporation rates under
both conditions are very low. In particular, the incorporation rate during phototrophy was
approximately 30%, when one would typically expect nutrient consumption to be just in
quantities suﬃcient for biomass production since energy is already derived from light.
All of the ﬁndings mentioned above are consistent in depicting a seemingly “greedy” be-
havior by Halobacterium salinarum. We believe that these are actually adaptations of the
halophile to its natural environments (Gonzalez et al., 2008), where nutrient availability is
not only irregular but can also be absent for extended periods of time. In the salt lakes
and solar salterns where Halobacterium salinarum may be found, life is characterized by
blooms that may not occur for years after a previous episode. In the Dead Sea for example,
no growth of the unicellular green alga Dunaliella parva, which is responsible for all of the
primary productivity, is possible when the salt concentration of the water column is invari-
ably high. Blooms of Dunaliella in the Dead Sea occur only after signiﬁcant dilution of the
upper levels by the inﬂux of freshwater. In turn, this allows the archaeal community to
bloom at the expense of the organic material produced by the alga (Oren and Shilo, 1982).
The fact that the conditions which allow these blooms may not be realized for years after a
previous episode (Oren and Gurevich, 1995a; Oren, 1983b) may have predisposed Halobac-
terium salinarum to grow as much as possible when the conditions become favorable. In
turn, this increases the probability of its survival until the next growth-conducive period.
Consistent with this, the capacity of the halobacteria to survive in adverse conditions for
extended periods is well established (Grant and Norton, 1998; Grant et al., 1998). In this
respect, we should note that a considerable number of the reported viable ancient cells
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that have been recovered are at least moderately halophilic (halotolerant) (Vreeland et al.,
2000; Denner et al., 1994; Norton et al., 1993).
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Chapter 6
Analysis of N. pharaonis Growth
6.1 The Polyextremophile
Natronomonas pharaonis can be isolated from soda lakes where it has to cope with two ex-
treme conditions; high salt concentrations and an alkaline pH of 11. Two strains have been
described so far; strain Gabara from lake Gabara in Egypt (DSM 2160) (Soliman and Truper,
1982) and strain SP1 from lake Magadi in Kenya (DSM 3395) (Tindall et al., 1984). Similar
to Halobacterium salinarum, Natronomonas pharaonis belongs to the order Halobacteriales,
and accordingly also to the family Halobacteriaceae.
Figure 6.1: Electron microscopic image of
Natronomonas pharaonis. The archaeon is
a polyextremophile that is adapted to both high
salinity and alkaline pH. The image shows two
long ﬂagellar bundles that emerge from the rod-
shaped cell body. The photo was taken from the
Max-Planck Institute for Biochemistry website1.
1http://www.biochem.mpg.de/en/rd/oesterhelt/web page list/Org Napha/
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The genome of Natronomonas pharaonis type strain Gabara (DSM 2160) is orga-
nized into a 2.6-Mb chromosome, a typical haloarchaeal 131-kb plasmid (PL131) and
a unique multicopy 23-kb plasmid (PL23) (Falb et al., 2005). The chromosome is GC
rich (63.4%GC) and contains an integrated copy of PL23. 2843 protein-coding genes
were predicted, 65% of which could be assigned to a COG (cluster of orthologous group,
Tatusov et al., 1997, 2001). 45% and 12% of the predicted proteome could be assigned
speciﬁc and general functions, respectively.
Consistent with other haloarchaea, cytoplasmic Natronomonas pharaonis proteins con-
tain a high proportion of acidic amino acids (Falb et al., 2005). This leads to low isoelectric
points (average pI 4.6), which can increase protein stability in the presence of extremely
high ionic concentrations (Section 2.3.1). In addition, the archaeon was reported to use
2-sulfotrehalose as an osmolyte, by producing it in amounts that increase with the con-
centration of external NaCl (Desmarais et al., 1997). Its genome also codes for a typical
compatible solute transporter (NP3588A).
6.2 Metabolic Reconstruction
We reconstructed the metabolic network of Natronomonas pharaonis using the same proce-
dure used for Halobacterium salinarum (Section 3.3). The resulting network, which gener-
ally has the same coverage as the ﬁrst, consists of 592 genes and 675 reactions. 56% of the
ORFs have reliable proteomic identiﬁcation (Konstantinidis et al., 2007; Aivaliotis et al.,
2007). A breakdown of the reactions into high-level functional categories is provided in
Figure 6.2. Compared to Halobacterium salinarum, very little literature was available
for Natronomonas pharaonis. As such, most reactions were included in the network with
bioinformatic evidence only.
6.2.1 Central Metabolism
Similar to Halobacterium salinarum, a gene for the key Embden-Meyerhof pathway enzyme
6-phosphofructokinase (EC 2.7.1.11) could not be assigned, and neither for the new archaeal
types of the enzyme that use ADP as co-substrate instead of ATP. Accordingly, glucose
degradation via glycolysis is also unlikely in Natronomonas pharaonis. In addition, the
polyextremophile also seems to have the last two enzymes of the methylglyoxal bypass,
glyoxylase I (EC 4.4.1.5) and glyoxylase II (EC 3.1.2.6), but not methylglyoxal synthase
(EC 4.2.3.3) (see Section 3.5.3).
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Figure 6.2: The distribution of reactions by category. The reconstructed metabolic
network for Natronomonas pharaonis includes 676 reactions, which were subdivided into eight
high-level functional categories. The “Lipid and s-layer” and “Vitamins and cofactors” categories
are likely signiﬁcantly underrepresented because several pathways belonging to these are yet to
be characterized.
Natronomonas pharaonis has the complete set of enzymes associated with the tricar-
boxylic acid (TCA) cycle (Figure 6.3). However, while the cycle allows for the catabolism
of acetate for the production of energy, neither it nor its reversal is enough for the process
of carbohydrate biosynthesis from the compound (Section 3.5.3). Rather, this capability
is aﬀorded for by the glyoxylate shunt, which bypasses the reactions of the TCA cycle
where carbon is lost in the form of CO2. Since Natronomonas pharaonis is able to grow
with acetate as the sole carbon source, the occurrence of the glyoxylate cycle is necessary.
Indeed, genes for both isocitrate lyase (EC 4.1.3.1; NP4432A) and malate synthase (EC
2.3.3.9; NP4430A) could be assigned.
6.2.2 Nutritional Self-suﬃciency and Bioenergetics
The enzyme inventory of Natronomonas pharaonis indicates a great level of nutritional self-
suﬃciency. Unlike that of Halobacterium salinarum, it shows the capability to synthesize all
20 proteinogenic amino acids. In addition, genes for the production of critical vitamins and
cofactors, such as quinones, thiamine, coenzyme A, ﬂavins, tetrahydrofolate, hemes, and
molydopterin, are also present. Consistent with this, we were able to grow the archaeon
in deﬁned medium with only acetate, inorganic phosphate, sulfate, amonia, and other
inorganic ions provided. We should mention that prior to this study, the simplest medium
used to grow Natronomonas pharaonis contained leucine because it was previously thought
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Figure 6.3: EM pathway, TCA cycle and some associated reactions in Natronomonas
pharaonis. Green and red arrows represent reactions that occur and do not occur in the
halophile, respectively. The level of bioinformatic evidence associated with each occuring reaction
is indicated by the color of a nearby box: green - strong, red - none, and yellow - intermediate.
Similar to Halobacterium salinarum, glucose degradation via the EM pathway is not possible,
and a complete TCA cycle seems to be present. However, wheras only experimental evidence is
present for the glyoxylate cycle enzymes in the other halophile, literature evidence is not available
for Natronomonas pharaonis but the relevant genes could be assigned. Note that the glyoxylate
cycle is necessary in the case of the polyextremophile because it can grow on 2-carbon substrates.
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that the amino acid is essential for growth of the microorganism, due to disruption in the
5’-region of the isopropylmalate synthase gene (NP2206A) (Falb et al., 2005). However, it
is now clear that leucine is not required.
The respiratory chains of the archaea show high degrees of plasticity with respect
to composition, often diﬀering greatly from the classical ﬁve complex systems found in
mitochondria and Escherichia coli (Falb et al., 2005). In particular, the type, number,
and composition of terminal oxidases vary widely, and NADH is not oxidized by proton
pumping type I NADH dehydrogenase complexes because the relevant acceptor modules are
not present. In the speciﬁc case of Natronomonas pharaonis, it is particularly interesting
that while analogs of Complexes I, II, IV and V were found, not a single Complex III subunit
could be identiﬁed. Since the archaeon only has the Cl− pump halorhodopsin and not the
proton pump bacteriorhodopsin, it is therefore not capable of sustained photosynthetic
growth, and accordingly is likely to rely primarily on respiration for the production of
energy. Indeed, a working respiratory system has been shown for Natronomonas pharaonis
(Falb et al., 2005), despite the apparent absence of one of the respiratory complexes.
6.3 Methods
6.3.1 Culture Conditions and Sample Preparation
Natronomonas pharaonis strain Gabara (DSM 2160) cells were grown under aerobic condi-
tions in chemically-deﬁned media that were prepared according to Table 6.1. Preparatory
cultures were grown in 100 ml ﬂasks containing 35 ml of the medium to a cell density of
approximately 50 Klett (0.5 OD), from which 1 ml inoculants were taken to start suc-
ceeding ones. Cultures were prepared in ﬂasks that had side arms to measure turbidity
(cell density) via a Klett photometer. All cultures were carried out in duplicates. Cell
suspensions were shaken at 105 rpm at 40◦C in the dark. At speciﬁc points, samples were
taken from the cultures so that 6 samples were collected over the growth period, and these
were stored at 4◦C. To separate the cells from the medium, the samples were centrifuged
for ﬁve minutes at 15,000 rpm, using a SS34 rotor. Pellets were resuspended in 500 µl
basal salt (medium without acetate) and spun down as before. Amino acid analysis was
performed on the pellets using an Amino Acid Analyzer (Biotronik LC3000).
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Table 6.1: Composition of defined media used for Natronomonas pharaonisa
Description Value Description Value
NaCl 3.4 M FeSO4 x 7 H2O 5 µM
Na2CO3 175 mM CuSO4 x 5 H2O 4 µM
KCl 27 mM MnCl2 4 µM
Na2HPO4 x H20 2mM CaCl2 x 2 H2O 3 µM
NaH2PO4 x 7 H2O 2mM ZnSO4 x 7 H2O 3µM
MgSO4 x 7 H2O 1mM Acetate 20 mM
NH4Cl 12mM
5 µM
apH was adjusted to 7.2
6.3.2 Acetate Assay
The concentration of acetic acid in the medium was measured using the K-ACETRM
assay kit from Megazyme (Wicklow, Ireland). It is principled on the following sequence of
reactions: acetate kinase in the presence of ATP converts acetic acid into acetyl-phosphate
Acetic acid + ATP → acetyl-phosphate + ADP
This reaction is driven to completion by the rapid conversion of acetyl-phosphate into
acetyl-CoA and inorganic phosphate via the action of phosphotransacetylase in the presence
of CoA
acetyl-phosphate + CoA → acetyl-CoA + Pi
The ATP used by the ﬁrst reaction is regenerated from ADP via the action of pyruvate
kinase
ADP + PEP → pyruvate + ATP
Via the action of D-lactate dehydrogenase, pyruvate is reduced to D-lactate by NADH
with the production of NAD+
pyruvate + NADH → NAD+ + D-lactate
Since the amount of NAD+ formed by the above reactions is stoichiometric with the amount
of acetic acid, then the amount of NADH consumption, which can be measured through the
decrease in absorbance at 340 nm, can be used to determine the concentration of acetate.
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6.4 Biomass
The procedure used to determine the biomass amino acid content of Halobacterium sali-
narum (Section 4.3) was repeated for Natronomonas pharaonis (Figure 6.4). Despite the
diﬀerences between the two halophiles, their amino acid contents are remarkably similar,
especially in relative terms (Figure 6.5). From the ones that we were able to measure,
only histidine seems to be an exception, which is underrepresented by more than 50% in
Natronomonas pharaonis.
With the exclusion of amino acids, all other biomass components of Natronomonas
pharaonis were determined computationally. Specifcially, we calculated the ratio between
its amino acid content and that of Halobacterium salinarum, and then simply multiplied
the other biomass components of the latter by this factor. These include nucleic acids,
lipids, vitamins and cofactors.
6.5 Aerobic Growth
6.5.1 Growth as a Function of Acetate and Oxygen Consumption
Given the much simpler nutritional requirements of Natronomonas pharaonis compared
to Halobacterium salinarum, it presents an opportunity to analyze in more detail the
relationships between network inputs and growth. For example, when the alkaliphile is
grown aerobically on just acetate, it has to derive all of its energy and carbon skeleton solely
from the compound. Figure 6.6 shows the maximum (theoretical) biomass production for
speciﬁc combinations of oxygen and acetate consumption, calculated using ﬂux balance
analysis.
Distinct growth regimes can readily be discerned from Figure 6.6. Clearly, both acetate
and oxygen need to be present in order for biomass production to be possible. That growth
is unachievable without a carbon source (acetate), no matter how much oxygen is available,
is obvious. However, that simulations predict that growth cannot occurr if only the carbon
source is present indicates that there is currently no way to produce energy from acetate
without oxygen (or any terminal electron acceptor), given the current reactions that are
believed to occur within the halophile.
Figure 6.7 shows a cross section of Figure 6.6 for a particular oxygen consumption
rate (190 nmol / ml hr). As expected, maximum growth increases as acetate consump-
tion is increased from zero. However, after the rate has reached a particular point, the
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Figure 6.4: Amino acid composition of the Natronomonas pharaonis biomass. The
values indicated are inclusive of protein residues and free metabolites. The red broken lines show
the best linear ﬁts. Due to experimental limitations, we were not able to obtain values for cysteine
and tryptophan, and the values for aspartate and glutamate are already inclusive of asparagine
and glutamine, respectively.
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Figure 6.5: Biomass amino acid composition comparison between Natronomonas
pharaonis and Halobacterium salinarum. Despite the diﬀerences between the two
halophiles, their amino acid contents are remarkably similar, especially in relative terms (bot-
tom). From the ones that we were able to measure, the only exception seems to be histidine,
which is underrepresented by more than 50% in Natronomonas pharaonis.
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Figure 6.6: Maximum growth as a function of acetate and oxygen consumption. The
maximum biomass production was calculated using ﬂux balance analysis for speciﬁc combinations
of oxygen and acetate consumption. Distinct growth regimes brought about by the interactions
between these two vaiables can readily be discerned.
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eﬀect becomes negative, and growth starts to diminish. The reason is that when oxy-
gen is limiting, the network does not have the capability to degrade excess amounts of
acetate to CO2. This in turn necessitates that the excess materials be secreted as more
complex compounds. In our simulations, the ﬁrst non CO2 by-product produced was lac-
tate, a 3-carbon coumpound, and was then followed by the 4-carbon compound succinate
after acetate consumption was further increased. The energy used to produce these larger
molecules competes with the energy that could have been used for biomass production, and
accordingly diminshes growth. Clearly, such a behavior, if it occurs in vivo, is suboptimal.
6.5.2 An Actual Culture
The left graph in Figure 6.8 shows the growth of an actual culture of Natronomonas
pharaonis grown aerobically on acetate. We observed a log phase doubling time of about
6.5 hours and a maximum optical density of about 64 klett. The concentration of acetate in
the medium as a function of time is shown in the right graph of the same ﬁgure. Simulation
of acetate consumption, which is represented by the red broken curve, was performed with
the same procedure used for the consumption of metabolites by Halobacterium salinarum
(Section 4.2.1).
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Figure 6.8: Natronomonas pharaonis grown aerobically on acetate. The left and right
graphs show the population size and the concentration of acetate in the medium, respectively, as
a function of time. We observed a log phase doubling time of about 6.5 hours.
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Figure 6.9: Aerobic growth summary. (Left:) The red curve summarizes the data for
the aerobic culture grown on acetate. The x and y axes correspond to acetate and oxygen
consumption rates, respectively, and the z-axis shows the growth rates for the corresponding
points. Blue lines are drawn to provide a clearer impression of height. (Right:) The curve on the
left graph (experimental data) superimposed on the calculations for the maximum (theoretical)
possible growth for speciﬁc combinations of acetate and oxygen consumption rates. The proximity
of the curve to the surface indicates that our model parameters, including those of the growth
(biomass) function, are already within reasonable ranges, but are still in need of improvement.
The red curve in the left graph of Figure 6.9 summarizes the data for the aerobic culture
grown on acetate. The x and y axes correspond to acetate and oxygen consumption rates,
respectively, and the z-axis shows the growth rates for the corresponding points. The
right graph in the same ﬁgure shows this summary curve superimposed on the calculations
for the maximum (theoretical) possible growth for speciﬁc combinations of acetate and
oxygen consumption rates (from Figure 6.6). Since the surface corresponds to maximum
growth, then all parts of the curve, which represents actual data, should be on or below
it. Accordingly, the proximity of the curve to the surface indicates that the parameters of
our model, including those of the growth (biomass) function, are already within reasonable
ranges, but are still in need of improvement.
There are several possible reasons why the curve in Figure 6.9 is above the surface in
some areas. One is that oxygen measurments may be too low (by at least about 20%);
note that moving the curve a little bit in the positive direction of the y-axis will put the
curve below the surface. Another possibility is that the acetate measurements are too high.
However, the experimental method used to assay the compound is much more accurate
than the method used to determine oxygen consumption, so this is more unlikely. And a
third possibility is that the growth function parameters are too high, i.e., we overestimated
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the biomass content. Note that components of the growth function, save for the amino
acids, were simply taken in proportion to the values from Halobacterium salinarum for lack
of available data.
6.5.3 Summary of the Napha Model
While the computational model for Natronomonas pharaonis is still not at the same level
as the model for Halobacterium salinarum, in part because the body of knowledge that
exists for the latter organism is considerably larger, the reconstructed network for the
haloalkaliphile has already proven valuable by providing a platform for integrating available
information. For example, in the previous section we showed that some of the settings
for biologically relevant parameters cannot explain actual growth data. For these, we
suggested possible explanations that can then be validated experimentally, which can then
be subsequently used to adjust the parameters.
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Chapter 7
Conclusions and Outlook
Metabolism refers to the set of biochemical processes that occur within living organisms
that allow them to maintain life. The availability of complete genome sequences for nu-
merous organisms permit genome-scale reconstructions of metabolic networks because they
can be used to supplement literature data, which is often very limited. In this work we de-
scribed the reconstruction of the metabolic networks of two extremely halophilic archaeal
species and the development and use of computational models derived from them.
7.1 Contributions of this Thesis
This thesis consists of interdisciplinary work by the author; it contains both computational
modeling and experimental work. Most of the experimental results used for the modeling
and simulations were produced by the author in Prof. Oesterhelt’s group at the Max
Planck Institute of Biochemistry (MPI).
One of the most important contributions of this work is the reconstructed network for
Halobacterium salinarum. This network is composed of 695 reactions, which are linked to
either genetic or literature evidence, or both. Extensive manual curation was performed
on the network to achieve high reliability. Although one of the primary uses of such
reconstructed networks is to serve as foundation for the development of computational
models, the network in itself is already valuable, prior to any formal modeling eﬀort,
because it represents a summary of the current knowledge regarding the metabolism of
Halobacterium salinarum. We demonstrated this value by systematically searching the
network for “knowledge gaps”, and then forming biological hypotheses from them. Two
separate research eﬀorts – one related to aromatic amino acid metabolism and the other
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to pentose synthesis – were initiated, the work done by colleagues at the MPI, in part due
to the results of the reconstruction eﬀort. In addition, the reconstruction eﬀort itself lead
to improvements to the existing primary annotation for Halobacterium salinarum.
Important components of the two core constraints-based models used in this study are
the growth (pseudo-)reactions. Each of these two reactions was derived from a characteri-
zation of the respective biomass composition. In the case of Halobacterium salinarum, the
protein fraction was determined experimentally using measurements of individual amino
acids at diﬀerent optical densities, and the rest were derived from external data. The pro-
tein fraction of the Natronomonas pharaonis biomass was also determined experimentally,
which allowed for a comparison between the two species.
We performed growth simulations by employing constraints-based models with the use
of appropriate growth data, including nutrient consumption and growth rates. These data
were integrated into the model by translating them into additional constraints. All of the
relevant data were generated in this study. In the case of Halobacterium salinarum, the
data includes time-series of 16 nutrients, under both aerobic and phototrophic conditions,
and continuous measurements of oxygen usage for the aerobic case. This allowed us to
compare growth under the two bioenergetic modes of respiration and photosynthesis. In
the case of Natronomonas pharaonis, the data includes time series of acetate and oxygen
consumption.
The models we used in our simulations are hybrids that have both kinetic (dynamic)
and constraints-based components. Although similar models have been created in the past,
one common limitation of the previously used methodologies is that they cannot account
for transport patterns that change qualitatively during growth. This proved to be a partic-
ularly restrictive limitation for this study; multiple nutrients were included in the growth
media, and most of these metabolites displayed qualitative changes in their transport pat-
terns. To overcome this, we developed a new system for constructing the dynamic compo-
nents of the hybrid models. This method not only could account for qualitatively changing
transport patterns, but could actually automatically detect their presence. Moreover, our
method could also uncover relationships between the metabolites themselves, by detecting
possible interactions (e.g., competitive inhibition). This latter feature was demonstrated
by automatically detecting the relationship between arginine and ornithine, which is rooted
in the arginine fermentation pathway. More possible relationships between other pairs of
the supplied nutrients were also discussed.
While the computational models were derived from the reconstructed metabolic net-
7.2 Future Directions 139
works, in turn, the computational models through simulations lead to improvements to the
reconstruction. Moreoever, by virtue of the improvements, the computational models also
contributed information to the relevant physiology. For example, during the initial recon-
struction, neither bioinformatic nor experimental evidence could be found for degradative
pathways for phenylalanine, tyrosine and lysine. However, simulations indicated that these
capabilities are likely present.
Our integrative analysis of bioenergetics, nutrient utilization and growth of Halobac-
terium salinarum allowed us a glimpse of life under the harsh conditions that very few
other species on Earth have been able to adapt to. Our analysis led to several unexpected,
biologically relevant ﬁndings, including: (1) that the organism degrades essential amino
acids under both aerobic and phototrophic conditions. Such behavior can lead to cells ter-
minating their growth earlier than necessary. This was particularly surprising because cells
should already have abundant energy and nonessential nutrients were available; (2) that
carbon incorporation rates were surprisingly low even under phototrophic conditions. Dur-
ing phototrophy, one would typically expect nutrient consumption to be just in quantities
that are suﬃcient for biomass production since energy could already be derived from light
rather than from the supplied nutrients. Due to the low incorporation rates, the model
predicts that considerable amounts of metabolites are likely produced and accumulated
in the medium, some of which may be derived from the essential amino acids; and (3)
that arginine fermentation occurs simultaneously with, and is in fact comparable in terms
of energy output to, respiration and photosynthesis. This is in contrast to the common
assumption that the fermentation process only plays a secondary, alternative role to the
two main bioenergetic modes.
We hypothesized that the initially surprising behavior exhibited by Halobacterium sali-
narum actually consists of adaptations to its natural environments, where nutrients are not
only irregularly available but may altogether be absent for extended periods that may span
several years. Such a setting probably predisposed the cells to grow as much as possible
when the conditions become favorable. In turn, this increases the probability of its survival
until the next growth-conducive period.
7.2 Future Directions
Systems biology is an inter-disciplinary ﬁeld of study that focuses on the systematic anal-
ysis of complex interactions in biological systems. Accordingly, the integration of as much
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relevant information or components into the models is often desirable. While the networks
analyzed in this study are already quite large, they still only account for small fractions of
the complexities of the biological systems to which they belong. For example, although the
reactions in the two metabolic networks are linked to their respective genomes by virtue
of the fact that the reactions are linked to enzymes which are encoded by genes, details of
the interactions at the genomic level are not integrated in the models. The models would
probably beneﬁt from the inclusion of gene regulatory networks, which could further re-
strict the solution spaces via the imposition of additional constraints (Covert and Palsson,
2003). While the construction of detailed gene regulatory networks at a genome-scale would
probably not be feasible for some time, except for organisms that are as widely studied
as E. coli, speciﬁc aspects of interest could be focused on for inclusion into the network.
For example, the genes related to switching from photosynthetic to aerobic growth, or vice
versa, could be determined with targeted experiments. Even if the regulatory relation-
ships between these genes (e.g., causality) prove diﬃcult to establish, the regulation data
themselves (eg., regulation factors) could be compared to the results of the basic metabolic
model, and then subsequently used to add more constraints (albeit static ones).
In addition to Halobacterium salinarum and Natronomonas pharaonis, complete genome
sequences are also available for four other haloarchaeal species, and more are currently
being sequenced. Metabolic reconstructions for these other species would be useful for
performing a comparative study.
Analysis with constraints-based models typically do not result in unique solutions. For
example, with ﬂux variability analysis we could only describe ﬂuxes that are compatible
with our experimental data. While we found that ﬂuxes for a large fraction of the reactions
in the network are already constrained enough to be qualitatively invariable, more detailed
information on these ﬂuxes are desirable. Not to mention the reactions that are not even
qualitatively constrained. To address this issue, quantitative measurements of the ﬂuxes
themselves would have to be experimentally obtained, for example using ﬂux analysis with
labeled substrates. While the task will be very laborious, due to the available methods
or techniques, the data that could be obtained is potentially very useful. For example, it
would reveal details on the fates of the individual carbon sources. In addition, performing
ﬂux analysis under diﬀerent conditions (e.g., phototrophic v.s. aerobic) could yield insights
on the metabolic strategy of the microorganism.
One of the predictions of our model is that large amounts of metabolites, possibly by-
products, are formed and accumulate in the medium, under both aerobic and phototrophic
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conditions. This is particularly remarkable because our analysis suggests that the secreted
metabolites account for over 50% of the carbon consumed by the cells, some of which
may be derived from the degradation of essential nutrients. In the future, we intend
to experimentally conﬁrm this prediction, and elucidate the identities of the metabolites
themselves. Subsequently, we would also like to ﬁnd out the reasons why these metabolites
are secreted in the ﬁrst place.
Besides the integration of other components (e.g., the genetic regulatory networks men-
tioned above) into the models, one of the future directions we would like to take is to
introduce dynamics to at least some more parts of the network; in the current hybrid
model for Halobacterium salinarum, only parts associated with nutrient transport have
dynamic elements. Although creating a fully kinetic metabolic model with the same scale
is currently infeasible due to the fact that only a very small percentage of reactions have
available kinetic information, we would nevertheless like to integrate the current model
with kinetic models of respiration and photosynthesis, which are currently being developed
by colleagues at the MPI.
142 7. Conclusions and Outlook
Appendix A
Reconstructed Networks
Table A.1: Halobacterium salinarum reaction list. In cases where there is
ambiguity in the genetic evidence, all of the candidate genes are listed.
Id Definition EC No. Genes Ref
R01737 ATP + D-Gluconic acid => ADP +
6-Phospho-D-gluconate
2.7.1.12
R01737 ATP + D-Gluconic acid => ADP +
6-Phospho-D-gluconate
2.7.1.12
R00396 L-Alanine + NAD+ + H2O <=> Pyruvate + NH3
+ NADH + H+
1.4.1.1 PMID:486498
PMID:7371854
R03869 (S)-Methylmalonate semialdehyde + NAD+ + H2O
=> Methylmalonate + NADH
1.2.1.3 OE2133R OE2190R
OE2367F OE4529F
R01731 L-Aspartate + Prephenate <=> Oxaloacetate +
L-Arogenate
2.6.1.57
R01734 Dimethylbenzimidazole <=> Riboflavin -
R01736 (R)-S-Lactoylglutathione + H2O <=> Glutathione
+ (R)-Lactate
3.1.2.6 OE7071F OE6191F
OE7077F OE6197F
R00782 Hydrogen sulfide + Pyruvate + NH3 =>
L-Cysteine + H2O
4.4.1.1
4.4.1.8
OE2173F OE2681F
R00489 L-Aspartate => beta-Alanine + CO2 4.1.1.11
4.1.1.15
OE1498R
R01728 Prephenate + NAD+ =>
3-(4-Hydroxyphenyl)pyruvate + CO2 + NADH +
H+
1.3.1.12
1.3.1.52
1.3.1.43
OE2770F
R02487 Glutaryl-CoA + FAD => FADH2 +
Crotonoyl-CoA + CO2
1.3.99.7 OE4500R
R02485 Deoxycytidine + H2O => Deoxyuridine + NH3 3.5.4.5 OE2313R
R02742 gamma-L-Glutamyl-L-cysteine + NADP+ <=>
Bis-gamma-glutamylcystine + NADPH
1.8.1.13 PMID:3136140
PMID:2910862
R00885 GTP + D-Mannose 1-phosphate <=>
Pyrophosphate + GDPmannose
2.7.7.13 OE4022R
R02748 Deoxyinosine + Orthophosphate <=>
Hypoxanthine + 2-Deoxy-D-ribose 1-phosphate
2.4.2.1 PMID:9457844
R02340 Indoleglycerol phosphate <=> Indole +
D-Glyceraldehyde 3-phosphate
4.2.1.20 OE1470F OE1471F
R00481 L-Aspartate + Oxygen => Iminoaspartate + H2O2 1.4.3.16 OE3646F
R02749 2-Deoxy-D-ribose 1-phosphate <=>
2-Deoxy-D-ribose 5-phosphate
5.4.2.7 OE2318R
R00789 Nitrite + NADPH + H+ => NADP+ + NH3 +
H2O
1.7.1.4 PMID:629538
R00480 ATP + L-Aspartate => ADP +
4-Phospho-L-aspartate
2.7.2.4 OE4333R
R01724 Nicotinate + 5-Phospho-alpha-D-ribose
1-diphosphate => Nicotinate D-ribonucleotide +
Pyrophosphate
2.4.2.11 OE4565F
Continued on next page
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R00485 L-Asparagine + H2O => L-Aspartate + NH3 3.5.1.1 OE3633R
R05048 2,5-Diaminopyrimidine nucleoside triphosphate =>
2,5-Diamino-6-(5’-triphosphoryl-3’,4’-trihydroxy-2’-
oxopentyl)-
3.5.4.16 PMID:17032654
R00479 Isocitrate <=> Succinate + Glyoxylate 4.1.3.1 PMID:5780095
R05046 Formamidopyrimidine nucleoside triphosphate +
H2O => 2,5-Diaminopyrimidine nucleoside
triphosphate + Formate
3.5.4.16 PMID:17032654
R00376 dGTP => Pyrophosphate + dGMP 2.7.7.7 OE4293R OE1777F
OE4390F OE6036F
OE7114F
R00377 dCTP => Pyrophosphate + dCMP 2.7.7.7 OE4293R OE1777F
OE4390F OE6036F
OE6234F OE7114F
R00891 L-Serine + Sulfide => L-Cysteine + H2O 4.2.1.22 OE1916F OE2860R
R00378 dTTP => Pyrophosphate + dTMP 2.7.7.7 OE4293R OE1777F
OE4390F OE6036F
OE6234F OE7114F
R05815 Cobyrinate + L-Glutamine + ATP + H2O =>
Cob(II)yrinate a,c diamide + L-Glutamate + ADP
+ Orthophosphate
6.3.1.-
6.3.5.9
OE3243F
R01090 L-Leucine + 2-Oxoglutarate <=>
4-Methyl-2-oxopentanoate + L-Glutamate
2.6.1.42
2.6.1.6
OE3959R
R05814 Cobalt-precorrin 8 => Cobyrinate 5.4.1.2 OE3237F
R02472 (R)-Pantoate + NADP+ <=> 2-Dehydropantoate
+ NADPH
1.1.1.169 OE2078R
R00897 O-Acetyl-L-serine + Hydrogen sulfide =>
L-Cysteine + Acetate
2.5.1.47 OE1916F OE2860R
R05811 Cobalt-precorrin 5 + S-Adenosyl-L-methionine +
H2O => Cobalt-precorrin 6 +
S-Adenosyl-L-homocysteine + Acetaldehyde
2.1.1.- OE3994F
R00375 dATP => Pyrophosphate + dAMP 2.7.7.7 OE4293R OE1777F
OE4390F OE6036F
OE6234F OE7114F
R00896 Mercaptopyruvate + Glutamate <=> L-Cysteine
+ 2-Oxoglutarate
2.6.1.1 OE1755F OE1944R
OE2619F
R02473 ATP + (R)-Pantoate + beta-Alanine => AMP +
Pyrophosphate + Pantothenate
6.3.2.1
R05810 Cobalt-precorrin 4 + S-Adenosyl-L-methionine =>
Cobalt-precorrin 5 + S-Adenosyl-L-homocysteine
2.1.1.133 OE3212F
R05813 Cobalt-dihydro-precorrin 6 +
S-Adenosyl-L-methionine => Cobalt-precorrin 8 +
S-Adenosyl-L-homocysteine + CO2
2.1.1.132 OE3207F OE3238F
R05812 Cobalt-precorrin 6 + NADPH + H+ =>
Cobalt-dihydro-precorrin 6 + NADP+
1.3.1.54
R00751 L-Threonine <=> Glycine + Acetaldehyde 4.1.2.5 OE4436R
R01752 D-Glyceraldehyde + NAD+ + H2O <=>
D-Glycerate + NADH + H+
1.2.1.3 OE2133R OE2190R
OE2367F OE4529F
R02372 dUTP + Cytidine => dUDP + CMP 2.7.1.48 OE2749F
R03990 Tetradecanoyl-CoA + FAD =>
trans-Tetradec-2-enoyl-CoA + FADH2
1.3.3.6
1.3.99.3
1.3.99.13
OE2710F OE1555F
OE2013R OE2138F
OE3123R OE4500R
R03991 Tetradecanoyl-CoA + Acetyl-CoA <=> CoA +
3-Oxopalmitoyl-CoA
2.3.1.16 OE3884F
R05617 1,4-Dihydroxy-2-naphthoate + all-trans-Octaprenyl
diphosphate => 2-Demethylmenaquinone +
Pyrophosphate + CO2
2.5.1.- OE2559R OE2650F
OE3503F OE3505R
OE4010F
R01899 Isocitrate + NADP+ <=> Oxalosuccinate +
NADPH + H+
1.1.1.42 OE3634F PMID:4393394
PMID:5058691
PMID:5780095
PMID:5802601
PMID:9827332
R05612 all-trans-Hexaprenyl diphosphate + Isopentenyl
diphosphate => all-trans-Heptaprenyl diphosphate
+ Pyrophosphate
2.5.1.30 OE4010F OE2650F PMID:2857171
Continued on next page
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R05613 all-trans-Pentaprenyl diphosphate + Isopentenyl
diphosphate <=> all-trans-Hexaprenyl diphosphate
+ Pyrophosphate
2.5.1.33 OE4010F OE2650F PMID:2857171
R00369 L-Alanine + Glyoxylate => Pyruvate + Glycine 2.6.1.44 OE4391F PMID:3700337
PMID:8157586
R05611 all-trans-Heptaprenyl diphosphate + Isopentenyl
diphosphate <=> all-trans-Octaprenyl diphosphate
+ Pyrophosphate
2.5.1.11
2.5.1.-
OE2559R OE2650F
OE3503F OE3505R
OE4010F
PMID:2857171
R00362 Citrate <=> Acetate + Oxaloacetate 4.1.3.6 OE1942F
R02765 (R)-2-Methyl-3-oxopropanoyl-CoA <=>
(S)-2-Methyl-3-oxopropanoyl-CoA
5.1.99.1 OE1718R
R03194 S-Adenosyl-L-methionine + Uroporphyrinogen III
=> S-Adenosyl-L-homocysteine + Precorrin 2
2.1.1.107 OE4277F
R00762 D-Fructose 1,6-bisphosphate + H2O =>
D-Fructose 6-phosphate + Orthophosphate
3.1.3.11 OE2020F PMID:2256927
PMID:3255682
PMID:6642538
PMID:9827332
R02864 Iron + Sirohydrochlorin => Siroheme + H+ 4.99.1.4 OE3498R
R05809 Cobalt-precorrin 3 + S-Adenosyl-L-methionine =>
Cobalt-precorrin 4 + S-Adenosyl-L-homocysteine
2.1.1.131 OE3214F OE3216F
R05808 Cobalt-precorrin 2 + S-Adenosyl-L-methionine =>
Cobalt-precorrin 3 + S-Adenosyl-L-homocysteine
2.1.1.130 OE3209F
R00768 L-Glutamine + D-Fructose 6-phosphate =>
L-Glutamate + D-Glucosamine 6-phosphate
2.6.1.16 OE1013R
R05807 Sirohydrochlorin + Cobalt => Cobalt-precorrin 2 4.99.1.3 OE3221F
R02872 Presqualene diphosphate + NADPH + H+ =>
Pyrophosphate + Squalene + NADP+
2.5.1.21 OE2014F PMID:2857171
R00771 D-Glucose 6-phosphate <=> D-Fructose
6-phosphate
5.3.1.9 OE3792F PMID:2256927
PMID:3255682
PMID:6642538
PMID:9827332
R00354 (3S)-Citryl-CoA <=> Acetyl-CoA + Oxaloacetate 4.1.3.34 OE1942F
R00355 L-Aspartate + 2-Oxoglutarate <=> Oxaloacetate
+ L-Glutamate
2.6.1.1 OE1755F OE1944R
OE2619F
R00357 L-Aspartate + H2O + Oxygen => Oxaloacetate +
NH3 + H2O2
1.4.3.16 OE3646F
R02771 dTDPglucose <=>
dTDP-4-dehydro-6-deoxy-alpha-D-glucose + H2O
4.2.1.46 OE1115F
R07280 5-Amino-6-(5’-phosphoribitylamino)uracil + H2O
=> 4-(1-D-Ribitylamino)-5-amino-2,6-
dihydroxypyrimidine +
Orthophosphate
3.1.3.- OE2299F
R07281 D-Ribulose 5-phosphate => 3,
4-Dihydroxy-2-butanone 4-phosphate + Formate
5.4.99.- OE3963R
R01073 Anthranilate + 5-Phospho-alpha-D-ribose
1-diphosphate =>
N-(5-Phospho-D-ribosyl)anthranilate +
Pyrophosphate
2.4.2.18 OE3334R
R01072 L-Glutamine + 5-Phospho-alpha-D-ribose
1-diphosphate + H2O => 5-Phosphoribosylamine
+ Pyrophosphate + L-Glutamate
2.4.2.14 OE3139R
R01776 Acetyl-CoA + L-Homoserine <=> CoA +
O-Acetyl-L-homoserine
2.3.1.31 OE4397F
R01775 L-Homoserine + NADP+ <=> L-Aspartate
4-semialdehyde + NADPH + H+
1.1.1.3 OE4722R
R01074 ATP + Biotin <=> Pyrophosphate +
Biotinyl-5’-AMP
6.3.4.15 OE3186F OE1987F
R02914 Urocanate + H2O <=>
4-Imidazolone-5-propanoate
4.2.1.49 OE2734F
R01880 dGTP + Uridine => dGDP + UMP 2.7.1.48 OE2749F
R02918 ATP + L-Tyrosine + tRNA(Tyr) <=> AMP +
Pyrophosphate + L-Tyrosyl-tRNA(Tyr)
6.1.1.1 OE4139R
R01071 ATP + 5-Phospho-alpha-D-ribose 1-diphosphate
<=> Phosphoribosyl-ATP + Pyrophosphate
2.4.2.17 OE4152R PMID:3700337
R01676 Guanine + H2O => Xanthine + NH3 3.5.4.3 OE2730R PMID:9457844
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R01070 D-Fructose 1,6-bisphosphate <=> Glycerone
phosphate + D-Glyceraldehyde 3-phosphate
4.1.2.13 OE2019F
R01876 Uridine + Orthophosphate <=> Uracil +
alpha-D-Ribose 1-phosphate
2.4.2.3 OE2311R OE3603R
R06977 L-Glutamate + L-Aspartate 4-semialdehyde <=>
2-Oxoglutarate + L-2,4-Diaminobutanoate
2.6.1.76 OE5094F
R01878 Cytidine + H2O => Uridine + NH3 3.5.4.5 OE2313R
R03084 3-Dehydroquinate <=> 3-Dehydroshikimate +
H2O
4.2.1.10
4.2.1.11
OE1477R OE2640F PMID:3700337
R01975 Acetoacetyl-CoA + NADH <=>
(S)-3-Hydroxybutanoyl-CoA + NAD+
1.1.1.35 OE2015R OE2871F
R01976 Acetoacetyl-CoA + NADPH <=>
(S)-3-Hydroxybutanoyl-CoA + NADP+
1.1.1.157 OE2015R OE2871F
R01977 Acetoacetyl-CoA + NADPH <=>
(R)-3-Hydroxybutanoyl-CoA + NADP+
1.1.1.36 OE4695F
R01978 Acetyl-CoA + H2O + Acetoacetyl-CoA =>
(S)-3-Hydroxy-3-methylglutaryl-CoA + CoA
2.3.3.10 OE3296F PMID:3700337
R01086 N-(L-Arginino)succinate <=> Fumarate +
L-Arginine
4.3.2.1 OE4419R
R00086 ATP + H2O => ADP + Orthophosphate 3.6.1.15 OE3863R
R01083 N6-(1,2-Dicarboxyethyl)-AMP <=> Fumarate +
AMP
4.3.2.2 OE1623F
R00084 Porphobilinogen + H2O => Hydroxymethylbilane
+ NH3
2.5.1.61 OE4276F
R01870 Orotidine 5’-phosphate + Pyrophosphate <=>
Orotate + 5-Phospho-alpha-D-ribose 1-diphosphate
2.4.2.10 OE1672F OE3953R
R02237 ATP + Dihydropteroate + L-Glutamate => ADP
+ Orthophosphate + Dihydrofolate
6.3.2.17
6.3.2.12
2.1.1.45
OE1615R
R01082 (S)-Malate <=> Fumarate + H2O 4.2.1.2 OE2935R PMID:5780095
PMID:9827332
R01665 ATP + dCMP => ADP + dCDP 2.7.4.14 OE3429F
R01664 dCMP + H2O => Deoxycytidine +
Orthophosphate
3.1.3.5 OE3017R
R02235 Dihydrofolate + NAD+ <=> Folate + NADH +
H+
1.5.1.3 PMID:17416665
PMID:15554970
R02236 Dihydrofolate + NADP+ <=> Folate + NADPH
+ H+
1.5.1.3 OE2921R PMID:15554970
PMID:17416665
R01867 (S)-Dihydroorotate + Oxygen => Orotate + H2O2 1.3.3.1 OE4508R
R02245 ATP + (R)-Mevalonate => ADP +
(R)-5-Phosphomevalonate
2.7.1.36 OE2645F PMID:3700337
R01968 dGMP + H2O => Deoxyguanosine +
Orthophosphate
3.1.3.5 OE3017R
R01969 Deoxyguanosine + Orthophosphate <=> Guanine
+ 2-Deoxy-D-ribose 1-phosphate
2.4.2.1 PMID:9457844
R01863 Inosine + Orthophosphate <=> Hypoxanthine +
alpha-D-Ribose 1-phosphate
2.4.2.1 PMID:9457844
R01771 ATP + L-Homoserine => ADP +
O-Phospho-L-homoserine
2.7.1.39 OE3531R PMID:3700337
R02100 dUTP + H2O => dUMP + Pyrophosphate 3.6.1.23 OE4610R
R02331 ATP + dUDP <=> ADP + dUTP 2.7.4.6 OE2667F
R01057 alpha-D-Ribose 1-phosphate <=> D-Ribose
5-phosphate
5.4.2.7 OE2318R PMID:15205420
R02332 dUTP + Uridine => dUDP + UMP 2.7.1.48 OE2749F
R01056 D-Ribose 5-phosphate <=> D-Ribulose
5-phosphate
5.3.1.6 OE4185F
R01051 ATP + D-Ribose => ADP + D-Ribose
5-phosphate
2.7.1.15 OE3606R
R02719 Xanthosine 5’-phosphate + H2O => Xanthosine +
Orthophosphate
3.1.3.5 OE3017R
R01655 5,10-Methenyltetrahydrofolate + H2O <=>
10-Formyltetrahydrofolate + H+
3.5.4.9
6.3.4.3
OE3038F
R01658 Dimethylallyl diphosphate + Isopentenyl
diphosphate => Pyrophosphate + Geranyl
diphosphate
2.5.1.10
2.5.1.29
2.5.1.1
OE2650F OE4010F PMID:3700337
R01857 ATP + dGDP <=> ADP + dGTP 2.7.4.6 OE2667F
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R02328 dTTP + D-Glucose 1-phosphate <=>
Pyrophosphate + dTDPglucose
2.7.7.24 OE1578F OE1016R
OE1078F OE1114F
OE2530F OE1014R
R01858 dGDP + Phosphoenolpyruvate => dGTP +
Pyruvate
2.7.1.40 OE1495R
R02327 dCTP + Uridine => dCDP + UMP 2.7.1.48 OE2749F
R01859 ATP + Propanoyl-CoA + HCO3- => ADP +
Orthophosphate +
(S)-2-Methyl-3-oxopropanoyl-CoA
6.4.1.3 OE1939F OE3175F
R02329 dTTP + alpha-D-Galactose 1-phosphate <=>
Pyrophosphate + dTDPgalactose
2.7.7.32 OE1578F OE1016R
OE1078F OE1114F
OE2530F OE1014R
R01993 (S)-Dihydroorotate + H2O <=>
N-Carbamoyl-L-aspartate
3.5.2.3 OE4558R
R00999 O-Succinyl-L-homoserine + H2O =>
2-Oxobutanoate + Succinate + NH3
2.5.1.48 OE2173F OE2681F
R02519 Homogentisate + Oxygen => 4-Maleylacetoacetate 1.13.11.5
R02326 ATP + dCDP <=> ADP + dCTP 2.7.4.6 OE2667F
R01049 ATP + D-Ribose 5-phosphate <=> AMP +
5-Phospho-alpha-D-ribose 1-diphosphate
2.7.6.1 OE4085R
R00996 L-Threonine => 2-Oxobutanoate + NH3 4.3.1.19 OE3931R
R02325 dCTP + H2O => dUTP + NH3 3.5.4.13 OE1384F
R01068 D-Fructose 1,6-bisphosphate <=> Glycerone
phosphate + D-Glyceraldehyde 3-phosphate
4.1.2.13 OE2019F PMID:2256927
PMID:3255682
PMID:6642538
PMID:9827332
R10005 Prephytoene diphosphate + H+ + NADPH =>
Pyrophosphate + Phytoene + NADP+
2.5.1.32 OE3093R OE3376F PMID:2857171
R01066 2-Deoxy-D-ribose 5-phosphate <=>
D-Glyceraldehyde 3-phosphate + Acetaldehyde
4.1.2.4 OE3616F
R10004 all-trans-Octaprenyl diphosphate + Isopentenyl
diphosphate => all-trans-Nonaprenyl diphosphate
+ Pyrophosphate
2.5.1.11 PMID:2857171
R10003 Geranylgeranyl diphosphate + Isopentenyl
diphosphate => all-trans-Pentaprenyl diphosphate
+ Pyrophosphate
2.5.1.- OE2650F OE4010F PMID:2857171
R01061 D-Glyceraldehyde 3-phosphate + Orthophosphate
+ NAD+ <=> 3-Phospho-D-glyceroyl phosphate
+ NADH + H+
1.2.1.12
1.2.1.59
OE1154F PMID:2256927
PMID:3255682
PMID:6642538
PMID:9827332
R02530 Glutathione + Methylglyoxal =>
(R)-S-Lactoylglutathione
4.4.1.5 OE2610F FEMS
Microbiology
Letters, 1995,
125:83-88
R02531 Methylglyoxal + NADH + H+ <=> Lactaldehyde
+ NAD+
1.1.1.21 OE1698R OE2451R
OE2486F OE3312R
R01648 4-Aminobutanoate + 2-Oxoglutarate <=>
Succinate semialdehyde + L-Glutamate
2.6.1.19 OE3168R
R02722 L-Serine + Indoleglycerol phosphate <=>
L-Tryptophan + Glyceraldehyde 3-phosphate +
H2O
4.2.1.20 OE1470F OE1471F
R02413 Shikimate + NADP+ <=> 3-Dehydroshikimate +
NADPH + H+
1.1.1.25 OE1565F PMID:3700337
R02412 ATP + Shikimate => ADP + Shikimate
3-phosphate
2.7.1.71 OE2785R PMID:3700337
R05064 (S)-3-Hydroxyisobutyryl-CoA + H2O <=> CoA +
(S)-3-Hydroxyisobutyrate
3.1.2.4
R02521 3-(4-Hydroxyphenyl)pyruvate + Oxygen =>
Homogentisate + CO2
1.13.11.27
R05066 (S)-3-Hydroxyisobutyrate + NAD+ <=>
(S)-Methylmalonate semialdehyde + NADH + H+
1.1.1.35 OE2015R
R01058 D-Glyceraldehyde 3-phosphate + NADP+ + H2O
=> 3-Phospho-D-glycerate + NADPH
1.2.1.9 OE2133R OE2190R
OE2367F OE4529F
PMID:2256927
PMID:9827332
R02313 N6-(L-1,3-Dicarboxypropyl)-L-lysine + NAD+ +
H2O <=> L-Glutamate + L-2-Aminoadipate
6-semialdehyde + NADH + H+
1.5.1.9 PMID:3700337
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R04509 ATP +
4-Amino-2-methyl-5-phosphomethylpyrimidine =>
ADP +
2-Methyl-4-amino-5-hydroxymethylpyrimidine
diphosphate
2.7.4.7 OE4654F
R00691 L-Arogenate => L-Phenylalanine + H2O + CO2 4.2.1.51 OE4117F PMID:3700337
R02408 L-Cystine + H2O => Pyruvate + NH3 +
Thiocysteine
4.4.1.1
4.4.1.8
OE2173F OE2681F
R00694 L-Phenylalanine + 2-Oxoglutarate <=>
Phenylpyruvate + L-Glutamate
2.6.1.9
2.6.1.1
2.6.1.5
2.6.1.57
OE2507R OE1755F
OE1944R OE2619F
R00405 ATP + Succinate + CoA <=> ADP +
Orthophosphate + Succinyl-CoA
6.2.1.5 OE3195F OE3196F PMID:5780095
PMID:9827332
R00303 D-Glucose 6-phosphate + H2O => D-Glucose +
Orthophosphate
3.1.3.9 PMID:3255682
PMID:9827332
R00408 Succinate + FAD <=> FADH2 + Fumarate 1.3.99.1 OE2865R OE2866R
OE2867R OE2868R
PMID:5780095
R03045 3-Hydroxypropionyl-CoA <=> Propenoyl-CoA +
H2O
4.2.1.17 OE3846R
R03038 ATP + L-Alanine + tRNA(Ala) <=> AMP +
Pyrophosphate + L-Alanyl-tRNA
6.1.1.7 OE4198F
R00586 L-Serine + Acetyl-CoA => O-Acetyl-L-serine +
CoA
2.3.1.30 OE3122F
R03243 3-(Imidazol-4-yl)-2-oxopropyl phosphate +
L-Glutamate <=> L-Histidinol phosphate +
2-Oxoglutarate
2.6.1.9 OE2507R PMID:3700337
R00585 Hydroxypyruvate + L-Alanine <=> L-Serine +
Pyruvate
2.6.1.51 OE4391F
R03145 Ferricytochrome b1 + Pyruvate + H2O =>
Ferrocytochrome b1 + Acetate + CO2
1.2.2.2 PMID:8157586
R02685 (3S)-3-Hydroxyacyl-CoA <=>
trans-2,3-Dehydroacyl-CoA + H2O
4.2.1.17 OE3846R
R01168 L-Histidine => Urocanate + NH3 4.3.1.3 OE2739F
R06447 trans,trans,cis-Geranylgeranyl diphosphate +
Isopentenyl diphosphate =>
di-trans,poly-cis-Undecaprenyl diphosphate +
Pyrophosphate
2.5.1.31
2.5.1.-
OE3503F OE3505R
OE2559R OE2650F
OE4010F
PMID:2857171
R00582 O-Phospho-L-serine + H2O => L-Serine +
Orthophosphate
3.1.3.3 OE4405R
R03035 ATP + Pantetheine 4’-phosphate =>
Pyrophosphate + Dephospho-CoA
2.7.7.3 OE2992R
R03530 ATP + dIDP <=> ADP + dITP 2.7.4.6 OE2667F
R00578 ATP + L-Aspartate + L-Glutamine + H2O =>
AMP + Pyrophosphate + L-Asparagine +
L-Glutamate
6.3.5.4 OE2278F
R03027 (R)-3-Hydroxybutanoyl-CoA <=> Crotonoyl-CoA
+ H2O
4.2.1.55 OE1641R
R00575 ATP + L-Glutamine + HCO3- + H2O => ADP +
Orthophosphate + L-Glutamate + Carbamoyl
phosphate
6.3.5.5 OE3554F OE3556R
R01175 Butanoyl-CoA + FAD => FADH2 +
Crotonoyl-CoA
1.3.3.6
1.3.99.2
1.3.99.3
OE2013R OE2710F
OE1555F OE2138F
OE3123R OE4500R
R01177 Acetyl-CoA + Butanoyl-CoA <=> CoA +
3-Oxohexanoyl-CoA
2.3.1.9
2.3.1.16
OE3884F
R03665 ATP + L-Valine + tRNA(Val) <=> AMP +
Pyrophosphate + L-Valyl-tRNA(Val)
6.1.1.9 OE4572R
R00674 L-Serine + Indole => L-Tryptophan + H2O 4.2.1.20 OE1470F OE1471F
R00673 L-Tryptophan + H2O => Indole + Pyruvate +
NH3
4.1.99.1 OE4331R
R01171 Butanoyl-CoA + NAD+ <=> Crotonoyl-CoA +
NADH + H+
1.3.99.2 OE2013R OE1555F
OE2138F OE2710F
OE3123R OE4500R
R03132 O-Acetyl-L-serine + Thiosulfate =>
S-Sulfo-L-cysteine + Acetate
2.5.1.47
2.5.1.48
OE1916F OE2860R
OE2173F OE2681F
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R00425 GTP + H2O => Formate + 2,5-Diamino-6-
hydroxy-4-(5’-phosphoribosylamino)-pyrimidine +
Pyrophosphate
3.5.4.25
R00420 UDP-N-acetyl-D-glucosamine <=>
UDP-N-acetyl-D-mannosamine
5.1.3.14 OE4703R
R03067 2-Amino-7,8-dihydro-4-hydroxy-6-
(diphosphooxymethyl)pteridine + 4-Aminobenzoate
=> Pyrophosphate + Dihydropteroate
2.5.1.15 OE1615R
R00428 GTP + H2O => Formamidopyrimidine nucleoside
triphosphate
3.5.4.16 PMID:17032654
R00570 ATP + CDP <=> ADP + CTP 2.7.4.6 OE2667F
R00571 ATP + UTP + NH3 => ADP + Orthophosphate
+ CTP
6.3.4.2 OE3572R
R02557 Deoxyadenosine + Orthophosphate <=> Adenine
+ 2-Deoxy-D-ribose 1-phosphate
2.4.2.1 PMID:9457844
R00573 ATP + UTP + L-Glutamine + H2O => ADP +
Orthophosphate + CTP + L-Glutamate
6.3.4.2 OE3572R
R01698 Dihydrolipoamide + NAD+ <=> Lipoamide +
NADH
1.8.1.4 OE4116F PMID:6266826
R03905 Glutaminyl-tRNA + L-Glutamate +
Orthophosphate + ADP <=>
L-Glutamyl-tRNA(Gln) + L-Glutamine + ATP
6.3.5.7 OE3591F
R00566 L-Arginine => Agmatine + CO2 4.1.1.19 OE3803R
R00568 CTP + H2O => UTP + NH3 3.5.4.13 OE1384F
R03260 O-Succinyl-L-homoserine + L-Cysteine =>
L-Cystathionine + Succinate
2.5.1.48 OE2173F OE2681F
R00430 GDP + Phosphoenolpyruvate => GTP + Pyruvate 2.7.1.40 OE1495R
R02662 S-(2-Methylpropanoyl)-dihydrolipoamide + CoA
=> 2-Methylpropanoyl-CoA + Dihydrolipoamide
2.3.1.-
R02661 2-Methylpropanoyl-CoA + FAD <=>
2-Methylprop-2-enoyl-CoA + FADH2
1.3.99.3 OE2710F OE1555F
OE2013R OE2138F
OE3123R OE4500R
R02660 2-Methylpropanoyl-CoA + Oxygen =>
2-Methylprop-2-enoyl-CoA + H2O
1.3.99.2 OE2013R OE1555F
OE2138F OE2710F
OE3123R OE4500R
R03696 L-threo-3-Methylaspartate <=> Mesaconate +
NH3
4.3.1.2 OE4207F
R03509 N-(5-Phospho-D-ribosyl)anthranilate <=>
1-(2-Carboxyphenylamino)-1’-deoxy-D-ribulose
5’-phosphate
5.3.1.24 OE3333R
R03508 1-(2-Carboxyphenylamino)-1’-deoxy-D-ribulose
5’-phosphate => Indoleglycerol phosphate + CO2
+ H2O
4.1.1.48 OE1469F
R00414 UDP-N-acetyl-D-glucosamine + H2O <=>
N-Acetyl-D-mannosamine + UDP
5.1.3.14 OE4703R
R04798 zeta-Carotene <=> Neurosporene + Hydrogen 1.14.99.30
1.14.99.-
OE1426F OE3381R
OE3468R
R04799 zeta-Carotene + NADP+ <=> Lycopene +
NADPH
- OE3381R OE3468R
R00410 Succinyl-CoA + Acetoacetate <=> Succinate +
Acetoacetyl-CoA
2.8.3.5 OE5189F OE4211F
R03503 ATP + 2-Amino-4-hydroxy-6-hydroxymethyl-7,8-
dihydropteridine => AMP +
2-Amino-7,8-dihydro-4-hydroxy-6-
(diphosphooxymethyl)pteridine
2.7.6.3
R06613 5,10-Methylenetetrahydrofolate + dUMP + FADH2
=> Tetrahydrofolate + dTMP + FAD
2.1.1.148 OE2898R PMID:12423760
R02568 D-Fructose 1-phosphate <=> Glycerone phosphate
+ D-Glyceraldehyde
4.1.2.13 OE2019F
R03504 2-Amino-4-hydroxy-6-(D-erythro-1,2,3-
trihydroxypropyl)-7,8- <=> Glycolaldehyde +
2-Amino-4-hydroxy-6-hydroxymethyl-7,8-
dihydropteridine
4.1.2.25
R03815 Dihydrolipoylprotein + NADP+ <=>
Lipoylprotein + NADPH
1.8.1.4 OE4116F
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R00552 L-Arginine + H2O => L-Citrulline + NH3 3.5.3.6 OE5208R PMID:6933439
PMID:7868583
PMID:8759859
R02571 Glutaryl-CoA + Dihydrolipoamide <=> CoA +
S-Glutaryldihydrolipoamide
2.3.1.61 PMID:3700337
R01290 L-Serine + L-Homocysteine => L-Cystathionine +
H2O
4.2.1.22 OE1916F OE2860R
R01196 Oxidized ferredoxin + Pyruvate + CoA =>
Reduced ferredoxin + Acetyl-CoA + CO2
1.2.7.1 OE2622R OE2623R PMID:6266826
PMID:6266827
PMID:8157586
PMID:9827332
R06558 Adenosyl cobinamide + GTP => Adenosyl
cobinamide phosphate + GDP
2.7.1.156
R01197 Reduced ferredoxin + Succinyl-CoA + CO2 <=>
Oxidized ferredoxin + 2-Oxoglutarate + CoA
1.2.7.3 OE1710R OE1711R PMID:5780095
PMID:6266826
PMID:6266827
PMID:9827332
R04620 2-Amino-4-hydroxy-6-(erythro-1,2,3-
trihydroxypropyl) + H2O =>
2-Amino-4-hydroxy-6-(D-erythro-1,2,3-
trihydroxypropyl)-7,8- +
Orthophosphate
3.1.3.1 OE5192R
R04621 Dihydroneopterin phosphate + H2O => 2-Amino-
4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-
+ Orthophosphate
3.6.1.-
R01199 Oxidized ferredoxin + 2-Oxobutanoate + CoA
<=> Reduced ferredoxin + Propanoyl-CoA + CO2
1.2.7.1
1.2.7.2
OE2622R OE2623R PMID:6816594
FEBS Letters
1980,
118:271-273.
FEBS Letters
1977, 83:197-201
R02577 Lactaldehyde + NADPH + H+ <=>
Propane-1,2-diol + NADP+
1.1.1.21 OE1698R OE2451R
OE2486F OE3312R
R06411 cis-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA +
H2O => 3-Hydroxy-2,6-dimethyl-5-methylene-
heptanoyl-CoA
4.2.1.17 OE3846R
R06412 trans-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA +
H2O => 3-Hydroxy-2,6-dimethyl-5-methylene-
heptanoyl-CoA
4.2.1.17 OE3846R
R00344 ATP + Pyruvate + HCO3- + H+ => ADP +
Orthophosphate + Oxaloacetate
6.4.1.1 OE3177F PMID:8157586
PMID:9827332
R00443 UTP => Pyrophosphate + UMP 2.7.7.6 OE4740R OE4739R
OE4741R OE4742R
R00442 CTP => Pyrophosphate + CMP 2.7.7.6 OE4740R OE4739R
OE4741R OE4742R
R00549 ATP + Riboflavin => ADP + FMN 2.7.1.26
R00351 Acetyl-CoA + H2O + Oxaloacetate => Citrate +
CoA
2.3.3.1
2.3.3.3
OE3934R PMID:5780095
PMID:9827332
R03181 4-Maleylacetoacetate <=> 4-Fumarylacetoacetate 5.2.1.2
R00548 FMN + H2O => Riboflavin + Orthophosphate 3.1.3.2 OE2782F
R03823 Lycopene + NADPH => beta-Carotene + NADP+ - OE3983R PMID:12003928
R03778 Octanoyl-CoA + Acetyl-CoA <=> CoA +
3-Oxodecanoyl-CoA
2.3.1.16 OE3884F
R03777 Octanoyl-CoA + FAD => trans-Oct-2-enoyl-CoA
+ FADH2
1.3.3.6
1.3.99.3
1.3.99.13
OE2710F OE1555F
OE2013R OE2138F
OE3123R OE4500R
R03269 (R)-4’-Phosphopantothenoyl-L-cysteine =>
Pantetheine 4’-phosphate + CO2
4.1.1.36 OE1856R
R00439 GDP => Orthophosphate + GMP 2.7.7.8 The Enzymes,
3rd. Ed. (Boyer,
P.D., ed.) 15B,
517-553
R00332 ATP + GMP <=> ADP + GDP 2.7.4.8
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R04639 2,5-Diamino-6-(5’-triphosphoryl-3’,4’-trihydroxy-2’-
oxopentyl)- <=>
2-Amino-4-hydroxy-6-(erythro-1,2,3-
trihydroxypropyl) +
H2O
3.5.4.16 PMID:17032654
R03425 Glycine + Lipoylprotein =>
S-Aminomethyldihydrolipoylprotein + CO2
1.4.4.2 OE3274R OE3275R
R04638 2-Amino-4-hydroxy-6-(erythro-1,2,3-
trihydroxypropyl) + H2O => Dihydroneopterin
phosphate + Pyrophosphate
3.6.1.-
R00438 UDP => Orthophosphate + UMP 2.7.7.8 The Enzymes,
3rd. Ed. (Boyer,
P.D., ed.) 15B,
517-553
R00437 ADP => Orthophosphate + AMP 2.7.7.8 The Enzymes,
3rd. Ed. (Boyer,
P.D., ed.) 15B,
517-553
R00435 ATP => Pyrophosphate + AMP 2.7.7.6 OE4740R OE4739R
OE4741R OE4742R
R04640 5-(5-Phospho-D-ribosylaminoformimino)-1-(5-
phosphoribosyl)- <=>
N-(5’-Phospho-D-1’-ribulosylformimino)-5-amino-1-
(5”-phospho-D-
5.3.1.16 OE4218F PMID:3700337
R00440 CDP => Orthophosphate + CMP 2.7.7.8 The Enzymes,
3rd. Ed. (Boyer,
P.D., ed.) 15B,
517-553
R00441 GTP => Pyrophosphate + GMP 2.7.7.6 OE4740R OE4739R
OE4741R OE4742R
R03174 S-(2-Methylbutanoyl)-dihydrolipoamide + CoA =>
2-Methylbutanoyl-CoA + Dihydrolipoamide
2.3.1.-
R03172 2-Methylbutanoyl-CoA + FAD <=>
2-Methylbut-2-enoyl-CoA + FADH2
1.3.99.3 OE2710F OE1555F
OE2013R OE2138F
OE3123R OE4500R
R00342 (S)-Malate + NAD+ <=> Oxaloacetate + NADH
+ H+
1.1.1.37 OE4323F PMID:901751
PMID:901752
PMID:7297556
PMID:5780095
PMID:9827332
R03170 2-Methylbutanoyl-CoA + Oxygen =>
2-Methylbut-2-enoyl-CoA + H2O
1.3.99.2 OE2013R OE1555F
OE2138F OE2710F
OE3123R OE4500R
R00533 Sulfite + Oxygen + H2O => Sulfate + H2O2 1.8.3.1 OE2569R
R03026 Crotonoyl-CoA + H2O <=>
(S)-3-Hydroxybutanoyl-CoA
4.2.1.17 OE3846R
R03661 ATP + L-Proline + tRNA(Pro) <=> AMP +
Pyrophosphate + L-Prolyl-tRNA(Pro)
6.1.1.15 OE1595F
R03662 ATP + L-Serine + tRNA(Ser) <=> AMP +
Pyrophosphate + L-Seryl-tRNA(Ser)
6.1.1.11 OE3893F
R03663 ATP + L-Threonine + tRNA(Thr) <=> AMP +
Pyrophosphate + L-Threonyl-tRNA(Thr)
6.1.1.3 OE3580R
R03664 ATP + L-Tryptophan + tRNA(Trp) <=> AMP +
Pyrophosphate + L-Tryptophanyl-tRNA(Trp)
6.1.1.2 OE4101R OE4132R
R00671 L-Ornithine <=> L-Proline + NH3 4.3.1.12 OE4121R OE2945F
R03457 D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate
<=> 3-(Imidazol-4-yl)-2-oxopropyl phosphate +
H2O
4.2.1.19 OE4220F PMID:3700337
R03458 5-Amino-6-(5’-phosphoribosylamino)uracil +
NADPH =>
5-Amino-6-(5’-phosphoribitylamino)uracil +
NADP+
1.1.1.193 OE2802F
R03660 ATP + L-Phenylalanine + tRNA(Phe) <=> AMP
+ Pyrophosphate + L-Phenylalanyl-tRNA(Phe)
6.1.1.20 OE4505F OE4507F PMID:8061624
R03459 2,5-Diamino-6-hydroxy-4-(5’-phosphoribosylamino)-
pyrimidine + H2O =>
5-Amino-6-(5’-phosphoribosylamino)uracil + NH3
3.5.4.26
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R03659 ATP + L-Methionine + tRNA(Met) <=> AMP +
Pyrophosphate + L-Methionyl-tRNA
6.1.1.10 OE1496R
R00472 Acetyl-CoA + H2O + Glyoxylate => (S)-Malate +
CoA
2.3.3.9 PMID:5780095
R03658 ATP + L-Lysine + tRNA(Lys) <=> AMP +
Pyrophosphate + L-Lysyl-tRNA
6.1.1.6 OE3826F
R00529 ATP + Sulfate => Pyrophosphate +
Adenylylsulfate
2.7.7.4 OE1684F
R03165 Hydroxymethylbilane <=> Uroporphyrinogen III
+ H2O
4.2.1.75 OE4281F
R06529 Adenosyl cobyrinate hexaamide +
D-1-Aminopropan-2-ol O-phosphate + ATP =>
Adenosyl cobinamide phosphate + ADP +
Orthophosphate
6.3.1.10 OE3253F OE3259F PMID:14645280
R03460 Phosphoenolpyruvate + Shikimate 3-phosphate
<=> Orthophosphate +
5-O-(1-Carboxyvinyl)-3-phosphoshikimate
2.5.1.19 OE2762R PMID:3700337
R03655 ATP + L-Histidine + tRNA(His) => AMP +
Pyrophosphate + L-Histidyl-tRNA(His)
6.1.1.21 OE3812R
R03654 ATP + Glycine + tRNA(Gly) <=> AMP +
Pyrophosphate + Glycyl-tRNA(Gly)
6.1.1.14 OE4307F
R03657 ATP + L-Leucine + tRNA(Leu) <=> AMP +
Pyrophosphate + L-Leucyl-tRNA
6.1.1.4 OE4118R
R03947 Precorrin 2 + NAD+ => Sirohydrochlorin +
NADH + H+
2.1.1.107
1.3.1.76
OE4277F OE3498R
R03656 ATP + L-Isoleucine + tRNA(Ile) <=> AMP +
Pyrophosphate + L-Isoleucyl-tRNA(Ile)
6.1.1.5 OE4068F
R03758 L-2-Amino-3-oxobutanoate => Aminoacetone +
CO2
-
R00330 ATP + GDP <=> ADP + GTP 2.7.4.6 OE2667F
R03018 ATP + Pantothenate => ADP +
D-4’-Phosphopantothenate
2.7.1.33
R03759 Aminoacetone + NADH + H+ <=>
(R)-1-Aminopropan-2-ol + NAD+
1.1.1.75
R03013 L-Histidinol phosphate + H2O => L-Histidinol +
Orthophosphate
3.1.3.15 OE2276F
R03012 L-Histidinol + NAD+ => L-Histidinal + NADH +
H+
1.1.1.23 OE3071F PMID:3700337
R00316 ATP + Acetate => Pyrophosphate + Acetyl
adenylate
6.2.1.1 OE2450F OE1726F
R03651 ATP + L-Glutamate + tRNA(Gln) <=> AMP +
Pyrophosphate + L-Glutamyl-tRNA(Gln)
6.1.1.17 OE2652F
R00658 2-Phospho-D-glycerate <=> Phosphoenolpyruvate
+ H2O
4.2.1.11 OE2640F PMID:2256927
PMID:3255682
PMID:6642538
PMID:9827332
R00516 UTP + Cytidine => UDP + CMP 2.7.1.48 OE2749F
R03647 ATP + L-Aspartate + tRNA(Asn) <=> AMP +
Pyrophosphate + L-Aspartyl-tRNA(Asn)
6.1.1.12 OE1687F
R00517 GTP + Cytidine => GDP + CMP 2.7.1.48 OE2749F
R03646 ATP + L-Arginine + tRNA(Arg) <=> AMP +
Pyrophosphate + L-Arginyl-tRNA(Arg)
6.1.1.19 OE5203F
R00654 L-Methionine + H2O => Methanethiol + NH3 +
2-Oxobutanoate
4.4.1.11 OE2173F OE2681F
OE4398F
PMID:8206953
R00651 O-Acetyl-L-homoserine + Methanethiol =>
L-Methionine + Acetate
2.5.1.49 OE4398F PMID:8206953
R00511 CMP + H2O => Cytidine + Orthophosphate 3.1.3.5 OE3017R
R03858 Lauroyl-CoA + Acetyl-CoA <=> CoA +
3-Oxotetradecanoyl-CoA
2.3.1.16 OE3884F
R03857 Lauroyl-CoA + FAD => 2-trans-Dodecenoyl-CoA
+ FADH2
1.3.3.6
1.3.99.3
1.3.99.13
OE2710F OE1555F
OE2013R OE2138F
OE3123R OE4500R
R04520 Geranylgeranyl diphosphate +
sn-3-O-(Geranylgeranyl)glycerol 1-phosphate <=>
Pyrophosphate +
2,3-Bis-O-(geranylgeranyl)glycerol 1-phosphate
2.5.1.42 PMID:16788058
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R00512 ATP + CMP <=> ADP + CDP 2.7.4.14 OE3429F
R03005 ATP + Nicotinate D-ribonucleotide =>
Pyrophosphate + Deamino-NAD+
2.7.7.1
2.7.7.18
OE1462R
R00513 ATP + Cytidine => ADP + CMP 2.7.1.48 OE2749F
R01354 ATP + Propanoate => Pyrophosphate + Propinol
adenylate
6.2.1.1 OE2450F OE1726F
R05218 Cob(II)yrinate a,c diamide + H+ + NADH <=>
Cob(I)yrinate a,c diamide + NAD+
1.16.8.1
R00220 L-Serine => Pyruvate + NH3 4.3.1.17
4.3.1.19
OE3931R
R04463 ATP + 5’-Phosphoribosyl-N-formylglycinamide +
L-Glutamine + H2O => ADP + Orthophosphate
+
2-(Formamido)-N1-(5’-phosphoribosyl)acetamidine
+ L-Glutamate
6.3.5.3 OE2274R OE3731R
R90107 L-Proline (E) + Sodium (E) [pmf] <=> L-Proline
+ Sodium
OE2322F PMID:889797
R90106 Daunorubicin + ATP + H2O => Daunorubicin (E)
+ Orthophosphate + ADP + H+
OE1704R
R04560 10-Formyltetrahydrofolate + 1-(5’-Phosphoribosyl)-
5-amino-4-imidazolecarboxamide <=>
Tetrahydrofolate + 1-(5’-Phosphoribosyl)-5-
formamido-4-imidazolecarboxamide
2.1.2.3 OE1620R
R90105 ATP + H2O + Copper (E) => ADP +
Orthophosphate + H+ + Copper
OE2042F
R90104 Arsenite (E) + ATP + H2O => Arsenite + ADP
+ Orthophosphate + H+
OE1547R OE4649F
OE5440F
R90103 Vitamin B12 (E) + ATP + H2O => Vitamin B12
+ ADP + Orthophosphate + H+
OE1480F
R90102 3-Phospho-D-Glycerate (E) + ATP + H2O =>
3-Phospho-D-glycerate + ADP + Orthophosphate
+ H+
OE1420F
R90101 Sodium + H+ (pmf associated) <=> H+ +
Sodium (E) [pmf]
OE3960F OE5204R
OE3961R
PMID:35540
R90100 Nitrate (E) + Photon => Nitrate OE1299R PMID:9233791
R04859 O-Acetyl-L-serine + Thiosulfate + Thioredoxin +
H+ => L-Cysteine + Sulfite + Oxidized
thioredoxin + Acetate
2.5.1.47
2.5.1.49
OE1916F OE2860R
OE4398F
R04559 1-(5’-Phosphoribosyl)-5-amino-4-(N-
succinocarboxamide)-imidazole <=> Fumarate +
1-(5’-Phosphoribosyl)-5-amino-4-
imidazolecarboxamide
4.3.2.2 OE1623F
R04558 N-(5’-Phospho-D-1’-ribulosylformimino)-5-amino-1-
(5”-phospho-D- + L-Glutamine <=>
1-(5’-Phosphoribosyl)-5-amino-4-
imidazolecarboxamide + L-Glutamate +
D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate
2.4.2.- OE2268R OE3913F
R04170 (S)-3-Hydroxydodecanoyl-CoA <=>
2-trans-Dodecenoyl-CoA + H2O
4.2.1.17 OE3846R
R03346 Nicotinate D-ribonucleotide + H2O => Nicotinate
D-ribonucleoside + Orthophosphate
3.1.3.5 OE3017R
R90108 Cl- (E) + H+ (pmf associated) => Cl- + H+ OE3200R
R04173 O-Phospho-L-serine + 2-Oxoglutarate <=>
3-Phosphonooxypyruvate + L-Glutamate
2.6.1.52 OE4391F
R03348 Pyridine-2,3-dicarboxylate +
5-Phospho-alpha-D-ribose 1-diphosphate =>
Nicotinate D-ribonucleotide + Pyrophosphate +
CO2
2.4.2.19 OE3648F
R90109 Pantothenate (E) + Sodium (E) [pmf] =>
Pantothenate + Sodium
OE3511F
R05221 Adenosyl cobinamide + ATP => Adenosyl
cobinamide phosphate + ADP
2.7.1.156
R05222 Adenosyl cobinamide phosphate + GTP =>
Adenosine-GDP-cobinamide + Pyrophosphate
2.7.7.62 OE3227F
R00216 (S)-Malate + NADP+ => Pyruvate + CO2 +
NADPH
1.1.1.38
1.1.1.39
OE3308F PMID:8157586
PMID:9827332
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R00217 Oxaloacetate => Pyruvate + CO2 1.1.1.40 OE3308F
R05220 Cob(I)yrinate a,c diamide + ATP => Adenosyl
cobyrinate a,c diamide + Pyrophosphate +
Orthophosphate
2.5.1.17 OE3245F
R05225 Adenosyl cobyrinate a,c diamide + L-Glutamine +
ATP + H2O => Adenosyl cobyrinate hexaamide +
L-Glutamate + Orthophosphate + ADP
6.3.5.10 OE3246F PMID:14645280
R05226 Adenosyl cobyrinate hexaamide +
(R)-1-Aminopropan-2-ol <=> Adenosyl cobinamide
6.3.1.10 OE3253F OE3259F PMID:14645280
R04457 4-(1-D-Ribitylamino)-5-amino-2,6-
dihydroxypyrimidine + 3, 4-Dihydroxy-2-butanone
4-phosphate =>
6,7-Dimethyl-8-(1-D-ribityl)lumazine +
Orthophosphate + H2O
2.5.1.9 OE1946R OE4683F
R05223 Adenosine-GDP-cobinamide + alpha-Ribazole =>
Cobamide coenzyme + GMP
2.7.8.26 OE3255F
R00908 beta-Alanine + 2-Oxoglutarate <=>
3-Oxopropanoate + L-Glutamate
2.6.1.19 OE3168R OE5094F
R00214 (S)-Malate + NAD+ => Pyruvate + CO2 +
NADH
1.1.1.38
1.1.1.39
OE3308F
R01364 4-Fumarylacetoacetate + H2O => Acetoacetate +
Fumarate
3.7.1.2
R01360 (S)-3-Hydroxy-3-methylglutaryl-CoA =>
Acetyl-CoA + Acetoacetate
4.1.3.4 OE3296F
R00502 UTP + alpha-D-Galactose 1-phosphate <=>
Pyrophosphate + UDP-D-galactose
2.7.7.10 OE1578F OE1016R
OE1078F OE1114F
OE2530F OE1014R
R01220 5,10-Methylenetetrahydrofolate + NADP+ <=>
5,10-Methenyltetrahydrofolate + NADPH
1.5.1.5 OE3038F
R01221 5,10-Methylenetetrahydrofolate + NH3 + CO2 +
NADH + H+ <=> Glycine + Tetrahydrofolate +
NAD+
2.1.2.10 OE3278R
R00509 ATP + Adenylylsulfate => ADP +
3’-Phosphoadenylyl sulfate
2.7.1.25
R01214 L-Valine + 2-Oxoglutarate <=>
3-Methyl-2-oxobutanoate + L-Glutamate
2.6.1.42
2.6.1.6
OE3959R
R04740 (S)-3-Hydroxytetradecanoyl-CoA <=>
trans-Tetradec-2-enoyl-CoA + H2O
4.2.1.17 OE3846R
R00615 Thiamin diphosphate + H2O => Thiamin
monophosphate + Orthophosphate
3.6.1.15 OE3863R
R04742 Decanoyl-CoA + Acetyl-CoA <=> CoA +
3-Oxododecanoyl-CoA
2.3.1.16 OE3884F
R00617 ATP + Thiamin monophosphate => ADP +
Thiamin diphosphate
2.7.4.16 OE3818F
R04741 (S)-3-Hydroxydodecanoyl-CoA + NAD+ <=>
3-Oxododecanoyl-CoA + NADH
1.1.1.35 OE2015R
R03471 ATP +
4-Amino-5-hydroxymethyl-2-methylpyrimidine =>
ADP +
4-Amino-2-methyl-5-phosphomethylpyrimidine
2.7.1.49 OE4654F
R03472 Aminoimidazole ribotide =>
4-Amino-5-hydroxymethyl-2-methylpyrimidine
OE2057F
R01230 ATP + Xanthosine 5’-phosphate + NH3 => AMP
+ Pyrophosphate + GMP
6.3.4.1
6.3.5.2
OE1363F OE3571R
R00610 Sarcosine + H2O + Oxygen => Glycine +
Formaldehyde + H2O2
1.5.3.1 OE1432F
R01231 ATP + Xanthosine 5’-phosphate + L-Glutamine +
H2O => AMP + Pyrophosphate + GMP +
L-Glutamate
6.3.5.2 OE1363F OE3571R
R01229 Guanine + 5-Phospho-alpha-D-ribose
1-diphosphate => GMP + Pyrophosphate
2.4.2.7 OE1504F PMID:9457844
R01228 ATP + Guanosine => ADP + GMP 2.7.1.73 OE3606R PMID:9457844
R01227 GMP + H2O => Guanosine + Orthophosphate 3.1.3.5 OE3017R
R01226 5,10-Methylenetetrahydrofolate +
3-Methyl-2-oxobutanoate + H2O =>
Tetrahydrofolate + 2-Dehydropantoate
2.1.2.11 OE3119R
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R01325 Citrate <=> cis-Aconitate + H2O 4.2.1.3
4.2.1.4
OE4613F PMID:5780095
PMID:9827332
R04737 (S)-3-Hydroxyhexadecanoyl-CoA + NAD+ <=>
3-Oxopalmitoyl-CoA + NADH
1.1.1.35 OE2015R OE2871F
OE3846R
R01324 Citrate <=> Isocitrate 4.2.1.3 OE4613F PMID:5780095
PMID:9827332
R04738 (S)-3-Hydroxyhexadecanoyl-CoA <=>
trans-Hexadec-2-enoyl-CoA + H2O
4.2.1.17 OE3846R OE1641R
R04739 (S)-3-Hydroxytetradecanoyl-CoA + NAD+ <=>
3-Oxotetradecanoyl-CoA + NADH
1.1.1.35 OE2015R
R04591 ATP + 1-(5-Phospho-D-ribosyl)-5-amino-4-
imidazolecarboxylate + L-Aspartate <=> ADP +
Orthophosphate + 1-(5’-Phosphoribosyl)-5-amino-
4-(N-succinocarboxamide)-imidazole
6.3.2.6 OE3724F
R04751 Hexanoyl-CoA + FAD => trans-Hex-2-enoyl-CoA
+ FADH2
1.3.3.6
1.3.99.2
1.3.99.3
1.3.99.13
OE2013R OE2710F
OE1555F OE2138F
OE3123R OE4500R
R04594 N1-(5-Phospho-alpha-D-ribosyl)-5,6-
dimethylbenzimidazole + H2O => alpha-Ribazole
+ Orthophosphate
3.1.3.73
R00622 2-Oxoglutarate + Thiamin diphosphate =>
Succinate semialdehyde-thiamin diphosphate anion
+ CO2
2.5.1.64 OE2563R
R00104 ATP + NAD+ => ADP + NADP+ 2.7.1.23 OE3671F
R04749 (S)-Hydroxyhexanoyl-CoA <=>
trans-Hex-2-enoyl-CoA + H2O
4.2.1.17 OE3846R
R00203 Methylglyoxal + NAD+ + H2O => Pyruvate +
NADH + H+
1.2.1.22 OE4529F OE2133R
OE2190R OE2367F
R04747 Hexanoyl-CoA + Acetyl-CoA <=> CoA +
3-Oxooctanoyl-CoA
2.3.1.16 OE3884F
R04391 ATP + N-((R)-Pantothenoyl)-L-cysteine => ADP
+ (R)-4’-Phosphopantothenoyl-L-cysteine
2.7.1.33
R00200 ADP + Phosphoenolpyruvate => ATP + Pyruvate 2.7.1.40 OE1495R PMID:3255682
R04748 (S)-Hydroxyhexanoyl-CoA + NAD+ <=>
3-Oxohexanoyl-CoA + NADH
1.1.1.35 OE2015R
R04745 (S)-Hydroxyoctanoyl-CoA + NAD+ <=>
3-Oxooctanoyl-CoA + NADH
1.1.1.35 OE2015R
R00206 ATP + Pyruvate + Orthophosphate => AMP +
Phosphoenolpyruvate + Pyrophosphate
2.7.9.1 OE1500R PMID:2256927
PMID:9827332
R03102 L-2-Aminoadipate 6-semialdehyde + NAD+ + H2O
=> L-2-Aminoadipate + NADH + H+
1.2.1.31 PMID:3700337
R04746 (S)-Hydroxyoctanoyl-CoA <=>
trans-Oct-2-enoyl-CoA + H2O
4.2.1.17 OE3846R
R04743 (S)-Hydroxydecanoyl-CoA + NAD+ <=>
3-Oxodecanoyl-CoA + NADH
1.1.1.35 OE2015R
R04744 (S)-Hydroxydecanoyl-CoA <=>
trans-Dec-2-enoyl-CoA + H2O
4.2.1.17 OE3846R
R01446 (S)-Lactaldehyde + NAD+ + H2O => (S)-Lactate
+ NADH
1.2.1.22 OE4529F OE2133R
OE2190R OE2367F
R90148 GAP (E) + H+ (pmf associated) <=>
D-Glyceraldehyde 3-phosphate + H+
R90149 Fumarate (E) + H+ (pmf associated) <=>
Fumarate + H+
R90146 ATP + H2O + Molybdenum (E) => ADP +
Orthophosphate + H+ + Molybdenum
R90000 NADH + Menaquinone + H+ => NAD+ +
Menaquinol + H+ (pmf associated)
1.6.5.3 OE1953F OE1954F
OE1956F OE1957F
OE1958F OE1959F
OE1960F OE1963F
OE1964F OE1965F
OE1967F OE4005F
OE4007F
PMID:9932647
R90147 (S)-Malate (E) + H+ (pmf associated) <=>
(S)-Malate + H+
R90144 Isopentenyl phosphate + ATP => Isopentenyl
diphosphate + ADP
OE2647F PMID:1621811
PMID:3700337
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R01253 (S)-1-Pyrroline-5-carboxylate + NADPH <=>
L-Proline + H2O + NADP+
1.5.99.8 OE3955F PMID:9827332
R90145 Pyruvate (E) + H+ (pmf associated) <=>
Pyruvate + H+
R90142 Molybdenum cofactor + GTP => MoCo
dinucleotide (Guanine) + Pyrophosphate
OE2217R OE2219R
R01398 Carbamoyl phosphate + L-Ornithine <=>
Orthophosphate + L-Citrulline
2.1.3.3 OE5205R PMID:7868583
PMID:8759859
R90003 ADP + Orthophosphate + H+ (pmf associated)
<=> ATP + H2O + H+
3.6.3.14 OE3984R OE3985R
OE3986R OE3987R
OE3988R OE3989R
OE3991R OE3992R
OE3978R
PMID:21098
R01397 Carbamoyl phosphate + L-Aspartate =>
Orthophosphate + N-Carbamoyl-L-aspartate
2.1.3.2 OE5201F OE5202F
R90004 Reduced ferredoxin + Menaquinone + H+ =>
Oxidized ferredoxin + Menaquinol + H+ (pmf
associated)
1.6.5.3 OE1953F OE1954F
OE1956F OE1957F
OE1958F OE1959F
OE1960F OE1963F
OE1964F OE1965F
OE1967F OE4005F
OE4007F
R90143 (R)-5-Phosphomevalonate + ATP => Isopentenyl
phosphate + ADP + Orthophosphate + CO2
OE1893F PMID:16621811
PMID:3700337
R90140 Cyclic pyranopterin monophosphate =>
Molybdopterin + Pyrophosphate
OE1139F OE3595R
OE1140R
PMID:15716436
R90001 Menaquinol + H+ + Halocyanin (oxidized) =>
Menaquinone + H+ (pmf associated) + Halocyanin
(reduced)
1.10.2.2 OE1872R OE1874R
OE1876R
PMID:9932647
R90002 Oxygen + H+ + Halocyanin (reduced) => H2O +
H+ (pmf associated) + Halocyanin (oxidized)
1.9.3.1 OE1979R OE1984F
OE1988R OE4070R
OE4071R
PMID:2542239
R90141 Molybdopterin + Molybdenum => Molybdenum
cofactor
OE1146R OE1143R
R90005 H+ + Photon => H+ (pmf associated) OE3106F PMID:9729742
R04754 Decanoyl-CoA + FAD => trans-Dec-2-enoyl-CoA
+ FADH2
1.3.3.6
1.3.99.3
1.3.99.13
OE2710F OE1555F
OE2013R OE2138F
OE3123R OE4500R
R04224 2-Methylprop-2-enoyl-CoA + H2O <=>
(S)-3-Hydroxyisobutyryl-CoA
4.2.1.17 OE3846R
R04225 3-Methyl-2-oxopentanoate + Lipoamide =>
S-(2-Methylbutanoyl)-dihydrolipoamide + CO2
1.2.4.4 OE4114F OE3712R
OE4113F
R90138 Hexadecanoic acid (E) + ATP + H2O =>
Hexadecanoic acid + ADP + Orthophosphate +
H+
R04326 5’-Phosphoribosylglycinamide +
5,10-Methenyltetrahydrofolate + H2O <=>
5’-Phosphoribosyl-N-formylglycinamide +
Tetrahydrofolate
2.1.2.2 OE1620R
R90139 GTP + S-Adenosyl-L-methionine => Cyclic
pyranopterin monophosphate +
S-Adenosyl-L-homocysteine
OE1142F OE2825F PMID:15716436
R04325 10-Formyltetrahydrofolate +
5’-Phosphoribosylglycinamide => Tetrahydrofolate
+ 5’-Phosphoribosyl-N-formylglycinamide
2.1.2.2 OE1620R
R90133 6-Deoxy-5-ketomannitol-1-phosphate + L-Aspartate
4-semialdehyde => Compound I +
D-Glyceraldehyde 3-phosphate
OE1472F PMID:15182204
R90134 Inosine (E) + H+ (pmf associated) => Inosine +
H+
PMID:9457844
R03224 (3R)-3-Hydroxyacyl-CoA <=>
cis-2,3-Dehydroacyl-CoA + H2O
4.2.1.17 OE3846R
R90135 Menaquinol + Oxygen => Menaquinone + H2O2 1.10.3.- OE7065F OE6185F
OE7066F OE6186F
R90136 Methanethiol <=> Methanethiol (E) PMID:8206953
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R90130 4-Ketofructose-1,6-bisphosphate + NADH =>
6-Deoxy-5-Ketofructose 1 phosphate +
Orthophosphate + NAD+
PMID:15182204
R90131 2-amino-3,7-dideoxy-hept-6-ulsonic acid =>
3-Dehydroquinate
OE1475F PMID:15182204
R90132 6-Deoxy-5-Ketofructose 1 phosphate + NAD+
<=> 6-Deoxy-5-ketomannitol-1-phosphate +
NADH
PMID:15182204
R04233 CTP + D-4’-Phosphopantothenate + L-Cysteine
=> CDP + Orthophosphate +
(R)-4’-Phosphopantothenoyl-L-cysteine
6.3.2.5 OE1856R
R04231 CTP + D-4’-Phosphopantothenate + L-Cysteine
=> CMP + Pyrophosphate +
(R)-4’-Phosphopantothenoyl-L-cysteine
6.3.2.5 OE1856R
R03314 L-Glutamate 5-semialdehyde =>
(S)-1-Pyrroline-5-carboxylate + H2O
- PMID:9827332
R04230 ATP + D-4’-Phosphopantothenate + L-Cysteine
=> ADP + Orthophosphate +
(R)-4’-Phosphopantothenoyl-L-cysteine
6.3.2.5 OE1856R
R03217 O-Acetyl-L-homoserine + L-Cysteine <=>
L-Cystathionine + Acetate
2.5.1.49 OE4398F
R90124 L-Citrulline (E) + H+ (pmf associated) =>
L-Citrulline + H+
PMID:5903088
R90125 Succinate (E) + H+ (pmf associated) <=>
Succinate + H+
R90122 Guanine (E) + H+ (pmf associated) => Guanine
+ H+
OE3950R PMID:9457844
R90123 Hypoxanthine (E) + H+ (pmf associated) =>
Hypoxanthine + H+
OE3950R PMID:9457844
R05341 Lycopene <=> gamma-Carotene OE3983R
R90128 D-Ribose 1,5-bisphosphate + NAD+ <=>
D-Ribulose 1,5-bisphosphate + NADH
OE4651F PMID:15375115
R90129 D-Fructose 1,6-bisphosphate + NAD+ =>
4-Ketofructose-1,6-bisphosphate + NADH
PMID:15182204
R90126 UDP-D-galactose + H2O => D-Galactose + UDP
R01466 O-Phospho-L-homoserine + H2O => L-Threonine
+ Orthophosphate
4.2.3.1 OE1807R OE3941F
OE4412R
PMID:3700337
R01465 L-Threonine + NAD+ =>
L-2-Amino-3-oxobutanoate + NADH + H+
1.1.1.103 OE4674F
R90127 Adenosine => Adenosine (E)
R01567 ATP + Thymidine => ADP + dTMP 2.7.1.21 OE3159R
R04786 Phytoene <=> Phytofluene + Hydrogen 1.14.99.- OE3381R OE3468R
OE1808F
R90120 Manganese (E) + ATP + H2O => Manganese +
ADP + Orthophosphate + H+
OE5146R OE5147R
R90121 Adenine (E) + H+ (pmf associated) => Adenine +
H+
OE3950R PMID:9457844
R01569 dTMP + H2O => Thymidine + Orthophosphate 3.1.3.5 OE3017R
R01373 Prephenate <=> Phenylpyruvate + H2O + CO2 4.2.1.51 OE4117F PMID:3700337
R04095 3-Methylbutanoyl-CoA + FAD <=>
3-Methylcrotonyl-CoA + FADH2
1.3.99.3 OE2710F OE2013R
OE2138F OE3123R
OE4500R OE1555F
R04203 (2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA +
NAD+ <=> 2-Methylacetoacetyl-CoA + NADH
1.1.1.35 OE2015R
R04097 S-(3-Methylbutanoyl)-dihydrolipoamide + CoA =>
3-Methylbutanoyl-CoA + Dihydrolipoamide
2.3.1.-
R90111 Zinc => Zinc (E) OE3619R
R01286 L-Cystathionine + H2O => L-Homocysteine +
NH3 + Pyruvate
4.4.1.8 OE2173F OE2681F
R90112 Cadmium => Cadmium (E) OE3619R
R01288 O-Succinyl-L-homoserine + Sulfide <=>
L-Homocysteine + Succinate
2.5.1.48 OE2173F OE2681F
R90113 Potassium + H+ (pmf associated) => Potassium
(E) + H+
OE3889R
R01287 O-Acetyl-L-homoserine + Hydrogen sulfide =>
L-Homocysteine + Acetate
2.5.1.49 OE4398F
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R90114 Phosphonate (E) + ATP + H2O +
Orthophosphate => Phosphonate + ADP + H+
OE3908R OE3907R
OE3910R
R90116 Oligopeptide (E) + ATP + H2O => Oligopeptide
+ ADP + Orthophosphate + H+
OE4302R OE4317F PMID:10064582
R90117 Dipeptide (E) + ATP + H2O => Dipeptide +
ADP + Orthophosphate + H+
OE4303R OE4555F
OE4304R OE4305R
OE4550F OE4551F
OE4552F
PMID:10064582
R90118 Ferrichrome (E) + ATP + H2O => Ferrichrome +
ADP + Orthophosphate + H+
OE4577F OE4579F
R01280 ATP + Hexadecanoic acid + CoA <=> AMP +
Palmitoyl-CoA + Pyrophosphate
6.2.1.3 OE2912F OE3891R
OE1271F
R04204 2-Methylbut-2-enoyl-CoA + H2O <=>
(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA
4.2.1.17 OE3846R
R01385 UDPglucuronate <=> UDP-D-galacturonate 5.1.3.6 OE2110R OE1113R
R04209 1-(5-Phospho-D-ribosyl)-5-amino-4-
imidazolecarboxylate <=> Aminoimidazole
ribotide + CO2
4.1.1.21 OE1951F OE1952F
R04208 ATP +
2-(Formamido)-N1-(5’-phosphoribosyl)acetamidine
=> ADP + Orthophosphate + Aminoimidazole
ribotide
6.3.3.1 OE2292F
R90110 Betaine (E) => Betaine
R04993 2-Demethylmenaquinone +
S-Adenosyl-L-methionine => Menaquinol +
S-Adenosyl-L-homocysteine
2.1.1.- OE3994F
R04992 Succinate semialdehyde-thiamin diphosphate anion
+ Isochorismate => 2-Succinyl-6-hydroxy-2,4-
cyclohexadiene-1-carboxylate + Thiamin
diphosphate + Pyruvate
2.5.1.64 OE2563R
R04787 Phytofluene <=> zeta-Carotene 1.14.99.- OE3381R OE3468R
OE1808F
R04212 L-Asparaginyl-tRNA(Asn) + L-Glutamate +
Orthophosphate + ADP <=>
L-Aspartyl-tRNA(Asn) + L-Glutamine + ATP
6.3.5.6 OE1522F OE2283F
OE2284F
PMID:10993083
R90119 Zinc (E) + ATP + H2O => Zinc + ADP +
Orthophosphate + H+
OE5146R OE5147R
R01279 Palmitoyl-CoA + FAD =>
trans-Hexadec-2-enoyl-CoA + FADH2
1.3.3.6
1.3.99.3
1.3.99.13
OE2710F OE1555F
OE2013R OE2138F
OE3123R OE4500R
R00158 ATP + UMP <=> ADP + UDP 2.7.4.14 OE3429F
R02022 dCTP + Oxidized thioredoxin + H2O <=> CTP
+ Thioredoxin
1.17.4.2 OE3328R OE4345R
OE4346R
R02023 dUTP + Oxidized thioredoxin + H2O <=> UTP
+ Thioredoxin
1.17.4.2 OE3328R OE4345R
OE4346R
R02024 Thioredoxin + CDP => dCDP + Oxidized
thioredoxin + H2O
1.17.4.1 OE3328R OE4345R
OE4346R
PMID:8990160
R00156 ATP + UDP <=> ADP + UTP 2.7.4.6 OE2667F
R02971 ATP + Pantetheine => ADP + Pantetheine
4’-phosphate
2.7.1.33
2.7.1.34
R01157 Agmatine + H2O => Putrescine + Urea 3.5.3.11 OE3486R
R02020 dGTP + Oxidized thioredoxin + H2O <=> GTP
+ Thioredoxin
1.17.4.2 OE3328R OE4345R
OE4346R
R00985 Chorismate + NH3 => Anthranilate + Pyruvate +
H2O
4.1.3.27 OE1568F OE1570F
OE1573A1F
OE3331R OE3332R
R00986 Chorismate + L-Glutamine => Anthranilate +
Pyruvate + L-Glutamate
4.1.3.27 OE1568F OE1570F
OE1573A1F
OE3331R OE3332R
R02021 Thioredoxin + 3’-Phosphoadenylyl sulfate =>
Oxidized thioredoxin + Sulfite + Adenosine
3’,5’-bisphosphate + H+
1.8.4.8
R01015 D-Glyceraldehyde 3-phosphate <=> Glycerone
phosphate
5.3.1.1 OE2500R PMID:2256927
PMID:9827332
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R02164 Succinate + Menaquinone <=> Fumarate +
Menaquinol
1.3.5.1 OE2865R OE2866R
OE2867R OE2868R
PMID:11803024
PMID:4004256
PMID:5780095
PMID:9827332
R00299 ATP + D-Glucose => ADP + D-Glucose
6-phosphate
2.7.1.2
2.7.1.1
OE4691R PMID:2256927
PMID:3255682
PMID:6642538
R02805 P1,P4-Bis(5’-xanthosyl) tetraphosphate + H2O =>
XTP + Xanthosine 5’-phosphate
3.6.1.17 OE1648R
R90046 Glycine (E) + H+ (pmf associated) <=> Glycine
+ H+
OE2560R PMID:889797
R90045 L-Leucine (E) + H+ (pmf associated) <=>
L-Leucine + H+
PMID:10779875
PMID:889797
R00705 3-Oxopropanoate + CoA + NAD+ => Acetyl-CoA
+ CO2 + NADH + H+
1.2.1.18 OE4529F OE2367F
OE2190R OE2133R
R01547 ATP + dAMP <=> ADP + dADP 2.7.4.3 OE3425F
R01548 dATP + Cytidine => dADP + CMP 2.7.1.48 OE2749F
R00704 (R)-Lactate + NAD+ <=> Pyruvate + NADH +
H+
1.1.1.28 OE4399F PMID:8157586
R90048 L-Valine (E) + H+ (pmf associated) <=> L-Valine
+ H+
PMID:889797
R01549 dATP + Uridine => dADP + UMP 2.7.1.48 OE2749F
R00703 (S)-Lactate + NAD+ <=> Pyruvate + NADH +
H+
1.1.1.27 OE4036R OE4021F
OE1778R OE2916F
PMID:7736359
PMID:8157586
PMID:9827332
R90047 L-Threonine (E) + H+ (pmf associated) =>
L-Threonine + H+
PMID:889797
R90049 L-Alanine (E) + H+ (pmf associated) <=>
L-Alanine + H+
PMID:889797
R00708 (S)-1-Pyrroline-5-carboxylate + NADP+ + H2O
=> L-Glutamate + NADPH + H+
1.5.1.12 OE2133R OE2190R
OE2367F OE4529F
PMID:9827332
R05595 Crotonoyl-CoA + H2O <=>
3-Hydroxybutanoyl-CoA
4.2.1.17 OE3846R
R00707 (S)-1-Pyrroline-5-carboxylate + NAD+ + H2O =>
L-Glutamate + NADH + H+
1.5.1.12 OE2133R OE2190R
OE2367F OE4529F
PMID:9827332
R02019 GDP + Thioredoxin => dGDP + Oxidized
thioredoxin + H2O
1.17.4.1 OE3328R OE4345R
OE4346R
PMID:8990160
R00161 ATP + FMN => Pyrophosphate + FAD 2.7.7.2
R00160 FAD + H2O => AMP + FMN 3.6.1.9
3.6.1.18
R90040 L-Lysine (E) + H+ (pmf associated) <=> L-Lysine
+ H+
OE1288F OE5101R PMID:889797
R00702 trans,trans-Farnesyl diphosphate =>
Pyrophosphate + Presqualene diphosphate + H+
2.5.1.21 OE2014F PMID:2857171
R02016 Oxidized thioredoxin + NADPH + H+ =>
Thioredoxin + NADP+
1.8.1.9 OE2805R OE4227F
R90042 L-Asparagine (E) + H+ (pmf associated) <=>
L-Asparagine + H+
PMID:889797
R90041 L-Phenylalanine (E) + H+ (pmf associated) =>
L-Phenylalanine + H+
OE2779F PMID:889797
R90044 L-Serine (E) + H+ (pmf associated) <=> L-Serine
+ H+
PMID:35540
PMID:889797
R02018 Thioredoxin + UDP => dUDP + Oxidized
thioredoxin + H2O
1.17.4.1 OE3328R OE4345R
OE4346R
PMID:8990160
R02017 Thioredoxin + ADP => dADP + Oxidized
thioredoxin + H2O
1.17.4.1 OE3328R OE4345R
OE4346R
PMID:8990160
R01163 L-Histidinal + H2O + NAD+ => L-Histidine +
NADH + H+
1.1.1.23 OE3071F PMID:3700337
R90043 L-Isoleucine (E) + H+ (pmf associated) <=>
L-Isoleucine + H+
PMID:889797
R00970 ITP + Uridine => IDP + UMP 2.7.1.48 OE2749F
R00032 beta-Carotene + Oxygen => Retinal 1.14.99.36 PMID:11092896
PMID:11226271
R01561 Adenosine + Orthophosphate <=> Adenine +
alpha-D-Ribose 1-phosphate
2.4.2.1 PMID:9457844
R01939 L-2-Aminoadipate + 2-Oxoglutarate <=>
2-Oxoadipate + L-Glutamate
2.6.1.39 PMID:3700337
R90037 L-Glutamine (E) + H+ (pmf associated) =>
L-Glutamine + H+
PMID:889797
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R90036 L-Glutamate (E) + H+ (pmf associated) <=>
L-Glutamate + H+
OE5200R PMID:889797
R90035 L-Aspartate (E) + H+ (pmf associated) =>
L-Aspartate + H+
OE5200R PMID:35540
PMID:889797
R90039 L-Histidine (E) + H+ (pmf associated) <=>
L-Histidine + H+
OE1288F OE5101R PMID:889797
R01010 Glycerone phosphate + H2O => Glycerone +
Orthophosphate
3.1.3.1 OE5192R
R90038 L-Tryptophan (E) + H+ (pmf associated) <=>
L-Tryptophan + H+
OE2779F
R90033 L-Methionine (E) + H+ (pmf associated) =>
L-Methionine + H+
PMID:889797
R90032 L-Tyrosine (E) + H+ (pmf associated) <=>
L-Tyrosine + H+
OE2779F PMID:889797
R90031 L-Arginine (E) + H+ (pmf associated) =>
L-Arginine + H+
OE1288F OE5101R PMID:889797
R00177 ATP + L-Methionine + H2O => Orthophosphate
+ Pyrophosphate + S-Adenosyl-L-methionine
2.5.1.6 OE2857F
R90030 L-Cysteine (E) + H+ (pmf associated) =>
L-Cysteine + H+
R00965 Orotidine 5’-phosphate => UMP + CO2 4.1.1.23 OE3363F PMID:10672188
R01135 GTP + IMP + L-Aspartate => GDP +
Orthophosphate + N6-(1,2-Dicarboxyethyl)-AMP
6.3.4.4 OE2579F
R00966 Uracil + 5-Phospho-alpha-D-ribose 1-diphosphate
=> UMP + Pyrophosphate
2.4.2.9 OE4234R
R00963 UMP + H2O => Uridine + Orthophosphate 3.1.3.5 OE3017R
R01138 dADP + Phosphoenolpyruvate => dATP +
Pyruvate
2.7.1.40 OE1495R
R01137 ATP + dADP <=> ADP + dATP 2.7.4.6 OE2667F
R01940 2-Oxoadipate + Lipoamide =>
S-Glutaryldihydrolipoamide + CO2
1.2.4.2 PMID:3700337
R00964 ATP + Uridine => ADP + UMP 2.7.1.48 OE2749F
R00962 ITP + Cytidine => IDP + CMP 2.7.1.48 OE2749F
R00969 P1,P4-Bis(5’-uridyl) tetraphosphate + H2O =>
UTP + UMP
3.6.1.17 OE1648R
R01036 Glycerol + NAD+ <=> D-Glyceraldehyde +
NADH + H+
1.1.1.1
1.1.1.21
OE3563R OE4674F
OE1698R OE2451R
OE2486F OE3312R
R00967 UTP + Uridine => UDP + UMP 2.7.1.48 OE2749F
R01039 Glycerone + NADPH + H+ <=> Glycerol +
NADP+
1.1.1.156
R00968 GTP + Uridine => GDP + UMP 2.7.1.48 OE2749F
R01521 NADP+ + D-Glucose <=> D-Glucono-1,5-lactone
+ NADPH
1.1.1.47 PMID:10650712
R04109 L-Glutamyl-tRNA(Glu) + NADPH =>
(S)-4-Amino-5-oxopentanoate + tRNA(Glu) +
NADP+ + H2O
1.2.1.- OE3496R
R01523 ATP + D-Ribulose 5-phosphate => ADP +
D-Ribulose 1,5-bisphosphate
2.7.1.19 PMID:3255682
R90068 Potassium <=> Potassium (E) OE1931R
R90067 ATP + Potassium (E) + H2O => ADP +
Orthophosphate + Potassium + H+
OE5051A1F
OE5052F OE5053F
OE5054F
R00286 UDPglucose + H2O + NAD+ <=>
UDPglucuronate + NADH + H+
1.1.1.22 OE1077R OE2524R
R05578 tRNA(Glu) + L-Glutamate + ATP <=>
L-Glutamyl-tRNA(Glu) + Pyrophosphate + AMP
6.1.1.17 OE2652F
R90069 L-Ornithine (E) + H+ (pmf associated) =>
L-Ornithine + H+
PMID:6933439
R05577 tRNA(Asp) + L-Aspartate + ATP <=>
L-Aspartyl-tRNA(Asp) + Pyrophosphate + AMP
6.1.1.12 OE1687F
R00188 Adenosine 3’,5’-bisphosphate + H2O => AMP +
Orthophosphate
3.1.3.7
R90064 2,3-Bis-O-(geranylgeranyl)glycerol 1-phosphate +
H2O + NADPH + H+ =>
2,3-Di-O-phytanyl-sn-glycerol + Orthophosphate +
NADP+
PMID:16788058
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R01528 6-Phospho-D-gluconate + NADP+ => D-Ribulose
5-phosphate + CO2 + NADPH + H+
1.1.1.44 OE4581F PMID:3255682
R90063 HCO3- + H+ <=> H2O + CO2
R90066 Sodium (E) => Sodium
R90065 H+ (pmf associated) + Sodium + Potassium (E)
=> H+ + Potassium + Sodium (E) [pmf]
OE2841R OE3422R
OE4599F OE5301F
R90060 FADH2 + Menaquinone => FAD + Menaquinol 1.3.99.1 OE2865R OE2866R
OE2867R OE2868R
R00183 AMP + H2O => Adenosine + Orthophosphate 3.1.3.5 OE3017R
R90062 L-Ornithine + L-Arginine (E) => L-Ornithine (E)
+ L-Arginine
PMID:6933439
R90061 L-Ornithine => L-Ornithine (E)
R01127 IMP + H2O <=> 1-(5’-Phosphoribosyl)-5-
formamido-4-imidazolecarboxamide
3.5.4.10 OE4329F PMID:11844782
R01126 IMP + H2O => Inosine + Orthophosphate 3.1.3.5 OE3017R
R01818 D-Mannose 6-phosphate <=> D-Mannose
1-phosphate
5.4.2.8 OE2318R OE4094F
R00189 ATP + Deamino-NAD+ + NH3 => AMP +
Pyrophosphate + NAD+
6.3.1.5 OE3843F
R02058 Acetyl-CoA + D-Glucosamine 6-phosphate =>
CoA + N-Acetyl-D-glucosamine 6-phosphate
2.3.1.4
R01954 ATP + L-Citrulline + L-Aspartate => AMP +
Pyrophosphate + N-(L-Arginino)succinate
6.3.4.5 OE4420R
R00289 UTP + D-Glucose 1-phosphate <=>
Pyrophosphate + UDPglucose
2.7.7.9 OE1578F OE1016R
OE1078F OE1114F
OE2530F OE1014R
PMID:10760168
R01541 ATP + 2-Dehydro-3-deoxy-D-gluconate => ADP
+ 2-Dehydro-3-deoxy-6-phospho-D-gluconate
2.7.1.45 OE1266R PMID:11271421
PMID:3255682
R00959 D-Glucose 1-phosphate <=> D-Glucose
6-phosphate
5.4.2.2 OE2318R OE4094F
OE4190F
R90150 Acetaldehyde (E) + H+ (pmf associated) <=>
Acetaldehyde + H+
R01034 Glycerone + NADH <=> Glycerol + NAD+ 1.1.1.6 OE5160F PMID:3255682
R00291 UDPglucose <=> UDP-D-galactose 5.1.3.2 OE2110R OE1113R
R00004 Pyrophosphate + H2O => Orthophosphate 3.6.1.1 OE1407F
R00190 Adenine + 5-Phospho-alpha-D-ribose 1-diphosphate
=> AMP + Pyrophosphate
2.4.2.7 OE1504F PMID:9457844
R90059 Cobalt (E) + ATP + H2O => Cobalt + ADP +
Orthophosphate + H+
OE3315R OE3317R
OE3318R OE3319R
OE4256F
R90058 Biotin (E) + H+ (pmf associated) => Biotin + H+
R00009 H2O2 => Oxygen + H2O 1.11.1.6 OE5186R PMID:7814327
R90057 Thiamin (E) + ATP + H2O => Thiamin + ADP
+ Orthophosphate + H+
OE3641F OE4358F
OE4359F
R90056 Folate (E) + H+ (pmf associated) => Folate + H+
R02147 Guanosine + Orthophosphate <=> Guanine +
alpha-D-Ribose 1-phosphate
2.4.2.1 PMID:9457844
R90151 Glycerol => Glycerol (E)
R90055 Sulfate (E) + ATP + H2O => Sulfate + ADP +
Orthophosphate + H+
OE3269R
R90054 Orthophosphate (E) + H+ (pmf associated) =>
Orthophosphate + H+
OE5132F
R01130 IMP + NAD+ + H2O => Xanthosine
5’-phosphate + NADH + H+
1.1.1.205 OE2458R
R00199 ATP + Pyruvate + H2O => AMP +
Phosphoenolpyruvate + Orthophosphate
2.7.9.2 OE1500R PMID:2256927
PMID:9827332
R90052 Nitrate (E) + H+ (pmf associated) => Nitrate +
H+
R90050 Iron (E) + H2O + ATP => Iron + ADP + H+ +
Orthophosphate
OE4591R OE4593R
OE2346R OE2348R
PMID:12196172
R00192 S-Adenosyl-L-homocysteine + H2O <=>
Adenosine + L-Homocysteine
3.3.1.1 OE4159F
R01131 ATP + Inosine => ADP + IMP 2.7.1.73 OE3606R PMID:9457844
R01132 Hypoxanthine + 5-Phospho-alpha-D-ribose
1-diphosphate => IMP + Pyrophosphate
2.4.2.8 OE1840R PMID:9457844
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R00066 6,7-Dimethyl-8-(1-D-ribityl)lumazine => Riboflavin
+ 4-(1-D-Ribitylamino)-5-amino-2,6-
dihydroxypyrimidine
2.5.1.9 OE1946R OE4683F
R04030 ATP + 2-Succinylbenzoate + CoA => AMP +
Pyrophosphate + 2-Succinylbenzoyl-CoA
6.2.1.26 OE2555R
R02061 trans,trans-Farnesyl diphosphate + Isopentenyl
diphosphate => Pyrophosphate + Geranylgeranyl
diphosphate
2.5.1.10
2.5.1.29
2.5.1.1
OE2650F OE4010F PMID:3700337
R00945 Tetrahydrofolate + L-Serine <=>
5,10-Methylenetetrahydrofolate + Glycine + H2O
2.1.2.1 OE3036F
R00258 L-Alanine + Oxaloacetate <=> Pyruvate +
L-Aspartate
2.6.1.1 OE1755F OE1944R
OE2619F
PMID:8157586
PMID:9827332
R04137 3-Hydroxyisovaleryl-CoA <=>
3-Methylcrotonyl-CoA + H2O
4.2.1.17 OE3846R
R00257 ATP + Deamino-NAD+ + L-Glutamine + H2O
=> AMP + Pyrophosphate + NAD+ +
L-Glutamate
6.3.5.1 OE3843F
R04037 Phosphoribosyl-AMP + H2O <=> 5-(5-Phospho-
D-ribosylaminoformimino)-1-(5-phosphoribosyl)-
3.5.4.19 OE4199R PMID:3700337
R00940 Tetrahydrofolate + NADP+ => Folate + NADPH 1.5.1.3 PMID:17416665
PMID:15554970
R04035 Phosphoribosyl-ATP + H2O =>
Phosphoribosyl-AMP + Pyrophosphate
3.6.1.31 OE4641R PMID:3700337
R02063 Geranylgeranyl diphosphate + NADPH + H+ =>
Phytyl diphosphate + NADP+
- OE1657R OE1699R
OE2720R OE4702F
PMID:3700337
R02257 Propane-1,2-diol + NAD+ <=> (S)-Lactaldehyde
+ NADH
1.1.1.77 OE4036R OE4021F
OE1778R OE2916F
R00943 Tetrahydrofolate + Formate + ATP => ADP +
Orthophosphate + 10-Formyltetrahydrofolate
3.5.4.9
6.3.4.3
OE3038F
R04031 2-Succinylbenzoate + H2O <=> 2-Succinyl-6-
hydroxy-2,4-cyclohexadiene-1-carboxylate
4.2.1.- OE2558R
R02065 Geranylgeranyl diphosphate => Pyrophosphate +
Prephytoene diphosphate + H+
2.5.1.32 OE3093R OE3376F PMID:2857171
R90091 6-Deoxy-5-Ketofructose 1 phosphate + L-Aspartate
4-semialdehyde => Compound I +
Hydroxypyruvaldehyde 3-P
OE1472F PMID:15182204
R90081 Thymidine (E) + H+ (pmf associated) =>
Thymidine + H+
R90082 Cytidine (E) + H+ (pmf associated) => Cytidine
+ H+
R00742 ATP + Acetyl-CoA + HCO3- => ADP +
Orthophosphate + Malonyl-CoA
6.4.1.2 OE1939F OE3175F
R90083 Guanosine (E) + H+ (pmf associated) =>
Guanosine + H+
OE3950R PMID:9457844
R01123 Isopentenyl diphosphate <=> Dimethylallyl
diphosphate
5.3.3.2 OE3560F OE6213R
OE7093R
PMID:3700337
R90084 Deoxyadenosine (E) + H+ (pmf associated) =>
Deoxyadenosine + H+
R00121 Oxygen + H2O + Sulfur <=> Hydrogen sulfide +
Sulfite
1.13.99.-
R00848 sn-Glycerol 3-phosphate + FAD => Glycerone
phosphate + FADH2
1.1.99.5 OE3763F OE3764F
OE3765F
PMID:3700337
PMID:5534921
R90085 Deoxyuridine (E) + H+ (pmf associated) =>
Deoxyuridine + H+
R90086 Deoxycytidine (E) + H+ (pmf associated) =>
Deoxycytidine + H+
R00849 sn-Glycerol 3-phosphate + NADP+ => Glycerone
phosphate + NADPH
1.1.99.4
1.1.99.5
OE3763F OE3764F
OE3765F
PMID:3700337
PMID:5534921
R90087 Deoxyguanosine (E) + H+ (pmf associated) =>
Deoxyguanosine + H+
R90088 Adenosine-GDP-Cobinamide (E) + ATP + H2O
=> Adenosine-GDP-cobinamide + ADP +
Orthophosphate + H+
R00847 ATP + Glycerol => ADP + sn-Glycerol
3-phosphate
2.7.1.30 OE3762R PMID:3255682
PMID:3700337
PMID:5534921
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R05553 4-amino-4-deoxychorismate <=> 4-Aminobenzoate
+ Pyruvate
4.1.3.38
R90089 D-Glucose (E) + ATP + H2O => D-Glucose +
ADP + H+ + Orthophosphate
OE1314F Arch Microbiol
155:131-136
R05555 trans,trans-Farnesyl diphosphate + Isopentenyl
diphosphate <=> trans,trans,cis-Geranylgeranyl
diphosphate + Pyrophosphate
2.5.1.31
2.5.1.-
OE3503F OE3505R
OE2559R OE2650F
OE4010F
PMID:2857171
R00262 L-threo-3-Methylaspartate <=> L-Glutamate 5.4.99.1 OE4204F OE4206F
R00261 L-Glutamate => 4-Aminobutanoate + CO2 4.1.1.19
4.1.1.15
OE1498R
R00935 (S)-Methylmalonate semialdehyde + CoA + NAD+
=> Propanoyl-CoA + CO2 + NADH + H+
1.2.1.27 OE4529F OE2367F
OE2190R OE2133R
R00937 Tetrahydrofolate + NAD+ => Folate + NADH 1.5.1.3 PMID:17416665
PMID:15554970
R00936 Dihydrofolate + NADH + H+ =>
Tetrahydrofolate + NAD+
1.5.1.3 PMID:17416665
PMID:15554970
R00939 Dihydrofolate + NADPH + H+ <=>
Tetrahydrofolate + NADP+
1.5.1.3 OE2921R PMID:15554970
PMID:17416665
R00267 Isocitrate + NADP+ <=> 2-Oxoglutarate + CO2
+ NADPH + H+
1.1.1.42 OE3634F PMID:4393394
PMID:5058691
PMID:5780095
PMID:5802601
PMID:9827332
R04125 Tetrahydrofolate +
S-Aminomethyldihydrolipoylprotein <=>
5,10-Methylenetetrahydrofolate + NH3 +
Dihydrolipoylprotein
2.1.2.10 OE3278R
R00268 Oxalosuccinate <=> 2-Oxoglutarate + CO2 1.1.1.42 OE3634F PMID:4393394
PMID:5058691
PMID:5780095
PMID:5802601
PMID:9827332
R00124 ATP + ADP <=> ADP + ATP 2.7.4.6 OE2667F
R01106 Nitrate + Halocyanin (reduced) => Nitrite +
Halocyanin (oxidized)
1.7.99.4 PMID:629538
PMID:4750772
R90080 Adenosine (E) + H+ (pmf associated) =>
Adenosine + H+
OE3950R PMID:9457844
R00127 ATP + AMP <=> ADP 2.7.4.3 OE3425F
R90072 Oxygen (E) <=> Oxygen
R90073 Hydrogen (E) <=> Hydrogen
R90070 H2O (E) <=> H2O
R90071 CO2 (E) <=> CO2
R00835 D-Glucose 6-phosphate + NADP+ <=>
D-Glucono-1,5-lactone 6-phosphate + NADPH +
H+
1.1.1.49 PMID:11271421
PMID:5780095
PMID:10650712
R90076 sn-Glycerol-3-P (E) + ATP + H2O => sn-Glycerol
3-phosphate + ADP + Orthophosphate + H+
OE5166F OE5168F
OE5169F OE5170F
PMID:3700337
R00130 ATP + Dephospho-CoA => ADP + CoA 2.7.1.24 OE4442F
R90077 (S)-Lactate (E) + H+ (pmf associated) <=>
(S)-Lactate + H+
OE6063F
R01519 D-Glucono-1,5-lactone + H2O => D-Gluconic acid 3.1.1.17 PMID:10650712
PMID:2256927
R01518 2-Phospho-D-glycerate <=>
3-Phospho-D-glycerate
5.4.2.1
5.4.2.4
OE3653R PMID:2256927
PMID:9827332
R00734 L-Tyrosine + 2-Oxoglutarate <=>
3-(4-Hydroxyphenyl)pyruvate + L-Glutamate
2.6.1.9
2.6.1.1
2.6.1.5
2.6.1.57
OE2507R OE1755F
OE1944R OE2619F
R90074 NH3 (E) <=> NH3
R02272 (S)-4-Amino-5-oxopentanoate <=>
5-Aminolevulinate
5.4.3.8 OE4268F
R90075 D-Ribose (E) + ATP + H2O => D-Ribose + ADP
+ Orthophosphate + H+
OE2314R OE2315R
OE2316R
R00275 O2.- + H+ <=> H2O2 + Oxygen 1.15.1.1 OE2708R OE2906R PMID:3341765
R00833 (R)-2-Methyl-3-oxopropanoyl-CoA <=>
Succinyl-CoA
5.4.99.2 OE1721R OE2005F
OE1972F
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R90078 Oxalate (E) + Formate => Oxalate + Formate (E) OE1265F
R90079 Cl- => Cl- (E)
R01513 3-Phospho-D-glycerate + NAD+ <=>
3-Phosphonooxypyruvate + NADH + H+
1.1.1.95 OE1165R OE3065R
OE4408F
R01512 ATP + 3-Phospho-D-glycerate <=> ADP +
3-Phospho-D-glyceroyl phosphate
2.7.2.3 OE2745R PMID:2256927
PMID:9827332
R04158 Geranylgeranyl diphosphate + sn-Glycerol
3-phosphate <=> Pyrophosphate +
sn-3-O-(Geranylgeranyl)glycerol 1-phosphate
2.5.1.41
R00236 Acetyl adenylate + CoA => AMP + Acetyl-CoA 6.2.1.1 OE2450F OE1726F
R00235 ATP + Acetate + CoA => AMP + Pyrophosphate
+ Acetyl-CoA
6.2.1.1 OE2450F OE1726F
R00927 CoA + 2-Methylacetoacetyl-CoA <=>
Propanoyl-CoA + Acetyl-CoA
2.3.1.16 OE3884F
R00926 Propinol adenylate + CoA <=> AMP +
Propanoyl-CoA
6.2.1.1 OE2450F OE1726F
R00238 Acetyl-CoA <=> CoA + Acetoacetyl-CoA 2.3.1.9
2.3.1.16
OE3884F PMID:12013440
PMID:3700337
R00924 Propanoyl-CoA + FAD <=> FADH2 +
Propenoyl-CoA
1.3.99.3 OE1555F OE2013R
OE2138F OE2710F
OE3123R OE4500R
R02082 (S)-3-Hydroxy-3-methylglutaryl-CoA + NADPH
<=> (R)-Mevalonate + CoA + NADP+
1.1.1.34 OE3637R PMID:3700337
R02003 Geranyl diphosphate + Isopentenyl diphosphate
=> Pyrophosphate + trans,trans-Farnesyl
diphosphate
2.5.1.10
2.5.1.29
2.5.1.1
OE2650F OE4010F PMID:3700337
R04150 2-Succinylbenzoyl-CoA <=>
1,4-Dihydroxy-2-naphthoate + CoA
4.1.3.36 OE2561R
R02085 (S)-3-Hydroxy-3-methylglutaryl-CoA <=>
3-Methylglutaconyl-CoA + H2O
4.2.1.18
R05145 Biotinyl-5’-AMP + Apo-[carboxylase] <=> AMP
+ Holo-[carboxylase]
6.3.4.15 OE3186F OE1987F
R00137 ATP + Nicotinamide D-ribonucleotide =>
Pyrophosphate + NAD+
2.7.7.1 OE1462R
R02088 dAMP + H2O => Deoxyadenosine +
Orthophosphate
3.1.3.5 OE3017R
R01900 Isocitrate <=> cis-Aconitate + H2O 4.2.1.3 OE4613F PMID:5780095
PMID:9827332
R02984 dTDPglucose <=> dTDPgalactose 5.1.3.2 OE2110R OE1113R
R02285 N-Formimino-L-glutamate + H2O => L-Glutamate
+ Formamide
3.5.3.8 OE2736F
R00722 ATP + IDP <=> ADP + ITP 2.7.4.6 OE2667F
R01701 3-Methyl-2-oxobutanoate + Lipoamide =>
S-(2-Methylpropanoyl)-dihydrolipoamide + CO2
1.2.4.4 OE4114F OE4113F
OE3712R
R02288 4-Imidazolone-5-propanoate + H2O =>
N-Formimino-L-glutamate
3.5.2.7 OE2738F
R01702 4-Methyl-2-oxopentanoate + Lipoamide =>
S-(3-Methylbutanoyl)-dihydrolipoamide + CO2
1.2.4.4 OE4114F OE4113F
OE3712R
R01001 L-Cystathionine + H2O => L-Cysteine + NH3 +
2-Oxobutanoate
4.4.1.1 OE2173F OE2681F
R00036 5-Aminolevulinate => Porphobilinogen + H2O 4.2.1.24 OE4262F
R00243 L-Glutamate + NAD+ + H2O <=>
2-Oxoglutarate + NH3 + NADH + H+
1.4.1.2
1.4.1.3
OE1270F OE2728R PMID:2917175
PMID:3700337
PMID:8157586
PMID:8605224
PMID:9827332
PMID:10076069
PMID:12052548
R00864 Sulfite + Sulfur <=> Thiosulfate
R00245 L-Glutamate 5-semialdehyde + NAD+ + H2O
<=> L-Glutamate + NADH + H+
1.5.1.12 OE2133R OE2190R
OE2367F OE4529F
PMID:9827332
R02199 L-Isoleucine + 2-Oxoglutarate <=>
(R)-2-Oxo-3-methylpentanoate + L-Glutamate
2.6.1.42
2.6.1.6
OE3959R
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R04148 Nicotinate D-ribonucleotide +
Dimethylbenzimidazole => Nicotinate +
N1-(5-Phospho-alpha-D-ribosyl)-5,6-
dimethylbenzimidazole
2.4.2.21 OE3242F
R02198 L-Isoleucine + 2-Oxoglutarate <=>
3-Methyl-2-oxopentanoate + L-Glutamate
2.6.1.42 OE3959R
R02094 ATP + dTMP <=> ADP + dTDP 2.7.4.9
2.7.4.12
OE3715R
R02014 dATP + Oxidized thioredoxin + H2O <=> ATP +
Thioredoxin
1.17.4.2 OE3328R OE4345R
OE4346R
R02093 ATP + dTDP <=> ADP + dTTP 2.7.4.6 OE2667F
R00248 L-Glutamate + NADP+ + H2O <=>
2-Oxoglutarate + NH3 + NADPH + H+
1.4.1.3
1.4.1.4
OE2728R OE1943F PMID:1980084
PMID:3700337
PMID:8157586
PMID:9827332
PMID:12052548
R02091 dGTP + Cytidine => dGDP + CMP 2.7.1.48 OE2749F
R04144 ATP + 5-Phosphoribosylamine + Glycine => ADP
+ Orthophosphate + 5’-Phosphoribosylglycinamide
6.3.4.13 OE2864F
R02098 ATP + dUMP <=> ADP + dUDP 2.7.4.9
2.7.4.4
OE3715R
R02097 dTTP + Uridine => dTDP + UMP 2.7.1.48 OE2749F
R00149 ATP + NH3 + CO2 + H2O => ADP +
Orthophosphate + Carbamoyl phosphate
6.3.4.16 OE3554F OE3556R
R02096 dTTP + Cytidine => dTDP + CMP 2.7.1.48 OE2749F
R04800 Neurosporene + Oxygen + NADPH => Lycopene
+ H2O + NADP+
1.14.99.30
1.14.99.-
OE1426F OE3381R
OE3468R
R04292 Iminoaspartate + Glycerone phosphate =>
Pyridine-2,3-dicarboxylate + H2O +
Orthophosphate
4.1.99.- OE3644F
R05679 Glycerone phosphate + NADH + H+ => Glycerol
1-phosphate + NAD+
1.1.1.261 OE1602F PMID:9973362
PMID:9419225
R02099 ATP + Deoxyuridine => ADP + dUMP 2.7.1.21 OE3159R
R90098 Glycerol (E) + ATP + H2O => Glycerol + ADP
+ Orthophosphate + H+
OE5166F OE5168F
OE5169F OE5170F
PMID:3700337
R00710 Acetaldehyde + NAD+ + H2O => Acetate +
NADH + H+
1.2.1.3 OE2133R OE2190R
OE2367F OE4529F
R00858 Sulfite + NADPH => Hydrogen sulfide + NADP+
+ H2O
1.8.1.2
R00711 Acetaldehyde + NADP+ + H2O => Acetate +
NADPH + H+
1.2.1.3 OE2133R OE2190R
OE2367F OE4529F
R90099 Cl- (E) + Photon => Cl- OE1299R PMID:9729742
R00713 Succinate semialdehyde + NAD+ + H2O =>
Succinate + NADH + H+
1.2.1.16
1.2.1.24
OE2190R OE2133R
OE2367F OE4529F
R90097 Formate => Formate (E)
R01714 5-O-(1-Carboxyvinyl)-3-phosphoshikimate =>
Chorismate + Orthophosphate
4.2.3.5 OE2761R PMID:3700337
R90094 D-Galactose (E) + ATP + H2O => D-Galactose +
ADP + H+ + Orthophosphate
OE1314F
R90095 Acetate (E) + H+ (pmf associated) <=> Acetate
+ H+
R00150 ADP + Carbamoyl phosphate => ATP + NH3 +
CO2
2.7.2.2 OE5206R PMID:7868583
PMID:8759859
R90092 Compound I + NAD+ =>
2-amino-3,7-dideoxy-hept-6-ulsonic acid + NADH
+ NH3
OE1475F PMID:15182204
R02297 Xanthosine + Orthophosphate <=> Xanthine +
alpha-D-Ribose 1-phosphate
2.4.2.1 PMID:9457844
R90093 Cobamide coenzyme (E) + ATP + H2O =>
Cobamide coenzyme + ADP + H+ +
Orthophosphate
OE2952F OE2955F
OE2951R
PMID:16109931
R05680 Glycerone phosphate + NADPH + H+ =>
Glycerol 1-phosphate + NADP+
1.1.1.261 OE1602F PMID:9973362
R01717 Chorismate <=> Isochorismate 5.4.4.2 OE2566R
R01716 Chorismate + L-Glutamine <=>
4-amino-4-deoxychorismate + L-Glutamate
6.3.5.8
R01715 Chorismate => Prephenate 5.4.99.5 OE2784R PMID:3700337
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R02291 4-Phospho-L-aspartate + NADPH + H+ =>
L-Aspartate 4-semialdehyde + Orthophosphate +
NADP+
1.2.1.11 OE3063F
R00714 Succinate semialdehyde + NADP+ + H2O =>
Succinate + NADPH + H+
1.2.1.16 OE2190R OE4529F
OE2133R OE2367F
R02292 L-Aspartate 4-semialdehyde + Pyruvate <=>
2,3-Dihydrodipicolinate + H2O
4.2.1.52 OE1665R
R04138 ATP + 3-Methylcrotonyl-CoA + HCO3- => ADP
+ Orthophosphate + 3-Methylglutaconyl-CoA
6.4.1.4 OE3177F
R00253 ATP + L-Glutamate + NH3 => ADP +
Orthophosphate + L-Glutamine
6.3.1.2 OE3922R
R00716 L-Lysine + 2-Oxoglutarate + NADPH + H+ =>
N6-(L-1,3-Dicarboxypropyl)-L-lysine + NADP+ +
H2O
1.5.1.8 PMID:3700337
Table A.2: Natronomonas pharaonis reaction list. In cases where there is
ambiguity in the genetic evidence, all of the candidate genes are listed.
Id Definition EC No. Genes
R04225 3-Methyl-2-oxopentanoate + Lipoamide =>
S-(2-Methylbutanoyl)-dihydrolipoamide + CO2
1.2.4.4 NP0560A NP2542A NP0558A
R03018 ATP + Pantothenate => ADP + D-4’-Phosphopantothenate 2.7.1.33
R02065 Geranylgeranyl diphosphate => Pyrophosphate +
Prephytoene diphosphate + H+
2.5.1.32 NP4770A
R01800 CDPdiacylglycerol + L-Serine => CMP + Phosphatidylserine 2.7.8.8 NP3230A
R03509 N-(5-Phospho-D-ribosyl)anthranilate <=>
1-(2-Carboxyphenylamino)-1’-deoxy-D-ribulose 5’-phosphate
5.3.1.24 NP3340A
R02649 ATP + N-Acetyl-L-glutamate => ADP +
N-Acetyl-L-glutamate 5-phosphate
2.7.2.8 NP5262A
R03096 Indole-3-acetamide + H2O <=> Indole-3-acetate + NH3 3.5.1.4 NP0178A NP0374A NP4212A
R00669 N-Acetylornithine + H2O => Acetate + L-Ornithine 3.5.1.16
3.5.1.14
NP0200A NP5266A
R90079 Cl- => Cl- (E)
R00344 ATP + Pyruvate + HCO3- => ADP + Orthophosphate +
Oxaloacetate
6.4.1.1 NP4252A NP4368A
R01398 Carbamoyl phosphate + L-Ornithine <=> Orthophosphate +
L-Citrulline
2.1.3.3 NP5268A
R05595 Crotonoyl-CoA + H2O <=> 3-Hydroxybutanoyl-CoA 4.2.1.17 NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R90124 L-Citrulline (E) + H+ (pmf associated) => L-Citrulline + H+
R00511 CMP + H2O => Cytidine + Orthophosphate 3.1.3.5 NP1854A NP2590A
R01196 Oxidized ferredoxin + Pyruvate + CoA <=> Reduced
ferredoxin + Acetyl-CoA + CO2
1.2.7.1 NP4044A NP4046A
R04144 ATP + 5-Phosphoribosylamine + Glycine <=> ADP +
Orthophosphate + 5’-Phosphoribosylglycinamide
6.3.4.13 NP3972A
R00160 FAD + H2O => AMP + FMN 3.6.1.9
3.6.1.18
R90082 Cytidine (E) + H+ (pmf associated) => Cytidine + H+
R03035 ATP + Pantetheine 4’-phosphate => Pyrophosphate +
Dephospho-CoA
2.7.7.3 NP3368A
R00485 L-Asparagine + H2O => L-Aspartate + NH3 3.5.1.1
3.5.1.38
NP2432A
R01056 D-Ribose 5-phosphate <=> D-Ribulose 5-phosphate 5.3.1.6 NP0786A
R00362 Citrate => Acetate + Oxaloacetate 4.1.3.6
R01220 5,10-Methylenetetrahydrofolate + NADP+ <=>
5,10-Methenyltetrahydrofolate + NADPH + H+
1.5.1.5 NP2054A
R00066 6,7-Dimethyl-8-(1-D-ribityl)lumazine => Riboflavin +
4-(1-D-Ribitylamino)-5-amino-2,6-dihydroxypyrimidine
2.5.1.9 NP1356A
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R04746 (S)-Hydroxyoctanoyl-CoA <=> trans-Oct-2-enoyl-CoA +
H2O
4.2.1.74
4.2.1.17
NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R01001 L-Cysteine + NH3 + 2-Oxobutanoate => L-Cystathionine +
H2O
4.4.1.1 NP4746A
R03217 O-Acetyl-L-homoserine + L-Cysteine => L-Cystathionine +
Acetate
2.5.1.49 NP0280A NP0284A
R05046 Formamidopyrimidine nucleoside triphosphate + H2O =>
2,5-Diaminopyrimidine nucleoside triphosphate + Formate
3.5.4.16
R04639 2,5-Diamino-6-(5’-triphosphoryl-3’,4’-trihydroxy-2’-oxopentyl)-
<=> 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl) +
H2O
3.5.4.16
R90075 D-Ribose (E) + ATP + H2O => D-Ribose + ADP +
Orthophosphate + H+
R00127 ATP + AMP <=> ADP 2.7.4.3 NP4910A
R00999 O-Succinyl-L-homoserine + H2O => 2-Oxobutanoate +
Succinate + NH3
2.5.1.48 NP4746A
R04125 Tetrahydrofolate + S-Aminomethyldihydrolipoylprotein =>
5,10-Methylenetetrahydrofolate + NH3 +
Dihydrolipoylprotein
2.1.2.10 NP4774A
R01900 Isocitrate <=> cis-Aconitate + H2O 4.2.1.3 NP0404A NP1994A
R03243 L-Histidinol phosphate + 2-Oxoglutarate <=>
3-(Imidazol-4-yl)-2-oxopropyl phosphate + L-Glutamate
2.6.1.9 NP2140A
R04148 Nicotinate D-ribonucleotide + Dimethylbenzimidazole =>
Nicotinate +
N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole
2.4.2.21 NP0736A
R00790 Nitrite + Reduced ferredoxin + H+ => NH3 + H2O +
Oxidized ferredoxin
1.7.7.1 NP4224A NP1146A NP4004A
R01514 ATP + D-Glycerate => ADP + 3-Phospho-D-glycerate 2.7.1.31 NP1162A
R00667 L-Ornithine + 2-Oxoglutarate <=> L-Glutamate
5-semialdehyde + L-Glutamate
2.6.1.13 NP5264A
R90061 L-Ornithine => L-Ornithine (E)
R90080 Adenosine (E) + H+ (pmf associated) => Adenosine + H+ NP1252A
R00571 ATP + UTP + NH3 => ADP + Orthophosphate + CTP 6.3.4.2 NP1968A
R00014 Thiamin diphosphate + Pyruvate =>
2-(alpha-Hydroxyethyl)thiamine diphosphate + CO2
2.2.1.6
1.2.4.1
NP1904A NP2200A NP2202A
R03503 ATP +
2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine =>
AMP + 2-Amino-7,8-dihydro-4-hydroxy-6-
(diphosphooxymethyl)pteridine
2.7.6.3
R01177 Acetyl-CoA + Butanoyl-CoA <=> CoA +
3-Oxohexanoyl-CoA
2.3.1.9
2.3.1.16
NP2214A NP2260A NP2606A
NP2612A NP3420A NP3438A
NP3650A NP4580A
R01968 dGMP + H2O => Deoxyguanosine + Orthophosphate 3.1.3.5 NP1854A NP2590A
R02473 ATP + (R)-Pantoate + beta-Alanine => AMP +
Pyrophosphate + Pantothenate
6.3.2.1
R01285 Cystathionine + H2O => L-Homocysteine + NH3 + Pyruvate 4.4.1.8 NP4746A
R00573 ATP + UTP + L-Glutamine + H2O => ADP +
Orthophosphate + CTP + L-Glutamate
6.3.4.2 NP1968A
R00858 Sulfite + NADPH => Hydrogen sulfide + NADP+ + H2O 1.8.1.2
R05578 tRNA(Glu) + L-Glutamate + ATP =>
L-Glutamyl-tRNA(Glu) + Pyrophosphate + AMP
6.1.1.17 NP3694A
R04672 2-(alpha-Hydroxyethyl)thiamine diphosphate + Pyruvate =>
(S)-2-Acetolactate + Thiamin diphosphate
2.2.1.6 NP1904A NP2200A NP2202A
R05809 Cobalt-precorrin 3 + S-Adenosyl-L-methionine <=>
Cobalt-precorrin 4 + S-Adenosyl-L-homocysteine
2.1.1.131 NP1114A NP1116A
R01137 ATP + dADP <=> ADP + dATP 2.7.4.6 NP3666A
R04620 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl) + H2O
=>
2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-
+ Orthophosphate
3.1.3.1
R02331 ATP + dUDP <=> ADP + dUTP 2.7.4.6 NP3666A
R90105 ATP + H2O + Copper (E) => ADP + Orthophosphate +
H+ + Copper
NP2668A
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R01702 4-Methyl-2-oxopentanoate + Lipoamide =>
S-(3-Methylbutanoyl)-dihydrolipoamide + CO2
1.2.4.4 NP0560A NP2542A NP0558A
R04173 3-Phosphonooxypyruvate + L-Glutamate <=>
O-Phospho-L-serine + 2-Oxoglutarate
2.6.1.52 NP2578A NP0884A
R90111 Zinc + H+ (pmf associated) => Zinc (E) + H+ NP3196A
R02325 dCTP + H2O => dUTP + NH3 3.5.4.13 NP5166A NP0954A
R04198 2,3,4,5-Tetrahydrodipicolinate + NAD+ <=>
L-2,3-Dihydrodipicolinate + NADH + H+
1.3.1.26 NP1492A
R03824 gamma-Carotene + H+ + NADPH => beta-Carotene +
NADP+
NP0652A
R04448 ATP + 5-(2-Hydroxyethyl)-4-methylthiazole => ADP +
4-Methyl-5-(2-phosphoethyl)-thiazole
2.7.1.50 NP4052A
R03457 D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate <=>
3-(Imidazol-4-yl)-2-oxopropyl phosphate + H2O
4.2.1.19 NP2258A
R04741 (S)-3-Hydroxydodecanoyl-CoA + NAD+ <=>
3-Oxododecanoyl-CoA + NADH
1.1.1.35
1.1.1.211
NP1906A NP2754A NP2630A
NP4322A
R00377 dCTP => Pyrophosphate + dCMP 2.7.7.7 NP0584A NP0476A NP0482A
NP2918A
R90107 L-Proline (E) + Sodium (E) [pmf] => L-Proline + Sodium NP4534A NP6036A
R00833 (R)-2-Methyl-3-oxopropanoyl-CoA <=> Succinyl-CoA 5.4.99.2 NP1226A NP2320A NP2710A
R04560 10-Formyltetrahydrofolate +
1-(5’-Phosphoribosyl)-5-amino-4-imidazolecarboxamide <=>
Tetrahydrofolate +
1-(5’-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide
2.1.2.3 NP1662A
R00024 D-Ribulose 1,5-bisphosphate + CO2 + H2O =>
3-Phospho-D-glycerate
4.1.1.39 NP2770A
R04993 2-Demethylmenaquinone + S-Adenosyl-L-methionine =>
Menaquinone + S-Adenosyl-L-homocysteine
2.1.1.- NP5034A
R02082 (S)-3-Hydroxy-3-methylglutaryl-CoA + NADPH =>
(R)-Mevalonate + CoA + NADP+
1.1.1.34 NP0368A NP2422A
R00104 ATP + NAD+ => ADP + NADP+ 2.7.1.23 NP2512A NP4558A
R00783 Nitrite + Ferrocytochrome c + H+ => Nitric oxide + H2O +
Ferricytochrome c
1.7.2.1 NP1958A
R03663 ATP + L-Threonine + tRNA(Thr) => AMP +
Pyrophosphate + L-Threonyl-tRNA(Thr)
6.1.1.3 NP2410A
R05553 4-amino-4-deoxychorismate <=> 4-Aminobenzoate +
Pyruvate
4.1.3.38
R02063 Geranylgeranyl diphosphate + H+ + NADPH <=> Phytyl
diphosphate + NADP+
R05807 Sirohydrochlorin + Cobalt <=> Cobalt-precorrin 2 4.99.1.3 NP1092A NP1108A NP1588A
R01229 Guanine + 5-Phospho-alpha-D-ribose 1-diphosphate => GMP
+ Pyrophosphate
2.4.2.7
2.4.2.22
NP1426A NP1254A
R01655 5,10-Methenyltetrahydrofolate + H2O <=>
10-Formyltetrahydrofolate + H+
3.5.4.9 NP2054A
R04475 N-Succinyl-LL-2,6-diaminoheptanedioate + 2-Oxoglutarate
<=> N-Succinyl-2-L-amino-6-oxoheptanedioate +
L-Glutamate
2.6.1.17
R07771 Lipoyl-AMP + Apoprotein => Protein N6-(lipoyl)lysine +
AMP
2.7.7.63 NP5116A
R01106 Nitrate + Ferrocytochrome c => Ferricytochrome c + Nitrite 1.7.99.4 NP1244A NP4226A
R90037 L-Glutamine (E) + H+ (pmf associated) => L-Glutamine +
H+
R90133 6-Deoxy-5-ketomannitol-1-phosphate + L-Aspartate
4-semialdehyde => Compound I + D-Glyceraldehyde
3-phosphate
NP3160A
R01717 Chorismate <=> Isochorismate 5.4.4.2 NP2724A
R02055 Phosphatidylserine => Phosphatidylethanolamine + CO2 4.1.1.65 NP4176A
R01954 ATP + L-Citrulline + L-Aspartate => AMP +
Pyrophosphate + N-(L-Arginino)succinate
6.3.4.5 NP5252A
R01724 Nicotinate + 5-Phospho-alpha-D-ribose 1-diphosphate =>
Nicotinate D-ribonucleotide + Pyrophosphate
2.4.2.11 NP1174A
R90035 L-Aspartate (E) + H+ (pmf associated) => L-Aspartate +
H+
R05225 Adenosyl cobyrinate a,c diamide + L-Glutamine + ATP <=>
Adenosyl cobyrinate hexaamide + L-Glutamate +
Orthophosphate + ADP
6.3.5.10 NP5126A
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R04559 1-(5’-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-
imidazole <=> Fumarate +
1-(5’-Phosphoribosyl)-5-amino-4-imidazolecarboxamide
4.3.2.2 NP1658A
R02292 L-Aspartate 4-semialdehyde + Pyruvate <=>
L-2,3-Dihydrodipicolinate + H2O
4.2.1.52 NP1490A
R04748 (S)-Hydroxyhexanoyl-CoA + NAD+ <=>
3-Oxohexanoyl-CoA + NADH
1.1.1.35
1.1.1.211
NP1906A NP2754A NP2630A
NP4322A
R03665 ATP + L-Valine + tRNA(Val) => AMP + Pyrophosphate +
L-Valyl-tRNA(Val)
6.1.1.9 NP0288A
R02017 Thioredoxin + ADP => dADP + Oxidized thioredoxin +
H2O
1.17.4.1 NP3346A NP4434A NP5066A
NP6166A NP6168A
R01214 L-Valine + 2-Oxoglutarate <=> 3-Methyl-2-oxobutanoic acid
+ L-Glutamate
2.6.1.42
2.6.1.6
NP0798A NP5036A
R03140 D-Ribulose 1,5-bisphosphate + Oxygen =>
3-Phospho-D-glycerate + 2-Phosphoglycolate
4.1.1.39 NP2770A
R03346 Nicotinate D-ribonucleotide + H2O => Nicotinate
D-ribonucleoside + Orthophosphate
3.1.3.5 NP1854A NP2590A NP4208A
R03223 2-Methyl-4-amino-5-hydroxymethylpyrimidine diphosphate +
4-Methyl-5-(2-phosphoethyl)-thiazole => Pyrophosphate +
Thiamin monophosphate
2.5.1.3 NP4054A
R01287 O-Acetyl-L-homoserine + Hydrogen sulfide =>
L-Homocysteine + Acetate
2.5.1.49 NP0280A NP0284A
R90044 L-Serine (E) + H+ (pmf associated) <=> L-Serine + H+
R00156 ATP + UDP <=> ADP + UTP 2.7.4.6 NP3666A
R04365 Succinyl-CoA + 2,3,4,5-Tetrahydrodipicolinate + H2O <=>
CoA + N-Succinyl-2-L-amino-6-oxoheptanedioate
2.3.1.117 NP1494A
R90003 ADP + Orthophosphate + H+ (pmf associated) <=> ATP +
H2O + H+
3.6.3.14 NP0264A NP1018A NP1020A
NP1022A NP1024A NP1026A
NP1028A NP1030A NP1032A
R03459 2,5-Diamino-6-hydroxy-4-(5’-phosphoribosylamino)-pyrimidine
+ H2O => 5-Amino-6-(5’-phosphoribosylamino)uracil + NH3
3.5.4.26
R90084 Deoxyadenosine (E) + H+ (pmf associated) =>
Deoxyadenosine + H+
R90147 Molybdenum (E) + ATP + H2O => Molybdenum + ADP +
Orthophosphate + H+
R02661 2-Methylpropanoyl-CoA + FAD =>
2-Methylprop-2-enoyl-CoA + FADH2
1.3.99.3 NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
R10003 Geranylgeranyl diphosphate + Isopentenyl diphosphate =>
all-trans-Pentaprenyl diphosphate + Pyrophosphate
2.5.1.- NP3696A NP0604A
R05071 (S)-2-Acetolactate <=>
(R)-3-Hydroxy-3-methyl-2-oxobutanoate
1.1.1.86 NP2198A
R90048 L-Valine (E) + H+ (pmf associated) <=> L-Valine + H+
R00369 L-Alanine + Glyoxylate => Pyruvate + Glycine 2.6.1.44 NP0884A NP2578A
R02236 Dihydrofolate + NADP+ <=> Folate + NADPH + H+ 1.5.1.3 NP2922A
R00291 UDPglucose <=> UDP-D-galactose 5.1.3.2 NP3504A NP4112A NP4662A
R04405 5-Methyltetrahydropteroyltri-L-glutamate + L-Homocysteine
=> Tetrahydropteroyltri-L-glutamate + L-Methionine
2.1.1.14 NP3670A NP3672A
R03194 S-Adenosyl-L-methionine + Uroporphyrinogen III <=>
S-Adenosyl-L-homocysteine + Precorrin 2
2.1.1.107 NP1328A
R03005 ATP + Nicotinate D-ribonucleotide => Pyrophosphate +
Deamino-NAD+
2.7.7.1 NP0310A NP0908A
R90103 Vitamin B12 (E) + ATP + H2O => Vitamin B12 + ADP +
Orthophosphate + H+
NP3814A NP3816A NP3818A
R01664 dCMP + H2O => Deoxycytidine + Orthophosphate 3.1.3.5 NP1854A NP2590A
R00548 FMN + H2O => Riboflavin + Orthophosphate 3.1.3.2 NP4208A
R00703 (S)-Lactate + NAD+ <=> Pyruvate + NADH + H+ 1.1.1.27 NP3764A NP1452A
R02739 alpha-D-Glucose 6-phosphate <=> beta-D-Glucose
6-phosphate
5.3.1.9 NP4992A
R06529 Adenosyl cobyrinate hexaamide + D-1-Aminopropan-2-ol
O-phosphate + ATP <=> Adenosyl cobinamide phosphate +
ADP + Orthophosphate
6.3.1.10 NP5308A
R00425 GTP + H2O => Formate +
2,5-Diamino-6-hydroxy-4-(5’-phosphoribosylamino)-pyrimidine
+ Pyrophosphate
3.5.4.25
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R90149 UDP-D-galactose + H2O => D-Galactose + UDP
R03321 beta-D-Glucose 6-phosphate <=> D-Fructose 6-phosphate 5.3.1.9 NP4992A
R02088 dAMP + H2O => Deoxyadenosine + Orthophosphate 3.1.3.5 NP1854A NP2590A
R00674 L-Serine + Indole <=> L-Tryptophan + H2O 4.2.1.20 NP3162A NP3164A
R02872 Presqualene diphosphate + NADPH + H+ =>
Pyrophosphate + Squalene + NADP+
2.5.1.21
R00442 CTP => Pyrophosphate + CMP 2.7.7.6 NP0114A NP0116A NP0112A
NP0110A NP2834A NP5080A
NP5078A NP3682A NP0108A
NP2844A NP4162A NP2842A
NP5234A
R00149 ATP + NH3 + CO2 + H2O => ADP + Orthophosphate +
Carbamoyl phosphate
6.3.4.16 NP4506A NP4830A
R07461 Thiamine biosynthesis intermediate 3 + Thiamine biosynthesis
intermediate 4 => Thiamine biosynthesis intermediate 5
NP3782A
R00557 L-Arginine + Oxygen + NADPH => Nitric oxide +
L-Citrulline + NADP+
1.14.13.39 NP1908A
R90088 Adenosine-GDP-Cobinamide (E) + ATP + H2O =>
Adenosine-GDP-cobinamide + ADP + Orthophosphate + H+
R01465 L-Threonine + NAD+ => L-2-Amino-3-oxobutanoic acid +
NADH + H+
1.1.1.103
R00004 Pyrophosphate + H2O => Orthophosphate 3.6.1.1 NP5192A
R07281 D-Ribulose 5-phosphate => 3, 4-Dihydroxy-2-butanone
4-phosphate + Formate
5.4.99.- NP0074A
R90069 L-Ornithine (E) + H+ (pmf associated) => L-Ornithine +
H+
R02329 dTTP + alpha-D-Galactose 1-phosphate <=> Pyrophosphate
+ dTDPgalactose
2.7.7.32 NP4652A NP4656A NP4674A
NP4680A NP2386A NP4276A
R00220 L-Serine => Pyruvate + NH3 4.3.1.19 NP1076A
R90145 D-Ribose 1,5-bisphosphate + NAD+ => D-Ribulose
1,5-bisphosphate + NADH
NP5174A NP3202A
R07459 ATP => Thiamine biosynthesis intermediate 4 +
Pyrophosphate
R05810 Cobalt-precorrin 4 + S-Adenosyl-L-methionine <=>
Cobalt-precorrin 5 + S-Adenosyl-L-homocysteine
2.1.1.133 NP1120A
R90086 Deoxycytidine (E) + H+ (pmf associated) => Deoxycytidine
+ H+
R03659 ATP + L-Methionine + tRNA(Met) => AMP +
Pyrophosphate + L-Methionyl-tRNA
6.1.1.10 NP1192A
R00722 ATP + IDP <=> ADP + ITP 2.7.4.6 NP3666A
R90101 Sodium + H+ (pmf associated) => H+ + Sodium (E) [pmf] NP4702A NP1832A
R01135 GTP + IMP + L-Aspartate => GDP + Orthophosphate +
N6-(1,2-Dicarboxyethyl)-AMP
6.3.4.4 NP1530A
R04800 Neurosporene + Oxygen + NADPH => Lycopene + H2O +
NADP+
1.14.99.30 NP4764A NP0204A NP1630A
R00429 ATP + GTP => AMP + Guanosine 3’-diphosphate
5’-triphosphate
2.7.6.5 NP3860A
R00248 L-Glutamate + NADP+ + H2O <=> 2-Oxoglutarate + NH3
+ NADPH + H+
1.4.1.3
1.4.1.4
NP1582A NP1806A NP6184A
R04208 ATP + 2-(Formamido)-N1-(5’-phosphoribosyl)acetamidine
=> ADP + Orthophosphate + Aminoimidazole ribotide
6.3.3.1 NP3940A
R06530 L-Threonine O-3-phosphate <=> D-1-Aminopropan-2-ol
O-phosphate + CO2
4.1.1.81
R01648 4-Aminobutanoate + 2-Oxoglutarate => Succinate
semialdehyde + L-Glutamate
2.6.1.19 NP6188A
R00200 ADP + Phosphoenolpyruvate => ATP + Pyruvate 2.7.1.40 NP1746A
R90046 Glycine (E) + H+ (pmf associated) <=> Glycine + H+ NP3588A
R04218 Prephytoene diphosphate + H+ + NADPH =>
Pyrophosphate + NADP+ + Phytoene
2.5.1.32 NP4770A
R90052 Nitrate (E) + H+ (pmf associated) => Nitrate + H+
R00177 ATP + L-Methionine + H2O => Orthophosphate +
Pyrophosphate + S-Adenosyl-L-methionine
2.5.1.6 NP3100A
R90114 Phosphonate (E) + ATP + H2O + Orthophosphate =>
Phosphonate + ADP + H+
NP6126A NP6124A NP6122A
R04233 CTP + D-4’-Phosphopantothenate + L-Cysteine => CDP +
Orthophosphate + (R)-4’-Phosphopantothenoyl-L-cysteine
6.3.2.5 NP1374A
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R01993 (S)-Dihydroorotate + H2O <=> N-Carbamoyl-L-aspartate 3.5.2.3 NP1706A
R03187 ATP + N-Methylhydantoin + H2O => ADP +
Orthophosphate + N-Carbamoylsarcosine
3.5.2.14 NP2954A NP6216A NP6218A
R00986 Chorismate + L-Glutamine <=> Anthranilate + Pyruvate +
L-Glutamate
4.1.3.27 NP0800A NP0802A NP3342A
NP3344A
R90119 Zinc (E) + ATP + H2O => Zinc + ADP + Orthophosphate
+ H+
R04787 Phytofluene => zeta-Carotene 1.3.99.- NP4764A NP0204A NP1630A
R04591 ATP +
1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate +
L-Aspartate <=> ADP + Orthophosphate + 1-(5’-
Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole
6.3.2.6 NP4996A
R90112 Cadmium + H+ (pmf associated) => Cadmium (E) + H+ NP3196A
R05611 all-trans-Heptaprenyl diphosphate + Isopentenyl diphosphate
=> all-trans-Octaprenyl diphosphate + Pyrophosphate
2.5.1.11 NP0604A NP4556A
R00316 ATP + Acetate => Pyrophosphate + Acetyl adenylate 6.2.1.1 NP4240A NP4242A NP5128A
NP5132A NP0164A
R01231 ATP + Xanthosine 5’-phosphate + L-Glutamine + H2O =>
AMP + Pyrophosphate + GMP + L-Glutamate
6.3.5.2 NP0620A NP1970A
R03651 ATP + L-Glutamate + tRNA(Gln) => AMP +
Pyrophosphate + L-Glutamyl-tRNA(Gln)
6.1.1.17
R90033 L-Methionine (E) + H+ (pmf associated) => L-Methionine +
H+
R03084 3-Dehydroquinate <=> 3-Dehydroshikimate + H2O 4.2.1.10
4.2.1.11
NP2240A
R00275 O2.- + H+ <=> H2O2 + Oxygen 1.15.1.1 NP4040A
R01070 D-Fructose 1,6-bisphosphate <=> Glycerone phosphate +
D-Glyceraldehyde 3-phosphate
4.1.2.13 NP1594A NP3160A
R00412 Succinate + FAD <=> Fumarate + FADH2 1.3.99.1 NP4264A NP4266A NP4268A
NP4270A
R90092 Compound I + NAD+ => 2-amino-3,7-dideoxy-hept-6-ulsonic
acid + NADH + NH3
NP2238A
R02765 (S)-2-Methyl-3-oxopropanoyl-CoA <=>
(R)-2-Methyl-3-oxopropanoyl-CoA
5.1.99.1
R00150 ADP + Carbamoyl phosphate => ATP + NH3 + CO2 2.7.2.2 NP3632A
R06411 cis-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA + H2O <=>
3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA
4.2.1.17 NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R00658 2-Phospho-D-glycerate <=> Phosphoenolpyruvate + H2O 4.2.1.11 NP2846A
R00923 (S)-2-Methyl-3-oxopropanoyl-CoA => Propanoyl-CoA + CO2 4.1.1.41
R04035 Phosphoribosyl-ATP + H2O <=> Phosphoribosyl-AMP +
Pyrophosphate
3.6.1.31 NP0470A
R00578 ATP + L-Aspartate + L-Glutamine + H2O => AMP +
Pyrophosphate + L-Asparagine + L-Glutamate
6.3.5.4 NP2978A
R90094 D-Galactose (E) + ATP + H2O => D-Galactose + ADP +
H+ + Orthophosphate
NP0530A
R90031 L-Arginine (E) + H+ (pmf associated) => L-Arginine + H+ NP0040A NP0042A NP0646A
NP2382A NP2676A NP4372A
NP6260A
R02662 2-Methylpropanoyl-CoA + Dihydrolipoamide =>
S-(2-Methylpropanoyl)-dihydrolipoamide + CoA
2.3.1.-
R03082 (R)-Lactaldehyde + Glutathione + NAD+ <=>
(R)-S-Lactoylglutathione + NADH
1.2.1.1 NP3020A NP1686A
R04520 Geranylgeranyl diphosphate +
sn-3-O-(Geranylgeranyl)glycerol 1-phosphate <=>
Pyrophosphate + 2,3-Bis-O-(geranylgeranyl)glycerol
1-phosphate
2.5.1.42
R01385 UDPglucuronate <=> UDP-D-galacturonate 5.1.3.6 NP4662A NP3504A NP4112A
R90130 4-Ketofructose-1,6-bisphosphate + NADH =>
6-Deoxy-5-Ketofructose 1 phosphate + Orthophosphate +
NAD+
R90050 Iron (E) + H2O + ATP => Iron + ADP + H+ +
Orthophosphate
NP3816A NP3818A NP5004A
NP5000A
R01134 IMP + NH3 + NADP+ <=> GMP + NADPH + H+ 1.7.1.7 NP3080A
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R00443 UTP => Pyrophosphate + UMP 2.7.7.6 NP0114A NP0116A NP0112A
NP0110A NP2834A NP5080A
NP5078A NP3682A NP0108A
NP2844A NP4162A NP2842A
NP5234A
R05221 Adenosyl cobinamide + ATP <=> Adenosyl cobinamide
phosphate + ADP
2.7.1.156
R00996 L-Threonine => 2-Oxobutanoate + NH3 4.3.1.19 NP1076A
R00375 dATP => Pyrophosphate + dAMP 2.7.7.7 NP0854A NP0476A NP0482A
NP2918A
R01086 N-(L-Arginino)succinate <=> Fumarate + L-Arginine 4.3.2.1 NP5254A
R04467 N6-Acetyl-LL-2,6-diaminoheptanedioate + 2-Oxoglutarate
<=> N-Acetyl-L-2-amino-6-oxopimelate + L-Glutamate
2.6.1.-
R00708 (S)-1-Pyrroline-5-carboxylate + NADP+ + H2O =>
L-Glutamate + NADPH + H+
1.5.1.12 NP3020A NP1686A
R90116 Oligopeptide (E) + ATP + H2O => Oligopeptide + ADP +
Orthophosphate + H+
NP0758A NP0760A NP0762A
NP0764A NP0766A NP3578A
NP3580A NP3582A NP3584A
R00519 Formate + NAD+ <=> H+ + CO2 + NADH 1.2.1.2 NP3710A NP4944A NP4946A
NP4960A NP4962A
R00939 Dihydrofolate + NADPH + H+ => Tetrahydrofolate +
NADP+
1.5.1.3 NP2922A
R01569 dTMP + H2O => Thymidine + Orthophosphate 3.1.3.5
3.1.3.35
NP1854A NP2590A
R01714 5-O-(1-Carboxyvinyl)-3-phosphoshikimate <=> Chorismate
+ Orthophosphate
4.2.3.5 NP3082A
R03026 (S)-3-Hydroxybutanoyl-CoA <=> Crotonoyl-CoA + H2O 4.2.1.17 NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R05223 Adenosine-GDP-cobinamide + alpha-Ribazole => Cobamide
coenzyme + GMP
2.7.8.26 NP5306A
R90098 Glycerol (E) + ATP + H2O => Glycerol + ADP +
Orthophosphate + H+
R07462 Thiamine biosynthesis intermediate 5 => C15815
R06860 2-Oxoglutarate + Isochorismate =>
2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate +
Pyruvate + CO2
2.5.1.64 NP2726A
R04558 1-(5’-Phosphoribosyl)-5-amino-4-imidazolecarboxamide +
L-Glutamate + D-erythro-1-(Imidazol-4-yl)glycerol
3-phosphate <=> N-(5’-Phospho-D-1’-ribulosylformimino)-5-
amino-1-(5”-phospho-D- +
L-Glutamine
2.4.2.- NP0082A NP4158A
R00502 UTP + alpha-D-Galactose 1-phosphate <=> Pyrophosphate
+ UDP-D-galactose
2.7.7.10 NP4652A NP4656A NP4674A
NP4680A NP2386A NP4276A
R01082 Fumarate + H2O <=> (S)-Malate 4.2.1.2 NP3778A
R02272 5-Aminolevulinate <=> (S)-4-Amino-5-oxopentanoate 5.4.3.8 NP1246A
R00671 L-Ornithine => L-Proline + NH3 4.3.1.12 NP0448A NP3802A
R01775 L-Homoserine + NADP+ <=> L-Aspartate 4-semialdehyde +
NADPH + H+
1.1.1.3 NP0302A
R03858 Lauroyl-CoA + Acetyl-CoA <=> CoA +
3-Oxotetradecanoyl-CoA
2.3.1.16 NP2214A NP2260A NP2606A
NP2612A NP3420A NP3438A
NP3650A NP4580A
R00704 (R)-Lactate + NAD+ <=> Pyruvate + NADH + H+ 1.1.1.28 NP3764A NP1452A
R02340 Indole + D-Glyceraldehyde 3-phosphate <=> Indoleglycerol
phosphate
4.2.1.20 NP3162A NP3164A
R90054 Orthophosphate (E) + H+ (pmf associated) =>
Orthophosphate + H+
NP1412A NP1270A NP4804A
R05811 Cobalt-precorrin 5 + S-Adenosyl-L-methionine + H2O <=>
Cobalt-precorrin 6 + S-Adenosyl-L-homocysteine +
Acetaldehyde
2.1.1.- NP1118A
R04426 3-Isopropylmalate + NAD+ <=>
3-Carboxy-4-methyl-2-oxopentanoate + NADH + H+
1.1.1.85 NP2190A
R04594 N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole +
H2O => alpha-Ribazole + Orthophosphate
3.1.3.73 NP2774A
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R03260 O-Succinyl-L-homoserine + L-Cysteine => L-Cystathionine +
Succinate
2.5.1.48 NP4746A
R01728 Prephenate + NAD+ <=> 3-(4-Hydroxyphenyl)pyruvate +
CO2 + NADH + H+
1.3.1.12
1.3.1.52
1.3.1.43
NP3358A
R90056 Folate (E) + H+ (pmf associated) => Folate + H+
R02093 ATP + dTDP <=> ADP + dTTP 2.7.4.6 NP3666A
R03012 L-Histidinol + NAD+ <=> L-Histidinal + NADH + H+ 1.1.1.23 NP2876A
R02540 2-Phenylacetamide + H2O <=> Phenylacetic acid + NH3 3.5.1.4 NP0178A NP0374A NP4212A
R04137 3-Hydroxyisovaleryl-CoA <=> 3-Methylcrotonyl-CoA + H2O 4.2.1.17 NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R00566 L-Arginine <=> Agmatine + CO2 4.1.1.19 NP4484A
R03777 Octanoyl-CoA + FAD => trans-Oct-2-enoyl-CoA + FADH2 1.3.99.13
1.3.99.3
1.3.3.6
NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
R03815 Dihydrolipoylprotein + NADP+ => Lipoylprotein + NADPH 1.8.1.4 NP0104A
R05069 (S)-2-Aceto-2-hydroxybutanoate <=>
(R)-3-Hydroxy-3-methyl-2-oxopentanoate
5.4.99.3
1.1.1.86
NP2198A
R02300 5,10-Methenyltetrahydrofolate + H2O =>
5-Formyltetrahydrofolate
2.1.2.10 NP0436A NP4774A
R90039 L-Histidine (E) + H+ (pmf associated) <=> L-Histidine +
H+
NP0040A NP0042A NP0646A
NP2382A NP2676A NP4372A
NP6260A
R02019 GDP + Thioredoxin => dGDP + Oxidized thioredoxin +
H2O
1.17.4.1 NP3346A NP4434A NP5066A
NP6166A NP6168A
R00944 10-Formyltetrahydrofolate + H2O => Formate +
Tetrahydrofolate
3.5.1.10 NP5006A
R04031 2-Succinylbenzoate + H2O <=>
2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate
4.2.1.- NP2736A
R04463 ATP + 5’-Phosphoribosyl-N-formylglycinamide +
L-Glutamine + H2O => ADP + Orthophosphate +
2-(Formamido)-N1-(5’-phosphoribosyl)acetamidine +
L-Glutamate
6.3.5.3 NP2982A NP5008A NP5010A
R01563 N-Carbamoylsarcosine + H2O => Sarcosine + CO2 + NH3 3.5.1.59 NP1274A NP1170A
R00235 ATP + Acetate + CoA => AMP + Pyrophosphate +
Acetyl-CoA
6.2.1.1 NP4240A NP4242A NP5128A
NP5132A NP0164A
R02530 Glutathione + Methylglyoxal => (R)-S-Lactoylglutathione 4.4.1.5 NP1228A NP3948A NP4460A
NP2650A
R00713 Succinate semialdehyde + NAD+ + H2O => Succinate +
NADH + H+
1.2.1.16
1.2.1.24
R04286 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl) =>
6-Pyruvoyltetrahydropterin + Triphosphate
4.2.3.12 NP1342A
R04751 Hexanoyl-CoA + FAD => trans-Hex-2-enoyl-CoA + FADH2 1.3.99.13
1.3.99.2
1.3.99.3
1.3.3.6
NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
R00942 ATP + Tetrahydrofolate + L-Glutamate <=> ADP +
Orthophosphate + Tetrahydrofolyl-[Glu](2)
6.3.2.17 NP1478A
R02328 dTTP + D-Glucose 1-phosphate <=> Pyrophosphate +
dTDPglucose
2.7.7.24 NP4652A NP4656A NP4674A
NP4680A NP2386A NP4276A
R04440 (R)-2,3-Dihydroxy-3-methylbutanoate + NADP+ <=>
(R)-3-Hydroxy-3-methyl-2-oxobutanoate + NADPH
1.1.1.86 NP2198A
R00158 ATP + UMP <=> ADP + UDP 2.7.4.14 NP4914A
R01325 Citrate <=> cis-Aconitate + H2O 4.2.1.3 NP0404A NP1994A
R90144 Isopentenyl phosphate + ATP => Isopentenyl diphosphate +
ADP
NP2852A
R01090 L-Leucine + 2-Oxoglutarate <=> 4-Methyl-2-oxopentanoate
+ L-Glutamate
2.6.1.42 NP0798A NP5036A
R02485 Deoxycytidine + H2O => Deoxyuridine + NH3 3.5.4.5
3.5.4.14
NP3512A
R04743 (S)-Hydroxydecanoyl-CoA + NAD+ <=>
3-Oxodecanoyl-CoA + NADH
1.1.1.35
1.1.1.211
NP1906A NP2754A NP2630A
NP4322A
R90134 Inosine (E) + H+ (pmf associated) => Inosine + H+ NP1252A
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R02283 N-Acetylornithine + 2-Oxoglutarate <=>
N-Acetyl-L-glutamate 5-semialdehyde + L-Glutamate
2.6.1.11 NP5264A
R00963 UMP + H2O => Uridine + Orthophosphate 3.1.3.5 NP1854A NP2590A
R02135 Thiamin monophosphate + H2O => Thiamin +
Orthophosphate
3.1.3.- NP2774A
R01226 5,10-Methylenetetrahydrofolate + 3-Methyl-2-oxobutanoic
acid + H2O => Tetrahydrofolate + 2-Dehydropantoate
2.1.2.11 NP4334A
R01518 2-Phospho-D-glycerate <=> 3-Phospho-D-glycerate 5.4.2.1 NP1332A NP1964A
R03313 L-Glutamyl 5-phosphate + NADPH + H+ <=> L-Glutamate
5-semialdehyde + Orthophosphate + NADP+
1.2.1.41 NP3978A
R00965 Orotidine 5’-phosphate => UMP + CO2 4.1.1.23 NP1734A
R90100 Nitrate (E) + Photon => Nitrate NP0642A
R04292 Iminoaspartate + Glycerone phosphate =>
Pyridine-2,3-dicarboxylate + H2O + Orthophosphate
4.1.99.- NP2418A
R90142 Molybdenum cofactor + GTP => MoCo dinucleotide
(Guanine) + Pyrophosphate
NP1536A NP2138A
R00352 ADP + Orthophosphate + Acetyl-CoA + Oxaloacetate <=>
ATP + Citrate + CoA
2.3.3.8
R01072 L-Glutamine + 5-Phospho-alpha-D-ribose 1-diphosphate +
H2O => 5-Phosphoribosylamine + Pyrophosphate +
L-Glutamate
2.4.2.14 NP4312A
R03425 Glycine + Lipoylprotein =>
S-Aminomethyldihydrolipoylprotein + CO2
1.4.4.2 NP4594A NP4596A
R00239 ATP + L-Glutamate => ADP + L-Glutamyl 5-phosphate 2.7.2.11 NP3976A
R90121 Adenine (E) + H+ (pmf associated) => Adenine + H+ NP1252A
R02734 N-Succinyl-LL-2,6-diaminoheptanedioate + H2O <=>
Succinate + LL-2,6-Diaminoheptanedioate
3.5.1.18
R02026 O-Acetyl-L-homoserine + Thiosulfate + Thioredoxin + H+
=> L-Homocysteine + Sulfite + Oxidized thioredoxin +
Acetate
2.5.1.49
R00405 ATP + Succinate + CoA <=> ADP + Orthophosphate +
Succinyl-CoA
6.2.1.5 NP4354A NP4356A
R05813 Cobalt-dihydro-precorrin 6 + S-Adenosyl-L-methionine <=>
Cobalt-precorrin 8 + S-Adenosyl-L-homocysteine + CO2
2.1.1.132 NP1088A NP1124A
R03530 ATP + dIDP <=> ADP + dITP 2.7.4.6 NP3666A
R04744 (S)-Hydroxydecanoyl-CoA <=> trans-Dec-2-enoyl-CoA +
H2O
4.2.1.74
4.2.1.17
NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R02537 Phenylacetaldehyde + NADP+ + H2O <=> Phenylacetic
acid + NADPH
1.2.1.5 NP1686A
R02199 L-Isoleucine + 2-Oxoglutarate <=>
(3R)-3-Methyl-2-oxopentanoic acid + L-Glutamate
2.6.1.42 NP0798A NP5036A
R04385 ATP + Holo-[carboxylase] + HCO3- <=> ADP +
Orthophosphate + Carboxybiotin-carboxyl-carrier protein
6.3.4.14 NP4252A NP4368A
R01975 (S)-3-Hydroxybutanoyl-CoA + NAD+ <=> Acetoacetyl-CoA
+ NADH
1.1.1.35 NP1906A NP2754A NP2630A
NP4322A
R00271 Acetyl-CoA + H2O + 2-Oxoglutarate =>
2-Hydroxybutane-1,2,4-tricarboxylate + CoA
2.3.3.14 NP2994A
R90000 NADH + Menaquinone + H+ => NAD+ + Menaquinol +
H+ (pmf associated)
1.6.5.3 NP2292A NP2294A NP2296A
NP2298A NP2300A NP2304A
NP2306A NP2308A NP2310A
NP2312A NP2314A NP2406A
NP3508A
R00694 L-Phenylalanine + 2-Oxoglutarate <=> Phenylpyruvate +
L-Glutamate
2.6.1.9
2.6.1.1
2.6.1.5
2.6.1.57
NP0824A NP1666A NP2140A
NP4024A NP4410A
R00480 ATP + L-Aspartate <=> ADP + 4-Phospho-L-aspartate 2.7.2.4 NP0550A
R00479 Isocitrate => Succinate + Glyoxylate 4.1.3.1 NP4432A
R02984 dTDPglucose <=> dTDPgalactose 5.1.3.2 NP4662A NP3504A NP4112A
R00086 ATP + H2O => ADP + Orthophosphate 3.6.1.15
3.6.3.14
NP4426A NP0264A NP1018A
NP1020A NP1022A NP1024A
NP1026A NP1028A NP1030A
NP1032A
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R00568 CTP + H2O => UTP + NH3 3.5.4.13 NP5166A NP0954A
R05815 Cobyrinate + L-Glutamine + ATP + H2O <=>
Cob(II)yrinate a,c diamide + L-Glutamate + ADP +
Orthophosphate
6.3.1.- NP0738A
R00927 CoA + 2-Methylacetoacetyl-CoA => Propanoyl-CoA +
Acetyl-CoA
2.3.1.16 NP2214A
R90071 CO2 (E) <=> CO2
R00258 L-Alanine + 2-Oxoglutarate <=> Pyruvate + L-Glutamate 2.6.1.2 NP0824A NP1666A NP4024A
NP4410A
R90060 FADH2 + Menaquinone => FAD + Menaquinol 1.3.99.1 NP4264A NP4266A NP4268A
NP4270A
R00303 H2O + alpha-D-Glucose 6-phosphate => D-Glucose +
Orthophosphate
3.1.3.9
R01051 ATP + D-Ribose => ADP + D-Ribose 5-phosphate 2.7.1.15 NP3184A
R00354 Acetyl-CoA + Oxaloacetate => (3S)-Citryl-CoA 4.1.3.34 NP4244A
R04738 (S)-3-Hydroxyhexadecanoyl-CoA <=>
trans-Hexadec-2-enoyl-CoA + H2O
4.2.1.74
4.2.1.17
NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R04037 Phosphoribosyl-AMP + H2O <=>
5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-
3.5.4.19 NP5154A
R00524 Formamide + H2O => Formate + NH3 3.5.1.49 NP6204A
R04150 2-Succinylbenzoyl-CoA <=> 1,4-Dihydroxy-2-naphthoate +
CoA
4.1.3.36 NP2730A
R01561 Adenosine + Orthophosphate <=> Adenine + D-Ribose
1-phosphate
2.4.2.1
R03471 ATP + 4-Amino-5-hydroxymethyl-2-methylpyrimidine =>
ADP + 4-Amino-2-methyl-5-phosphomethylpyrimidine
2.7.1.49 NP0564A
R04325 10-Formyltetrahydrofolate + 5’-Phosphoribosylglycinamide
<=> Tetrahydrofolate +
5’-Phosphoribosyl-N-formylglycinamide
2.1.2.2 NP1662A
R03504 2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-
<=> Glycolaldehyde +
2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine
4.1.2.25
R00188 Adenosine 3’,5’-bisphosphate + H2O => AMP +
Orthophosphate
3.1.3.7
R02412 ATP + Shikimate <=> ADP + Shikimate 3-phosphate 2.7.1.71 NP3982A
R02024 Thioredoxin + CDP => dCDP + Oxidized thioredoxin +
H2O
1.17.4.1 NP3346A NP4434A NP5066A
NP6166A NP6168A
R01512 ATP + 3-Phospho-D-glycerate <=> ADP +
3-Phospho-D-glyceroyl phosphate
2.7.2.3 NP4130A
R00768 L-Glutamine + D-Fructose 6-phosphate => L-Glutamate +
D-Glucosamine 6-phosphate
2.6.1.16 NP2384A NP4654A
R01057 D-Ribose 1-phosphate <=> D-Ribose 5-phosphate 5.4.2.2 NP4660A NP4676A NP5158A
NP3514A
R04204 2-Methylbut-2-enoyl-CoA + H2O =>
(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA
4.2.1.17 NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R01015 D-Glyceraldehyde 3-phosphate <=> Glycerone phosphate 5.3.1.1 NP2182A NP3716A
R04158 Geranylgeranyl diphosphate + Glycerol 1-phosphate =>
Pyrophosphate + sn-3-O-(Geranylgeranyl)glycerol
1-phosphate
2.5.1.41
R03045 3-Hydroxypropionyl-CoA <=> Propenoyl-CoA + H2O 4.2.1.17 NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R02748 Deoxyinosine + Orthophosphate => Hypoxanthine +
2-Deoxy-D-ribose 1-phosphate
2.4.2.4 NP3958A
R90138 Hexadecanoic acid (E) + ATP + H2O => Hexadecanoic acid
+ ADP + Orthophosphate + H+
R90058 Biotin (E) + H+ (pmf associated) => Biotin + H+
R05048 2,5-Diaminopyrimidine nucleoside triphosphate =>
2,5-Diamino-6-(5’-triphosphoryl-3’,4’-trihydroxy-2’-oxopentyl)-
6.-.-.-
3.5.4.16
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R00084 Porphobilinogen + H2O <=> Hydroxymethylbilane + NH3 2.5.1.61 NP1326A
R00867 ATP + D-Fructose => ADP + D-Fructose 6-phosphate 2.7.1.1
2.7.1.4
NP3184A
R00286 UDPglucose + H2O + NAD+ <=> UDPglucuronate +
NADH + H+
1.1.1.22 NP2322A NP4668A
R01737 ATP + D-Gluconic acid => ADP + 6-Phospho-D-gluconate 2.7.1.12
R00131 Urea + H2O => CO2 + NH3 3.5.1.5 NP2008A NP2010A NP2012A
NP2014A NP2016A NP2018A
NP2020A
R00137 ATP + Nicotinamide D-ribonucleotide => Pyrophosphate +
NAD+
2.7.7.1 NP0310A NP0908A
R90073 Hydrogen (E) <=> Hydrogen
R00935 (S)-Methylmalonate semialdehyde + CoA + NAD+ =>
Propanoyl-CoA + CO2 + NADH + H+
1.2.1.27 NP1686A NP3020A
R01858 dGTP + Pyruvate => dGDP + Phosphoenolpyruvate 2.7.1.40 NP1746A
R02147 Guanosine + Orthophosphate <=> Guanine + D-Ribose
1-phosphate
2.4.2.1
R01395 ATP + Carbamate => ADP + Carbamoyl phosphate 2.7.2.2 NP3632A
R04001 3-Isopropylmalate <=> 2-Isopropylmaleate + H2O 4.2.1.33 NP2192A NP2194A
R04457 4-(1-D-Ribitylamino)-5-amino-2,6-dihydroxypyrimidine + 3,
4-Dihydroxy-2-butanone 4-phosphate =>
6,7-Dimethyl-8-(1-D-ribityl)lumazine + Orthophosphate +
H2O
2.5.1.9 NP4412A
R90081 Thymidine (E) + H+ (pmf associated) => Thymidine + H+
R04859 O-Acetyl-L-serine + Thiosulfate + Thioredoxin + H+ =>
L-Cysteine + Sulfite + Oxidized thioredoxin + Acetate
2.5.1.47
2.5.1.49
NP3116A NP4748A
R04747 Hexanoyl-CoA + Acetyl-CoA <=> CoA +
3-Oxooctanoyl-CoA
2.3.1.16 NP2214A NP2260A NP2606A
NP2612A NP3420A NP3438A
NP3650A NP4580A
R90125 Succinate (E) + H+ (pmf associated) <=> Succinate + H+
R01801 CDPdiacylglycerol + Glycerol 1-phosphate => CMP +
Phosphatidylglycerophosphate
2.7.8.5 NP1334A NP2144A
R00190 Adenine + 5-Phospho-alpha-D-ribose 1-diphosphate => AMP
+ Pyrophosphate
2.4.2.7 NP1426A NP1254A
R03038 ATP + L-Alanine + tRNA(Ala) => AMP + Pyrophosphate
+ L-Alanyl-tRNA
6.1.1.7 NP0710A
R90146 AMP + Orthophosphate => D-Ribose 1,5-bisphosphate +
Adenine
NP3958A
R00472 Acetyl-CoA + H2O + Glyoxylate => (S)-Malate + CoA 2.3.3.9 NP4430A
R00259 Acetyl-CoA + L-Glutamate => CoA + N-Acetyl-L-glutamate 2.3.1.1
R03222 Protoporphyrinogen IX + Oxygen <=> Protoporphyrin +
H2O
1.3.3.4 NP4520A
R03629 Melatonin + Reduced flavoprotein + Oxygen <=>
6-Hydroxymelatonin + Oxidized flavoprotein + H2O
1.14.14.1 NP2540A
R04745 (S)-Hydroxyoctanoyl-CoA + NAD+ <=>
3-Oxooctanoyl-CoA + NADH
1.1.1.35
1.1.1.211
NP1906A NP2754A NP2630A
NP4322A
R01213 Acetyl-CoA + 3-Methyl-2-oxobutanoic acid + H2O =>
2-Isopropylmalate + CoA
2.3.3.13 NP0624A NP2206A NP2994A
R00355 L-Aspartate + 2-Oxoglutarate <=> Oxaloacetate +
L-Glutamate
2.6.1.1 NP0824A NP1666A NP4024A
NP4410A
R03220 Coproporphyrinogen III + Oxygen <=> Protoporphyrinogen
IX + CO2 + H2O
1.3.3.3
R00351 Acetyl-CoA + H2O + Oxaloacetate => Citrate + CoA 2.3.3.1
2.3.3.3
NP1314A
R03269 (R)-4’-Phosphopantothenoyl-L-cysteine => Pantetheine
4’-phosphate + CO2
4.1.1.36 NP1374A
R90110 Betaine (E) => Betaine NP3588A
R02326 ATP + dCDP <=> ADP + dCTP 2.7.4.6 NP3666A
R03968 2-Isopropylmalate <=> 2-Isopropylmaleate + H2O 4.2.1.33 NP2192A NP2194A
R00702 trans,trans-Farnesyl diphosphate => Pyrophosphate +
Presqualene diphosphate + H+
2.5.1.21 NP4556A NP0604A
R04199 2,3,4,5-Tetrahydrodipicolinate + NADP+ <=>
L-2,3-Dihydrodipicolinate + NADPH + H+
1.3.1.26 NP1492A
R03758 Aminoacetone + CO2 <=> L-2-Amino-3-oxobutanoic acid -
R01513 3-Phospho-D-glycerate + NAD+ <=>
3-Phosphonooxypyruvate + NADH + H+
1.1.1.95 NP0272A NP4720A
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R01397 Carbamoyl phosphate + L-Aspartate => Orthophosphate +
N-Carbamoyl-L-aspartate
2.1.3.2 NP3518A NP3520A
R01859 ATP + Propanoyl-CoA + HCO3- => ADP +
Orthophosphate + (S)-2-Methyl-3-oxopropanoyl-CoA
6.4.1.3 NP4250A NP4364A NP3464A
R01701 3-Methyl-2-oxobutanoic acid + Lipoamide =>
S-(2-Methylpropanoyl)-dihydrolipoamide + CO2
1.2.4.4 NP0560A NP2542A NP0558A
R02090 ATP + dGMP <=> ADP + dGDP 2.7.4.8
R00378 dTTP => Pyrophosphate + dTMP 2.7.7.7 NP0854A NP0476A NP0482A
NP2918A
R03990 Tetradecanoyl-CoA + FAD => trans-Tetradec-2-enoyl-CoA +
FADH2
1.3.99.13
1.3.99.3
1.3.3.6
NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
R90123 Hypoxanthine (E) + H+ (pmf associated) => Hypoxanthine
+ H+
NP1252A
R00451 meso-2,6-Diaminoheptanedioate <=> L-Lysine + CO2 4.1.1.20 NP1646A
R01244 Adenine + H2O => Hypoxanthine + NH3 3.5.4.2 NP0972A NP2032A NP4788A
R02198 L-Isoleucine + 2-Oxoglutarate <=>
3-Methyl-2-oxopentanoate + L-Glutamate
2.6.1.42 NP0798A NP5036A
R01197 Oxidized ferredoxin + 2-Oxoglutarate + CoA <=> Reduced
ferredoxin + Succinyl-CoA + CO2
1.2.7.3 NP1232A NP1234A NP3012A
R01157 Agmatine + H2O <=> Putrescine + Urea 3.5.3.11 NP3022A NP4754A
R00428 GTP + H2O => Formamidopyrimidine nucleoside
triphosphate
3.5.4.16
R00226 Pyruvate => (S)-2-Acetolactate + CO2 2.2.1.6 NP2200A NP2202A
R04638 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl) + H2O
=> Dihydroneopterin phosphate + Pyrophosphate
3.6.1.-
R90148 Glycine + Tetrahydropteroyltri-L-glutamate => NH3 + CO2
+ H+ + 5-Methyltetrahydropteroyltri-L-glutamate
R03508 1-(2-Carboxyphenylamino)-1’-deoxy-D-ribulose 5’-phosphate
<=> Indoleglycerol phosphate + CO2 + H2O
4.1.1.48 NP3166A
R00257 ATP + Deamino-NAD+ + L-Glutamine + H2O => AMP +
Pyrophosphate + NAD+ + L-Glutamate
6.3.5.1 NP0054A NP3828A
R00529 ATP + Sulfate <=> Pyrophosphate + Adenylylsulfate 2.7.7.4 NP4570A
R01658 Dimethylallyl diphosphate + Isopentenyl diphosphate =>
Pyrophosphate + Geranyl diphosphate
2.5.1.1
2.5.1.10
2.5.1.29
NP3696A NP4556A NP0604A
R03197 Uroporphyrinogen III <=> Coproporphyrinogen III + CO2 4.1.1.37
R01570 Thymidine + Orthophosphate => Thymine +
2-Deoxy-D-ribose 1-phosphate
2.4.2.4 NP3958A
R05064 (S)-3-Hydroxyisobutyryl-CoA + H2O => CoA +
(S)-3-Hydroxyisobutyrate
3.1.2.4
R03877 ATP + Protoporphyrin + Magnesium + H2O <=> ADP +
Orthophosphate + Magnesium protoporphyrin + H+
6.6.1.1 NP1094A
R90076 ATP + H2O + Glycerol 1-phosphate (E) => ADP +
Orthophosphate + H+ + Glycerol 1-phosphate
R90127 Adenosine => Adenosine (E)
R06558 Adenosyl cobinamide + GTP <=> Adenosyl cobinamide
phosphate + GDP
2.7.1.156
R90108 Cl- (E) + H+ (pmf associated) => Cl- + H+
R01665 ATP + dCMP <=> ADP + dCDP 2.7.4.14 NP4914A
R01163 L-Histidinal + H2O + NAD+ <=> L-Histidine + NADH +
H+
1.1.1.23 NP2876A
R00754 Ethanol + NAD+ <=> Acetaldehyde + NADH + H+ 1.1.1.1 NP1260A
R05226 Adenosyl cobyrinate hexaamide + 1-Aminopropan-2-ol <=>
Adenosyl cobinamide
6.3.1.10 NP5308A
R90062 L-Ornithine + L-Arginine (E) => L-Ornithine (E) +
L-Arginine
R90078 Oxalate (E) + Formate => Oxalate + Formate (E) NP3798A
R02472 (R)-Pantoate + NADP+ <=> 2-Dehydropantoate + NADPH 1.1.1.169 NP0942A
R01515 3-Phospho-D-glyceroyl phosphate + H2O =>
3-Phospho-D-glycerate + Orthophosphate
3.6.1.7 NP3750A
R90129 D-Fructose 1,6-bisphosphate + NAD+ =>
4-Ketofructose-1,6-bisphosphate + NADH
R90041 L-Phenylalanine (E) + H+ (pmf associated) =>
L-Phenylalanine + H+
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R00161 ATP + FMN => Pyrophosphate + FAD 2.7.7.2
R90140 Cyclic pyranopterin monophosphate => Molybdopterin +
Pyrophosphate
NP2274A NP2500A NP3946A
NP5020A NP0052A
R90064 2,3-Bis-O-(geranylgeranyl)glycerol 1-phosphate + H2O +
NADPH + H+ => 2,3-Di-O-phytanyl-sn-glycerol +
Orthophosphate + NADP+
R05577 tRNA(Asp) + L-Aspartate + ATP =>
L-Aspartyl-tRNA(Asp) + Pyrophosphate + AMP
6.1.1.12 NP1168A
R01138 dATP + Pyruvate => dADP + Phosphoenolpyruvate 2.7.1.40 NP1746A
R02291 L-Aspartate 4-semialdehyde + Orthophosphate + NADP+
<=> 4-Phospho-L-aspartate + NADPH + H+
1.2.1.11 NP1988A
R04798 zeta-Carotene => Neurosporene + Hydrogen 1.14.99.30 NP4764A NP0204A NP1630A
R02685 (3S)-3-Hydroxyacyl-CoA <=> trans-2,3-Dehydroacyl-CoA +
H2O
4.2.1.17 NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R01867 (S)-Dihydroorotate + Oxygen <=> Orotate + H2O2 1.3.3.1 NP0428A
R01884 Creatinine + H2O <=> Creatine 3.5.2.10 NP2120A
R07770 ATP + Lipoate => Pyrophosphate + Lipoyl-AMP 2.7.7.63 NP5116A
R05812 Cobalt-precorrin 6 + NADPH + H+ <=>
Cobalt-dihydro-precorrin 6 + NADP+
1.3.1.54
R00615 Thiamin diphosphate + H2O => Thiamin monophosphate +
Orthophosphate
3.6.1.15 NP4426A
R04439 (R)-2,3-Dihydroxy-3-methylbutanoate + NADP+ <=>
(S)-2-Acetolactate + NADPH + H+
1.1.1.86 NP2198A
R01958 Formylkynurenine + H2O <=> Formate + L-Kynurenine 3.5.1.49
3.5.1.9
NP6204A
R02085 (S)-3-Hydroxy-3-methylglutaryl-CoA <=>
3-Methylglutaconyl-CoA + H2O
4.2.1.18
R00698 L-Phenylalanine <=> 2-Phenylacetamide 1.11.1.7 NP2708A
R02245 ATP + (R)-Mevalonate => ADP + (R)-5-Phosphomevalonate 2.7.1.36 NP2850A
R02568 D-Fructose 1-phosphate <=> Glycerone phosphate +
D-Glyceraldehyde
4.1.2.13 NP1594A NP3160A
R90102 3-Phospho-D-Glycerate (E) + ATP + H2O =>
3-Phospho-D-glycerate + ADP + Orthophosphate + H+
NP5220A
R00742 ATP + Acetyl-CoA + HCO3- => ADP + Orthophosphate +
Malonyl-CoA
6.4.1.2 NP4250A NP4364A NP3464A
R90038 L-Tryptophan (E) + H+ (pmf associated) <=> L-Tryptophan
+ H+
R90002 Oxygen + H+ + Halocyanin (reduced) => H2O + H+ (pmf
associated) + Halocyanin (oxidized)
1.9.3.1 NP2448A NP2450A NP2456A
NP2962A NP2964A NP2966A
NP2968A NP4294A NP4296A
R01870 Orotidine 5’-phosphate + Pyrophosphate <=> Orotate +
5-Phospho-alpha-D-ribose 1-diphosphate
2.4.2.10 NP1256A
R00342 (S)-Malate + NAD+ <=> Oxaloacetate + NADH + H+ 1.1.1.37 NP0498A
R04030 ATP + 2-Succinylbenzoate + CoA => AMP +
Pyrophosphate + 2-Succinylbenzoyl-CoA
6.2.1.26 NP2738A
R05679 Glycerol 1-phosphate + NAD+ <=> Glycerone phosphate +
NADH + H+
1.1.1.261 NP4492A
R90045 L-Leucine (E) + H+ (pmf associated) <=> L-Leucine + H+
R01541 ATP + 2-Dehydro-3-deoxy-D-gluconate <=> ADP +
2-Dehydro-3-deoxy-6-phospho-D-gluconate
2.7.1.45 NP3184A
R03314 L-Glutamate 5-semialdehyde <=>
(S)-1-Pyrroline-5-carboxylate + H2O
-
R00261 L-Glutamate => 4-Aminobutanoate + CO2 4.1.1.19
4.1.1.15
NP1194A
R05066 (S)-3-Hydroxyisobutyrate + NAD+ <=> (S)-Methylmalonate
semialdehyde + NADH + H+
1.1.1.35 NP1906A NP2754A NP2630A
NP4322A
R01130 IMP + NAD+ + H2O => Xanthosine 5’-phosphate + NADH
+ H+
1.1.1.205 NP3384A NP3080A
R00705 3-Oxopropanoate + CoA + NAD+ => Acetyl-CoA + CO2 +
NADH + H+
1.2.1.18 NP1686A NP3020A
R04097 3-Methylbutanoyl-CoA + Dihydrolipoamide =>
S-(3-Methylbutanoyl)-dihydrolipoamide + CoA
2.3.1.-
R02094 ATP + dTMP <=> ADP + dTDP 2.7.4.9 NP2578A
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R01863 Inosine + Orthophosphate <=> Hypoxanthine + D-Ribose
1-phosphate
2.4.2.1
R00734 L-Tyrosine + 2-Oxoglutarate <=>
3-(4-Hydroxyphenyl)pyruvate + L-Glutamate
2.6.1.9
2.6.1.1
2.6.1.5
2.6.1.57
NP0824A NP1666A NP2140A
NP4024A NP4410A
R90085 Deoxyuridine (E) + H+ (pmf associated) => Deoxyuridine +
H+
R00441 GTP => Pyrophosphate + GMP 2.7.7.6 NP0114A NP0116A NP0112A
NP0110A NP2834A NP5080A
NP5078A NP3682A NP0108A
NP2844A NP4162A NP2842A
NP5234A
R01049 ATP + D-Ribose 5-phosphate <=> AMP +
5-Phospho-alpha-D-ribose 1-diphosphate
2.7.6.1 NP0606A
R00955 UDPglucose + alpha-D-Galactose 1-phosphate <=>
D-Glucose 1-phosphate + UDP-D-galactose
2.7.7.12 NP4652A NP4656A NP4674A
NP4680A NP2386A NP4276A
R90049 L-Alanine (E) + H+ (pmf associated) <=> L-Alanine + H+
R01288 O-Succinyl-L-homoserine + Sulfide => L-Homocysteine +
Succinate
2.5.1.48 NP4746A
R00617 ATP + Thiamin monophosphate => ADP + Thiamin
diphosphate
2.7.4.16 NP2280A
R00435 ATP => Pyrophosphate + AMP 2.7.7.6 NP0114A NP0116A NP0112A
NP0110A NP2834A NP5080A
NP5078A NP3682A NP0108A
NP2844A NP4162A NP2842A
NP5234A
R01251 (S)-1-Pyrroline-5-carboxylate + NADPH + H+ <=>
L-Proline + NADP+
1.5.1.2 NP3974A
R03656 ATP + L-Isoleucine + tRNA(Ile) => AMP + Pyrophosphate
+ L-Isoleucyl-tRNA(Ile)
6.1.1.5 NP0610A
R00203 Methylglyoxal + NAD+ + H2O => Pyruvate + NADH + H+ 1.2.1.22
1.2.1.23
NP1686A NP3020A
R00707 (S)-1-Pyrroline-5-carboxylate + NAD+ + H2O =>
L-Glutamate + NADH + H+
1.5.1.12 NP3020A NP1686A
R90132 6-Deoxy-5-Ketofructose 1 phosphate + NAD+ <=>
6-Deoxy-5-ketomannitol-1-phosphate + NADH
R03537 2’,3’-Cyclic AMP + H2O => 3’-AMP 3.1.4.16 NP1854A NP2590A
R03458 5-Amino-6-(5’-phosphoribosylamino)uracil + NADPH =>
5-Amino-6-(5’-phosphoribitylamino)uracil + NADP+
1.1.1.193 NP2672A
R03947 Precorrin 2 + NAD+ <=> Sirohydrochlorin + NADH + H+ 1.3.1.76 NP4500A
R04364 2,3,4,5-Tetrahydrodipicolinate + Acetyl-CoA <=>
N-Acetyl-L-2-amino-6-oxopimelate + CoA
2.3.1.-
2.3.1.89
R04209 1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate <=>
Aminoimidazole ribotide + CO2
4.1.1.21 NP2286A NP2290A
R90036 L-Glutamate (E) + H+ (pmf associated) <=> L-Glutamate
+ H+
R02016 Oxidized thioredoxin + NADPH + H+ => Thioredoxin +
NADP+
1.8.1.9 NP2680A
R00216 (S)-Malate + NADP+ => Pyruvate + CO2 + NADPH 1.1.1.40 NP1772A NP0132A
R01322 ADP + Orthophosphate + (3S)-Citryl-CoA => ATP +
Citrate + CoA
6.2.1.18
R01126 IMP + H2O => Inosine + Orthophosphate 3.1.3.5 NP2590A NP1854A
R90104 Arsenite (E) + ATP + H2O => Arsenite + ADP +
Orthophosphate + H+
NP1164A NP1382A NP1818A
NP6058A
R90066 Sodium (E) => Sodium
R01786 ATP + alpha-D-Glucose <=> ADP + alpha-D-Glucose
6-phosphate
2.7.1.1
2.7.1.2
NP3184A
R00582 O-Phospho-L-serine + H2O => L-Serine + Orthophosphate 3.1.3.3 NP0274A
R03067 2-Amino-7,8-dihydro-4-hydroxy-6-
(diphosphooxymethyl)pteridine + 4-Aminobenzoate =>
Pyrophosphate + Dihydropteroate
2.5.1.15 NP1478A NP3770A
R01221 5,10-Methylenetetrahydrofolate + NH3 + CO2 + NADH +
H+ <=> Glycine + Tetrahydrofolate + NAD+
2.1.2.10 NP4774A
R05575 (Hydroxymethylphenyl)succinyl-CoA + NAD+ <=>
Benzoylsuccinyl-CoA + NADH + H+
1.1.1.35 NP1906A NP2754A NP2630A
NP4322A
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R00575 ATP + L-Glutamine + HCO3- + H2O => ADP +
Orthophosphate + L-Glutamate + Carbamoyl phosphate
6.3.5.5 NP4506A NP4830A
R00032 beta-Carotene + Oxygen => Retinal 1.14.99.36
R00268 Oxalosuccinate <=> 2-Oxoglutarate + CO2 1.1.1.42 NP2430A
R04095 3-Methylbutanoyl-CoA + FAD => 3-Methylcrotonyl-CoA +
FADH2
1.3.99.3 NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
R07465 C15815 + L-Tyrosine + Iminoglycine =>
4-Methyl-5-(2-phosphoethyl)-thiazole
ThiG NP2394A NP2398A
R00549 ATP + Riboflavin => ADP + FMN 2.7.1.26
R90083 Guanosine (E) + H+ (pmf associated) => Guanosine + H+ NP1252A
R02864 Siroheme + H+ <=> Iron + Sirohydrochlorin 4.99.1.4 NP4500A
R05808 Cobalt-precorrin 2 + S-Adenosyl-L-methionine <=>
Cobalt-precorrin 3 + S-Adenosyl-L-homocysteine
2.1.1.130 NP1122A
R90043 L-Isoleucine (E) + H+ (pmf associated) <=> L-Isoleucine +
H+
R05220 Cob(I)yrinate a,c diamide + ATP <=> Adenosyl cobyrinate
a,c diamide + Pyrophosphate + Orthophosphate
2.5.1.17 NP4974A
R01286 L-Cystathionine + H2O => L-Homocysteine + NH3 +
Pyruvate
4.4.1.8 NP4746A
R03013 L-Histidinol phosphate + H2O <=> L-Histidinol +
Orthophosphate
3.1.3.15
R90004 Reduced ferredoxin + Menaquinone + H+ => Oxidized
ferredoxin + Menaquinol + H+ (pmf associated)
1.6.5.3 NP2292A NP2294A NP2296A
NP2298A NP2300A NP2304A
NP2306A NP2308A NP2310A
NP2312A NP2314A NP2406A
NP3508A
R00430 GTP + Pyruvate => GDP + Phosphoenolpyruvate 2.7.1.40 NP1746A
R07460 L-Cysteine => Thiamine biosynthesis intermediate 3 +
L-Alanine
2.8.1.7 NP0936A NP0790A
R01063 D-Glyceraldehyde 3-phosphate + Orthophosphate + NADP+
<=> 3-Phospho-D-glyceroyl phosphate + NADPH + H+
1.2.1.59 NP0012A
R02740 alpha-D-Glucose 6-phosphate <=> D-Fructose 6-phosphate 5.3.1.9 NP4992A
R01969 Deoxyguanosine + Orthophosphate <=> Guanine +
2-Deoxy-D-ribose 1-phosphate
2.4.2.4 NP3958A
R03443 N-Acetyl-L-glutamate 5-semialdehyde + Orthophosphate +
NADP+ <=> N-Acetyl-L-glutamate 5-phosphate + NADPH
+ H+
1.2.1.38 NP5260A
R03662 ATP + L-Serine + tRNA(Ser) => AMP + Pyrophosphate +
L-Seryl-tRNA(Ser)
6.1.1.11 NP1692A
R03224 (3R)-3-Hydroxyacyl-CoA <=> cis-2,3-Dehydroacyl-CoA +
H2O
4.2.1.17 NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R00124 ATP + ADP <=> ADP + ATP 2.7.4.6 NP3666A
R01771 ATP + L-Homoserine => ADP + O-Phospho-L-homoserine 2.7.1.39 NP4524A
R02237 ATP + Dihydropteroate + L-Glutamate => ADP +
Orthophosphate + Dihydrofolate
6.3.2.17 NP1478A
R04673 2-Oxobutanoate + 2-(alpha-Hydroxyethyl)thiamine
diphosphate => (S)-2-Aceto-2-hydroxybutanoate + Thiamin
diphosphate
2.2.1.6 NP1904A NP2200A NP2202A
R90118 Ferrichrome (E) + ATP + H2O => Ferrichrome + ADP +
Orthophosphate + H+
NP3816A NP3818A
R00009 H2O2 => Oxygen + H2O 1.11.1.6 NP2708A
R90087 Deoxyguanosine (E) + H+ (pmf associated) =>
Deoxyguanosine + H+
R02297 Xanthosine + Orthophosphate <=> Xanthine + D-Ribose
1-phosphate
2.4.2.1
R04109 L-Glutamyl-tRNA(Glu) + NADPH <=>
(S)-4-Amino-5-oxopentanoate + tRNA(Glu) + NADP+ +
H2O
1.2.1.70 NP4502A
R05218 Cob(II)yrinate a,c diamide + H+ + NADH <=>
Cob(I)yrinate a,c diamide + NAD+
1.16.8.1
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R04749 (S)-Hydroxyhexanoyl-CoA <=> trans-Hex-2-enoyl-CoA +
H2O
4.2.1.74
4.2.1.17
NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R00410 Succinyl-CoA + Acetoacetate <=> Succinate +
Acetoacetyl-CoA
2.8.3.5 NP6032A NP6034A
R01280 ATP + Hexadecanoic acid + CoA <=> AMP +
Palmitoyl-CoA + Pyrophosphate
6.2.1.3 NP2626A NP3386A NP3422A
NP4150A NP4174A NP4256A
R07280 5-Amino-6-(5’-phosphoribitylamino)uracil + H2O =>
4-(1-D-Ribitylamino)-5-amino-2,6-dihydroxypyrimidine +
Orthophosphate
3.1.3.- NP2774A
R00512 ATP + CMP <=> ADP + CDP 2.7.4.14 NP4914A
R90068 Potassium (E) => Potassium NP0220A NP0330A NP0332A
NP3602A NP3604A NP4902A
NP4904A NP4906A NP6110A
NP6112A
R04336 L-2-Amino-6-oxoheptanedioate <=>
2,3,4,5-Tetrahydrodipicolinate + H2O
-
R00192 S-Adenosyl-L-homocysteine + H2O <=> Adenosine +
L-Homocysteine
3.3.1.1 NP0968A
R90089 D-Glucose (E) + ATP + H2O => D-Glucose + ADP + H+
+ Orthophosphate
NP0530A
R02750 Deoxyribose + ATP => 2-Deoxy-D-ribose 5-phosphate +
ADP
2.7.1.15 NP3184A
R01388 Hydroxypyruvate + NADH + H+ => D-Glycerate + NAD+ 1.1.1.81 NP1162A
R90117 Dipeptide (E) + ATP + H2O => Dipeptide + ADP +
Orthophosphate + H+
NP0758A NP0760A NP0762A
NP0764A NP0766A NP3578A
NP3580A NP3582A NP3584A
R02101 dUMP + 5,10-Methylenetetrahydrofolate => Dihydrofolate +
dTMP
2.1.1.45 NP2924A
R00509 ATP + Adenylylsulfate => ADP + 3’-Phosphoadenylyl
sulfate
2.7.1.25
R00199 ATP + Pyruvate + H2O => AMP + Phosphoenolpyruvate +
Orthophosphate
2.7.9.2 NP1196A
R90095 Acetate (E) + H+ (pmf associated) <=> Acetate + H+
R03857 Lauroyl-CoA + FAD => 2-trans-Dodecenoyl-CoA + FADH2 1.3.99.13
1.3.99.3
1.3.3.6
NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
R90109 Pantothenate (E) + Sodium (E) [pmf] => Pantothenate +
Sodium
NP4534A NP6036A
R02021 Thioredoxin + 3’-Phosphoadenylyl sulfate => Oxidized
thioredoxin + Sulfite + Adenosine 3’,5’-bisphosphate + H+
1.8.4.8
R90139 GTP + S-Adenosyl-L-methionine => Cyclic pyranopterin
monophosphate + S-Adenosyl-L-homocysteine
NP2822A NP3746A NP1040A
R00959 D-Glucose 1-phosphate <=> alpha-D-Glucose 6-phosphate 5.4.2.2 NP4660A NP4676A NP5158A
NP3514A
R03991 Tetradecanoyl-CoA + Acetyl-CoA <=> CoA +
3-Oxopalmitoyl-CoA
2.3.1.16
2.3.1.154
NP2214A NP2260A NP2606A
NP2612A NP3420A NP3438A
NP3650A NP4580A
R04378 1-(5’-Phosphoribosyl)-5-amino-4-imidazolecarboxamide +
Pyrophosphate <=> 5-Amino-4-imidazolecarboxyamide +
5-Phospho-alpha-D-ribose 1-diphosphate
2.4.2.7 NP1426A NP1254A
R05070 (R)-2,3-Dihydroxy-3-methylpentanoate <=>
(3R)-3-Methyl-2-oxopentanoic acid + H2O
4.2.1.9 NP4926A
R04780 H2O + D-Fructose 1,6-bisphosphate => Orthophosphate +
D-Fructose 6-phosphate
3.1.3.11 NP1592A
R01778 (3S)-3-Hydroxyacyl-CoA + NAD+ <=> 3-Oxoacyl-CoA +
NADH
1.1.1.35
1.1.1.211
NP1906A NP2754A NP2630A
NP4322A
R03165 Hydroxymethylbilane <=> Uroporphyrinogen III + H2O 4.2.1.75 NP1330A
R01326 ATP + D-Mannose <=> ADP + D-Mannose 6-phosphate 2.7.1.1
2.7.1.7
NP3184A
R00585 L-Serine + Pyruvate <=> Hydroxypyruvate + L-Alanine 2.6.1.51 NP0884A NP2578A
R90091 6-Deoxy-5-Ketofructose 1 phosphate + L-Aspartate
4-semialdehyde => Compound I + Hydroxypyruvaldehyde 3-P
NP3160A
R04138 ATP + 3-Methylcrotonyl-CoA + HCO3- => ADP +
Orthophosphate + 3-Methylglutaconyl-CoA
6.4.1.4
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R00489 L-Aspartate => beta-Alanine + CO2 4.1.1.15 NP1194A
R06531 L-Threonine <=> L-Threonine O-3-phosphate
R01248 (S)-1-Pyrroline-5-carboxylate + NADH + H+ <=> L-Proline
+ NAD+
1.5.1.2 NP3974A
R03472 Aminoimidazole ribotide =>
4-Amino-5-hydroxymethyl-2-methylpyrimidine
NP2210A
R02003 Geranyl diphosphate + Isopentenyl diphosphate =>
Pyrophosphate + trans,trans-Farnesyl diphosphate
2.5.1.1
2.5.1.10
2.5.1.29
NP3696A NP4556A NP0604A
R90042 L-Asparagine (E) + H+ (pmf associated) <=> L-Asparagine
+ H+
R03654 ATP + Glycine + tRNA(Gly) => AMP + Pyrophosphate +
Glycyl-tRNA(Gly)
6.1.1.14 NP0328A
R01715 Chorismate <=> Prephenate 5.4.99.5 NP3980A
R04230 ATP + D-4’-Phosphopantothenate + L-Cysteine => ADP +
Orthophosphate + (R)-4’-Phosphopantothenoyl-L-cysteine
6.3.2.5 NP1374A
R00317 Acetyl phosphate + H2O => Acetate + Orthophosphate 3.6.1.7 NP3750A
R90047 L-Threonine (E) + H+ (pmf associated) => L-Threonine +
H+
R07463 Glycine => Iminoglycine 1.4.3.19
R03083 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate <=>
3-Dehydroquinate + Orthophosphate
4.2.3.4 NP2238A
R02508 Cystathionine + Succinate <=> O-Succinyl-L-homoserine +
L-Cysteine
2.5.1.48 NP4746A
R01411 5-Methylcytosine + H2O <=> Thymine + NH3 3.5.4.1 NP0972A NP4788A
R06412 trans-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA + H2O <=>
3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA
4.2.1.17 NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R90070 H2O (E) <=> H2O
R04786 Phytoene => Phytofluene + Hydrogen 1.3.99.- NP4764A NP0204A NP1630A
R02029 Phosphatidylglycerophosphate + H2O =>
Phosphatidylglycerol + Orthophosphate
3.1.3.27
R10001 D-Glucose + NADP+ => D-Glucono-1,5-lactone + NADPH 1.1.1.119 NP0126A NP0254A
R04170 (S)-3-Hydroxydodecanoyl-CoA <=> 2-trans-Dodecenoyl-CoA
+ H2O
4.2.1.74
4.2.1.17
NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R01127 IMP + H2O <=>
1-(5’-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide
3.5.4.10 NP0732A
R90097 Formate => Formate (E)
R01899 Isocitrate + NADP+ <=> Oxalosuccinate + NADPH + H+ 1.1.1.42 NP2430A
R00332 ATP + GMP <=> ADP + GDP 2.7.4.8
R00253 ATP + L-Glutamate + NH3 => ADP + Orthophosphate +
L-Glutamine
6.3.1.2 NP0076A NP4376A
R04740 (S)-3-Hydroxytetradecanoyl-CoA <=>
trans-Tetradec-2-enoyl-CoA + H2O
4.2.1.74
4.2.1.17
NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R01776 Acetyl-CoA + L-Homoserine => CoA +
O-Acetyl-L-homoserine
2.3.1.31 NP0282A
R01716 Chorismate + L-Glutamine <=> 4-amino-4-deoxychorismate
+ L-Glutamate
6.3.5.8
R04509 ATP + 4-Amino-2-methyl-5-phosphomethylpyrimidine =>
ADP + 2-Methyl-4-amino-5-hydroxymethylpyrimidine
diphosphate
2.7.4.7 NP0546A
R90131 2-amino-3,7-dideoxy-hept-6-ulsonic acid => 3-Dehydroquinate NP2238A
R01083 N6-(1,2-Dicarboxyethyl)-AMP <=> Fumarate + AMP 4.3.2.2 NP1658A
R00920 ATP + Propanoate + CoA => ADP + Orthophosphate +
Propanoyl-CoA
6.2.1.13 NP2858A
R00376 dGTP => Pyrophosphate + dGMP 2.7.7.7 NP0854A NP0476A NP0482A
NP2918A
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R03778 Octanoyl-CoA + Acetyl-CoA <=> CoA +
3-Oxodecanoyl-CoA
2.3.1.16 NP2214A NP2260A NP2606A
NP2612A NP3420A NP3438A
NP3650A NP4580A
R00183 AMP + H2O => Adenosine + Orthophosphate 3.1.3.5 NP2590A NP1854A
R05068 (R)-2,3-Dihydroxy-3-methylpentanoate + NADP+ <=>
NADPH + (R)-3-Hydroxy-3-methyl-2-oxopentanoate
1.1.1.86 NP2198A
R90113 Potassium + H+ (pmf associated) => Potassium (E) + H+ NP0826A NP0828A NP0830A
NP0832A NP0834A NP0836A
NP0838A NP0840A NP0842A
NP5056A
R90055 Sulfate (E) + ATP + H2O => Sulfate + ADP +
Orthophosphate + H+
NP1412A NP3040A NP3042A
NP3044A NP3046A NP3928A
NP3930A NP3932A
R02018 Thioredoxin + UDP => dUDP + Oxidized thioredoxin +
H2O
1.17.4.1 NP3346A NP4434A NP5066A
NP6166A NP6168A
R06895 Coproporphyrinogen III + S-Adenosyl-L-methionine <=>
Protoporphyrinogen IX + CO2 + L-Methionine +
5’-Deoxyadenosine
1.3.99.22
R05814 Cobalt-precorrin 8 <=> Cobyrinate 5.4.1.2 NP1090A
R90053 Orthophosphate (E) + ATP + H2O => ADP + H+ +
Orthophosphate
NP1978A NP1980A NP1982A
NP1984A NP6098A NP6100A
NP6102A NP6104A
R01071 Phosphoribosyl-ATP + Pyrophosphate <=> ATP +
5-Phospho-alpha-D-ribose 1-diphosphate
2.4.2.17 NP1062A
R03657 ATP + L-Leucine + tRNA(Leu) => AMP + Pyrophosphate
+ L-Leucyl-tRNA
6.1.1.4 NP0452A
R02719 Xanthosine 5’-phosphate + H2O => Xanthosine +
Orthophosphate
3.1.3.5 NP1854A NP2590A
R01066 2-Deoxy-D-ribose 5-phosphate <=> D-Glyceraldehyde
3-phosphate + Acetaldehyde
4.1.2.4 NP3200A
R05612 all-trans-Hexaprenyl diphosphate + Isopentenyl diphosphate
=> all-trans-Heptaprenyl diphosphate + Pyrophosphate
2.5.1.30 NP0604A NP4556A
R01676 Guanine + H2O => Xanthine + NH3 3.5.4.3 NP0972A NP2032A NP4788A
R90093 Cobamide coenzyme (E) + ATP + H2O => Cobamide
coenzyme + ADP + H+ + Orthophosphate
NP3814A NP3816A NP3818A
R02735 LL-2,6-Diaminoheptanedioate <=>
meso-2,6-Diaminoheptanedioate
5.1.1.7
R04754 Decanoyl-CoA + FAD => trans-Dec-2-enoyl-CoA + FADH2 1.3.99.13
1.3.99.3
1.3.3.6
NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
R03348 Pyridine-2,3-dicarboxylate + 5-Phospho-alpha-D-ribose
1-diphosphate => Nicotinate D-ribonucleotide +
Pyrophosphate + CO2
2.4.2.19 NP2414A
R05222 Adenosyl cobinamide phosphate + GTP <=>
Adenosine-GDP-cobinamide + Pyrophosphate
2.7.7.62
R01324 Citrate <=> Isocitrate 4.2.1.3 NP0404A NP1994A
R00966 UMP + Pyrophosphate => Uracil +
5-Phospho-alpha-D-ribose 1-diphosphate
2.4.2.9 NP1408A
R01547 ATP + dAMP <=> ADP + dADP 2.7.4.3 NP4910A
R90001 Menaquinol + H+ + Halocyanin (oxidized) => Menaquinone
+ H+ (pmf associated) + Halocyanin (reduced)
1.10.2.2
R03650 ATP + L-Cysteine + tRNA(Cys) => AMP + Pyrophosphate
+ L-Cysteinyl-tRNA(Cys)
6.1.1.16 NP4440A
R04203 (2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA + NAD+ <=>
2-Methylacetoacetyl-CoA + NADH
1.1.1.35 NP1906A NP2754A NP2630A
NP4322A
R01878 Cytidine + H2O => Uridine + NH3 3.5.4.5 NP3512A
R04441 (R)-2,3-Dihydroxy-3-methylbutanoate <=>
3-Methyl-2-oxobutanoic acid + H2O
4.2.1.9 NP4926A
R01354 ATP + Propanoate => Pyrophosphate + Propinol adenylate 6.2.1.1 NP4240A NP4242A NP5128A
NP5132A NP0164A
R04621 Dihydroneopterin phosphate + H2O =>
2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-
+ Orthophosphate
3.6.1.-
R04737 (S)-3-Hydroxyhexadecanoyl-CoA + NAD+ <=>
3-Oxopalmitoyl-CoA + NADH
1.1.1.35
1.1.1.211
NP1906A NP2754A NP2630A
NP4322A
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R01054 ADPribose + H2O => AMP + D-Ribose 5-phosphate 3.6.1.13 NP0392A
R00985 Chorismate + NH3 <=> Anthranilate + Pyruvate + H2O 4.1.3.27 NP0800A NP0802A NP3342A
NP3344A
R01734 Dimethylbenzimidazole <=> Riboflavin -
R00357 L-Aspartate + H2O + Oxygen => Oxaloacetate + NH3 +
H2O2
1.4.3.16 NP2416A
R02301 ATP + 5-Formyltetrahydrofolate => ADP + Orthophosphate
+ 5,10-Methenyltetrahydrofolate
6.3.3.2 NP2438A
R01857 ATP + dGDP <=> ADP + dGTP 2.7.4.6 NP3666A
R01528 6-Phospho-D-gluconate + NADP+ => D-Ribulose
5-phosphate + CO2 + NADPH + H+
1.1.1.44 NP0286A
R01073 N-(5-Phospho-D-ribosyl)anthranilate + Pyrophosphate <=>
Anthranilate + 5-Phospho-alpha-D-ribose 1-diphosphate
2.4.2.18 NP0532A NP3062A NP3338A
R02731 D-Fructose 2,6-bisphosphate + H2O => Orthophosphate +
D-Fructose 6-phosphate
3.1.3.46 NP1332A
R00570 ATP + CDP <=> ADP + CTP 2.7.4.6 NP3666A
R90141 Molybdopterin + Molybdenum => Molybdenum cofactor NP1440A NP1442A
R00289 UTP + D-Glucose 1-phosphate <=> Pyrophosphate +
UDPglucose
2.7.7.9 NP4652A NP4656A NP4674A
NP4680A NP2386A NP4276A
R90057 Thiamin (E) + ATP + H2O => Thiamin + ADP +
Orthophosphate + H+
R90040 L-Lysine (E) + H+ (pmf associated) <=> L-Lysine + H+ NP0040A NP0042A NP0646A
NP2382A NP2676A NP4372A
NP6260A
R00330 ATP + GDP <=> ADP + GTP 2.7.4.6 NP3666A
R02557 Deoxyadenosine + Orthophosphate <=> Adenine +
2-Deoxy-D-ribose 1-phosphate
2.4.2.4 NP3958A
R00586 L-Serine + Acetyl-CoA <=> O-Acetyl-L-serine + CoA 2.3.1.30 NP4172A
R01736 (R)-S-Lactoylglutathione + H2O => Glutathione +
(R)-Lactate
3.1.2.6 NP0980A NP1136A NP1688A
NP1898A NP1974A NP2670A
NP2870A NP3944A NP3970A
NP4032A NP0092A
R90099 Cl- (E) + Photon => Cl- NP0642A
R03174 2-Methylbutanoyl-CoA + Dihydrolipoamide =>
S-(2-Methylbutanoyl)-dihydrolipoamide + CoA
2.3.1.-
R06836 D-Ribose 1,5-bisphosphate + ATP <=>
5-Phospho-alpha-D-ribose 1-diphosphate + ADP
2.7.4.23
R00481 L-Aspartate + Oxygen => Iminoaspartate + H2O2 1.4.3.16 NP2416A
R05341 Lycopene => gamma-Carotene NP0652A
R02061 trans,trans-Farnesyl diphosphate + Isopentenyl diphosphate
=> Pyrophosphate + Geranylgeranyl diphosphate
2.5.1.29 NP3696A NP4556A NP0604A
R00230 Acetyl-CoA + Orthophosphate <=> CoA + Acetyl phosphate 2.3.1.8 NP1772A NP0132A
R07769 Lipoyl-[acp] + Apoprotein => Protein N6-(lipoyl)lysine +
Acyl-carrier protein
2.3.1.181 NP0556A
R90143 (R)-5-Phosphomevalonate + ATP => Isopentenyl phosphate
+ ADP + Orthophosphate + CO2
NP1580A
R03180 4-Guanidinobutanamide + H2O <=> 4-Guanidinobutanoate
+ NH3
3.5.1.4 NP0178A NP0374A NP4212A
R00238 Acetyl-CoA <=> CoA + Acetoacetyl-CoA 2.3.1.9
2.3.1.16
NP2214A NP2260A NP2606A
NP2612A NP3420A NP3438A
NP3650A NP4580A
R01466 O-Phospho-L-homoserine + H2O => L-Threonine +
Orthophosphate
4.2.3.1 NP1632A NP4464A NP5280A
R01519 D-Glucono-1,5-lactone + H2O <=> D-Gluconic acid 3.1.1.17
R05613 all-trans-Pentaprenyl diphosphate + Isopentenyl diphosphate
=> all-trans-Hexaprenyl diphosphate + Pyrophosphate
2.5.1.33 NP4556A NP0604A
R03647 ATP + L-Aspartate + tRNA(Asn) => AMP +
Pyrophosphate + L-Aspartyl-tRNA(Asn)
6.1.1.12 NP1168A
R00036 5-Aminolevulinate <=> Porphobilinogen + H2O 4.2.1.24 NP0920A
R01227 GMP + H2O => Guanosine + Orthophosphate 3.1.3.5 NP1854A NP2590A
R00897 O-Acetyl-L-serine + Hydrogen sulfide => L-Cysteine +
Acetate
2.5.1.47 NP3116A NP4748A
R03172 2-Methylbutanoyl-CoA + FAD => 2-Methylbut-2-enoyl-CoA
+ FADH2
1.3.99.3 NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
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R04742 Decanoyl-CoA + Acetyl-CoA <=> CoA +
3-Oxododecanoyl-CoA
2.3.1.16 NP2214A NP2260A NP2606A
NP2612A NP3420A NP3438A
NP3650A NP4580A
R01373 Prephenate <=> Phenylpyruvate + H2O + CO2 4.2.1.51 NP0106A
R00908 beta-Alanine + 2-Oxoglutarate => 3-Oxopropanoate +
L-Glutamate
2.6.1.19 NP6188A
R90030 L-Cysteine (E) + H+ (pmf associated) => L-Cysteine + H+
R00236 Acetyl adenylate + CoA => AMP + Acetyl-CoA 6.2.1.1 NP4240A NP4242A NP5128A
NP5132A NP0164A
R00229 ATP + Acetate + CoA => ADP + Acetyl-CoA +
Orthophosphate
6.2.1.13 NP2858A
R01652 4-Methyl-2-oxopentanoate + CO2 <=>
3-Carboxy-4-methyl-2-oxopentanoate
-
R90074 NH3 (E) <=> NH3
R01123 Isopentenyl diphosphate <=> Dimethylallyl diphosphate 5.3.3.2 NP4826A NP5124A NP0360A
R02058 Acetyl-CoA + D-Glucosamine 6-phosphate => CoA +
N-Acetyl-D-glucosamine 6-phosphate
2.3.1.4
R02413 Shikimate + NADP+ <=> 3-Dehydroshikimate + NADPH +
H+
1.1.1.25 NP0806A
R90059 Cobalt (E) + ATP + H2O => Cobalt + ADP +
Orthophosphate + H+
NP1396A NP1394A NP1398A
R01279 Palmitoyl-CoA + FAD => trans-Hexadec-2-enoyl-CoA +
FADH2
1.3.99.13
1.3.99.3
1.3.3.6
NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
R01978 (S)-3-Hydroxy-3-methylglutaryl-CoA + CoA <=>
Acetyl-CoA + H2O + Acetoacetyl-CoA
2.3.3.10 NP2608A NP4836A
R02536 Phenylacetaldehyde + NAD+ + H2O <=> Phenylacetic acid
+ NADH + H+
1.2.1.5
1.2.1.39
NP1686A NP3020A
R07768 Octanoyl-[acp] + Sulfur + S-Adenosyl-L-methionine =>
Lipoyl-[acp] + L-Methionine + 5’-Deoxyadenosine
2.8.1.8 NP0562A
R02484 Deoxyuridine + Orthophosphate => Uracil + Deoxy-ribose
1-phosphate
2.4.2.4 NP3958A
R01392 Hydroxypyruvate + NADPH + H+ => D-Glycerate +
NADP+
1.1.1.81 NP1162A
R90122 Guanine (E) + H+ (pmf associated) => Guanine + H+ NP1252A
R00089 ATP => 3’,5’-Cyclic AMP + Pyrophosphate 4.6.1.1 NP3092A
R05617 1,4-Dihydroxy-2-naphthoate + all-trans-Octaprenyl
diphosphate => 2-Demethylmenaquinone + Pyrophosphate +
CO2
2.5.1.- NP2734A
R03460 Phosphoenolpyruvate + Shikimate 3-phosphate <=>
Orthophosphate + 5-O-(1-Carboxyvinyl)-3-phosphoshikimate
2.5.1.19 NP3078A
R01818 D-Mannose 6-phosphate <=> D-Mannose 1-phosphate 5.4.2.8 NP4660A NP4676A NP5158A
NP3514A
R90032 L-Tyrosine (E) + H+ (pmf associated) <=> L-Tyrosine + H+
R02749 2-Deoxy-D-ribose 1-phosphate <=> 2-Deoxy-D-ribose
5-phosphate
5.4.2.7 NP3514A
R00130 ATP + Dephospho-CoA => ADP + CoA 2.7.1.24 NP0870A
R04224 2-Methylprop-2-enoyl-CoA + H2O =>
(S)-3-Hydroxyisobutyryl-CoA
4.2.1.17 NP0032A NP0488A NP0916A
NP1462A NP2256A NP2632A
NP2754A NP2758A NP2936A
NP3434A NP3830A NP4248A
NP4322A
R00926 Propinol adenylate + CoA <=> AMP + Propanoyl-CoA 6.2.1.1 NP4240A NP4242A NP5128A
NP5132A NP0164A
R04640 5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-
<=> N-(5’-Phospho-D-1’-ribulosylformimino)-5-amino-1-(5”-
phospho-D-
5.3.1.16 NP1268A
R90120 Manganese (E) + ATP + H2O => Manganese + ADP +
Orthophosphate + H+
R01876 Uridine + Orthophosphate <=> Uracil + D-Ribose
1-phosphate
2.4.2.3 NP3180A NP3510A
R00710 Acetaldehyde + NAD+ + H2O => Acetate + NADH + H+ 1.2.1.3 NP1686A
R00945 Tetrahydrofolate + L-Serine =>
5,10-Methylenetetrahydrofolate + Glycine + H2O
2.1.2.1 NP2050A
R00691 L-Arogenate <=> L-Phenylalanine + H2O + CO2 4.2.1.51 NP0106A
R00866 ATP + D-Fructose => ADP + D-Fructose 1-phosphate 2.7.1.3 NP3184A
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R02098 ATP + dUMP <=> ADP + dUDP 2.7.4.9 NP2478A
R00714 Succinate semialdehyde + NADP+ + H2O => Succinate +
NADPH + H+
1.2.1.16 NP3020A NP1686A
R90072 Oxygen (E) <=> Oxygen
R00924 Propanoyl-CoA + FAD <=> FADH2 + Propenoyl-CoA 1.3.99.3 NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
R00227 Acetyl-CoA + H2O => CoA + Acetate 3.1.2.1 NP4924A NP2700A
R04739 (S)-3-Hydroxytetradecanoyl-CoA + NAD+ <=>
3-Oxotetradecanoyl-CoA + NADH
1.1.1.35
1.1.1.211
NP1906A NP2754A NP2630A
NP4322A
R02142 Xanthine + 5-Phospho-alpha-D-ribose 1-diphosphate =>
Xanthosine 5’-phosphate + Pyrophosphate
2.4.2.22 NP1426A NP1254A
R01175 Butanoyl-CoA + FAD => FADH2 + Crotonoyl-CoA 1.3.99.2
1.3.99.3
1.3.3.6
NP1596A NP1754A NP1870A
NP2620A NP2628A NP2934A
NP3004A NP3460A NP4050A
NP4214A NP4254A NP6180A
R01290 L-Serine + L-Homocysteine => L-Cystathionine + H2O 4.2.1.22 NP3116A NP4748A
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